| ID | CAS | Name | Synonyms | Description |
|---|---|---|---|---|
| 1 | 1005450-55-4 | N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide | Cinacalcet-11 -N-(1-(Naphthalen-1-yl) N-[1-(R)-(1-Naphthyl)ethyl]-3-[3-trifluoroMethylphenyl]propanaMide N-[1-(R)-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-propanamide N-《R)-I-(naphthalen-I-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide lN-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide | Standard;Raw materials;Medical raw materials;Pesticide intermediate;Pharmaceutical raw materials;Impurity reference substance |
| 2 | 1021949-47-2 | 5-[1-(2,3-Dimethylphenyl)ethenyl]-1H-imidazole | Dexmedetomidine Impurity 5 (N-Benzyl Hydroxymedetomidine) 5-[1-(2,3-Dimethylephenyl]-1H-imidazole Dexmedetomidine Hydrochloride Impurity B 5-[1-(2,3-DiMethylphenyl)ethenyl]iMidazole 5-[1-(2,3-Dimethylphenyl)Ethenyl]Imidazole 5-[1-(2,3-Dimethylphenyl)vinyl]-1H-imidazole 5-(1-(2,3-DiMethylphenyl)vinyl)-1H-iMidazole 4-[1-(2,3-DiMethyl-phenyl)-vinyl]-1H-iMidazole 5-[1-(2,3-Dimethylphenyl)ethenyl]-1H-imidazole | Organic materials;Hydrocarbon compounds |
| 3 | 102767-28-2 | Levetiracetam | Keppra UCB-6474 UCB 6474 UCB-L 059 102767-28-2 LEVITIRACETAM Levetiracetam Levetiracetame alpha-ethyl-2-oxo- Levetiracetam [INN] 1-Pyrrolidineacetamide Etiracetamum [INN-Latin] (S)-1-pyrrolidineacetamid Levetiracetamum [INN-Latin] (s)-2-(2-oxopyrrolidin-1-yl)butanamide (2R)-2-(2-oxopyrrolidin-1-yl)butanamide (2S)-2-(2-oxopyrrolidin-1-yl)butanamide alpha-Ethyl-2-oxo-1-pyrrolidineacetamide (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide (+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide | |
| 4 | 1029364-73-5 | 6,8-Dimethoxymoxifloxacin | Mosisasin Impurity B 6,8-Dimethoxymoxifloxacin Moxifloxacin IMpurity B (EP) Moxifloxacin EP Impurity B HCl Moxifloxacin related substance B 1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid 1-cyclopropyl-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6,8-dimethoxy-4-oxoquinoline-3-carboxylic acid | Impurities;Moxifloxacin impurity;Impurity World-Moxifloxacin;Impurity reference substance;Reference substance-impurity reference substance |
| 5 | 105310-75-6 | cis-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-N,N-diethyl-1-phenylcyclopropanecarboxamide | (Z)-1-phenyl-1-diethylamino carbonyl-2-phthalimidomethyl cyclopropane (Z)-1-Phenyl-2-(Phthalimidomethyl)-N,N-diethyl-cyclopropanecarboxamide 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-N,N-diethyl-1-phenylcyclopropa 2-[(1,3-dioxo-2-isoindolyl)methyl]-N,N-diethyl-1-phenyl-1-cyclopropanecarboxamide (1S,2R)-N,N-Diethyl-2-[(1,3-dioxoisoindolin-2-yl)Methyl]-1-phenylcyclopropanecarboxaMide 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)Methyl-N,N-diethyl-1-phenylcyclopropanecarboxaMide (1R,2R)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N,N-diethyl-1-phenylcyclopropanecarboxamide cis-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-N,N-diethyl-1-phenylcyclopropanecarboxamide 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)Methyl-N,N-diethyl-1-phenylcyclopropanecarboxaMide, cis- 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-N,N-diethyl-1-phenylcyclopropanecarboxamide, cis- (1R,2S)-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropanecarboxamide (1R,2)-2-[(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenyl-cyclopropanecarboxamide REL-(1R,2S)-2-[(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOL-2-YL)METHYL]-N,N-DIETHYL-1-PHENYLCYCLOPROPANECARBOXAMIDE | Aromatics;Chiral Reagents;Pharmaceuticals;Organic materials;Aromatics Compounds;Hydrocarbon compounds;Intermediates & Fine Chemicals |
| 6 | 10563-27-6 | N,N'-Bis(2-hydroxyethyl)-1,3-propanediamine | Amifostine Impurity 14 2,2'-(1,3-Propanediyldiimino)diethanol 2,2'-(3-aMinopropylazanediyl)diethanol 2,2'-(Propan-1,3-diyldiimino)diethanol 2,2'-(Propane-1,3-diyldiimino)diethanol 2,2'-(1,3-propanediyldiimino)bisethanol Ethanol, 2,2'-(1,3-propanediyldiimino)bis- N,N'-Bis(2-Hydroxyethyl)propane-1,3-diamine N,N'-Bis(2-hydroxyethyl)-1,3-propanediamine 2,2'-(Propane-1,3-diylbis(azanediyl))diethanol 2-({3-[(2-hydroxyethyl)aMino]propyl}aMino)ethan-1-ol N,N'-Bis(β-hydroxyethyl)triMethylenediaMine HydrobroMide | Hydroethylamines;Hydroxyethylamines;Hydroxyethyl Amine;Impurity reference substance |
| 7 | 1083-57-4 | bucetin | bucetin betadid 3-hydroxy-p-butyrophenetidid 3-hydroxybutyr-4-phenetidide 3-HYDROXY-P-BUTYROPHENETIDINE 3-Hydroxy-p-butyrophenetidine 4'-ethoxy-3-hydroxy-butyranilid beta-oxybuttersaeure-p-phenetidid N-(3-HYDROXYBUTYRYL)-P-PHENETIDINE beta-hydroxybutyricacid-p-phenetidide N-(4-ethoxyphenyl)-3-hydroxybutanamide N-(4-ETHOXYPHENYL)-3-HYDROXYBUTANAMIDE Bucetin (3-Hydroxy-p-butyrophenetidide) | Chemical reagents;Reagents and supplements;Small molecule inhibitors |
| 8 | 108321-09-1 | sulfochlorophenol S mixed*sodium-calcium | SULFOCHLOROPHENOL S sulfochlorophenolssodiumsaltcrystalline sulfochlorophenol S mixed*sodium-calcium SULFOCHLOROPHENOL S MIXED SODIUM-CALCIUM SALT 2,7-BIS(5-CHLORO-2-HYDROXY-3-SULFOPHENYLAZO)CHROMOTROPIC ACID TETRASODIUM SALT 2,7-bis(2-hydroxy-3-sulfo-5-chlorophenylazo)-1,8-di-hydroxynaphthalene-3,6-disulfonic acid 1,8-DIHYDROXY-2,7-BIS(5-CHLORO-2-HYDROXY-3-SULFOPHENYLAZO)-3,6-NAPHTHALENEDISULFONIC ACID TETRASODIUM SALT 2,7-BIS[2-HYDROXY-3-SULFO-5-CHLOROPHENYLAZO]-1,8-DI-HYDROXY-NAPHTHALENE-3,6-DISULFONIC ACID MIXED SODIUM-CALCIUM SALT | Stains and dyes;Hematology and Histology;Other biochemical reagents |
| 9 | 1136-45-4 | 5-methyl-3-phenylisoxazole-4-carboxylic acid | PMI-acid AKOS BBS-00003754 RARECHEM AL BE 0514 TIMTEC-BB SBB010075 5-METHYL-3-PHENYL-4-ISOXAZOLIC ACID 3-phenyl-5-methylisoxazol-4-carbonsaeure 5-methyl-3-phenylisoxazole-4-carboxylic acid 5-METHYL-3-PHENYL-4-ISOXAZOLECARBOXYLIC ACID 5-METHYL-3-PHENYLISOXAZOLE-4-CARBOXYLIC ACID 5-Methyl-3-phenylisoxazole-4-carboxylic acid 5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid | Oxacilline;Isoxazoles;Organic acids;Building Blocks;Oxazole&Isoxazole;Heterocyclic Series;Organic raw materials;Carboxylic acid compounds;Heterocyclic Building Blocks |
| 10 | 113913-36-3 | 2-Methyl-4-Hydroxy-2H-1,2-Benzothiazine-3-Carboxylic Acid Ethyl Ester 1,1-Dioxide | ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide 2-METHYL-4-HYDROXY-2H-1,2-BENZOTHIAZINE-3-CARBOXYLIC ETHYL ESTER-1,1-DIOXIDE 2-METHYL-4-HYDROXY-2H-1,2-BENZOTHIAZE-3-CAPROXYLIC ACID-1,1-DIOXIDE ETHYL ESTER 4-Hydroxy-2-methyl-[2H]-1,2-benzothiazine 3-carboxylate-1,1-dioxide, ethyl ester 2-Methyl-4-Hydroxy-2H-1,2-Benzothiazine-3-Carboxylic Acid Ethyl Ester 1,1-Dioxid 2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide 2-METHYL-4-HYDROXY-2H-1,2-BENZOTHIAZINE-1,1-DIOXIDE-3-CARBOXYLIC ACID ETHYL ESTER 2-Methyl-4-Hydroxy-2H-1,2-Benzothiazine-3-Carboxylic Acid Ethyl Ester 1,1-Dioxide 2-METHYL-4-HYDROXY-2H-1,2-BENZOTHIAZINE-3-CARBOXYLIC ACID ETHYL ESTER-1,1-DIOXIDE 2-Methyl-4-Hydroxy-2H-1,2-Benzothiazine-3-Carboxylic Acid Ethyl ester-1,1-Dioxide 4-HYDROXY-2-METHYL-2H-1,2-BENZOTHIAZINE-3-CARBOXYLIC ACID ETHYL ESTER-1,1-DIOXIDE 2H-1,2-BENZOTHIAZINE-3-CARBOXYLIC ACID, 3,4-DIHYDRO-4-HYDROXY-2-METHYL-, ETHYL ESTER, 1,1-DIOXIDE | Organic raw materials;INTERMEDIATESOFMELOXICAN;Carboxylic acid compounds;(intermediate of piroxicam) |
| 11 | 120011-70-3 | Donepezil hydrochloride | E-2020 ARICEPT AKOS 226-31 DonepezilHCL DONEPEZIL HCL Donepezil HCl Donepezil hydrochloride Donezepil hydrochloride DONEPEZIL HYDROCHLORIDE DonepezilHcl120011-70-3 An oxidized polyethylene wax Aricept, E-2020 Donepezil HCl DONEPEZIL (DONEPEZIL HYDROCHLORIDE) 2-(1-Benzylpiperidin-4-ylmethyl)-5,6-dimethoxyindan-1-one hydrochloride 2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one hydrochloride 2,3-dihydro-5,6-dimethoxy-2-{[1-(phemylmethyl)-4-piperidinyl]methyl}-1H-indan-1-one HCL 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1h-inden-1-one hydrochloride | API;Inorganic salt;Inorganic Chemical Engineering |
| 12 | 120014-07-5 | 1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine | 1-Benzyl-4-(5,6-dimethoxy-1-ox Dehydro Donepezil (Donepezil Impurity) 1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2- 2-[(1-Benzyl-4-piperidyl)methyleen]-5,6-dimethoxyindan-1-on 2-(1-Benzylpiperidin-4-ylmethylidene)-5,6-dimethoxyindan-1-one 1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine 1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-ylidene)methyl]piperidine 1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-yl indenemethyl)-piperidine 2-[(E)-(1-BENZYL-4-PIPERIDINYL)METHYLIDENE]-5,6-DIMETHOXY-1-INDANONE (2Z)-2-[(1-benzylpiperidin-4-yl)methylidene]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one (2E)-2-[(1-benzylpiperidin-4-yl)methylidene]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one 2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methylene]-1H-inden-1-one | Aromatics;Heterocycles;Intermediates;Pharmaceuticals;Intermediates & Fine Chemicals |
| 13 | 120202-71-3 | Clopidogrel USP Related Compound C | Clopidogrel EP IMP C Clopidogrel Impurity C Clopidogrel Related Compound C Clopidogrel EP Impurity C Sulfate Clopidogrel USP Related Compound C Clopidogrel Hydrogen Sulfate Impurity C Clopidogrel EP Impurity C Sulfate ((R)-Clopidogrel Sulfate) methyl (2R)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate sulfate (R)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate (R)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogensulfate Methyl(-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate CLOPIDOGREL RELATED COMPOUND C (20 MG) (METHYL (-)-(R)-(O-CHLOROPHENYL)-6,7-DIHYDROTHIE-NO[3,2-C]PYRIDINE-5(4H)-ACETATE, HYDROGEN SUL- FATE) | Impurities;Heterocycles;Chiral Reagents;Pharmaceuticals;Standard substance;Sulfur & Selenium Compounds;Pharmaceutical intermediates;Impurity reference substance;Intermediates & Fine Chemical;Intermedi |
| 14 | 1210348-34-7 | Ethanediamide impurity A | Ethanediamide impurity A tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate(for Edoxaban) | Idoseban intermediate;impurity reference substance;cardiovascular and cerebrovascular;pharmaceutical raw material intermediate;reference substance-impurity reference substance |
| 15 | 123040-79-9 | Azasetron Intermediate | Azasetron Intermediate 6-Chloro-3,4-dihydro-4-methyl- 6-Chloro-3,4-dihydro-4-methyl-3-oxo-2h-1,4-benzoxazine-8-aarboxylicacid 6-Chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxanine-8-carboxylic acid 6-chloro-3,4-dihydro-4-methyl-3-oxo-2h-1,4-benzoxanine-8-carboxylic acid 6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxylic acid 6-CHLORO-3,4-DIHYDRO-4-METHYL-3-OXO-2H-1,4-BENZOXAZINE-8-CARBOXYLIC ACID 6-Chloro-3,4-dihydro-4-methyl-3-oxy-2H-1,4-benzoxazine-8-carboxylic acid 2H-1,4-BENZOXANINE-8-CARBOXYLICACID-6-CHLORO-3,4-DIHYDRO-4-METHYL-3-OXO- 2H-1,4-BENZOXANINE-8-CARBOXYLICACID-6-CHLORO-3,4-DIHYDRO-4-METHYL-3-OXO- 6-chloro-3,4-dihydro-4-methyl-3-oxo-2H-benzo[b][1,4]oxazine-8-carboxylic acid 6-Chloro-3,4-dihydro-4-methyl-3-oxo-(9Cl). 2H-1,4-benzoxazine-8-carboxylic acid | Organic acids;Organic materials;Intermediate of azasetron hcl |
| 16 | 1243308-37-3 | Ethanediamide impurity C HCL | Edoxaban-3 Edoxaban iMpurities 3 Ethanediamide impurity C HCL EthanediaMide iMpurity C HCL ethyl 2-(5-Methylpyridin-2-ylaMino)-2-oxoacetate ethyl [(5-chloropyridin-2-yl)carbamoyl]formate hydrochloride Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate hydrochloride 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride | Inorganic salt;Inorganic Chemical Engineering |
| 17 | 129496-10-2 | Milbemycin oxime | Milbemite CGA-179246 Milbemycin oxime Milbemycin, oxime Milbemycin oxime CRS Milbemycin A, 5-oxime Milbemycin Oxime (200 mg) Milbemycin oxime fandachem Milbemycin Oxime (1443806) Milbemycin Oxime (Mixture of Milbemycin Oxime A3 and A4) | API;Antip;Additives;Inhibitors;Raw materials;APIs for Veterinary;Medical raw materials;Organic raw materials;Microbial metabolites;Pharmaceutical intermediates |
| 18 | 131020-57-0 | 1H-Benzimidazole-5-carboxylic acid, 4,5,6,7-tetrahydro-,monohydrochloride | Ramosetron Impurity 11 HCl 4,5,6,7-TetrahydrobenziMidazole-5-carboxylic Acid Hydrochloride 4,5,6,7-Tetrahydro-1H-benzimidazole-5-carboxylic acid hydrochloride 4,5,6,7-Tetrahydro-1H-benzoiMidazole-5-carboxylic acid hydrochloride 4,5,6,7-Tetrahydro-1H-benzo[d]iMidazole-5-carboxylic acid hydrochloride 4,5,6,7-Tetrahydro-3H-Benzo[D]IMidazole-5-Carboxylic Acid Hydrochloride 1H-Benzimidazole-5-carboxylic acid, 4,5,6,7-tetrahydro-,monohydrochloride 1H-BenziMidazole-5-carboxylic acid, 4,5,6,7-tetrahydro-, Monohydrochloride | Organic acids;Organic materials |
| 19 | 13138-48-2 | 3,3'-dimethylnaphthidine | 3,3-DIMETHYLNAPHTHIDINE 3,3'-DIMETHYLNAPHTHIDINE 3,3'-dimethylnaphthidine 4,4'-DIAMINO-3,3'-DIMETHYL-1,1'-BINAPHTHYL 1,1-Binaphthalene-4,4-diamine, 3,3-dimethyl- 3,3'-DIMETHYL-(1,1'-BINAPHTHALENE)-4,4'-DIAMINE 3,3-Dimethylnaphthidine (for colorimetric detemination of Cl in water) | Titration;Analytical reagents;Other biochemical reagents |
| 20 | 135729-78-1 | Palonosetron Intermediate | Palonosetron Impurity 20 Palonosetron Impurity 1 Palonosetron Impurity 25 Palonosetron Impurity 27 Palonosetron Intermediate (S)-N-(Quinuclidin-3-yl)-5,6,7,8-tetrahydronaphthalene-1-carboxaMide (S)-N-(quinuclidin-3-yl)-5,6,7,8- tetrahydronaphthalene-1-carboxamide N-(1-azabicyclo[2.2.2]octan-3-yl)-5,6,7,8-tetrahydronaphthalene-1-carboxamide (S)-N-1-azabicyclo[2.2.0]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide (S)-N-(1-Azabicyclo[2.2.2]Oct-3-Yl)-5,6,7,8-Tetrahydro-1-Naphthalenecarboxamide (S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamide N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-5,6,7,8-tetrahydronaphthalene-1-carboxamide | Inorganic salt;Inorganic Chemical Engineering;Intermediate of palonosetron hcl |
| 21 | 137973-76-3 | 7-chloro-1-[2-methyl-4-[(2-methylbenzoyl)amino]benzoyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine | Dehydrotolvaptan 5-Dehydro Tolvaptan N-[4-(7-chloro-5-oxo-3,4-dihydro-2H-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide 7-chloro-1-[2-methyl-4-[(2-methylbenzoyl)amino]benzoyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine N-(4-(7-Chloro-5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbe N-(4-(7-Chloro-5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-Methylphenyl)-2-MethylbenzaMide N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide N-[4-[7-Chloro-2,3,4,5-Tetrahydro-5-oxo-1H-1-Benzazepine-1-yl)carbonyl]-3-MethylPhenyl]-2-MethylBenzamide | Intermediates;Tolvaptan intermediate;Pharmaceutical intermediates |
| 22 | 1405-54-5 | Tylosin, [R-(R*,R*)]-2,3-dihydroxybutanedioate (salt) | 1405-54-5 pharmasin Tylosintartrate tylosin solution Tylosin tartrate TYLOSINE TARTRATE Tylosintartrate,BP Tylosin tartrate salt tylosin hydrogen tartrate Tylosin, (2R,3R)-2,3-dihydroxybutanedioate (salt) Tylosin, [R-(R*,R*)]-2,3-dihydroxybutanedioate (salt) [(2R,4E,6E,9R,11R,13S,14R)-12-{[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-3-(dimethylamino)-β-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside 2,3-dihydroxybutanedioate (salt) [(2R,4E,6E,9R,11R,12S,13S,14R)-12-{[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-3-(dimethylamino)-β-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside 2,3-dihydroxybutanedioate (salt) | |
| 23 | 147489-06-3 | t-Butyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate | P-1 tert-butyl 2-((4R,6S) pitavastatin intermediate 3R5S isomer 3-dioxane-6-heptene?acid?tert-butyl?ester 6E)-7-[2-cyclopropyl-4-(4-fluoro?phenyl)3-quinoline-base]-2 (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-2,2-Dimethyl-1,3-dioxane-6-heptenoate t-Butyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate t-Butyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6- heptenoate tert-Butyl(3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-isopropylidenedioxy-6-heptenoate 2-[6-[2-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetic acid tert-butyl ester tert-butyl [(4R,6S)-6-{(E)-2-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]ethenyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluoro?phenyl)3-quinoline-base]-2,2-dimethyl-1,3-dioxane-6-heptene?acid?tert-butyl?ester (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-2,2-Dimethyl-1,3-dioxane-6-heptenoic acid,1,1-dimethylethyl ester (4R,6S)-6-[(1E)-2-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester | Organic fluoride;Organic raw materials |
| 24 | 147770-06-7 | (+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl) | (S)-Repaglinide Ethyl Ester (Repaglinide Impurity) (S)-Repaglinide Ethyl Ether (Repaglinide Impurity) (+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl) Ethyl (S)-ethoxy-4[N-1-(2-piperidino-phenyl)-3-methyl-1-butyl)amino carbonyl]methyl benzoate (+)-2-ETHOXY-4-(N-3-METHYL-1(S)-(2-(1-PEPERIDINYL)PHENYL)-BUTYL)CARBAMOYLMETHYL) BENZOIC ACID (+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Peperidinyl)Phenyl)-Butyl)Carbamoylmethyl) Benzoic Acid ethyl 2-ethoxy-4-(2-{[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino}-2-oxoethyl)benzoate Ethyl 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoate (S)-Ethyl 2-ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]amino]carbonyl]methyl]benzoate 2-Ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid Ethyl Ester Benzoic acid,2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-,ethyl ester | Impurities;Pharmaceuticals;Chiral Reagents;Impurity reference substance;Intermediates & Fine Chemicals;Drug impurities and intermediates;Pharmaceutical material and intermeidates |
| 25 | 149968-11-6 | METHYL 2-(3-{(E)-3-[2-(7-CHLORO-2-QUINOLYL)VINYL]PHENYL}-3-OXOPROPYL)BENZOATE | Montelukast Impurity 1 Methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-oxopropyl)benzoate METHYL 2-(3-{(E)-3-[2-(7-CHLORO-2-QUINOLYL)VINYL]PHENYL}-3-OXOPROPYL)BENZOATE Methyl (E)-2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoate 2-(3-(2-(7-chloro-2-quinolinyl)-ethenyl-phenyl)-3-oxo-propyl)-1-methoxycarbonylbenzene (E)-2-[3-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoic acid methyl ester 2-[3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoic Acid Methyl Ester (E)-2-[3-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-oxopropyl]-1-(Methoxy-carbonyl)benzene | Aromatics;Heterocycles;Pharmaceuticals;Organic materials;Organic acid esters;Intermediates & Fine Chemicals |
| 26 | 150727-06-3 | Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)- | 4-tert-Butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2 N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-B 4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide N-6-Chloro-5-2-methoxyphenoxy2,2'-bipyrimidin-4-yl-4-(1,1-dimethylethyl)benzenesulfonamide N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)Benzenesulfonamide N-[6-Chloro-5-[2-methoxyphenoxy][2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide n-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide N-[6-CHLORO-5-(2-METHOXYPHENOXY)-(2,2-BIPYRIMIDINE)4-4-YL]-(1,1-DIMETHYLETHYL)-BENZENESULFONAMIDE Benzenesulfonamide,N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)- Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)- Benzenesulfonamide, N-[6-Chloro-5-(2-Methoxyphenoxy)[2,2'-Bi-Pyrimidin]-4-Yl]-4-(1,1-Dimethylethyl)-(9ci) Benzenesulfonamide,N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-(bosentanintermediate) Benzenesulfonamide, N-[6-chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)- (bosentan intermediate) | pyrimidine;Pyrimidine;Nucleotides;Intermediates;Pharmaceuticals;Bases & Related Reagents;Pharmaceutical intermediates;Impurity reference substance;Intermediates & Fine Chemicals |
| 27 | 15087-24-8 | Camphor benzylidene | Camphor benzylidene BENZYLIDENE CAMPHOR 3-benzylidene Camphor 3-BENZYLIDENE CAMPHOR 3-BENZYLIDENE-BORNAN-2-ONE 3-Benzylidene-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one 1,7,7-Trimethyl-3-benzylidenebicyclo[2.2.1]heptane-2-one 1,7,7-trimethyl-3-(phenylmethylene)-bicyclo[2.2.1]heptan-2-on 1,7,7-trimethyl-3-(phenylmethylene)bicyclo[2.2.1]heptan-2-one Bicyclo2.2.1heptan-2-one, 1,7,7-trimethyl-3-(phenylmethylene)- 1,7,7-trimethyl-3-(phenylmethylene)-Bicyclo[2.2.1]heptan-2-one (3E)-1,7,7-trimethyl-3-(phenylmethylidene)bicyclo[2.2.1]heptan-2-one (1R,3E,4S)-1,7,7-trimethyl-3-(phenylmethylidene)bicyclo[2.2.1]heptan-2-one | Organic materials;Hydrocarbon compounds |
| 28 | 154026-93-4 | Hexanoic acid, 6-chloro-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3R,5S)- | Rosuvastatin Impurity 89 Rosuvastatin Related Compound 5 -tert-Butyl 6-chloro-3,5-dihydroxyhexanoate (3R,5S)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate 6-chloro-3,5-dihydroxyhexanoic acid tert-butyl ester (3R,5S)-6-Chloro-3,5-dihydroxyhexanoic Acid tert-Butyl Ester Hexanoic acid, 6-chloro-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3R,5S)- Hexanoic acid, 6-chloro-3,5-dihydroxy-, 1,1-diMethylethyl ester, (3R,5S)- | Organic materials;Organic acid esters |
| 29 | 161696-76-0 | 2-Methyl-4-(1-piperazinyl)-10H-thienol[2,3-b][1,5]benzodiazepine | LY 170055 Olanzapine-6 Desmethylolanzapine N-Demethyl olanzapine 4'-Desmethylolanzapine Olanzapine EP Impurity G 2-Methyl-4-(1-piperazinyl)-10H-thienol[2,3-b][1,5]benzodiazepine 2-Methyl-4-(1-Piperazinyl)-10H-Thieno-[2,3-b][1,5]Benzodiazepine 2-methyl-4-(piperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine | Olanzapine;Piperazine;Metabolites;Pharmaceutical intermediates |
| 30 | 168683-02-1 | 4-[[(1,1-Dimethylethoxy)Carbonyl]Amino]-2-Cyclopentene-1-Carboxylic Acid Methyl Ester | PeraMivir InterMediate Methyl 4-((tert-butoxycarbonyl)aMino)cyclopent-2-enecarboxylate (1S,4R)-methyl4-(tert-butoxycarbonyl)cyclopent-2-enecarboxylate (1S,4R)-methyl 4-(tert-butoxycarbonyl)cyclopent-2-enecarboxylate Cis-(1S,4R)-4-Boc-aMino-2-Cyclopentene-1-carboxylic acid Methyl ester (1S,4R)-Methyl 4-((tert-butoxycarbonyl)aMino)cyclopent-2-enecarboxylate methyl(1S,4R)-4-((tert-butoxycarbonyl)amino)cyclopent-2-ene-1-carboxylate Methyl (1S,4R)-4-[(tert-butoxycarbonyl)amino]cyclopent-2-ene-1-carboxylate 4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2-CYCLOPENTENE-1-CARBOXYLIC ACID METHYL ESTER 4-[[(1,1-Dimethylethoxy)Carbonyl]Amino]-2-Cyclopentene-1-Carboxylic Acid Methyl Ester 2-Cyclopentene-1-carboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (1S,4R)- 2-cyclopentene-1-carboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (1S,4R)- | Intermediates;Pharmaceutical intermediates |
| 31 | 168828-90-8 | (S)-N-[[3-[3-Fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]amine | InterMediate of Linezolid -3-(3-fluoro-4-morpholinophenyl) (S)-5-(aMinoMethyl)-3(3-fluoro-4-Morpholinphenyl)oxazolidin-2-one (S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one (S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl) oxazolidin-2-one (S)-N-3-3-Fluoro-4-4-morpholinylphenyl-2-oxo-5-oxazolidinylmethylamine (5S)-5-(AMinoMethyl)-3-[3-fluoro-4-(4-Morpholinyl)phenyl]-2-oxazolidinone (5S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)-1,3-oxazolidin-2-one (S)-(-)-5-Aminomethyl-3-(3-fluoro-4-morpholinophenyl)-1,3-oxazolidin-2-one (S)-N-[3-[3-Fluoro-4-[4-morpholinyl phenyl]-2-oxo-5-oxazolidinyl]methyl]amine (S)-N-[[3-[3-Fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]amine (S)-N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]amine | Aromatics;Linezolid;Intermedi;Impurities;Heterocycles;Intermediates;Chiral Reagents;Pharmaceuticals;Linezolid intermediate;Renezolide intermediate |
| 32 | 173140-90-4 | 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone | 8-benzoxy-5-(R)-oxiranyl-1H-quinolin-2-one 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone (R)-5-(2-oxiranyl)-8-benzyloxy-2(1H)-quinolinone 2 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone (R)-8-(Benzyloxy)-5-(oxiran-2-yl)quinolin-2(1H)-one 8-(Benzyloxy)-5-[(2R)-oxiran-2-yl]quinolin-2(1H)-one 2(1H)-Quinolinone, 5-(2R)-oxiranyl-8-(phenylmethoxy)- | Organic materials;Hydrocarbon compounds |
| 33 | 175481-37-5 | (S)-2-Acetamido-N-benzyl-3-methoxypropanamide | Lacosamide imp A Lacosamide EP Impurity A ((S)-Lacosamide) (S)-2-Acetamido-N-benzyl-3-methoxypropanamide (2S)-2-acetamido-N-benzyl-3-methoxypropanamide Lacosamide Impurity 1(Lacosamide EP Impurity A) Lacosamide EP Impurity A (Lacosamide (S)-Isomer) Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2S)- | API;Amino compounds;Organic raw materials |
| 34 | 17762-90-2 | 2-Methylamino-1-(3',4'-methylenedioxyphenyl)butan-1-one hydrochloride | Bk-MBDB Butylone Butylone HCl Butylone (hydrochloride) 2-methylamino-1-(3,4-methylenedioxyphenyl)butan-1-one 1-(1,3-Benzodioxol-5-yl)-2-methylamino-1-butanone hydrochloride 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one hydrochloride 1-(1,3-Benzodioxol-5-yl)-2-(methylamino)butan-1-one hydrochloride 2-(Methylamino)-3',4'-(methylenedioxy)-butyrophenonehydrochloride 2-Methylamino-1-(3',4'-methylenedioxyphenyl)butan-1-one hydrochloride 1-(2H-1,3-Benzodioxol-5-yl)-2-(methylamino)-butan-1-one hydrochloride 1-(benzo[d][1,3]dioxol-5-yl)-2-(methylamino)butan-1-one hydrochloride | Amines;Aromatics;Heterocycles;Intermediates;organic chemical.;Other intermediates |
| 35 | 1806-23-1 | 2-chloro-4'-fluorobenzophenone | 2,4'-CFBP 2-Chloro-4'-fluorobe 4'-FLUORO-2-CHLOROBENZOPHENONE 2-Chloro-4-Fluoro Benzophenone 2-chloro-4'-fluorobenzophenone 2-CHLORO-4'-FLUOROBENZOPHENONE 2-Chloro-4'-fluorobenzophenone (2-Chlorophenyl)(4-fluorophenyl)methanone (2-chlorophenyl)(4-fluorophenyl)-methanon (2-chlorophenyl)(4-fluorophenyl)methanone | Ketones;Organic materials;Fluorobenzene Series |
| 36 | 184177-83-1 | 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one | 4-Triazol-3-one 2S)-1-ethyl-2-bezyloxypropyl]-2 Posaconazole Diastereoisomer Related Compound 7 Posaconazole Diastereoisomer Related Compound 6 4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1 1-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one 2-((2S,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2H-1,2,4-triazol-3(4H)-one 1-[(2S,3S)-2-(benzyloxy)pentan-3-yl]-4-{4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one, 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one | Piperazine;Posaconazole;Chiral Reagents;Pharmaceuticals;Pharmaceutical intermediates;Intermediates & Fine Chemicals |
| 37 | 19902-91-1 | dihydromethysticin | dhm dihydromethysticin DIHYDROMETHYSTICIN DIHYDROMETHYLSTICIN (+)-DIHYDROMETHYSTICIN 7,8-dihydromethysticin 7,8-DIHYDROMETHYLSTICIN 5,6-Dihydro-4-methoxy-6-[2-(1,3-benzodioxol-5-yl)ethyl]-2H-pyran-2-one 6-[2-(1,3-benzodioxol-5-yl)ethyl]-4-methoxy-5,6-dihydro-2H-pyran-2-one 6-[2-(1,3-Benzodioxol-5-yl)ethyl]-4-methoxy-5,6-dihydro-2H-pyran-2-one 6-dihydro-4-methoxy-6-(3,4-(methylenedioxy)phenethyl)-(s)-2h-pyran-2-on 6-(2-(1,3-benzodioxol-5-yl)ethyl)-5,6-dihydro-4-methoxy-2h-pyran-2-on(s) (6S)-6-[2-(1,3-Benzodioxol-5-yl)ethyl]-4-methoxy-5,6-dihydro-2H-pyran-2-one 2H-pyran-2-one, 6-[2-(1,3-benzodioxol-5-yl)ethyl]-5,6-dihydro-4-methoxy-, (6S)- | Coumarins;Plant extract;Standard substance;Reference substance;Reference substance-tradi;Chinese medicine reference substance;Standard substance-reference substance;Standard substance, reference subst |
| 38 | 199191-69-0 | Ziprasidone mesilate | ziprasidone mesilate ZIPRASIDONE MESYLATE Ziprasidone mesilate Ziprasidone Mesylate Ziprasidone mesylate trihydrate Ziprasidone mesilate trihydrate CRS 5-[2-[4-(1,2-benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one mesilate 5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one mesilate 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-,monomethanesulfonate, trihydrate 2H-INDOL-2-ONE, 5-[2-[4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL]ETHYL]-6-CHLORO-1,3-DIHYDRO-, MONOMETHANESULFONATE, TRIHYDRATE | Organic raw materials;Carboxylic acid compounds |
| 39 | 2002-29-1 | flumethasone pivalate | locacorten 21-pivalate FLUMETHASONE PIVALATE flumethasone pivalate flumetasone 21-pivalate Flumethasone 21-pivalate flumethasone 21-pivalate 6a,9a-difluoro-16a-methyl-prednisolone-21-pivalate 6,9-difluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl 2,2-dimethylpropanoate 6α,9-difluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 21-(2,2-dimethylpropionate) 6ALPHA,9-DIFLUORO-11BETA,17,21-TRIHYDROXY-16ALPHA-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-[2,2-DIMETHYLPROPIONATE] (6alpha,11beta,16alpha)-6,9-difluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl 2,2-dimethylpropanoate (6alpha,8xi,11beta,14xi,16alpha)-6,9-difluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl 2,2-dimethylpropanoate (6alpha,8xi,10xi,11beta,13xi,16alpha)-6,9-difluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl 2,2-dimethylpropanoate Pregna-1,4-diene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-6,9-difluoro-11,17-dihydroxy-16-methyl-, (6.alpha.,11.beta.,16.alpha.)- | Steroids;Organics;Pharmaceuticals;Organic materials;Organic acid esters;Intermediates & Fine Chemicals |
| 40 | 205393-21-1 | Bortezomib intermediates II | Bortezomib intermediates I Bortezomib Intermediate II Bortezomib Impurity 54 HCl BortezoMib InterMediate II Bortezomib intermediates II BortezoMib interMediates N-2 N-[(1S)-1-benzyl-2-({(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}amino)-2-oxoethyl] (S)-2-amino-N-((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)-3-phenylpropanamide hydrochloride (αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride (alphaS)-alpha-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]benzenepropanamide hydrochloride | |
| 41 | 20850-49-1 | 2-(3,4-dimethoxyphenyl)-3-Methylbutyronitrile | Verapamil Impurity K alpha-Isopropyl homoveratronitrile α-Isopropyl-3,4-dimethoxybenzeneacetonitrile 3-METHYL-2-(3,4-DIMETHOXYPHENYL)BUTYRONITRILE 3-Methyl-2-(3,4-dimethoxyphenyl)butyronitrile 2-(3,4-dimethoxyphenyl)-3-Methylbutyronitrile 2-(3,4-dimethoxyphenyl)-3-methyl butyronitrile 2-(3,4-DiMethoxy phenyl)-ó-Methylbutyronitrile 2-(3,4-DiMethoxy phenyl)-d-Methylbutyronitrile 2-(3,4-Dimethoxy phenyl)-β-methylbutyronitrile 2-(3,4-DiMethoxy phenyl)-β-Methylbutyronitrile 2-(3,4-Dimethoxy phenyl)-d-methylbutyronitrile 2-(3,4-Dimethoxyphenyl)-2-isopropylacetonitrile BENZENEACETONITRILE,3,4-DIMETHOXY-A-(1-METHYLETHYL)- | Aromatics;Organic materials;Nitrile compounds;(intermediate of rerapamil hcl) |
| 42 | 213464-77-8 | ORTHOSULFAMURON | famuron OrthosuL 213464-77-8 Orthosulfamuron ORTHOSULFAMURON Orthosulfamuron [iso] Orthosulfamuron solution 1-(4,6-Dimethoxypyrimidin-2-yl)-3-[2-(dimethylcarbamoyl)phenylsulfamoyl]urea 2-((N-((4,6-Dimethoxypyrimidin-2-yl)carbamoyl)sulfamoyl)amino)-N,N-dimethylbenzamide benzamide, 2-[[[[[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl]amino]sulfonyl]amino]-N,N-dimethyl- | Amino compounds;Organic raw materials |
| 43 | 216854-24-9 | (R)-1-Benzyl-3-N-Boc-aminopiperidine | (R)-1-Benzyl-3-N-Boc-aminopiperidine (R)-1-BENZYL-3-N-BOC-AMINOPIPERIDINE (R)-N-Benzyl-3-N-boc-aminopiperidine (S)-3-(BOC-AMINO)-1-BENZYL-PIPERIDINE (S)-tert-butyl 1-benzylpiperidin-3-ylcarbamate tert-Butyl [(3S)-1-benzylpiperidin-3-yl]carbamate tert-butyl N-[(3S)-1-benzylpiperidin-3-yl]carbaMate (R)-(1-BENZYL-PIPERIDIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER Carbamic acid, N-[(3S)-1-(phenylmethyl)-3-piperidinyl]-, 1,1-dimethylethyl ester Carbamic acid, [(3S)-1-(phenylmethyl)-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI) | Intermediates;Pharmaceutical intermediates |
| 44 | 24047-72-1 | (1R,2R,5R)-(+)-2-hydroxy-3-pinanone | (1R,2R,5R)- (+)-2-Hydroxy-3-pinanone (+)-(1R,2R,5R)-2-HYDROXY-3-PINANONE (1R,2R,5R)-(+)-2-HYDROXY-3-PINANONE (1R,2R,5R)-(+)-2-Hydroxy-3-pinanone (1R,2R,5R)-(+)-2-hydroxy-3-pinanone (1R,2R,5R)-2-Hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one (1R,2R,5R)-2-HYDROXY-2,6,6-TRIMETHYL-BICYCLO[3.1.1]HEPTAN-3-ONE (1R,2R,5R)-(+)-2-HYDROXY-2,6,6-TRIMETHYLBICYCLO[3.1.1]HEPTAN-3-ONE bicyclo[3.1.1]heptan-3-one, 2-hydroxy-2,6,6-trimethyl-, (1R,2R,5R)- | Ketones;Terpenes;Biochemistry;Pharmaceuticals;Chiral Reagents;API intermediates;Organic materials;Asymmetric Synthesis;Bicyclic Monoterpenes;Synthetic Organic Chemistry |
| 45 | 2503-56-2 | 5-Methyl-s-triazolo[1,5-a]pyrimidin-7-ol | Methyl hydroxytriazaindolizine 5-Hydroxy-7-methyltriazoindolizine 5-Methyl-s-trazolo[1,5-]pyrimidin-7-ol 5-a)pyrimidin-7-ol,5-methyl-s-triazolo( 5-Methyl-s-triazolo[1,5-a]pyrimidin-7-ol 5-Methyl-7-hydroxy-1,3,4-triazindolizine 5-methyl-s-triazolo(1,5-a)pyrimidin-7-ol 7-Hydroxy-5-methyl-1,3,4-triazaindolizine 5-methyl[1,2,4]triazolo[1,5-a]pyridin-7-ol 5-Methyl-[1,2,4]triazolo[1,5-a]pyridin-7-ol 5-methyl(1,2,4)triazolo(1,5-a)pyrimidin-7-ol 5-Methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-ol 2,4]Triazolo[1,5-a]pyrimidin-7-ol,5-methyl-[1 5-Methyl (1,2,4)trizolo(1,5-α)pyrimidin-7-ol 7-Hydroxy-5-methyl[1,2,4]triazole[1,5a]pyrimidine 5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7(1H)-one 7-Hydroxy-5-methyl-1,2,4-triazolo[1,5-a]pyrimidine 7-Hydroxy-5-methyl[1,2,4]triazolo[1,5-a]pyrimidine 5-Methyl-7-hydroxy-1,2,4-triazolo[1,5-a]pyrimidine | Others;Pyrimidine;Benzotriazoles;Building Blocks;C-C Bond Formation;Chemical Synthesis;Synthetic Reagents;Industrial/Fine Chemicals;Heterocyclic Building Blocks;Pharmaceutical intermediates |
| 46 | 29518-11-4 | 4-phenylmorpholin-3-one | 4-Phenylmorpholin-3-one 4-Phenyl-3-morpholinone 4-phenylmorpholin-3-one 3-Morpholinone, 4-phenyl- 3-morpholinone, 4-phenyl- | Ketones;Organic materials |
| 47 | 29547-00-0 | sodium S-[2-(dimethylamino)-3-(sulfosulfanyl)propyl] sulfurothioate | hx1020 monosultap MONOSULTAP S,S'-[2-(Dimethylamino)trimethylene]thiosulfatesodiumsalt s,s'-(2-(dimethylamino)trimethylene)thiosulfatesodiumsalt S,S'-(2-(Dimethylamino)trimethylene)thiosulfate sodium salt Natrium-S-[2-(dimethylamino)-3-(sulfosulfanyl)propyl]thiosulfat sodium S-[2-(dimethylamino)-3-(sulfosulfanyl)propyl] sulfurothioate Sodium hydrogen S,S'-[2-(dimethylamino)trimethylene]di(thiosulfate) Thiosulfuricacid,S,S'-[2-(dimethylamino)trimethylene]ester,monosodiumsalt thiosulfuricacid,s,s'-(2-(dimethylamino)trimethylene)ester,monosodiumsalt Thiosulfuric acid S,S''-[2-(dimethylamino)-1,3-propanediyl ester monosodium Thiosulfuric acid, S,S'-(2-(dimethylamino)trimethylene)ester, monosodium salt Thiosulfuric acid,S,S'-[2-(dimethylamino)-1,3-propanediyl] ester monosodium salt thiosulfuric acid (H2S2O3) S,S'-[2-(dimethylamino)-1,3-propanediyl] ester monosodium salt Monomehypo, Thiosultap monosodium, Thiosulfuric acid S,Sμ-[2-(dimethylamino)trimethylene] ester monosodium salt | Intermediates;Pharmaceutical intermediates |
| 48 | 301-01-9 | methyl 4,7,10,13,16,19-docosahexaenoate | methyl 4,7,10,13,16,19-docosahexaenoate METHYL 4,7,10,13,16,19-DOCOSAHEXAENOATE cis-4,7,10,13,16,19-docosahexaenoic methyl ester cis-4,7,10,13,16,19-docosahexaenoic*acid methyl E CIS-4,7,10,13,16,19-DOCOSAHEXAENOIC*ACID METHYL EST CIS-4,7,10,13,16,19-DOCOSHEXAENOIC ACID METHYL ESTER CIS-4,7,10,13,16,19-DOCOSAHEXAENOIC ACID METHYL ESTER Methyl?Docosahexaenoate?(?4c,?7c,?10c,?13c,?16c,?19c)? cis-4,7,10,13,16,19-Docosahexaenoic acid methyl ester,Methyl 4,7,10,13,16,19-docosahexaenoate | FAMEs;Organic materials;Organic acid esters;Lipid Analytical Standards;Other Lipid Related Products;Neats&Single Component Solutions;Fatty AcidsFA/FAME/Lipids/Steroids |
| 49 | 3070-86-8 | N,N'-(oxydi-4,1-phenylene)bisacetamide | Acetaminophen Impurity N Paracetamol EP Impurity N 44DIACETAMIDODIPHENYLETHER Bis(p-acetylaminophenyl) Ether N,N'-(oxydi-4,1-phenylene)bisacetamide N,N'-(OXYDI-4,1-PHENYLENE)BISACETAMIDE N,N'-(oxybis(4,1-phenylene))diacetamide Paracetamol Impurity 14(Paracetamol EP Impurity N) Acetaminophen EP Impurity N(N,N'-(oxydi-4,1-phenylene)bisacetamide) | Others;Paracetamol impurities;Pharmaceutical raw materials;Impurity reference substance;Reference substance-impurity reference substance |
| 50 | 33045-53-3 | Ethyl 2-methoxy-5-sulfamoylbenzoate | Sulpiride IMpurity C Sulpiride EP Impurity C Sulpiride Impurity C(EP) Ethyl 5-sulphamoyl-o-anisate Ethyl 2-methoxy-5-sulfamoylbenzoate 2-Methoxy-5-sulfamoyl ethyl benzoate Ethyl 2-methoxy-5-(sulfamoylmethyl)benzoate 2-Methoxy-5-sulfamoylbenzoic acid ethyl ester 2-METHOXYL-5-METHYLSULFONYLBENZOIC ACID METHYL ESTER | Organic materials;Organic acid esters;FINE Chemical & INTERMEDIATES |
| 51 | 33100-15-1 | Benzeneethanamine,2-nitro- | RARECHEM AL BW 0266 2-NITROPHENETHYLAMINE 2-Nitro-phenethylamine Benzeneethanamine,2-nitro- 2-(2-NITROPHENYL)ETHANAMINE b-(o-Nitrophenyl)ethylamine 2-(2-Aminoethyl)nitrobenzene 2-(2-nitrophenyl)ethan-1-amine Phenethylamine,o-nitro- (6CI,8CI) | Organic materials;Hydrocarbon compounds |
| 52 | 34161-24-5 | fipexide hydrochloride | FIPEXIDE fipexide fipexide hydrochloride 1-[(p-Chlorophenoxy)acetyl]-4-piperonylpiperazine 1-(4-Chlorophenoxyacetyl)-4-(1,3-benzodioxole-5-ylmethyl)piperazine 1-(2-[4-chlorophenoxy]acetyl)-4-(3,4-methylenedioxybenzyl)piperazine 1-(2-[4-Chlorophenoxy]acetyl)-4-(3,4-methylenedioxybenzyl)piperazine 1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone Ethanone, 1-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-2-(4-chlorophenoxy)- | Small molecule inhibitor |
| 53 | 35475-03-7 | 2-Thiophenecarboxylic acid, 5-chloro-, methyl ester | Rivaroxaban Impurity 149 Methyl 2-chloro-5-thiophenecarboxylate Methyl-5-chlorothiophene-2-carboxylate Methyl 5-chloro-2-thiophenecarboxylate 5-Chlorothiophene-2-carboxylic Acid Methyl Ester 5-chloro-2-Thiophenecarboxylic acid methyl ester 5-chloro-2-Thiophene carbocylic acid methyl ester 2-Thiophenecarboxylic acid, 5-chloro-, methyl ester 2-Thiophenecarboxylic acid, 5-chloro-, Methyl ester | Organic materials;Organic acid esters |
| 54 | 3564-09-8 | Ponceau 3R | CI 16155 Ponceau 3R PONCEAU 3R C.I. 16155 CI NO 16155 CUMIDINE RED C.I. Food Red 6 C.I. Food Red 6, disodium salt C.I. Food Red 6, disodium salt (8CI) DISODIUM 1-(DIMETHYLPHENYLAZO)-2-NAPHTHOL-3,6-DISULFONATE DISODIUM 1-(2,4,5-TRIMETHYLPHENYLAZO)-2-NAPHTHOL-3,6-DISULFONATE 1-(DIMETHYLPHENYLAZO)-2-NAPHTHOL-3,6-DISULFONIC ACID DISODIUM SALT 1-(2,4,5-TRIMETHYLPHENYLAZO)-2-NAPHTHOL-3,6-DISULFONIC ACID DISODIUM SALT disodium (4E)-3-oxo-4-[(2,4,5-trimethylphenyl)hydrazono]-3,4-dihydronaphthalene-2,7-disulfonate disodium (4Z)-3-oxo-4-[(2,4,5-trimethylphenyl)hydrazono]-3,4-dihydronaphthalene-2,7-disulfonate | |
| 55 | 36157-42-3 | 5-chlorothiophene-3-carboxylic acid | AKOS 92001 Rivaroxaban Impurity 78 5-chloro-3-Thiophenecarboxylicacid 5-CHLOROTHIOPHENE-3-CARBOXYLIC ACID 5-Chlorothiophene-3-carboxylic acid 5-chlorothiophene-3-carboxylic acid 3-thiophenecarboxylic acid, 5-chloro- 3-Thiophenecarboxylic acid, 5-chloro- | Organic raw materials;Carboxylic acid compounds |
| 56 | 376608-75-2 | Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[7-chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d] pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy ]- | Ticagrelor-18 Ticagrelor Related Compound 99 2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethan 2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol 2-[[(3Ar,4S,6R,6As)-6-[7-Chloro-5-(Propylthio)-3H-1,2,3-Triazolo[4,5-D]Pyrimidin-3-Yl]Tetrahydro-2,2-Dimethyl-4H-Cyclopenta-1,3-Dioxol-4-Yl]Oxy]-Ethanol Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[7-chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyriMidin-3-yl]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[7-chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[7-chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d] pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy ]- 2-(((3aR,4S,6R,6aS)-6-(7-Chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol 2-[[(3aR,4S,6R,6aS)-6-(7-chloro-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol | Alcohols;Organic materials |
| 57 | 3809-32-3 | 2,5-dimethylcyclohexan-1-ol | Einecs 223-281-3 Hexahydro-p-xylenol 2,5-DIMETHYLCYCLOHEXANOL 2,5-dimethylcyclohexan-1-ol Cyclohexanol, 2,5-dimethyl- 2,5-DIMETHYLCYCLOHEXANOL, MIXTURE OFISOM ERS | D;Alpha Sort;Organic materials;Hydrocarbon compounds;Volatiles/ Semivolatiles |
| 58 | 4093-35-0 | bromopride | Plesium Praiden Opridan Artomey BROMOPRID Valopride VAL 13081 Bromopride bromopride Bromoprida BROMOPRIDE BRN 2381893 Bromopridum UNII-75473V2YZK Bromoprida [Spanish] Bromopridum [INN-Latin] Bromoprida [INN-Spanish] 4-Amino-5-bromo-N-(2-(diethylamino)ethyl)-o-anisamide o-Anisamide, 4-amino-5-bromo-N-(2-(diethylamino)ethyl)- N-(Diethylaminoethyl)-2-methoxy-4-amino-5-bromobenzamide 2-Methoxy-4-aMino-5-broMo-N,N-diethylaMinoethylbenzaMide 4-amino-5-bromo-n-(2-(diethylamino)ethyl)-2-methoxy-benzamid 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide 4-azanyl-5-bromo-N-(2-diethylaminoethyl)-2-methoxy-benzamide Benzamide, 4-amino-5-bromo-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI) 4-Amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide,Emepride,Emoril,Viadil | Amines;EMEPRIDE;Aromatics;Pharmaceuticals;Chemical raw materials;Small molecule inhibitors;Intermediates & Fine Chemicals |
| 59 | 50298-90-3 | (1S,2S,4R,9beta,16alpha,17xi)-1,2,16,20,25-pentahydroxy-9,10,14-trimethyl-4,9-cyclo-9,10-secocholest-5-ene-11,22-dione | Hemslecin B Cucurbitacin Ⅱb Cucurbitacin IIb Cucurbitacin Iib Dihydrocucurbitacin F 23,24-Dihydrocucurbitacin F (10α)-2β,3α,16α,20,25-Pentahydroxy-9β-methyl-19-norlanost-5-ene-11,22-dione 19-Norlanost-5-ene-11,22-dione, 2,3,16,20,25-pentahydroxy-9-methyl-, (2β,3α,9β,10α,16α)- (1S,2S,4R,9β,16α,17ξ)-1,2,16,20,25-pentahydroxy-9,10,14-trimethyl-4,9-cyclo-9,10-secocholest-5-ene-11,22-dione (1S,2S,4R,9beta,16alpha,17xi)-1,2,16,20,25-pentahydroxy-9,10,14-trimethyl-4,9-cyclo-9,10-secocholest-5-ene-11,22-dione estr-5-en-11-one, 17-[(1R)-1,5-dihydroxy-1,5-dimethyl-2-oxohexyl]-2,3,16-trihydroxy-4,4,9,14-tetramethyl-, (2beta,3alpha,9beta,10alpha,16alpha)- (2S,3S,8S,9R,10R,13R,14S,16R,17R)-17-[(2R)-2,6-dihydroxy-6-methyl-3-oxoheptan-2-yl]-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one | Referen;phytochemical;Plant extract;chemical reagent;Standard substance;pharmaceutical intermediate;standardized herbal extract;Standard substance-reference substance;Traditional Chinese medicine refe |
| 60 | 503614-92-4 | 1-(4-Methoxyphenyl)-7-Oxo-6-[4-(2-Oxopiperidin-1-Yl)Phenyl]-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylic Acid | Apixaban-5 BMS-589154-01 Apixaban Carboxylic Acid Imp Apixaban Impurity 41 (BMS-591455-01) 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylic acid 1-(4-Methoxyphenyl)-7-Oxo-6-[4-(2-Oxopiperidin-1-Yl)Phenyl]-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylic Acid 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid 1H-Pyrazolo[3,4-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]- | Pyridine;Pharmaceutical intermediates |
| 61 | 53242-88-9 | 4-[(4-chlorophenyl)methyl]phthalazin-1(2H)-one | Azelastine Impurity D(USP) Azelastine Related CoMpound D Phthalazinone Azelastine Analog 4-(4-chlorobenzyl)phthalazin-1(2H)-one 4-(4-Chlorobenzyl)-1(2H)-phthalazinone 4-(4-Chloro-benzyl)-2H-phthalazin-1-one 4-(4-chloro-benzyl)-2h-phthalazin-1-one 4-((4-Chlorophenyl)methyl)phthalazin-1(2H)-one 4-[(4-Chlorophenyl)methyl]-1(2H)-phthalazinone 4-[(4-chlorophenyl)methyl]phthalazin-1(2H)-one 4-[(4-chlorophenyl)methyl]phthalazin-1(2h)-one 4-(4-Chlorobenzyl)-1,2-dihydrophthalazine-1-one | Ketone;Ketones;Aromatics;Inhibitors;Heterocycles;Pharmaceuticals;Organic materials;Intermediates & Fine Chemicals |
| 62 | 5424-47-5 | 3-Dimethylamino-1-(2-Thienyl)-1-Propanone HCl | SALOR-INT L158135-1EA 2-THIENYL-2-DIMETHYLAMINOETHYL KETONE HCL 2-Thienyl-2-Dimethylaminoethyl Ketone Hcl 3-DIMETHYLAMINO-1-(2-THIENYL)-1-PROPANONE HCl 3-Dimethylamino-1-(2-Thienyl)-1-Propanone HCl 3-(dimethylamino)-1-(thiophen-2-yl)propan-1-one 2-Thienyl-2-dimethylaminoethyl ketone hydrochloride 2-[3-(Dimethylamino)propionyl]thiophene Hydrochloride 3-Dimethyl amino-1-(2-thienyl)-1-propanone hydrochloride 3-(Dimethylamino)-1-(2-thienyl)-1-propanone hydrochloride 1-Propanone-3-(diMethylaMino)-1-(2-thienyl)- hydrochloride 3-(dimethylamino)-1-thiophen-2-ylpropan-1-one hydrochloride 3-(DIMETHYLAMINO)-1-(THIOPHEN-2-YL)PROPAN-1-ONE HYDROCHLORIDE | Intermediates;Pharmaceutical intermediates |
| 63 | 55682-91-2 | methyl heptacosanoate | METHYL HEPTACOSANOATE methyl heptacosanoate SCVPLVIKFSVDDH-UHFFFAOYSA-N HEPTACOSANOIC ACID METHYL ESTER METHYL HEPTACOSANOATE STANDARD FOR GC | Aliphatic compound;Analytical standard;Fatty acid methyl ester |
| 64 | 55954-23-9 | Methyl 2,4-dichlorophenylacetate | 47339 2,4-dcaa methyl ester Methyl 2,4-dichlorophenylacetate METHYL 2,4-DICHLOROPHENYLACETATE methyl 2,4-dichlorophenylacetate solution 2,4-DICHLOROPHENYLACETIC ACID METHYL ESTER 2,4-DICHLOROPHENYLACETIC ACID METHYL ESTER STANDARD | M;EPA;MAlphabetic;Alpha Sort;META - METH;H-MAlphabetic;Method 8150/8151;Organic materials;Organic acid esters;Acids and Derivatives |
| 65 | 56425-91-3 | Flurprimidol | el500 CUTLESS FLURPRIMIDOL Flurprimidol compound72500 flurprimidol (bsi, draft e-iso, draft f-iso, ansi) 2-Methyl-1-pyrimidin-5-yl-1-[4-(trifluoromethoxy)phenyl]propan-1-ol alpha-isopropyl-alpha-(p-(trifluoromethoxy)phenyl)-5-pyrimidinemethanol alpha-(1-methylethyl)-alpha-(4-(trifluoromethoxy)phenyl)-5-pyrimidinemethano 5-Pyrimidinemethanol, .alpha.-(1-methylethyl)-.alpha.-4-(trifluoromethoxy)phenyl- | Alcohols;plantmedia;Organic materials |
| 66 | 56718-76-4 | rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol | Metoprolol-13 Metoprolol USP RC B Metoprolol impurity 14 Metoprolol USP IMpurity B Metoprolol Related CoMpound B Metoprolol USP Related Compound B 1-chloro-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol rac 1-Chloro-3-[4-(2-methoxyethyl)phenoxy]-2-propanol | Reference substance-impurity reference substance |
| 67 | 5802-82-4 | methyl hexacosanoate | Hexacosanoic METHYL CEROTATE Methylhexacosanoat METHYL HEXACOSANOATE methyl hexacosanoate HEXACOSANOIC ACID METHYL ESTER METHYL HEXACOSANOATE, STANDARD FOR GC | Analytical standard;Fatty acid methyl ester;Food and beverage standards |
| 68 | 592533-90-9 | (3As,4R,6S,6Ar)-6-Aminotetrahydro-2,2-Dimethyl-4H-Cyclopenta-1,3-Dioxol-4-Ol | Ticagrelor Impurity 87 Ticagrelor Related Compound 2 (3As,4R,6S,6Ar)-6-Aminotetrahydro-2,2-Dimethyl-4H-Cyclopenta... (3aS,4R,6S,6aR)-6-Amino-2,2-dimethyl-hexahydrocyclopenta[d][1,3]dioxol-4-ol (3aS,4R,6S,6aR)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol (3As,4R,6S,6Ar)-6-Aminotetrahydro-2,2-Dimethyl-4H-Cyclopenta-1,3-Dioxol-4-Ol (3aS,4R,6S,6aR)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol 4H-Cyclopenta-1,3-dioxol-4-ol, 6-aMinotetrahydro-2,2-diMethyl-, (3aS,4R,6S,6aR)- (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-((S)-propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol | Alcohols;Organic materials |
| 69 | 60137-06-6 | (4R,9beta,16alpha,24S)-2,25-dihydroxy-9,10,14-trimethyl-16,24-epoxy-4,9-cyclo-9,10-secocholesta-2,5-diene-1,11,22-trione | hemsecin A Cucurbitacins cucurbitacins cucuritacin IIa dihydrocucurbitacin F,25-0-acetate (4R,9beta,16alpha,24S)-2,25-dihydroxy-9,10,14-trimethyl-16,2... (10α,24S)-16α,24-Epoxy-2,25-dihydroxy-9β-methyl-19-norlanosta-1,5-diene-3,11,22-trione 19-Norlanosta-1,5-diene-3,11,22-trione, 16,24-epoxy-2,25-dihydroxy-9-methyl-, (9β,10α,16α,24S)- 19-Norlanosta-1,5-diene-3,11,22-trione, 16,24-epoxy-2,25-dihydroxy-9-methyl-, (9beta,10alpha,16alpha,24S)- (4R,9beta,16alpha,24S)-2,25-dihydroxy-9,10,14-trimethyl-16,24-epoxy-4,9-cyclo-9,10-secocholesta-2,5-diene-1,11,22-trione | Xuedanin A;phytochemical;Plant extract;chemical reagent;Standard substance;Reference substance;pharmaceutical intermediate;standardized herbal extract;Analysis of standard substance;Traditional Chines |
| 70 | 60547-97-9 | 2-Piperazine-4-amino-6,7-dimethoxyquinazoline | 6,7-Dimethoxy-2(1-Piperazinyl)-Quinozoline 2-piperazine-4-amino-6,7-dimethoxyquinazoline 2-Piperazine-4-amino-6,7-dimethoxyquinazoline 6,7-DIMETHOXY-2-PIPERAZINO-4-AMINOQUINAZOLINE 2(1-Piperazinly)-4-amino-6,7-dimethoxyquinazoline 6,7-Dimethoxy-2-(1-piperazinyl)-4-quinazolinamine 6,7-DIMETHOXY-2-(1-PIPERAZINYL)-4-QUINAZOLINAMINE 6,7-dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine 6,7-DIMETHOXY-2-(PIPERAZIN-1-YL)QUINAZOLIN-4-AMINE 4-QUINAZOLINAMINE, 6,7-DIMETHOXY-2-(1-PIPERAZINYL) 2-(1-PIPERAZINYL)-4-AMINO-6,7-DIMETHOXYQUINAZOLINE 6,7-DIMETHOXY-2-PIPERAZIN-1-YL-QUINAZOLIN-4-YLAMINE 4-amino-2-(1-piperazinyl)-6,7-dimethoxy quinazoline | Intermediates;Pharmaceuticals;Doxazosin Mesylate;Metabolites & Impurities;Pharmaceutical intermediates;Intermediates & Fine Chemicals |
| 71 | 609-19-8 | 3,4,5-trichlorophenol | HSDB 6292 NSC 243667 CCRIS 6110 3.4.5-Trichlor 3,4,5-TRICHLOROPHENOL 3,4,5-trichloro-pheno 3,4,5-trichlorophenol 3,4,5-Trichlorophenol Phenol, 3,4,5-trichloro- | TP - TZ;Alpha Sort;Halogenated;T-ZAlphabetic;Chemical Class;Organic materials;Phenolic compounds;Analytical Standards;AromaticsChemical Class;ChloroAnalytical Standards |
| 72 | 6233-83-6 | Oxytocin Acetate | Pitocin Acetate Synpitan Acetate Oxytocin Acetate Uteracon Acetate Orasthin Acetate Perlacton Acetate Syntocinon Acetate Oxytocin Monoacetate Oxytocin, monoacetate (salt) Oxytocin Identification (15 mg) (COLD SHIPMENT REQUIRED) | Raw drugs;Drug peptides;Pharmaceuticals;Amino Acids & Derivatives;Intermediates & Fine Chemicals |
| 73 | 63516-30-3 | alpha-Hydroxy-alpha-phenylbenzeneacetic acid (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride | TrospiuM Chloride Related CoMpound B endo-8-Azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride 2-[3-(8-azabicyclo[3.2.1]octan-3-yl)phenyl]-2-hydroxy-2-phenylacetic acid hydrochloride endo-α-Hydroxy-α-phenylbenzeneacetic Acid 8-Azabicyclo[3.2.1]oct-3-yl Ester Hydrochloride ALPHA-HYDROXY-ALPHA-PHENYLBENZENEACETIC ACID (3-ENDO)-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER HYDROCHLORID alpha-Hydroxy-alpha-phenylbenzeneacetic acid (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride Trospium Chloride Related Compound B (20 mg) ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate) | Organic materials;Hydrocarbon compounds |
| 74 | 63547-24-0 | 2-Benzhydrylsulphinylacetic acid | Modafinic Acid Modafinil Acid Benzyhydrylsulfinylacetic acid (Benzhydrylsulfinyl)acetic acid 2-Benzhydrylsulphinylacetic acid 2-(benzhydryl sulfinyl)acetic acid (Diphenylmethylsulfinyl)acetic acid 2-[benzhydryl sulfinyl] acetic acid (diphenylmethanesulfinyl)acetic acid 2-[(Diphenylmethyl)sulfinyl]acetic acid Acetic acid, [(diphenylmethyl)sulfinyl]- 2-[(Diphenyl-methyl)sulfinyl]acetic Acid | Neurochemicals;Pharmaceuticals;Organic raw materials;Metabolites & Impurities;Carboxylic acid compounds;Metabolite Reference Standard;Intermediates & Fine Chemicals |
| 75 | 63775-96-2 | Cyclosporin D | CYCLOSPORIN D Cyclosporin D Val2-cyclosporine 7-L-Valinecyclosporin A Cyclosporine IMpurity-D Cyclosporin D, froM MicroMonospora (3R,4R)-3-Hydroxy-N-methyl-5-[(E)-1-propenyl]cyclo(L-Leu-L-Val-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-) (3R,4R)-3-Hydroxy-N-methyl-5-[(E)-1-propenyl]-cyclo(L-Leu-L-Val-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-) Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl] (3S,6S,9R,12R,15S,18S,21S,24S,30S)-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-3,21,30-tris(1-methylethyl)-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | Peptides;Pharmaceuticals;Organic materials;Anti-cancer&immunity;Hydrocarbon compounds;Intermediates & Fine Chemicals;ACTIVE PHARMACEUTICAL INGREDIENTS |
| 76 | 638-36-8 | PHYTANE | Phytan PHYTANE tetrahydroneophytadiene PHYTANE, STANDARD FOR GC 2,6,10,14-Tetramethylhexdecane 2,6,10,14-TETRAMETHYLHEXADECANE hexadecane,2,6,10,14-tetramethyl- Hexadecane, 2,6,10,14-tetramethyl- | Alkane |
| 77 | 64372-56-1 | 5-Isobenzofurancarboxamide,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro- | CitalopraM EP IMpurity A Escitalopram EP Impurity A CitalopraM Related CoMpound A Citalopram Impurity 3(Citalopram EP Impurity A) 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carboxamide 1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-5-ISOBENZOFURANCARBOXAMIDE 1-[3-(DiMethylaMino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarboxaMide 5-Isobenzofurancarboxamide,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro- (S)-1-[3-Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3- dihydro-5-isobenzofuran-carbonitrile oxalate (ESCITALOPRAM OXALAT Citalopram Related Compound A (25 mg) (1-(3-(dimethylamino)propyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide) | Amino compounds;Organic raw materials;Neurochemicals,Pharmaceuticals, Intermediates & Fine Chemicals |
| 78 | 6588-68-7 | 1,3-Dimethyl-5-nitroadamantane | Adamantane Impurity 8 Adamantane Impurity 7 Adamantane Impurity 1 Memantine Impurity 11 1,3-Dimethyl-5-nitroadamantane 3,5-DiMethyl-1-nitroadaMantane 1-Nitro-3,5-Dimethyladamantane 3,5-Dimethyl-1-nitroadamantane AdaMantane-2 (1-Nitro-3,5-DiMethyladaMantane) | Organic materials;Hydrocarbon compounds |
| 79 | 66985-17-9 | Ipratropium bromide hydrate | Unii-J697uz2A9j pratropium Bromide IPRATROPIUM BROMIDE Ipratropium bromide CRS Ipratropium bromide hydrate Ipratropium Bromide (100 mg) Ipratropium bromide monohydrate IPRATROPIUM BROMIDE MONOHYDRATE 8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl 3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane bromide monohydrate | VASOTEC;Standard products;Triazinone compounds;Small molecule inhibitors;Pharmaceutical raw materials;Traditional Chinese medicine reference products;Pharmaceutical ingredients (for research experimen |
| 80 | 67118-31-4 | Ethyl-2-oxo-1-pyrrolidine acetic acid | Levetiracetam EP Impurity A ETHYL 2-OXO-1-PYRROLIDINEACETATE 2-(2-oxopyrrolidin-1-yl)butanamide Ethyl (2-oxopyrrolidin-1-yl)acetate Ethyl-2-oxo-1-pyrrolidineacetic acid Ethyl-2-oxo-1-pyrrolidine acetic acid ethyl 2-(2-oxopyrrolidin-1-yl)acetate 2-(2-oxopyrrolidin-1-yl)butanoic acid alpha-Ethyl-2-oxo-1-pyrrolidineacetic acid (2RS)-2-(2-Oxopyrrolidin-1-yl)butanoic acid 2-(2-oxo-1-pyrrolidinyl)acetic acid ethyl ester | Heterocycles;Neurochemicals;Pharmaceuticals;Organic raw materials;Carboxylic acid compounds;Intermediates & Fine Chemicals |
| 81 | 70476-82-3 | Mitoxantrone hydrochloride | 70476-82-3 Mitoxantrone hcl Mitoxantrone hydrochloride 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione dihydrochloride | Quinones;Organic materials |
| 82 | 7098-26-2 | octatetracontane | ALKANE C48 OCTATETRACONTANE octatetracontane n-Octatetracontane N-OCTATETRACONTANE n-Octyl tetracontane OCTATETRACONTANE, STANDARD FOR GC | O;Alphabetic;Hydrocarbons;Chemical Class;Chemical Class;Analytical standards;Aliphatic hydrocarbons;NeatsAnalytical Standards;NeatsAnalytical Standards;Gas chromatography standards (color code) |
| 83 | 73278-98-5 | N-[3-[3-(1-Piperidinylmethyl)phenoxy]propyl]amine | Roxatidine Imp.II (Free Base) N-[3-[3-(1-Piperidinylmethyl)p N-[3-[3-aminopropoxy]benzyl]piperidine 3-[3-piperidine methyl phenate] propylamine 3-[3-(1-Piperidinomethyl)phenoxy]propylamine 3-[3-(l-Piperidinomethyl)phenoxyl]propytamine 3-(3-PIPERIDIN-1-YLMETHYL-PHENOXY)-PROPYLAMINE N-(3-[3-(1-PIPERIDINOMETHYL)PHENOXY])PROPYLAMINE 3-[3-(piperidin-1-ylmethyl)phenoxy]propan-1-amine N-[3-[3-(1-PIPERIDINYLMETHYL)PHENOXY]PROPYL]AMINE N-[3-[3-(1-Piperidinylmethyl)phenoxy]propyl]amine [3-(1-PIPERIDINYLMETHYL)PHENOXY]PROPYLAMINE(WXG01189) | Roxatidine;Intermediate;Impurity reference substance;Reference substance-impurity reference substance |
| 84 | 7529-16-0 | 5-Vinylpyrrolidone | MDL 17637-03 5-Vinylpyrrolidone 5-VINYLPYRROLIDONE 5-Vinylpyrrolidon-2 5-vinyl-2-pyrrolidone 5-Vinyl-2-pyrrolidinone 5-Ethenyl-2-pyrrolidinone 5-Ethenylpyrrolidin-2-one (±)-5-Vinylpyrrolidin-2-one Vigabatrin Related CoMpound A | Impurities;Heterocycles;Organic materials;Hydrocarbon compounds |
| 85 | 757251-39-1 | 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide | Regorafenib Impurity 35 4-(4-amino-3-fluorophenoxy) 4-(4-Amino-3-Fluorophenoxy)-N-Methylpicolinamide 4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamid 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide 4-(4-Amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide 2-Pyridinecarboxamide,4-(4-amino-3-fluorophenoxy)-N-methyl- 4-(4-Amino-3-fluorophenoxy)pyridine-2-carboxylic acid methylamine 4-(4-Amino-3-fluorophenoxy)pyridine-2-carboxylic acid methylamide | Regorafenib;Intermediates;Pharmaceutical intermediates |
| 86 | 76497-39-7 | 3-(Acetylthio)-2-methylpropanoic acid | 3-(Acetylthio)-2-methylpropanoic acid D-3-acetylthio-2-methylpropionic acid (S)-β-(Acetylmercapto)isobutyric acid 3-(acetylthio)-2-methylpropionic acid D-3-(Acetylthio)-2-methylpropanoic acid d-(-)-3-acetylthio-2-methylpropionic acid 3-(acetylsulfanyl)-2-methylpropanoic acid D-(S)-3-Acetylthio-2-methylpropionic acid (-)-3-(Acetylthio)-2-methylpropanoic acid D-(-)-3-Acetylthio-2-methylpropionic acid D(-)S-ACETYL-BETA-MERCAPTO ISOBUTYRIC ACID (2S)-3-(acetylsulfanyl)-2-methylpropanoate D-(-)-S-Acetyl-beta-mercaptoisobutyric acid D-(-)-3-ACETYLSULFANYL-2-METHYLPROPIONIC ACID (2S)-3-(acetylsulfanyl)-2-methylpropanoic acid D-(S)-3-ACETYL-3-MERCAPTO-2-METHYL PROPANOIC ACID | Organic raw materials;Chiral Building Blocks;Organic sulfur compounds;Carboxylic Acids (Chiral);Synthetic Organic Chemistry |
| 87 | 78281-02-4 | Safflomin A | HSYA SAFFLOMIN A Safflomin A Hydroxysafflor yellow Hydroxysafflor yellow A Hydroxysafflor yellow A,Safflomin A Hydroxysafflor yellow A,SaffloMin A,HSYA 2,5-Cyclohexadien-1-one, 2,4-di-beta-D-glucopyranosyl-3,4,5-trihydroxy-6-((2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl)- | Trad;phytochemical;Plant extract;chemical reagent;Reference substance;standardized herbal extra;pharmaceutical intermediate;Analysis of reference substance;Plant extraction standard substance;Standard |
| 88 | 79277-67-1 | Thifensulfuron | DPX-6316 Thifensulfuron THIFENSULFURON Thifensulfuron acid Thifensulfuron-methyl suspension 3-[(4-methoxy-6-methyl-s-triazin-2-yl)carbamoylsulfamoyl]-2-thenoic acid 3-[[(4-Methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl]thiophene-2-carboxylic acid 3-[[[[(4-Methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]amino]sulfonyl]thiophene-2-carboxylic acid | Herbicides;Pesticides;Analytical standards |
| 89 | 81525-13-5 | Forsythoside B | Forsythoside B β-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl O-D-apio-β-D-furanosyl-(1→6)-O-[6-deoxy-α-L-mannopyranosyl-(1→3)]-, 4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate] (E)-O-D-Apio-beta-D-furanosyl-(1-6)-O-[6-deoxy-alpha-L-mannopyranosyl-(1-3)]-beta-D-glucopyranoside 2-(3,4-dihydroxyphenyl)ethyl 4-[3-(3,4-dihydroxyphenyl)-2-propenoate] [(2R,3R,4R,5R,6R)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate (2R,3R,4R,5R,6R)-2-((((2R,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)methyl)-6-(3,4-dihydroxyphenethoxy)-5-hydroxy-4-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-3-yl (E)-3-(3,4-dihydroxyphenyl)acrylate | phytochemical;Plant extract;chemical reagent;Standard substance;Fine chemical industry;Standard substance-refe;pharmaceutical intermediate;standardized herbal extract;Traditional Chinese medicine refe |
| 90 | 81886-51-3 | 2-(4-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol | Fluconazole-4 Fluconazole Impurity 4 2-Desfluoro Fluconazole Fluconazole EP Impurity C 2-(4-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol 2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol 2-(4-Fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)-2-propanol 2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol alpha-(4-Fluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol 1H-1,2,4-Triazole-1-ethanol, alpha-(4-fluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)- Fluconazole Related Compound B (10 mg) (2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) FLUCONAZOLE RELATED COMPOUND B (10 MG) (2-(4-FLUOROPHENYL)-1,3-BIS(1 H-1,2,4-TRIAZOL-1 -YL)-PROPAN-2-OL) | Fluconazole;Chemical impurity;Standard substance;High purity reagent;Impurity reference substance |
| 91 | 84110-34-9 | 4,6-Methano-1,3,2-benzodioxaborole,hexahydro-3a,5,5-trimethyl-2-(2-methylpropyl)-, (3aS,4S,6S,7aR)- | (3aS,4S,6S,7aR) Bortezomib Impurity 50 2-Methylpropaneboronicacid(1S,2S,3R,5S)-(+)-2,3-pinanediolester 2-Methylpropaneboronic Acid (1S,2S,3R,5S)-(+)-2,3-Pinanediol Ester 2-Methylpropaneboronic acid (1S,2S,3R,5S)-(+)-2,3-pinanediol ester (2-Methyl propyl) boronic acid (1S,2S,3R,5S ) -(+) -2,3-pinanediol ester -2-Isobutyl-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborole (3aS,4S,6S,7aR)-2-Isobutyl-3a,5,5-triMethylhexahydro-4,6-Methanobenzo[d][1,3,2]dioxaborole 2-(2-methylpropyl)-(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborole 2-(2-Methylpropyl)-(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborole 4,6-Methano-1,3,2-benzodioxaborole,hexahydro-3a,5,5-trimethyl-2-(2-methylpropyl)-, (3aS,4S,6S,7aR)- 4,6-Methano-1,3,2-benzodioxaborole,hexahydro-3a,5,5-trimethyl-2-(2-methylpropyl)-, [3aS-(3aa,4b,6b,7aa)]- | Organic materials;Organic acid esters |
| 92 | 881677-11-8 | 5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-Pyrrole-3-carboxaldehyde | Vonoprazan-026 TAK-438( Vonoprazan fumarate) intermediate 4 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldenhyde 5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-Pyrrole-3-carboxaldehyde 1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- 5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrole-3-carboxaldehyde (5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | Organic fluoride;Organic raw materials |
| 93 | 881995-69-3 | Benzenebutanoic acid, b-amino-2,4,5-trifluoro-, methyl ester, (bR)- | Sitagliptin Impurity 51 (R)-Sitagliptin Methyl-Ester IMpurity (R)-methyl 3-amino-4-(2,4,5-trifluorophenyl) (3R)-3-aMino-4-(2,4,5-trifluorophenyl)butanoate Methyl (R)-b-Amino-2,4,5-F3-benzenebutanoate HCl (R)-Methyl 3-aMino-4-(2,4,5-trifluoro phenyl) butanoate Benzenebutanoicacid,b-aMino-2,4,5-trifluoro-,Methylester,(bR)- Benzenebutanoic acid,3-amino-2,4,5-trifluoro-, methyl ester, (3R)- Benzenebutanoic acid, b-amino-2,4,5-trifluoro-, methyl ester, (bR)- Benzenebutanoic acid, β-amino-2,4,5-trifluoro-, methyl ester, (βR)- | Intermediates;Pharmaceutical intermediates |
| 94 | 89-16-7 | diisodecyl phthalate | DPHP Einecs 201-884-2 diisodecyl phthalate DI-ISO-DECYL PHTHALATE Bis(8-methylnonyl)phthalat di-isodecyl orthophthalate bis(8-methylnonyl) phthalate Bis(8-methylnonyl) phthalate DI-8-METHYL-1-NONYL PHTHALATE Di-8-methyl-1-nonyl phthalate Phthalic acid diisodecyl ester bis(8-methylnonyl) benzene-1,2-dicarboxylate 1,2-Benzenedicarboxylic acid diisodecylester bis(7,7-dimethyloctyl) benzene-1,2-dicarboxylate 1,2-Benzenedicarboxylic Acid Bis(8-Methylnonyl) Ester 1,2-Benzenedicarboxylic Acid 1,2-Bis(8-Methylnonyl) Ester | Aromatics;Pharmaceuticals;Organic materials;Organic acid esters;Intermediates & Fine Chemicals |
| 95 | 89913-60-0 | 3-O-Acetyl-α-boswellic acid | Boswellic Acid Impurity 1 3-O-Acetyl-α-boswellic acid Acetyl-alpha-boswellic acid alpha-Boswellic acid acetate alpha-boswellic acid,3-acetyl 3-O-Acetyl-alpha-boswellic acid 3α-(Acetyloxy)olean-12-en-24-oic acid (3α)-3-Acetoxyolean-12-en-24-oic acid (3α,4β)-3-(Acetyloxy)olean-12-en-23-oic acid olean-12-en-24-oic acid, 3-(acetyloxy)-, (3α)- Olean-12-en-23-oic acid, 3-(acetyloxy)-, (3α,4β)- (3alpha,4beta)-3-(Acetyloxy)olean-12-en-23-oic acid | Organic acids;Organic materials |
| 96 | 90721-27-0 | 1-benzofuran-5-carboxylic acid | RARECHEM AL BE 1369 5-Benzofurancarboxylic acid Benzofuran-5-carboxylic acid 1-BENZOFURAN-5-CARBOXYLIC ACID 1-benzofuran-5-carboxylic acid 1-benzofunan-5-carboxylic acid Benzo[b]furan-5-carboxylic acid 3a,7a-dihydrobenzofuran-5-carboxylic acid 1-Benzofuran-5-carboxylic acid, 5-Carboxybenzo[b]furan | Furan&Benzofuran;Organic raw materials;Carboxylic acid compounds |
| 97 | 915-76-4 | 2,4,6-tris(heptafluoropropyl)-1,3,5-triazine | PERFLUOROTRIPROPYL-S-TRIAZINE Tris(perfluoropropyl)-s-triazine TRIS(PERFLUOROPROPYL)-S-TRIAZINE TRIS(HEPTAFLUOROPROPYL)-S-TRIAZINE TRIS(HEPTAFLUOROPROPYL)-1,3,5-TRIAZINE 2,4,6-Tris(perfluoropropyl)-1,3,5-triazine 2,4,6-tris(heptafluoropropyl)-1,3,5-triazine 2,4,6-TRIS(HEPTAFLUOROPROPYL)-1,3,5-TRIAZINE 1,3,5-Triazine, 2,4,6-tris(heptafluoropropyl)- 2,4,6-TRIS(HEPTAFLUOROPROPYL)-1,3,5-TRIAZINE, MASS SPEC STD. 2,4,6-Tris(heptafluoropropyl)-1,3,5-triazine [for Mass spectrometry] | TP-TZ;TP - TZ;Spectroscopy;MS Standards;MS Standards;Mass Spectrometry;Mass spectrometry;Analytical Chemistry;Analytical Standards;Analytical Standards |
| 98 | 93413-61-7 | 1-[1-(4-Benzyloxyphenyl)-2-(dimethylamino)ethyl]cyclohexanol | 1-[2-Amino-1-(4-Benzyloxyphenyl)-Ethyl]-Cyclohexanol 1-[2-Amino-1-(4-benzyloxyphenyl)-ethyl]-cyclohexanol 1-[1-(4-Benzyloxyphenyl)-2-(dimethylamino)ethyl]cyclohexanol 1-{1-[4-(Benzyloxy)phenyl]-2-(dimethylamino)ethyl}cyclohexanol 1-(1-(4-(Benzyloxy)phenyl)-2-(dimethylamino)ethyl)cyclohexan-1-ol cyclohexanol, 1-[2-(dimethylamino)-1-[4-(phenylmethoxy)phenyl]ethyl]- 2-cyclohexylidene-2-(4-methoxyphenyl)-N,N-dimethylethan-1-amine hydrochloride Venlafaxine IMpurity (1-[1-(4-Benzyloxyphenyl)-2-diMethylaMinoethyl]-cyclohexanol) | Alcohols;Organic materials;Medicine intermediate |
| 99 | 96946-42-8 | Cisatracurium besilate | 96946-42-8 Cisatracurium Besilete Cisatracurium besilate Cisatracurium besylate (1R,2R,1'R,2'R)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate (1R,1'R,2R,2'R)-2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium dibenzenesulfonate (1R,2R)-1-(3,4-dimethoxybenzyl)-2-(3-{[5-({3-[(2R,4R)-4-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl}oxy)pentyl]oxy}-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium bisbenzenesulfonate | |
| 100 | 97886-45-8 | Dithiopyr | mon7200 DICTRAN mon15100 Dithiopyr DITHIOPYR DIMENSION oromethyl)-,s,s-dimethylester 3,5-pyridinedicarbothioicacid,2-(difluoromethyl)-4-(2-methylpropyl)-6-(triflu S,S'-Dimethyl 2-Difluoromethyl-4-isobutyl-6-trifluoromethylpyridine-3,5-dicarbothioate S~3~,S~5~-Dimethyl-2-(difluormethyl)-4-isobutyl-6-(trifluormethyl)pyridin-3,5-dicarbothioat S~3~,S~5~-Dimethyl-2-(difluormethyl)-4-isobutyl-6-(trifluormethyl)-3,5-pyridindicarbothioat S3,S5-dimethyl 2-(difluoromethyl)-4-isobutyl-6-(trifluoromethyl)pyridine-3,5-dicarbothioate Dimethyl 2-(difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-3,5-pyridinedicarbothioate S~3~,S~5~-Dimethyl 2-(difluoromethyl)-4-isobutyl-6-(trifluoromethyl)-3,5-pyridinedicarbothioate S~3~,S~5~-Dimethyl 2-(difluoromethyl)-4-isobutyl-6-(trifluoromethyl)pyridine-3,5-dicarbothioate S,S'-Dimethyl 2-(Difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-3,5-pyridinedicarbothioate 2-(Difluorométhyl)-4-isobutyl-6-(trifluorométhyl)-3,5-pyridinedicarbothioate de S~3~,S~5~-diméthyle S~3~,S~5~-dimethyl 2-(difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3,5-dicarbothioate 3,5-pyridinedicarbothioic acid, 2-(difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-, S~3~,S~5~-dimethyl ester | Herbicide;Analytical standards;Organochlorine pesticides |
| 101 | 1157938-97-0 | 1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone | Voriconazole Impurity 70 1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone Ethanone, 1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)- 1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethan-1-one Ethanone,1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-,1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)- Ethanone, 1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)- 1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone,1-(2,5-difluorophenyl)-2-(1H-1,2 1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)- 1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone,1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone Ethanone, 1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)- 1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone,1-(2,5-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone | Exaconazole impurity;Exaconazole intermediate |
| 102 | 39807-15-3 | Oxadiargyl | Raft Topstar Oxadiargyl OXADIARGYL STANDARD oxadiargyl (pa iso) OXADIARGYL PESTANAL 3,5,6-Trichloro-2-pyridinol, Pestanal 5-tert-butyl-3-(2,4-dichloro-5-(prop-2-ynyloxy)phenyl)-1,3,4-oxadiazol-2-(3H)-one 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one 1,3,4-Oxadiazol-2(3H)-one, 3-(2,4-dichloro-5-(2-propynyloxy)phenyl)-5- (1,1-dimethylethyl)- | Aromatics;Raw drugs;Pesticide;Herbicides;Pesticides;Heterocycles;Agro-Products;Raw materials;Analytical standards;Medical raw materials |
| 103 | 26351-19-9 | Violuric Acid Monohydrate | Oximidomesoxalylurea VIOLURIC ACID HYDRATE Violuric Acid Monohydre Violuric Acid Monohydrate VIOLURIC ACID MONOHYDRATE 5-(HydroxyiMino)pyriMidine-2,4,6(1H,3H,5H)-trione hydrate 2,4,5,6(1H,3H)-Pyrimidinetetrone 5-oxime, 5-Isonitrosobarbituric acid, Alloxan-5-oxime | Spectrum;Analytical reagents;Biochemical reagents;Biochemical reagents-other chemical reagents |
| 104 | 52818-63-0 | 2-Pyridinamine,N-[(4-methoxyphenyl)methyl] | Mepyramine Impurity 1 Mepyramine EP Impurity A 2-(P-METHOXYBENZYL)AMINOPYRIDINE 2-(4-METHOXYBENZYLAMINO)PYRIDINE 2-(4-Methoxybenzylamino)pyridine N-(4-METHOXYBENZYL)PYRIDIN-2-AMINE 2-(P-METHOXYBENZYL)AMINOPYRIMIDINE N[(4-METHOXYPHENYL)METHYL]-2-PYRIDINAMINE 2-Pyridinamine,N-[(4-methoxyphenyl)methyl] (4-METHOXY-BENZYL)-PYRIDIN-2-YL-AMINE DIHYDROCHLORIDE | |
| 105 | 5233-42-1 | 5-Chloro Hydrochlorothiazide | 5-Chloro Hydrochlorothiazide Hydrochlorothiazide Impurity E 5-Chlorohydrochlorothiazide IMpurity Hydrochlorothiazide 5-Chloro Impurity 5,6-dichloro-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide 5,6-Dichloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonaMide 1,1-Dioxide 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 5,6-dichloro-3,4-dihydro-, 1,1-dioxide 5,6-dichloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide | Amines;Heterocycles;Pharmaceutical;Pharmaceuticals;167-hydrochlorothiazide;Sulfur & Selenium Compounds;Pharmaceutical raw materials;Impurity reference substance;Intermediates & Fine Chemicals;Referenc |
| 106 | 87579-78-0 | BENZHYDRYL 6,6-DIHYDROPENICILLIC ACID 1-OXIDE[TAZOBACTAM INTERMEDIATE] | Tazobactam Impurity 44 Tazobactam Acid Impurity 24 BENZHYDRYL 6,6-DIHYDROPENICILLIC ACID 1-OXIDE[TAZOBACTAM INTERMEDIATE] (2S,5R)-Benzhydryl 3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- (2S,5R)-Benzhydryl 3,3-diMethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4-oxide (2S,5R)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid diphenylmethyl ester 4-oxide (2S,5R)-3,3-dimethyl-7-oxo-4- oxide-4-Thia-1-azabicyclo[3.2. 0]heptane-2-carboxylic Acid Diphenylmethyl Ester 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-, diphenylmethyl ester, 4-oxide, (2S,5R)- | Reference substance;Chemical impurity-tazobactam |
| 107 | 64924-67-0 | Halofuginone hydrobromide | STENOROL Ru-19110 Tempostatin Unii-ptc2969mv1 HALOFUGINONEHYDROBROMIDE Halofuginone hydrobromide 7-BroMo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-onehydrobroMide 7-BroMo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one hydrobroMide rel-7-BroMo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinoneHydrobroMide rel-7-BroMo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinone HydrobroMide | Amines;Raw drugs;Standards;Pharmaceuti;Heterocycles;Chiral Reagents;Pharmaceuticals;Chemical intermediates;Intermediates & Fine Chemicals;Organic chemical raw materials |
| 108 | 629652-44-4 | (1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester | Tadalafil-004 Tadalafil-004-1R3S Tadalafil Impurity 9 Tadalafil Impurity 67 (1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester 1H-Pyrido[3,4-b]indole-3-carboxylic acid,1-(1,3-benzodioxol-5-yl)-2-(chloroacetyl)-2,3,4,9-tetrahydro-, methylester, (1R,3S)- 1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3S)- | Inhibitors;Chiralreagents;Chiral Reagents;Pharmaceuticals;Impurity controls;Controls-impurity controls;Intermediates & Fine Chemicals |
| 109 | 948-71-0 | THIABENDAZOLE-5-HYDROXY | Hydroxythiabendazole 5-hydroxythiabendazole THIABENDAZOLE-5-HYDROXY 2-(4-Thiazolyl)-5-benzimidazolol 2-(4-Thiazolyl)-1H-benzimidazol-5-ol 1H-Benzimidazol-5-ol, 2-(4-thiazolyl)- 5-Hydroxy-2-(4-thiazolyl)benzimidazole 2-(4-Thiazolyl)-5-benzimidazolol, 5-Hydroxy-2-(4-thiazolyl)benzimidazole 2-(4-Thiazolyl)-5-benzimidazolol, 5-Hydroxy-2-(4-thiazolyl)benzimidazole | Imidazoles;Heterocyces;Heterocycles;Microbicides;Pharmaceuticals;Analytical standards;Metabolites & Impurities;Metabolites & impedances;Mediates & Fine Chemicals;Sulfur & Selenium Compounds |
| 110 | 17103-52-5 | Sulfamethoxazole EP Impurity F | Sulfamethoxazole EP Impurity F Sulfamethoxazole impurity F (EP) SulfaMethoxazole Related CoMpound F 4-Amino-N-(3-methyl-5-isoxazolyl)benzenesulfonamide 4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide(Sulfamethoxazole impurity F) | Chemical reagent |
| 111 | 203395-59-9 | 7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE | Aripiprazole BroMo IMpurity 7-(4-BroMobutoxy)-2(1H)-quinolinone 7-(4-bromobutoxy)quinolin-2(1H)-one 7-(4-Bromobutoxy)-1H-quinolin-2-one 2(1H)-Quinolinone,7-(4- broMobutoxy)- 7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE 7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE (Related Reference) | Aromatics;Pharmaceuticals;Impurity controls;Aromatics Compounds;Aromatics compositions;Mediates & Fine Chemicals;Intermediates & Fine Chemicals |
| 112 | 26184-65-6 | Diquafosol Impurity 1 | α-UTP Diquafosol Impurity 3 Diuridine diphosphate Diquafosol Impurity 2 Diquafosol Impurity 1 Diquafosol Impurity 4(UP2U) Uridine 5'-(trihydrogen diphosphate), P'→5'-ester with uridine | Standard substance;Impurity control substance;Control substance-impurity control substance |
| 113 | 101-76-8 | 4,4'-DDM | 4,4'-DDM P,P'-DDM BIS-(4-CHLOROPHENYL)-METHANE p,p'-dichlorodiphenylmethane 1,1'-methylenebis(4-chloro-benzen 1,1'-methylenebis[4-chloro-Benzene | |
| 114 | 223580-51-6 | TIADINIL | r-4601 tradinil NNF 9850 TIADINIL TIADINIL SOLUTION TIADINIL STANDARD tiadinil (bsi, pa iso) 3'-chloro-4,4'-dimethyl-1,2,3-thiadazole-5-carboxanilide 5-(3-Chloro-4-methylanilinocarbonyl)-4-methyl-1,2,3-thiadiazole | Pesticides;Fungicides;Chemotherapeutic agents;Pharmaceuticals, pesticide intermediates |
| 115 | 2296729-00-3 | Pyrido[2,3-d]pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-, (1R)- | Storasib Sotorasib CID 137278711 AMG-510(Sotorasib) PYRIDO[2,3-D]PYRIMIDIN-2(1H)-ONE, 6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-1-[4-METHYL-2-(1-METHYLETHYL 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one Pyrido[2,3-d]pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-, (1R)- Pyrido[2,3-d]pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-, (1R)- 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one Pyrido[2,3-d]pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-, (1R)- 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one | API;Standard;Inhibitors |
| 116 | 2255-17-6 | FENITROTHION-O-ANALOG | bay42247 BAY 42247 accothiono-analog Accothion O-analog FENITROTHION-O-ANALOG FENITROTHION-O-ANALOG SOLUTION 4-nitro-m-cresodimethylphosphate 3-methyl-4-nitrophenyldimethylphosphate 3-Methyl-4-nitrophenyl dimethyl phosphate Dimethyl 3-methyl-4-nitrophenyl phosphate | Standard;Insecticide |
| 117 | 80-65-9 | 3-AMINO-2-OXAZOLIDINONE | AOZ NSC 38250 NSC 196570 NSC 111187 3-AMINO-OXAZOLIDINONE 3-AMINO-2-OXAZOLIDINONE 3-Amino-1,3-oxazolidin-2-one 3-azanyl-1,3-oxazolidin-2-one | VARIOUSAMINE;Isoxazoles, Oxadiazoles, Oxazoles;Various Metabolites and Impurities |
| 118 | 2214-72-4 | N,N'-bis-(2-Chloroethyl)urea | BCU NSC 36198 Carmustine impurity A CRS N,N'-bis-(2-Chloroethyl)urea CarMustine Related CoMpound A Urea, N,N'-bis(2-chloroethyl)- Carmustine impurity A (C0580010) 3-(diethylamino)-1-(2,4,6-trimethoxyphenyl)-1-propanone Carmustine Related Compound A (10 mg) (1,3-bis(2-chloroethyl)urea) | Mutagenesis Research Chemicals |
| 119 | 5385-75-1 | DIBENZO(A,E)FLUORANTHENE | DIBENZ(A,E)FLUORANTHENE DIBENZO(A,E)FLUORANTHENE Dibenz(a,e)aceanthrylene Dibenzo[a,E]aceanthrylene 2,3,5,6-Dibenzofluoranthene 48849, Dibenzo[a,e]fluoranthene (purity) | D;DIA - DIC;Alphabetic |
| 120 | 1253955-19-9 | (S)-4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate | Netadil Impurity 1 Netarsudil Impurity 7 Boc amino isoquinoline impurity (S)-4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate Benzoic acid, 2,4-dimethyl-, [4-[(1S)-1-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-2-(6-isoquinolinylamino)-2-oxoethyl]phenyl]methyl ester | |
| 121 | 113036-88-7 | N-[[4-[[[(4-chlorophenyl)-cyclopropyl-methylidene]amino]oxymethyl]phen yl]carbamoyl]-2,6-difluoro-benzamide | A 1335 Flucycloxuron Flucycloxuron [iso] benzamide, n-(((4-(((((4-chlorophenyl)cyclopropylmethylene)amino)oxy)methyl)phe 1-[α-(4-chloro-α-cyclopropylbenzylideneaminooxy)-p-tolyl]-3-(2,6-difluorobenzoyl)urea N-[[4-[[[(4-chlorophenyl)-cyclopropyl-methylidene]amino]oxymethyl]phen yl]carbamoyl]-2,6-difluoro-benzamide Benzamide, N-(((4-(((((4-chlorophenyl)cyclopropylmethylene)amino)oxy)methyl)phenyl)amino)carbonyl)-2,6-difluoro- | Insecticide;Reference substance;Organochlorine insecticide |
| 122 | 2362-57-4 | Phenol, 2-(2-phenyldiazenyl)- | Mesalazine Impurity 05 Mesalazine Impurity 27 (E)-2-(phenyldiazenyl)phenol Phenol, 2-(2-phenyldiazenyl)- | Mesalazine |
| 123 | 118854-48-1 | 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid isopropyl ester 1,1-dioxide | MeloxicaM IMpurity F Isopropyl 4-Hydroxy-2-methyl- Isopropyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide Isopropyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylater 1,1-dioxide 4-HYDROXY-2-METHYL-1H-1,2-BENZOTHIAZINE-3-CARBOXYLICACIDISOPROPYLESTER-1,1-DIOXIDE 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid isopropyl ester 1,1-dioxide Isopropyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide (Piroxicam Impurity L) Meloxicam Related Compound C (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide) 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid isopropylester-1,1-dioxide (intermediate of piroxicam) | Aromatics;Impurities;Organic acids;Pharmaceuticals;Sulfur & Selenium Compounds;(intermediate of piroxicam);Intermediates & Fine Chemicals |
| 124 | 29622-29-5 | N-(2,6-Dimethylphenyl)-2-[(5-chloropentyl)methylamino]acetamide | RAD-150 RAD 150 2-[5-chloropentyl(methyl)amino]-N-(2,6-dimethylphenyl)acetamide N-(2,6-Dimethylphenyl)-2-[(5-chloropentyl)methylamino]acetamide | Pharmaceutical raw materials |
| 125 | 438-22-2 | 5-ALPHA-ANDROSTANE | 5α-androstane 5-A-ANDROSTANE 5alpha-androsane 5ALPHA-ANDROSTAN 5-ALPHA-ANDROSTANE 5ALPHA(H)-ANDROSTANE 5-α-androstane solution | A;Steroids;Hormones;Alphabetic;AM to AQEPA;Clinical Standards;Diesel Range Organics (DRO)Chromatography |
| 126 | DifcoTM Skim Milk | abs9174 SM Growth Powder DifcoTM Skim Milk NONFAT POWDERED MILK (PROTEOMICS GRADE) | Raw material;Food additive;Nutrition agent;Chemical material;Biochemical reagent;Nutrition Fortifier;Flavor and fragrance;Biochemical reagent-other chemical reagent | |
| 127 | 116094-23-6 | Insulin Degludec | Insulin Degludec | API;Peptides;Raw materials;Biochemical industry |
| 128 | 4165-61-1 | ANILINE D5 | ANILINE D5 ANILINE (RING-D5) ANILINE-2,3,4,5,6-D5 [2,3,4,5,6-2H5]aniline 2,3,4,5,6-pentadeuterioaniline (2,3,4,5,6-pentadeuteriophenyl)amine | A;Amines;Aromatics;Stable Isotopes;Stable Isotopes;Alphabetical Listings;Alphabetical Listings;Isotope Labelled Compounds |
| 129 | 32510-61-5 | (6R-trans)-3-(acetoxymethyl)-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Cefazolin IMpurity D Cefazolin sodium impurity D Cefazolin EP Impurity D(Cefazolin USP Related Compound J) Cefazolin Impurity 4(Cefazolin EP Impurity D)(Cefazolin USP RC J) (6R-trans)-3-(acetoxymethyl)-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R)-3-[(Acetyloxy)methyl]-8-oxo-7α-[[(1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-,(6R,7R)- | Control substance-impurity control substance |
| 130 | 73-63-2 | 3-(1-Piperidinyl)propiophenone HCl | β-Piperidinopropiophenone 3-(1-Piperidinyl)propiophenone 1-Phenyl-3-piperidino-1-propanone 3-(1-Piperidinyl)propiophenone HCl (2-(-Piperidinyl)ethyl)phenyl ketone (2-(1-PIPERIDINYL)ETHYL)PHENYL KETONE 1-phenyl-3-(piperidin-1-yl)propan-1-one | |
| 131 | 5196-20-3 | 1,3-dihydro-6-methylfuro[3,4-c]pyridin-7-ol | Vitamin B6 EP Impurity A Pyridoxine Cyclic Ether IMpurity 6-Methyl-1H,3H-furo[3,4-c]pyridin-7-ol 6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol 1,3-dihydro-6-methylfuro[3,4-c]pyridin-7-ol 3-methyl-8-oxa-4-azabicyclo[4.3.0]nona-1,3,5-trien-2-ol | Aromatics;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 132 | 38398-32-2 | GANAXOLONE | GANAXOLONE 3α-hydroxy-3β-methyl-5α-pregnan-20-one (3α,5α)-3-Hydroxy-3-methylpregnan-20-one (3α,5α)-3-Hydroxy-3-methyl-pregnan-20-one 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone | |
| 133 | 209747-04-6 | Tolterodine Lactol IMpurity | Tolterodine Lactol IMpurity rac-6-Methyl-4-phenyl-2-chromanol Tolterodine Lactol Impurity (USP) 6-Methyl-4-phenylchroman-2 - alcohol 6-methyl-4-phenyl-3,4-dihydro-2H-chromen-2-ol 2H-1-Benzopyran-2-ol, 3,4-dihydro-6-methyl-4-phenyl- rac-6-Methyl-4-phenyl-2-chroManol (Tolterodine IMpurity) rac-6-Methyl-4-phenyl-2-chroManol (Tolterodine IMpurity) | Impurity reference substance |
| 134 | 287930-77-2 | 2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol | EOS-61012 Montelukast Diol Impurity Montelukast Sodium Impurity Montelukast (3S)-Hydroxy Propanol 2-[2-[3(S)-[3-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]phenyl-2-propanol 2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol 2-[(3S)-(2-(7-Chloro-2-quinolinyl)- ethenyl-phenyl)-3-hydroxy-propyl)] phenyl)-2-propanol (S)-α-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-Methylethyl)benzenepropanol Benzenepropanol, α-[3-[(1E)-2- (7-chloro-2-quinolinyl)ethenyl] phenyl]-2-(1-hydroxy-1- Methylethyl)-, (αS)- | Aromatics;Chiral Reagents;Pharmaceuticals;Intermediates & Fine Chemicals |
| 135 | 68525-86-0 | MAIZE POWDER | Corn,flour MAIZE POWDER Cornflour,pregelatinized MAIZE POWDER MA 1.0 IRMM CERTIFIED RE-F MAIZE POWDER MA 1.0 IRMM CERTIFIED RE-F | |
| 136 | 68513-95-1 | Soybean Flour | SBA SOYABEAN Soybean Flour SOYA BEAN POWDER SBA AGAROSE BOUND LECTIN GLYCINE MAX GMO SOYA BEAN POWDER GLYCINE MAX AGGLUTININ GLYCINE MAX AGGLUTININ SOYBEAN AGGLUTININ | Protein Extracts;Proteins and Derivatives;Biochemicals and Reagents |
| 137 | 7636-26-2 | 3-METHOXY-DL-TYROSINE | DL-3-O-METHYL-DOPA rac 3-O-Methyl DOPA 3-METHOXY-DL-TYROSINE DL-4-HYDROXY-3-METHOXYPHENYLALANINE 3-(4-Hydroxy-3-methoxyphenyl)alanine 2-Amino-3-(4-hydroxy-3-methoxyphenyl) Levodopa Impurity 3 (Levodopa EP Impurity C) 2-AMINO-3-(4-HYDROXY-3-METHOXYPHENYL)PROPANOIC ACID | Impurity control |
| 138 | 7758-79-4 | N-(Isoxazol-5-yl)sulphanilamide | SEC-SODIUM PHOSPHATE SODIUM HYDROGENHOSHATE SODIUM PHOSPHATE, DIBASIC MONOHYDROGEN SODIUM PHOSPHATE SODIUM MONOHYDROGEN PHOSPHATE N-(Isoxazol-5-yl)sulphanilamide 4-Amino-N-5-isoxazolylbenzenesulfonamide 4-amino-n-(1,2-oxazol-5-yl)benzenesulfonamide | Phosphate;Inorganic salt;Chemical raw materials;Pharmaceutical excipients;Inorganic chemical industry |
| 139 | 61012-46-2 | METHYL CIS CIS-11 14-EICOSADIENOATE | Eicosadienoic Acid methyl ester METHYL CIS CIS-11 14-EICOSADIENOATE all-cis-11,14-Methyl eicosadienoate Methyl 11-cis,14-cis-eicosadienoate 11(Z),14(Z)-Eicosadienoic Acid methyl ester (11Z,14Z)-11,14-Eicosadienoic acid methyl ester 11,14-Eicosadienoic acid, methyl ester, (11Z,14Z)- | FAMEs;Fatty AcidsAlphabetic;Lipid Analytical Standards |
| 140 | 2985-79-7 | Choline Fenofibrate Impurity 1 | Fenofibrate Impurity 1 -Chloro-2-hydroxy-benzophenone Choline Fenofibrate Impurity 1 (4-chlorophenyl)(2-hydroxyphenyl)methanone Methanone, (4-chlorophenyl)(2-hydroxyphenyl)- | 241-fenofibrate |
| 141 | 1022-46-4 | BENTRANIL | H-170 LGC(1605) Linarotox Linurotox BENTRANIL 'LGC' (1605) 2-Phenyl-3,1-benzoxazinone-(4) 3-Phenyl-1H-2,4-benzoxazin-1-one 2-Phenyl-4-[4H]-3,1-benzoxazinone 4H-3,1-Benzoxazin-4-one, 2-phenyl- | |
| 142 | 516-72-3 | 20ALPHA-HYDROXYCHOLESTEROL | 5-cholestene-3β,20α-diol 5-Cholestene-3B,20a-diol 20ALPHA-HYDROXYCHOLESTEROL Cholest-5-ene-3,20-diol, (3.beta.)- 20alpha-Hydroxycholesterol (not deuterated) (3S,8S,9S,10R,13S,14S,17S)-17-[(2R)-2-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | Steroids;Pharmaceuticals;Metabolites & Impurities;Intermediates & Fine Chemicals;Standards - 13C & 2H for GC-Mass Spectrometry |
| 143 | 5581-32-8 | Bisphenol A Bis(2,3-dihydroxypropyl) Ether | BISPHENOLADIGLYCIDYLETHERDIHYDRATE Bisphenol A Bis(2,3-dihydroxypropyl) Ether BISPHENOL A BIS(2,3-DIHYDROXYPROPYL) ETHER 2,2-BIS[4-(2,3-DIHYDROXYPROPOXY)PHENYL]PROPANE 2,2-BIS(4-(2,3-DIHYDROXYPROPANYL)PHENYL)PROPANE 3,3-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bispropane-1,2-diol 3,3-[(1-Methylethylidene)bis(4,1-phenylene)bis(oxy)]bis(1,2-propanediol) | Aromatics;Pharmaceuticals;Intermediates & Fine Chemicals |
| 144 | 129722-25-4 | DEHYDRO ARIPIPRAZOLE | DEHYDRO ARIPIPRAZOLE Aripiprazole Related CoMpound G 7-[4-[4-(2,3-Dichlorophenyl)-1-Piperazinyl]Butoxy]-2(1H)-Quinolinone 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one 2(1H)-Quinolinone,7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]- | Control substance;Aripiprazole impurity;Chemical raw materials;Impurity reference substance |
| 145 | 63659-16-5 | 4-[2-(CYCLOPROPYLMETHOXY)ETHYL]PHENOL | Betaxolol IMp. D (EP) Betaxolol EP Impurity D Betaxolol Hydrochloride Impurity D 4-[2-(Cyclopropylmethoxy)ethyl]phen Betaxolol Hydrochloride EP Impurity D 4-[2-(CYCLOPROPYLMETHOXY)ETHYL]PHENOL Phenol, 4-[2-(cyclopropylMethoxy)ethyl]- Betaxolol Impurity 4(Betaxolol EP Impurity D) | Aromatics;Intermediates;Aromatics Compounds |
| 146 | 3344-12-5 | ISO-MALATHION | 8063hc ISO-MALATHION S-(1,2-dicarboethoxyethyl)O,S-dimethyl phosphorodithioate (methoxy(methylthio)phosphinothioyl)butanedioicaciddiethylester butanedioicacid,((methoxy(methylthio)phosphinothioyl)thio)diethylester Diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl]butanedioate | ;Alphabetic;Metabolites;Analytical Standards;Pesticides&Metabolites;IEnvironmental Standards |
| 147 | 480452-36-6 | EthanediaMide iMpurity D | Edoxaban-4 Edoxaban impurity D Edoxaban iMpurities 4 EthanediaMide iMpurity D EthanediaMide iMpurity D N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-2-[(tert-Butoxycarbonyl)Amino ]-4-[(dimethylamino)carbonyl]-cyclohexyl) oxalamide tert-Butyl(1R,2S,5S)-2-({2-[(5-chloropyridin-2-yl)aMino]-2-oxoacetyl}aMino)-5-[(diMethylaMino)carbonyl]cyclohexyl-carbaMate Carbamic acid, n-[(1r,2s,5s)-2-[[2-[(5-chloro-2-pyridinyl) amino]-2-oxoacetyl]amino]-5-[(dimethylamino)carbonyl]cyclohexyl]-, 1,1-dimethylethyl ester | Chemical raw materials;Impurity reference substance;Pharmaceutical raw material intermediates;Reference substance-impurity reference substance |
| 148 | 1421312-32-4 | methyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate | ROXA-017 Roxadustat Impurities2 methyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate 3-Isoquinolinecarboxylic acid, 1,2-dihydro-4-hydroxy-1-oxo-7-phenoxy-, methyl ester | Impurity reference substance |
| 149 | 76002-91-0 | BISPHENOL A (2 3-DIHYDROXYPROPYL) GLYCID | Ccris 8664 BISPHENOL A (2 3-DIHYDROXYPROPYL) GLYCID 3-[4-[4-(Glycidyloxy)-α,α-dimethylbenzyl]phenoxy]propane-1,2-diol 3-[4-[1-[4-(Oxiranylmethoxy)phenyl]-1-methylethyl]phenoxy]propane-1,2-diol 3-[4-[1-Methyl-1-[4-(oxiranylmethoxy)phenyl]ethyl]phenoxy]-1,2-propanediol 4-(Glycidyloxy)-4-(2,3-dihydroxypropoxy)[1,1-(dimethylmethylene)bisbenzene] | |
| 150 | 20526-97-0 | 4-CHLOROBENZYLIDENE PHTHALIDE | 4-CHLOROBENZYLIDENE PHTHALIDE 3-(4-CHLOROBENZYLIDENE)PHTHALIDE 3-(p-Chlorobenzylidene)phthalide 3-[(4-chlorophenyl)methylene]phthalide 3-(4-Chlorobenzylidene)-1(3H)-isobenzofuranone 3-[(4-Chlorophenyl)methylene]-1(3H)-isobenzofuranone 3-[1-(4-Chloro-phenyl)-meth-(Z)-ylidene]-3H-isobenzofuran-1-one | Aromatics;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 151 | 13836-48-1 | BISPHENOL A (3-CHLORO-2-HYDROXYPROPYL) G | BISPHENOL A (3-CHLORO-2-HYDROXYPROPYL) G 2-[4-(3-chloro-2-hydroxypropyloxy)pheny]-2-[4-(glycidyloxy)phenyl]propane 2-Propanol, 1-chloro-3-[4-[1-methyl-1-[4-(2-oxiranylmethoxy)phenyl]ethyl]phenoxy]- BADGE-HCl, 2-[4-(3-Chloro-2-hydroxypropyloxy)pheny]-2-[4-(glycidyloxy)phenyl]propane | Impurity |
| 152 | 4809-35-2 | 2,2-BIS[4-(3-CHLORO-2-HYDROXYPROPOXY)PHENYL]PROPANE | 2,2-BIS[4-(3-CHLORO-2-HYDROXYPROPOXY)PHENYL]PROPANE 3,3-[1-Methylethylidenebis(4,1-phenyleneoxy)]bis(1-chloro-2-propanol) 3,3-[Isopropylidenebis(4,1-phenylene)bisoxy]bis(1-chloropropane-2-ol) | |
| 153 | 1985606-14-1 | Baloxavir marboxil | Xofluza XOFLUZA CS-2794 S-033188 aloxavir marboxil Baloxavir marboxil baloxavir marboxil S-033188 | API;Antivirus;Intermediates;Inorganic salts;Medical raw materials;Pharmaceutical raw materials;Reference substance-impurity reference substance;Pharmaceutical raw materials-scientific research raw m |
| 154 | 5353-15-1 | BENZENE,1,2,4-TRIMETHOXY-5-(2-PROPENYL)- | Euasarone Isoasarone 1,2,4-TRIMETHOXY-5-ALLYLBENZENE 2,4,5-Trimethoxy-1-allylbenzene 1,2,5-Trimethoxy-4-(2-propenyl)benzene 1,2,4-Trimethoxy-5-(2-propenyl)benzene BENZENE,1,2,4-TRIMETHOXY-5-(2-PROPENYL)- Benzene, 1,2,4-trimethoxy-5-(2-propen-1-yl)- | Standard;Phenylpropanine |
| 155 | 23560-59-0 | HEPTENOPHOS | hoe2982 RAGADAN hostavik Hoe 02982 HEPTENOPHOS 5-(o,o-dimethylphosphoryl)-6-chlorobicyclo(3.2.0)hepta-1,5-dien o,o'-dimethyl-o-(6-chlorobicyclo(3.2.0)heptadiene-1,5-yl)phosphate (7-chlorobicyclo(3.2.0)hepta-3,6-dien-6-yloxy)-phosphonicacidimethyles | Organochlorine insecticides |
| 156 | 934371-48-9 | Carbidopa impurity D | Carbidopa Impurity 2 Carbidopa impurity D Carbidopa EP Impurity D Carbidopa Methyl Ester N-Cyclohexylidene (S)-Carbidopa Methyl Ester N-Cyclohexylidene Carbidopa Impurity 4(Carbidopa EP Impurity D) Benzenepropanoic acid, α-(2-cyclohexylidenehydrazinyl)-3,4-dihydroxy-α-methyl-, methyl ester, (αS)- (+)-(L)-2-(N'-cyclohexylidenehydrazino)-3-(3,4-dihydroxyphenyl)-2-methyl propionic acid methyl ester | Carbidoba impurity;Reference substance;Impurity reference substance |
| 157 | 158812-85-2 | Omeprazole Sulfone N-Oxide | OMeprazole IMpurity-I (EP) Omeprazole Sulfone N-Oxide Omeprazole sulfonyl nitrogen oxide 4-Methoxy-2-[[5-Methoxy-1H-enziMidazol-2-l]sulfonl]Methyl]-3,5-diMenthlpridine 1-oxide 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole | Various Metabolites and Impurities |
| 158 | 869478-12-6 | Olodaterol Impurity 10 | Olodaterol Impurity 10 6-benzyloxy-(8R)-oxiranyl-4H-benzo[1,4]oxazin-3-one (R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one 8-(2R)-Oxiranyl-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one 8-(2R)-Oxiranyl-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-o... 2H-1,4-Benzoxazin-3(4H)-one, 8-[(2R)-2-oxiranyl]-6-(phenylmethoxy)- 6-(benzyloxy)-8-[(2R)-oxiran-2-yl]-3,4-dihydro-2H-1,4-benzoxazin-3-one (R) -6-benzoxy-8 - (ethylene oxide - 2-yl) -4H- benzo [1,4] oxazine - 3-1 (R)-6-(Benzyloxy)-8-(oxiran-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one (R)-6-(Benzyloxy)-8-(oxiran-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one | Impurity reference substance |
| 159 | 56490-94-9 | Olodaterol Impurity 11 | Olodaterol Impurity 11 2-(4-Methoxyphenyl)-1,1-dimethylethylamine 2-Methyl-1-(4-methoxyphenyl)-2-propanamine 1-(4-methoxyphenyl)-2-methylpropan-2-amine 1,1-dimethyl-2-(4-methoxyphenyl)ethylamine 1-(2-amino-2-methylpropyl)-4-methoxybenzene 1-(4-methoxyphenyl)-2-methylpropan-2-amine16 alpha,alpha-Dimethyl-4-methoxybenzeneethanamine [2-(METHOXYMETHOXY)PHENYL](4-PYRIDINYL)METHANONE | Impurity reference substance |
| 160 | 2227126-13-6 | Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborola | Crisaborole-007 Crisaborole Impurity 64 Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborola Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]- | Impurity reference substance |
| 161 | 384338-23-2 | 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE | Tofacitinib IMpurity F Tofacitinib Related Impurity 6 raceMic Mixture tofacitinib interMediat 1-Benzyl-4-methyl-3-(methylamino)piperidine N,4-dimethyl-1-(phenylmethyl)-3-Piperidinamine 3-PiperidinaMine, N,4-diMethyl-1-(phenylMethyl)- 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE (1-Benzyl-4-Methylpiperidin-3-yl)MethylaMine or dihydrochloride | toffatinib impurity |
| 162 | 1256584-80-1 | 9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile | 181484 Alectinib Impurity 12 IQWNZLQAANHDSH-UHFFFAOYSA-N 9-ethyl-8-iodo-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile 9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile 9-Ethyl-6,6-dimethyl-8-iodo-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile 9-ETHYL-8-IODO-6,6-DIMETHYL-11-OXO-6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE-3-CARBONITRILE 5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-8-iodo-6,6-dimethyl-11-oxo- 9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile-11 | Intermediates-Pharmaceutical Intermediates |
| 163 | 158062-67-0 | FLONICAMID | Aria F 1785 iki-220 FLONICAMID FLONICAMID STANDARD flonicamid (bsi, pa iso) N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide 3-Pyridinecarboxamide, N-(cyanomethyl)-4-(trifluoromethyl)- | Intermediates-Pharmaceutical Intermediates |
| 164 | 51481-10-8 | DEOXYNIVALENOL | DON VOMITOXIN NSC 269144 DEOXYNIVALENOL 4-Desoxynivalenol (3α,7α)-12,13-Epoxy-3,7,15-trihydroxytrichothec-9-en-8-one 3ALPHA,7ALPHA,15-TRIHYDROXY-12,13-EPOXYTRICHOTHEC-9-EN-8-ONE 12,13-epoxy-3,7,15-trihydroxy-,(3-alpha,7-alpha)-trichothec-9-en-8-on | Inhibitors;Chiral Reagents;Intermediates & Fine Chemicals |
| 165 | 23981-80-8 | (+|-)-2-(6-METHOXY-2-NAPHTHYL)PROPIONIC ACID | DL-NAPROXEN AKOS B006488 LABOTEST-BB LT00452004 2-(6-Methoxy-2-naphthyl)propionic acid DL-2-(6-METHOXY-2-NAPHTHYL)PROPIONIC ACID (+-)-2-(6-Methoxy-2-naphthalenyl)propionic acid | Aromatics;Pharmaceuticals;Intermediates & Fine Chemicals |
| 166 | 68813-55-8 | OXANTEL PAMOATE | OXANTEL PAMOATE 1-methyl-2-(3-hydroxyphenylethenyl)-1,4,5,6-tetrahydropyrimidine compound with 4,4'-methylenebis(3-hydroxy-2-naphthoic acid) | Aromatics;Heterocycles;Intermediates & Fine Chemicals |
| 167 | 43056-63-9 | 3-Amino-5-morpholinomethyl-2-oxazolidone | AMOZ 3-Amino-5-morpholinomethyl-2-oxazolidone 3-AMINO-5-MORPHOLINOMETHYL-2-OXAZOLIDINONE 5-Methylmorpholino-3-amino-2-oxazolidinone 3-AMINO-5-MORPHOLINO-METHYL-1,3-OXAZOLIDONE 5-(4-morpholinmethyl)-3-amino-2-oxazolidinone 3-amino-5-(4-morpholinomethyl)oxazolidin-2-one | Amines;Heterocycles;Metabolites & Impurities |
| 168 | 33103-93-4 | Demethyl Memantine Hydrochloride | Memantine Impurity 1 Adamantane Impurity 4 3-Methyl-1-aMinoadaMantane HCl 1-Amino -3-Methyladmantane HCl Demethyl Memantine Hydrochloride 3-MethyladaMantan-1-aMine hydrochloride (3-Methyl-1-adamantyl)amine hydrochloride 3-Methyltricyclo[3.3.1.13,7]decan-1-aMine | Amines;Pharmaceuticals;Intermediates & Fine Chemicals |
| 169 | 82373-95-3 | (22R,23R)-2A,3A,22,23-TETRAHYDROXY-24-ETHYL-BETA-HOMO-7-OXA-5A-CHOLESTAN-6-ONE | 28- high brassinolide (22R,23R)-2A,3A,22,23-TETRAHYDROXY-24-ETHYL-BETA-HOMO-7-OXA-5A-CHOLESTAN-6-ONE 6H-Benz[c]indeno[5,4-e]oxepin-6-one, 1-[(1S,2R,3R,4S)-4-ethyl-2,3-dihydroxy-1,5-dimethylhexyl]hexadecahydro-8,9-dihydroxy-10a,12a-dimethyl-, (1R,3aS,3bS,6aS,8S,9R,10aR,10bS,12aS)- | Intermediates-Pharmaceutical Intermediates |
| 170 | 42772-85-0 | 2-(4-Methylphenyl)sulfonyloxyethanol | OH-PEG1-Tos Theophylline Impurity 9 Doxofylline Impurity 26 2-(4-Methylphenyl)sulfonyloxyethanol 2-HYDROXYETHYL 4-METHYLBENZENESULFONATE 2-[(4-Methylbenzenesulfonyl)oxy]ethan-1-ol 2-Hydroxyethyl-4-methyl benzene sulphonate 1,2-Ethanediol, 1-(4-methylbenzenesulfonate) | Intermediates-Pharmaceutical Intermediates |
| 171 | 17685-04-0 | ETHYL B-D-GLUCURONIDE | ethyl glucuronide Ethyl -D-glucuronide ETHYL B-D-GLUCURONIDE Ethyl--D-6-glucuronide Ethyl beta-D-Glucuronide Ethyl-β-D-glucopyranosiduronsaeure b-D-Glucopyranosiduronic acid, ethyl- 6-Ethoxy-3,4,5-trihydroxy-tetrahydro-pyran-2-carboxylicAcid | Metabolites;Glucuronides;Carbohydrates & Derivatives |
| 172 | 128311-06-8 | (3S)-N-[(1R)-1-Phenylethyl]Quinuclidin-3-Amine Dihydrochloride | Solifenacin Impurity 25 (R-(R*,S*))-(-)-N-(1-phenylethyl)-1-aza-bicyclo(2 (3S)-N-[(1R)-1-Phenylethyl]Quinuclidin-3-Amine Dihydrochloride (-)-N-(1(R)-Phenylethyl)-1-azabicyclo[2.2.2]octan-3(S)-amine dihydrochloride (3S)-N-[(1R)-1-PHENYLETHYL]-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE (3S)-N-[(1R)-1-Phenylethyl]-1-azabicyclo[2.2.2]octan-3-aMine Dihydrochloride [R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE | Others;Amines;Heterocycles;Intermediates;Chiral Building Blocks;Chiral Building Blocks;Isotope Labelled Compounds;Heterocyclic Building Blocks;Heterocyclic Building Blocks |
| 173 | 154026-92-3 | TERT-BUTYL (S)-6-CHLORO-5-HYDROXY-3-OXOHEXANOATE | Rosuvastatin Impurity 83 Tert-Butyl 6-chloro-5(S)-hydroxy-3-oxohexanoate TERT-BUTYL (S)-6-CHLORO-5-HYDROXY-3-OXOHEXANOATE tert-butyl (5S)-6-chloro-5-hydroxy-3-oxohexanoate (S)-Tertiary-Butyl-6-Chloro-5-Hydroxy-3-Oxo Hexanoate 2-Methyl-2-Propanyl (5S)-6-Chloro-5-Hydroxy-3-Oxohexanoate Hexanoic acid, 6-chloro-5-hydroxy-3-oxo-, 1,1-dimethylethyl ester, (5S)- | Intermediates-Pharmaceutical Intermediates |
| 174 | 31078-36-1 | N-VANILLYLDECANAMIDE | N-VANILLYLDECANAMIDE Decylic acid vanillylamide N-[(4-Hydroxy-3-methoxyphenyl)methy N-(4-hydroxy-3-methoxybenzyl)decanamide n-((4-hydroxy-3-methoxyphenyl)methyl)-decanamid Decanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]- | Natural Plant Extract Analysis Standard |
| 175 | 42123-27-3 | Tetradehydropodophyllotoxin | Tetradehydropodophyllotoxin | reference substance;standard, reference substance |
| 176 | 7224-66-0 | coryneine | coryneine Trimethyl(3 Quaternary dopamine 4-dihydroxyphenethyl)aminium Trimethyl(3,4-dihydroxyphenethyl)aminium 4-dihydroxyphenyl)ethyl-trimethylazanium | Standard substance;Traditional Chinese medicine reference substance |
| 177 | 58493-47-3 | N-VANILLYLOCTANAMIDE | N-VANILLYLOCTANAMIDE Octanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]- | |
| 178 | 5578-73-4 | SANGUINARINE CHLORIDE | SANGUINARINE HCL PSEUDOCHELERYTHRINE SANGUINARINE CHLORIDE PSEUDOCHELERYTHRINE CHLORIDE Sanguinarine chloride, froM Macleaya cordata 13-METHYL-[1,3]BENZODIOXOLO[5,6-C]-1,3-DIOXOLO[4,5-I] PHENANTHRIDINIUM CHLORIDE | Standards;Analysis of standards |
| 179 | 638-97-1 | 18BETA(H)-OLEAN-12-EN-3-ONE | Β-AMYRONE β-Amyrone beta-Amyrone beta-AMyrenone Olean-12-en-3-one 18(H)-Olean-12-en-3-one 18(H)-OLEAN-12-EN-3-ONE 18BETA(H)-OLEAN-12-EN-3-ONE (6aR,6bS,8aR,12aS,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-2,4a,5,6,7,8,9,10,12,12a,14,14a-dodecahydro-1H-picen-3-one | Standard;Triterpene;Plant extract |
| 180 | 34000-39-0 | HOMOBUTEIN | HOMOBUTEIN HOMOBUTEIN hplc Einecs 251-782-7 3-O-methylbutein HOMOBUTEIN WITH HPLC 4,2',4'-Trihydroxy-3-methoxychalcone (E)-2',4,4'-trihydroxy-3-methoxychalcone (E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propen-1-one | Chalcones;Plant extract;Standard substance |
| 181 | 32897-26-0 | 1-Ethyl-3(3-dimethylamino)urea | synthesis-004 Avanafil Impurity 65 1-Ethyl-3(3-dimethylamino)urea 1-Ethyl-3-(3-dimethylaminopropyl)urea 1-[3-(DiMethylaMino)propyl]-3-ethylurea 1-ETHYL-1-3-(3-DIMETHYLAMINOPROPYL)UREA Urea, N-[3-(dimethylamino)propyl]-N'-ethyl- 1-Ethyl-3-(3-diMethylaMinopropyl)urea hydrochloride | Impurity reference substance;Synthetic material intermediate;Reference substance-impurity reference substance |
| 182 | 29801-94-3 | Potassium phthalate (2:1) | BUFFER REAGENT 551.1 CH BUFFER REAGENT POTASSIUM HYDROGEN PHTHALATE | Intermediates-Pharmaceutical Intermediates |
| 183 | 13707-88-5 | ALPRENOLOL HYDROCHLORIDE | aptin aptine aprobal apllobal betaptin aptolduriles alprenolhydrochloride ALPRENOLOL HYDROCHLORIDE 1-isopropylamino-3-(o-allylphenoxy)-2-propanolhydrochloride | Synthesis;hypoglycemic and antihypertensive products |
| 184 | 55665-95-7 | methyl sulfamate | methyl sulfamate Sulfamic acid, methyl ester Sulfamic Acid Impurity 1(Sulfamic Acid Methyl Ester) Sulfamic Acid Methyl Ester (Amidosulfuric Acid Methyl Ester) 9-chloro-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | Impurity reference substance |
| 185 | 1229428-89-0 | Posaconazole iMpurity | Posaconazole IMP ent-Posaconazole Posaconazole IMP Posaconazole iMpurity Posaconazole Impurity S 2,6-Difluoro Posaconazole (3R,5S,2R,3R)-posaconazole Posaconazole Diastereoisomer 14 Posaconazole Diastereoisomer 10 | Impurity reference substance |
| 186 | 1133-64-8 | (R,S)-N-NITROSOANABASINE | 1-nitroso-anabasin n-nitrosoanabasine 1-nitrosoanabasine n'-nitrosoanabasine (R,S)-N-NITROSOANABASINE 3-(1-nitroso-2-piperidyl)pyridine n-nitroso-2-(3'-pyridyl)piperidine (s)-3-(1-Nitrosopiperidin-2-yl)-pyridine 3-[(2S)-1-Nitroso-2-piperidinyl]pyridine | Heterocycles;Chiral Reagents |
| 187 | 5452-87-9 | N-Methyl-N,N-bis(2-pyridylethyl)amine | NSC19005 NSC 19005 Betahistine EP Impurity C Methylbis(2-pyridylethyl)aMine METHYLBIS(2-PYRIDYLETHYL)AMINE N-METHYLBIS[2-(2-PYRIDYLETHYL)]AMINE N-Methylbis[2-(2-pyridylethyl)]aMine N-Methyl-N,N-bis(2-pyridylethyl)aMine N-Methyl-N,N-bis(2-pyridylethyl)amine N-Methyl-N-[2-(2-pyridinyl)ethyl]-2-pyridineethanaMine N-METHYL-N-[2-(2-PYRIDINYL)ETHYL]-2-PYRIDINEETHANAMINE N-methyl-2-(pyridin-2-yl)-N-(2-(pyridin-2-yl)ethyl)ethanamine | Amines;Aromatics;Heterocycle;Heterocycles;Intermediates |
| 188 | 148-51-6 | 4-Deoxypyridoxine hydrochloride | Deoxypyridoxine hydrochloride 4-DesoxyaderMin Hydrochloride 4-Deoxypyridoxine hydrochloride 4-Desoxypyridoxine Hydrochloride 5-(HydroxyMethyl)-2,4-diMethyl-3-hydroxypyridine HCl 3-Hydroxy-5-hydroxyMethyl-2,4-diMethylpyridine Hydrochloride 2,4-DiMethyl-3-hydroxy-5-hydroxyMethylpyridine Hydrochloride | Pyridines;Pharmaceuticals |
| 189 | 54239-39-3 | CIMBUTEROL | CIMBUTEROL Cimbuterol Solution, 100ppm 5-[2-(tert-butylamino)-1-hydroxyethyl]anthranilonitrile Benzonitrile, 2-amino-5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]- | Amines;Aromatics |
| 190 | 132036-42-1 | Ramosetron Impurity 12 | Ramosetron Impurity 12 N-[4,5,6,7-Tetrahydrobenzimidazole-5-yl)carbonyl] pyrrolidine sulfate N-[4,5,6,7-TetrahydrobenziMidazole-5-yl)carbonyl] pyrrolidine hydrochloride 1-Pyrrolidinyl(4,5,6,7-tetrahydro-1H-benzimidazol-6-yl)methanone hydrochloride 1-[(4,5,6,7-Tetrahydro-1H-benzimidazol-5-yl)carbonyl]pyrrolidine monohydrochloride (4,5,6,7-tetrahydro-1H-benzo[d]iMidazol-5-yl)(pyrrolidin-1-yl)Methanone hydrochloride | Heterocycles |
| 191 | 844648-22-2 | 5,7-difluorochroMan-4-one | Tegoprazan Impurity 10 5,7-difluorochroMan-4-one 5,7-difluorochroman-4-one 5,7-Difluoro-3,4-dihydro-4H-chromen-4-one 5,7-Difluoro-2,3-dihydro-4H-chromen-4-one 5,7-DIFLUORO-2,3-DIHYDRO-1-BENZOPYRAN-4-ONE 5,7-difluoro-3,4-dihydro-2H-1-benzopyran-4-one 4H-1-Benzopyran-4-one, 5,7-difluoro-2,3-dihydro- | Impurity reference substance |
| 192 | 66082-42-6 | POLYGLYCERYL-3 DIISOSTEARATE | EMerest 2452 POLYGLYCERYL-3 DIISOSTEARATE Polyglycerol-3 diisostearate Isooctadecanoic acid, diester with triglycerol [2-hydroxy-3-[2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propoxy]propyl] 16-methylheptadecanoate | Organic raw materials;Organic chemical industry |
| 193 | 501-58-6 | 4,4''-Dimethoxyazoxybenzene | 4,4'-Azodianisole 4,4''-Dimethoxyazoxybenzene Bis(4-methoxyphenyl)diazene 1,2-Bis(4-methoxyphenyl)diazene Diazene, 1,2-bis(4-methoxyphenyl)- | Reference substance-impurity reference substance |
| 194 | 35572-78-2 | 2-AMINO-4,6-DINITROTOLUENE | 3,5-dinitro-o-toluidin o-Toluidine, 3,5-dinitro- 2-AMINO-4,6-DINITROTOLUENE 2,4-Dinitro-6-aminotoluene 2-Methyl-3,5-dinitroaniline 2-Methyl-3,5-dinitrobenzenamine Benzenamine, 2-methyl-3,5-dinitro- | Amines;AromaticsEnvironmental Standards |
| 195 | 22235-81-0 | endo-(±)-8-aza-8-isopropylbicyclo[3.2.1]oct-3-yl (hydroxymethyl)phenylacetate | Ipratropium Impurity E N-Isopropylnoratropine N-DesMethyl IpratropiuM Ipratropium Bromide Impurity 13(Ipratropium EP Impurity E) endo-(±)-8-aza-8-isopropylbicyclo[3.2.1]oct-3-yl (hydroxymethyl)phenylacetate α-(HydroxyMethyl)benzeneacetic Acid endo-8-(1-Methylethyl)-8- azabicyclo[3.2.1]oct-3-yl Ester α-(HydroxyMethyl)benzeneacetic Acid endo-8-(1-Methylethyl)-8- azabicyclo[3.2.1]oct-3-yl Ester α-(HydroxyMethyl)benzeneacetic Acid (3-Endo)-8-(1-Methylethyl)-8-azabicyclo[3.2.1]- oct-3-yl Ester α-(HydroxyMethyl)benzeneacetic Acid (3-Endo)-8-(1-Methylethyl)-8-azabicyclo[3.2.1]- oct-3-yl Ester rac-(R*)-α-(Hydroxymethyl)benzeneacetic acid (1R,5S)-8-isopropyl-8-azabicyclo[3.2.1]octane-3α-yl ester | Aroamtics;Pharmaceuticals;Intermediates & Fine Chemicals;Aroamtics, Pharmaceuticals, Intermediates;Aroamtics, Pharmaceuticals, Intermediates & Fine Chemicals |
| 196 | 496-76-4 | ISOBARBITURIC ACID | ISOBARBITURIC ACID Fluorouracil EP Impurity B dihydropyrimidine-2,4,5(3H)-trione 1,6-Dihydro-2,4,5(3H)-pyrimidinetrione 2-Hydroxy-1,6-dihydropyrimidine-4,5-dione 2,4,5(3H)-Pyrimidinetrione, dihydro- (9CI) 2,4,5-Trihydroxypyrimidine, 5-Hydroxyuracil Fluorouracil Impurity 2(Fluorouracil EP Impurity B) | Aromatic;PYRIMIDINE;Nucleotides;Heterocycles;APIs & Intermediate;Bases & Related Reagents |
| 197 | 134-05-4 | 10-Formylfolic Acid | 10-formylfolic acid 10-Formylfolic Acid N10-ForMylfolic Acid Folic Acid Impurity 12 10-FORMYLFOLIC ACID (25 MG) 10-ForMylpteroylglutaMic Acid N-[p-[N-[(2-AMino-4-hydroxy-6-pteridinyl)Methyl]forMaMido]benzoyl]-glutaMic Acid N-[4-[[(2-AMino-3,4-dihydro-4-oxo-6-pteridinyl)Methyl]forMylaMino]benzoyl]-L-glutaMic Acid | Aromatics;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 198 | 74663-48-2 | 2-Isopropyl-6-propylphenol (Propofol Impurity O) | Brn 4383251 PROPOFOL-IMI Propofol Impurity O Propofol EP Impurity O 2-(1-Methylethyl)-6-propyl 2-Isopropyl-6-propylphenol Phenol, 2-isopropyl-6-propyl- 2-(1-Methylethyl)-6-propylphenol 2-Isopropyl-6-propylphenol (Propofol Impurity O) | Impurities;Pharmaceuticals;Chemical Impurities;Intermediates & Fine Chemicals |
| 199 | 1807632-95-6 | Dapagliflozin iMpurity | Dapagliflozin-8 Dapagliflozin IMP Dapagliflozin α-Isomer Dapagliflozin iMpurity Deschloro Dapagliflozin Dapagliflozin 4-Bromo Analog 4-Deschloro-4-bromo Dapagliflozin D-Glucitol, 1,5-anhydro-1-C-[4-bromo-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)- | Reference substance-impurity reference substance;Analysis and detection of impurities in new drugs |
| 200 | 1355357-49-1 | Remdesivir impurity2 | Remdesivir impurity2 Remdesivir Impurity 5 Remdesivir intermediate Remdesivir Tri-o benzyl Nitrile Impurity (2R,3R,4R,5R)-2-(4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZIN-7-YL)-3,4-BIS(BENZYLOXY)-5-((BENZYLOXY)METHYL)T 2-C-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-3,4,6-tris-O-(phenylmethyl)-D-altrononitrile (2R,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carbonitrile | Chemical industry;Impurities of API;Synthetic intermediates |
| 201 | 26473-47-2 | 3-MERCAPTOISOBUTYRIC ACID | Captopril impurity C Captopril EP IMpurity C 3-MERCAPTOISOBUTYRIC ACID 2-(Mercaptomethyl)propanoic acid 3-MERCAPTO-2-METHYLPROPANOIC ACID 2-Methyl-3-sulfanylpropanoic acid Captopril Impurity 3(Captopril EP Impurity C) | Pharmaceuticals;Intermediates & Fine Chemicals |
| 202 | 6341-72-6 | alpha-Methyl-4-biphenylacetic acid | LY-71130 p-Phenylhydroatropic acid Flurbiprofen EP impurity A Flurbiprofen EP impurity A -E α-Methyl-4-biphenylacetic acid α-Methylbiphenyl-4-acetic acid 2-(Biphenyl-4-yl)propanoic acid alpha-Methyl-4-biphenylacetic acid 2-([1,1'-biphenyl]-4-yl)propanoic acid | Aromatics;Inhibitors |
| 203 | 23282-20-4 | NIVALENOL | NIV NIVALENOL 3-alpha,4-beta,7-alpha,15-tetrahydroxyscirp-9-en-8-one 12,13-epoxy-3,4,7,15-tetrahydroxytrichothec-9-en-8-one 3ALPHA,4BETA,7ALPHA,15-TETRAHYDROXY-12,13-EPOXYTRICHOTHEC-9-EN-8-ONE 12,13-epoxy-3alpha,4beta,7alpha,15-tetrahydroxy-trichothec-9-en-8-on 12,13-epoxy-3-alpha,4-beta,7-alpha,15-tetrahydroxy-trichothec-9-en-8-on trichothec-9-en-8-one,12,13-epoxy-3,4,7,15-tetrahydroxy-,(3-alpha,4-beta,7-al | Other;mycotoxin;Biotoxins;CRM&Matrix;Mycotoxins;RMBiotoxins;Antibiotics;CRM & Matrix;NeatApplication CRMs;Food and Agriculture CRM |
| 204 | 77568-65-1 | GAMMA-BUTYROLACTONE-D6 | 1,4-Butanolide-d6 GAMMA-BUTYROLACTONE-D6 2-Oxotetrahydrofuran-d6 1-Oxacyclopentan-2-one-d6 2,3,4,5-Tetrahydro-2-furanone-d6 dihydrofuran-2(3H)-one-3,3,4,4,5,5-d6 2(3H)-Furanone-3,3,4,5-d4, dihydro-d2- | B;Heterocycles;Intermediate;Stable Isotopes;Alphabetical Listings;Isotope Labelled Compounds |
| 205 | 1061604-41-8 | 3-(4-hydroxy-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | Lenalidomide-4-OH Benzoylchloride,4-chloro-4-fluoro- 3-(4-Hydroxy-1-oxo-isoindolin-2-yl)piperidine-2,6-dione 3-(4-hydroxy-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione 3-(4-hydroxy-1-oxo-2,3-dihydro-1H-isoindol-2-yl)pi peridine-2,6-dione 3-(4-hydroxy-1-oxo-2,3-dihydro-1H-isoindol-2-yl)pi peridine-2,6-dione 2,6-Piperidinedione, 3-(1,3-dihydro-4-hydroxy-1-oxo-2H-isoindol-2-yl)- | Impurity reference;Pharmaceutical R & D intermediates |
| 206 | 3585-49-7 | 2-(4-butylphenyl)propanoic acid | p-Butyl Ibuprofen p-Butylhydratropic Acid 2-(4-butylphenyl)propanoic acid 2-(p-Butylphenyl)propionic Acid 2-(4-n-Butylphenyl)propionic Acid 4-Butyl-α-Methylbenzeneacetic Acid (2RS)-2-(4-Butylphenyl)propionic acid 4-butyl-.alpha.-methylbenzeneacetic acid | Standard;Impurity reference substance |
| 207 | 64858-90-8 | Flurbiprofen Impurity | Ethyl Flurbiprofen Flurbiprofen Impurity Flurbiprofen Impurity L Flurbiprofen Ethyl Ester Flurbiprofen axetil impurity4 Flurbiprofen axetil impurity1426 ethyl2-(2-fluoro-4-biphenylyl)-propionate ethyl 2-(2-fluoro-[1,1'-biphenyl]-4-yl)propanoate [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-α-methyl-, ethyl ester | Impurity reference substance |
| 208 | 42771-79-9 | 4-Acetyl-2-fluorobiphenyl | FlurBiprofen impurity 4 4-ACETYL-2-FLUOROBPHENYL 2-Fluoro-4-acetylbiphenyl 4-Acetyl-2-fluorobiphenyl Flurbiprofen EP Impurity D 3-Fluoro-4-phenyl acetophenone 1-(3-fluoro-4-phenylphenyl)ethanone 1-(2-Fluoro-biphenyl-4-yl)-ethanone 1-(3-Fluoro-4-phenylphenyl)ethan-1-one 1-(2-fluoro-[1,1'-biphenyl]-4-yl)ethan-1-one | Standard;Flurbiprofen impurity;Impurity reference substance;Aromatics, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 209 | 55258-76-9 | 4-ETHYL-2-FLUORO-1,1'-BIPHENYL | Flurbiprofen Impurity G Flurbiprofen Impurity 6 Flurbiprofen EP Impurity Flurbiprofen EP Impurity F Flurbiprofen Related Impurity 4-ETHYL-2-FLUORO-1,1'-BIPHENYL 4-ethyl-2-fluoro-1-phenylbenzene 4-ethyl-2-fluoro-1,1-biphenyl(Flurbiprofen EP Impurity F) | Standard;Impurity reference substance |
| 210 | 137045-30-8 | 2-Fluorobiphenyl-4-carboxylic Acid | FlurBiprofen impurity 5 Flurbiprofen EP Impurity E 3-fluoro-4-phenylbenzoic acid 3-FLUORO-4-BIPHENYLCARBOXYLIC ACID 2-FLUOROBIPHENYL-4-CARBOXYLIC ACID 2-Fluorobiphenyl-4-carboxylic Acid 2-Fluoro-[1,1'-biphenyl]-4-carboxylic acid | Aromatics;Impurities;C13 to C42+;Pharmaceuticals;Carboxylic Acids;Carbonyl Compounds;Flurbiprofen impurity;Impurity reference substance;Intermediates & Fine Chemicals |
| 211 | 477860-13-2 | 3-Fluoro-4-phenylphenol | 3-Fluoro-4-phenylphenol Flurbiprofen Impurity 13 2-fluoro-[1,1'-biphenyl]-4-ol [1,1'-Biphenyl]-4-ol, 2-fluoro- Flurbiprofen 1,2,3-Propanetriol Esters (Mixture of Regio- and Stereoisomers) | Impurity reference substance |
| 212 | 1685278-08-3 | Desfluoro flurbiprofen axetil | Desfluoro flurbiprofen axetil 1-acetoxyethyl 2-([1,1'-biphenyl]-4-yl)propanoate Desfluoro Flurbiprofen Axetil (Mixture of Diastereomers) [1,1'-Biphenyl]-4-acetic acid, α-methyl-, 1-(acetyloxy)ethyl ester | Standard;Impurity reference substance |
| 213 | 953787-55-8 | PANTOPRAZOLE SULFONE N-OXIDE | Pantoprazole Impurity 6 Pantoprazole Impurity H PANTOPRAZOLE SULFONE N-OXIDE Pantoprazole IMpurity(Sulfone-N-Oxide) 6-(DifluoroMethoxy)-2-[[(3,4-diMethoxy-1-oxido-2-pyridinyl)Methyl]sulfonyl]-1H-benziMidazole 5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl] sulfonyl} benzimidazol-1-ide N-oxide 6-(difluoromethoxy)-2-[(3,4-dimethoxy-1-oxidopyridin-1-ium-2-yl)methylsulfonyl]-1H-benzimidazole 2-(((6-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)sulfonyl)methyl)-3,4-dimethoxypyridine 1-oxide 2-(((5-(difluoromethoxy)-1H-benzo[d]imidazol-2-yl)sulfonyl) methyl)-3,4-dimethoxypyridine 1-oxide | Reference substance-impurity reference substance |
| 214 | 43109-77-9 | o-AdaMantylanisole | ADAP-IMA o-AdaMantylanisole Adapalene Related CoMpound C 1-(o-Methoxyphenyl)adaMantane 2-(Adamant-1-yl)methoxybenzene 1-(2-Methoxyphenyl)ticyclo[3.3.1.13,7]decane 1-(2-Methoxyphenyl)-tricyclo[3.3.1.13,7]decane Adapalene Related Compound C (25 mg) (2-(adamant-1-yl)methoxybenzene) | Impurity reference substance |
| 215 | 4121-39-5 | NSC 77154 | NSC 77154 Tenofovir Impurity U 9-(2-Propenyl)adenine 9-Allyl-9H-purin-6-aMine Tenofovir 9-Allyl Impurity Tenofovir 9-Propenyl Impurity 9-(2-propen-1-yl)-9H-Purin-6-amine 9-(prop-2-en-1-yl)-9H-purin-6-aMine | Reference substance-impurity reference substance |
| 216 | 80508-23-2 | rac N'-Nitrosonornicotine | syn-NNitrosonornicotine anti-NNitrosonornicotine rac N'-Nitrosonornicotine 3-[(2R, S)-1-Nitroso-2-pyrrolidinyl]-pyridine Pyridine, 3-(1-nitroso-2-pyrrolidinyl)-, (S)- 1-Nitroso-2-(3-pyridyl)pyrrolidine, 3-(1-Nitroso-2-pyrrolidinyl)pyridine, NNN 1-Nitroso-2-(3-pyridyl)pyrrolidine, 3-(1-Nitroso-2-pyrrolidinyl)pyridine, NNN | Aromatics;Heterocycles;Chiral Reagents;Analytical standard;Nicotine Derivatives;Nitric Oxide Reagents;Mutagenesis Research Chemicals |
| 217 | 122008-78-0 | butyl 2-[4-(4-cyano-2-fluoro-phenoxy)phenoxy]propanoate | Cyhalofop Cyhalofop acid Cyhalofop [iso 2-(4-ARYLOXYPHENOXY)PROPIONICACID butyl 2-[4-(4-cyano-2-fluoro-phenoxy)phenoxy]propanoate (2R)-2-[4-(4-Cyano-2-fluorophenoxy)phenoxy]propanoic acid (R)-( )-2-(4-(2-Fluoro-4-cyanophenoxy)phenoxy)propanoic acid Propanoic acid, 2-(4-(4-cyano-2-fluorophenoxy)phenoxy)-, (R)- | Organochlorine insecticides |
| 218 | 1464851-21-5 | (Z)-Mutagenic Impurity of Tenofovir Disoproxil | Tenofovir Impurity 59 (Z)-9-Propenyladenine 9-[(Z)-1-Propenyl]-9H-purine-6-amine 9H-Purin-6-amine, 9-(1Z)-1-propen-1-yl- (Z)-9-(prop-1-en-1-yl)-9H-purin-6-amine (Z)-Mutagenic Impurity of Tenofovir Disoproxil (Z)-9-Propenyladenine ((Z)-Mutagenic Impurity of Tenofovir Disoproxil) | Impurity reference substance |
| 219 | 69675-10-1 | Paroxetine EP IMpurity G | Paroxetine USP RC E Paroxetine impurity G Paroxetine EP IMpurity G Paroxetine HCl Hemihydrate EP Impurity G 4-(4-fluorophenyl)-1-methyl-3,6-dihydro-2H-pyridine 4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine Pyridine,4-(4-fluorophenyl)-1,2,3,6-tetrahydro-1-methyl- Paroxetine Impurity 1(Paroxetine HCl Hemihydrate EP Impurity G) | Paroxetine;Pharmaceutical raw materials |
| 220 | 1609-00-3 | 1-METHYLBIGUANIDE SULPHATE | 1-Methylbiguanide Monomethylbiguanide Metformin USP Impurity B 1-METHYLBIGUANIDE SULPHATE N-Methyl-N'-guanylguanidine N-Methylimidodicarbonimidic diamide Imidodicarbonimidicdiamide, N-methyl- Metformin EP Impurity E(Not Continue) | Impurity reference substance |
| 221 | 6795-23-9 | AFLATOXIN M1 | AF M1 ALFATOXINM1 Aflatoxin M1 AFLATOXIN M1 aflatoxin m1solution aflatoxin m1 solution 4-Hydroxyaflatoxin B1 Aflatoxin M1 standard solution 38546, AFLATOXIN M STANDARD SOLUTIO | Pharmaceutical raw materials;Traditional Chinese medicine reference substance |
| 222 | 143545-90-8 | Cylindrospermopsin | cylindrospermopsin Cylindrospermopsin 5a-alpha,7-beta(r*))-(-)-h sulfooxy)-1h-1,8,8b-triazaacenaphthylen-7-yl)methyl)-,(2a-alpha,3-alpha,4-alp 2,4(1h,3h)-pyrimidinedione,6-(hydroxy(2,2a,3,4,5,5a,6,7-octahydro-3-methyl-4-( 6-[(R)-Hydroxy[(2aS,3R,4S,5aS,7R)-2,2a,3,4,5,5a,6,7-octahydro-3-methyl-4-(sulfooxy)-1H-1,8,8b-triazaacenaphthylen-7-yl]methyl]-2,4(1H,3H)-pyrimidinedione | Chemical reagent |
| 223 | 101043-37-2 | MICROCYSTIN-LR | MCYST-LR Microcystin-LR MICROCYSTIN-LR CYANOGINOSIN-LR 5-L-Arginine-cyanoginosin 5-l-arginine-cyanoginosinl 5-l-argininecyanoginosinla 5-L-ARGININE-MICROCYSTIN LA Cyanoginosin, Fast-death factor Cyclo[D-Ala-L-Leu-[(3S)-3-methyl-D-βAsp-]-L-Arg-[(2S,3S)-2-methyl-3-[(1E,3E,5S,6S)-3,5-dimethyl-6-methoxy-7-phenyl-1,3-heptadiene-1-yl]-βAla-]-D-γGlu-N-methyl-Dha-] | Biochemical industry;Chemical raw materials |
| 224 | 70110-59-7 | 5-Heneicosyl-1,3-dihydroxybenzene | 5-Heneicosylresorcinol 5-Heneicosyl-1,3-benzenediol 1,3-Benzenediol, 5-heneicosyl- 5-Heneicosyl-1,3-dihydroxybenzene | Reference substance;Synthetic material intermediate |
| 225 | 5436-43-1 | 2,2',4,4'-TETRABROMODIPHENYL ETHER | BDE-47 BDE No 47 PBDECONGENER47 BDE No 47 solution 1,1'-Oxybis(2,4-dibromobenzene) 4,4'-Oxybis(1,3-dibromobenzene) 2,2',4,4'-TETRABROMODIPHENYL ETHER 2,2μ,4,4μ-TetraBDE, 2,2μ,4,4μ-Tetrabromodiphenyl ether solution, PBDE 47 | Biphenyl;Chemical raw materials |
| 226 | 1445-75-6 | Diisopropyl Methylphosphonate | DIMP Dimp (phosphonate) Diisopropyl Methylphosphonate o,o-Diisopropyl methylphosphonate methyl-phosphonicaciddiisopropylester Diisopropyl methylphosphonate solution methyl-phosphonicacibis(1-methylethyl)ester Phosphonic acid,P-methyl-, bis(1-methylethyl) ester | Pharmaceutical raw materials |
| 227 | 33377-72-9 | Theaflavine-3,3'-digallate | THEAFLAVINGALLATES Teaflavin digallate theaflavin digallate Theaflavine bisgallate Theaflavine-3,3'-digallate THEAFLAVINE-3,3'-DIGALLATE Theaflavine-3,3'-digallate(TFBG) (2R,3R)-2-(3,5-dihydroxy-6-oxo-8-[(3R)-3,5,7-trihydroxy-3,4-... 3,4,5-Trihydroxybenzoic acid diester with 1,8-bis(3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-2-yl)-3,4,6-trihydroxy-5H-benzocyclohepten-5-one | Refer;Plant extract;Standard substance-reference substance;Standard substance, reference substance;Traditional Chinese medicine standard substance;Traditional Chinese medicine reference substance |
| 228 | 26296-54-8 | Physcion-1-O-β-D-glucoside | C10384 Physcionin Physcion 8-glucoside Physcion-1-O-β-D-glucoside Physcion-8-O-β-D- glucoside Physcion 8-o-beta-D-monoglucoside Physcion-1-O-beta-D-Glucopyranoside 3-Methyl-6-methoxy-1,8-dihydroxyanthraquinone 1-glucoside 1-Hydroxy-3-Methoxy-6-Methyl-8-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxyMethyl)tetrahydro-2H-pyran-2-yl)oxy)anthracene-9,10-dione | Plant extract;Standard substance;Reference substance;Standard substance-reference substance;Traditional Chinese medicine reference substance;Reference substance-traditional Chinese medicine refer |
| 229 | 86831-54-1 | Rhodiosin; Herbacetin-7-O-glucorhamnoside | Rhodiosin RHODIOSIN HERBACETIN-7-O-GLUCORHAMNOSIDE Rhodiosin Herbacetin-7-O-glucorhamnoside herbacetin 7-O-(3''-O-β-D-glucopyranosyl-α-L-rhamnopyranoside) 7-[(3-O-β-D-Glucopyranosyl-α-L-rhamnopyranosyl)oxy]-3,4',5,8-tetrahydroxyflavone 7-[3-O-(β-D-Glucopyranosyl)-α-L-rhamnopyranosyloxy]-3,5,8-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one 4H-1-Benzopyran-4-one, 7-[(6-deoxy-3-O-β-D-glucopyranosyl-α-L-mannopyranosyl)oxy]-3,5,8-trihydroxy-2-(4-hydroxyphenyl)- | Plant extract;Standard substance;Reference substanc;Penta-substituted Flavones;Plant extraction standard substance;Chinese medicine reference substance;Reference substance, standard substance, plant m |
| 230 | 63550-99-2 | Rebaudioside C | Dulcoside B RebaudiosideC Rebaudioside C Rebaudioside C 63550-99-2 Rebaudioside C (Dulcoside B) (4R)-13-[[2-O-(6-Deoxy-α-L-mannopyranosyl)-3-O-(β-D-glucopyranosyl)-β-D-glucopyranosyl]oxy]kaur-16-en-18-oic acid β-D-glucopyranosyl ester (4α)-13-[(O-6-Deoxy-α-L-mannopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid β-D-glucopyranosyl ester (4alpha)-13-[(O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid beta-D-glucopyranosyl ester | Diterpene;phytochemical;Plant extract;chemical reagent;Standard substance;Reference substance;pharmaceutical intermediate;standardized herbal extract;Standard substance-tradition;Plant extraction stan |
| 231 | 28371-16-6 | Aloin B；Isobarbaloin | Aloin B Isobarbaloin Aloin B；Isobarbaloin dihydroxy-3-(hydroxymethyl)-,(R)- 9(10H)-Anthracenone,10-β-D-glucopyranosyl-1,8- (R)-10-(β-D-Glucopyranosyl)-1,8-dihydroxy-3-(hydroxymethyl)-9(10H)-anthracenone (R)-10-(β-D-Glucopyranosyl)-1,8-dihydroxy-3-(hydroxymethyl)anthracen-9(10H)-one (10R)-10-β-D-Glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10H)-anthracenone 9(10H)-Anthracenone,10-b-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-,(10R)- | Standa;Plant extract;Standard substance;Reference substance;Standard substance-traditional Chinese medicine standard substance;Reference substance-traditional Chinese medicine reference substance |
| 232 | 38412-46-3 | Aloenin | Aloenin ALOENIN A ALOENIN A(SH) Aloenin A from Aloe arborescens 6-[2-(β-D-Glucopyranosyloxy)-4-hydroxy-6-methylphenyl]-4-methoxy-2H-pyran-2-one 6-[2-(beta-D-Glucopyranosyloxy)-4-hydroxy-6-methylphenyl]-4-methoxy-2H-pyran-2-one 6-[4-hydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4-m 6-[4-hydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4-methoxypyran-2-one | Standard substance;Plant extract standard substance;Traditional Chinese medicine standard substance;Reference substance-traditional Chinese medicin;Traditional Chinese medicine reference substance |
| 233 | 786593-06-4 | Dehydroandrographolide succinate | Andrographolide Impurity 2 DEHYDROANDROGRAPHOLIDESUCCINATE Dehydroandrographolide Succinat Dehydroandrographolide succinate 14-Deoxy-11,12-didehydroandrographolide bis(hemisuccinate) 4-(((1R,2R,4aR,5R,8aS)-2-((3-Carboxypropanoyl)oxy)-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)vinyl)decahydronaphthalen-1-yl)methoxy)-4-oxobutanoic acid Butanedioic acid 1-[[(1R,2R,4aR,5R,8aS)-2-(3-carboxy-1-oxopropoxy)-5-[(1E)-2-(2,5-dihydro-2-oxo-3-furanyl)ethenyl]decahydro-1,4a-dimethyl-6-methylene-1-naphthalenyl]methyl] ester 4-[[(1R,2R,4aS,5R,8aS)-2-(3-carboxypropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(2E)-2-(2-oxofuran-3-ylidene)ethyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoic acid | Plant extract;Standard substance;Analytical standard substance;Reference substance-traditional Chi;Traditional Chinese medicine standard substance;Traditional Chinese medicine reference substance |
| 234 | 35906-36-6 | Onjisaponin B | Sinegin 3 Senegin III Onjisaponin B Olean-12-ene-23,28-dioic acid, 3-(β-D-glucopyranosyloxy)-2,27-dihydroxy-, 28-[O-6-deoxy-α-L-mannopyranosyl-(1→3)-O-[O-β-D-galactopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)-6-deoxy-α-L-mannopyranosyl-(1→2)]-6-deoxy-4-O-[(2E)-3-(4-methoxyphenyl)-1-oxo-2-propen-1-yl]-β-D-galactopyranosyl] ester, (2β,3β,... | Triterpenoids;Plant extract;Standard substance;Reference substance;Analytical reagent standard substance;Traditional Chinese medicine reference substance;Standard substance-traditional Chinese medicin |
| 235 | 526-07-8 | Sesamolin | Sesamolin SESAMOLIN SESAMOLIN(SH) 5-[(1S,3aR,4R,6aR)-4-(1,3-Benzodioxol-5-yloxy)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole 5-[(1S,3aβ,4β,6aβ)-4-(1,3-Benzodioxol-5-yloxy)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole 5-[(1S,3aβ,4β,6aβ)-4-(1,3-Benzodioxole-5-yloxy)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole (+)-5-[(1S,3aβ,4R,6aβ)-4-(1,3-Benzodioxol-5-yloxy)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole (+)-5-[(1S,3aβ,4R,6aβ)-4-(1,3-Benzodioxole-5-yloxy)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole 5-[(1S,3aR,4R,6aR)-4-(1,3-benzodioxol-5-yloxy)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-1-yl]-1,3-benzodioxole | E;Sesame oil;phytochemical;Plant extract;chemical reagent;Standard substance;Reference substance;pharmaceutical intermediate;standardized herbal extract;Analysis of standard substance |
| 236 | 139891-98-8 | 3,6′-disinapoyl sucrose | －Disinapoyl sucrose 3,6'-Disinapoyl sucr 3,6′-disinapoyl sucrose c3,6'-Disinapoyl sucrose Disinapoyl Sucrose, 3,6'- 1)-alpha-D-[6-O-sinapoyl]-glucopyranoside (3-sinapoyl)fructofuranosyl-(6-sinapoyl)glucopyranoside beta-D-(3-O-Sinapoyl)-fructofuranosyl-(2-1)-alpha-D-[6-O-sinapoyl]-glucopyranoside | Plant extract;standard substance;reference substance;standard substance-reference substance;traditional Chinese medicine reference substance;reference substance-traditional Chinese medicine refer |
| 237 | 34208-98-5 | 7β-Hydroxylathyrol | 7β-Hydroxylathyrol 7-beta-Hydroxylathyrol 7β-Hydroxylathyrol 34208-98-5 4H-Cyclopenta[a]cyclopropa[f]cycloundecen-4-one, 1,1a,4a,5,6,7,7a,8,9,10,11,11a-dodecahydro-4a,7,8,10-tetrahydroxy-1,1,3,6-tetramethyl-9-methylene-, (1aR,2E,4aR,6S,7S,7aR,8R,10R,11aS)- | Plant extract;Standard substance;Standard substance-traditional Chinese medicine standard substance;Reference substance-traditional Chinese medicine reference substance |
| 238 | 1167424-32-9 | 9'''-Methyl lithospermate B | 9'''-Methyl salvianolate B 9'''-MethyllithosperMate B 9'''-Methyl lithospermate B 3-Benzofurancarboxylic acid, 2-(3,4-dihydroxyphenyl)-4-[(1E)-3-[(1R)-1-[(3,4-dihydroxyphenyl)methyl]-2-methoxy-2-oxoethoxy]-3-oxo-1-propen-1-yl]-2,3-dihydro-7-hydroxy-, (1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl ester, (2S,3S)- | Plant extract;Phenylpropanoids;Standard substance;Reference substance;9-salvianolic acid B monomethyl ester;Analytical reagent standard substance;Standard substance-traditional Chinese medici |
| 239 | 18470-06-9 | Malvidin 3-O-glucoside | Malvidin 3-O-glucoside | Reference substance |
| 240 | 50986-17-9 | Delphinidin 3-O-glucoside | Delphinidin 3-O-glucoside delphinidin 3-O-beta-D-glucoside 3-beta-D-galactopyranosyloxy-5,7-dihydroxy-2-(3,4,5-trihydroxy-phenyl)-chromenylium | Reference substance |
| 241 | 159001-25-9 | Dihydrocephalomannine | DIHYDROCEPHALOMANNIN DihydrocephaloMannine Dihydrocephalomannine Paclitaxel EP Impurity R N-debenzoyl-N-[2-methylbutanoyl]paclitaxel N-Debenzoyl-N-[(2S)-2-methylbutanoyl]paclitaxel | Standard substance;Traditional Chinese medicine reference substance |
| 242 | 1092368-67-6 | 8-epi-Diosbulbin E acetate | 8-epidiosbulbin E acetate 8-epi-Diosbulbin E acetate 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,8(1H,4aH)-dione, 6-(acetyloxy)-2-(3-furanyl)octahydro-, (2S,4aR,6S,6aS,7R,10R,11aS,11bS)- | Gold product;Standard substance;Reference substance;8-Table Lutein E Acetate;Analytical reagent standard substance;Standard substance-reference substance |
| 243 | 56316-75-7 | Quercetin 3-O-(6''-galloyl)-β-D-glucopyranoside | Tellimoside Quercetin 3-O-(6''-O-galloyl)-β-D-glucoside Quercetin 3-O-(6''-galloyl)-β-D-glucopyranoside Quercetin 3-O-(6''-galloyl)-β-D-glucopyranoside Quercetin 3-O-β-D-(6-O- galloyl)glucopyranoside Quercetin 3-O-(6''-galloyl)-beta-D-glucopyranoside 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[6-O-(3,4,5-trihydroxybenzoyl)-β-D-glucopyranosyl]oxy]- | Traditional Chinese medicine reference substance |
| 244 | 1165-39-5 | Aflatoxin G1 | AFLATOXIN G AFLATOXIN G1 Aflatoxin G1 10a-tetrahydro-5-methoxy- (7ar-cis)-10a-tetrahydro-5-methoxy | biochemical reagent |
| 245 | 7241-98-7 | AflatoxinG2 | AF G2 AflatoxinG2 AFLATOXIN G2(RG) 10a-hexahydro-5-methoxy-1(7ar-cis)- | biochemical reagent |
| 246 | 47592-59-6 | Xylotriose | Xylotriose XYLOTRIOSE 1,4-b-D-Xylotriose 4-O-[4-O-(β-D-Xylopyranosyl)-β-D-xylopyranosyl]-D-xylose D-Xylose, O-β-D-xylopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)- D-Xylose, O-b-D-xylopyranosyl-(1?4)-O-b-D-xylopyranosyl-(1?4)- O-beta-D-Xylopyranosyl-(1-4)-O-beta-D-xylopyranosyl-(1-4)-D-xylose D-Xylose, O-.beta.-D-xylopyranosyl-(1?4)-O-.beta.-D-xylopyranosyl-(1?4)- | Stan;Standard;Reference substance;Muoligosaccharide series;Sugar chemical analysis standard;Muoligosaccharide standard series;Reference substance-traditional Chinese medicine reference substance |
| 247 | 75829-43-5 | Pinocembroside | Pinocembroside Pinocembrin 7-O-glucoside Pinocembrin 7-O-β-D-glucoside Pinocembrin41-O-β-D-glucoside Pinocembrin 7-O-beta-D-glucoside Pinocembrin-7-O-β-D-glucopyranoside Ponocembrin-7-O-β-D-glucopyranoside 4H-1-Benzopyran-4-one, 7-(β-D-glucopyranosyloxy)-2,3-dihydro-5-hydroxy-2-phenyl-, (2S)- | Flavonoids;Standard substance;Reference substance;Analytical reagent standard substance;Standard substance-reference substance;Standard substance, reference substance |
| 248 | 111466-29-6 | Proanthocyanidin A4 | Procyanidin A4 Proanthocyanidin A4 8,14-Methano-2H,14H-1-benzopyrano[7,8-d][1,3]benzodioxocin-3,5,11,13,15-pentol,2,8-bis(3,4-dihydroxyphenyl)-3,4-dihydro-, (2S,3R,8S,14R,15R)- | Standard substance;Traditional Chinese medicine reference substance |
| 249 | 20126-76-5 | (−)-Terpinen-4-ol | L-4-terpineol L-terpinen-4-ol L-4-terpineneol (−)-Terpinen-4-ol P-MENTH-1-EN-4-OL (-)-P-MENTH-1-EN-4-OL p-Menth-1-en-4-ol, (R)-(-)- (R)-4-Isopropyl-1-methyl-1-cyclohexen-4-ol 3-Cyclohexen-1-ol, 4-methyl-1-(1-methylethyl)-, (R)- | Standard;Chiral block |
| 250 | 62322-84-3 | trans-11-Eicosenoic acid | trans-11-Eicosenoic 11TR-EICOSENOIC ACID 11(E)-Eicosenoic Acid trans-11-Eicosenoic acid 11-trans-Eicosenoic acid (11E)-11-Eicosenoic acid TRANS-11-EICOSENOIC ACID 11-Eicosenoic acid, (11E)- DELTA 11 TRANS EICOSENOIC ACID | E;Free Fatt;Alphabetic;Fatty acids;Free Fatty Acids;Analytical standards;Lipid Analytical Stan;Food and beverage standards;EA-EOOther Lipid Related Products;Fatty AcidsFA/FAME/Lipids/Steroids |
| 251 | 29743-97-3 | cis-10-Heptadecenoic acid | cis-10-Hepta cis-10-Heptadecenoic -Heptadec-10-enoic acid cis-10-Heptadecenoic acid (Z)-10-Heptadecenoic acid CIS-10-HEPTADECENOIC ACID DELTA 10 CIS HEPTADECENOIC ACID | Lipids;Fatty Acyls;Monoenoic fatty;Chemical Synthesis;Analytical standards;Monoenoic fatty acids;Organic Building Blocks;Fatty Acids and conjugates;Food and beverage standards;C13 to C42 Unsaturated |
| 252 | 22416-58-6 | Xylotetraose | Xylotetrose Xylotetraose 4-O-[4-O-[4-O-(β-D-Xylopyranosyl)-β-D-xylopyranosyl]-β-D-xylopyranosyl]-D-xylose D-Xylose, O-β-D-xylopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)- O-beta-D-Xylopyranosyl-(1-4)-O-beta-D-xylopyranosyl-(1-4)-O-beta-D-xylopyranosyl-(1-4)-D-xylose D-Xylose, O-.beta.-D-xylopyranosyl-(1?4)-O-.beta.-D-xylopyranosyl-(1?4)-O-.beta.-D-xylopyranosyl-(1?4)- | Sugar chemical analysis standard |
| 253 | 24404-49-7 | epipinoresinol-4-O-glucopyranoside | Simplocosin Epipinoresinol-4-O-glucopyranosid Epipinoresinol-4'-O-β-D-glucoside epipinoresinol-4'-O-β-D-glucoside epipinoresinol-4-O-glucopyranoside Epipinoresinol-4-O-beta-D-glucoside b-D-Glucopyranoside,2-methoxy-4-[(1S,3aR,4R,6aR)-tetrahydro-4-(4-hydroxy-3-methoxyphenyl)-1H,3H-furo[3,4-c]furan-1-yl]phenyl β-D-Glucopyranoside, 2-methoxy-4-[(1S,3aR,4R,6aR)-tetrahydro-4-(4-hydroxy-3-methoxyphenyl)-1H,3H-furo[3,4-c]furan-1-yl]phenyl | Standard, reference |
| 254 | 74983-66-7 | epipinoresinol-4'-O-glucopyranoside | epipinoresinol-4'-O-glucopyranoside (+)-epipinoresinol-4-O-β-D-glucoside (+)-Epipinoresinol-4′′-β-D-glucoside (+)-epipinoresinol-4-O-β-D- glucoside β-D-Glucopyranoside, 2-methoxy-4-[(1R,3aR,4S,6aR)-tetrahydro-4-(4-hydroxy-3-methoxyphenyl)-1H,3H-furo[3,4-c]furan-1-yl]phenyl | Standard substance;Reference substance;Standard substance, reference substance |
| 255 | 76639-93-5 | Florfenicol amine | Sch 40458 Florfenicol amine florfenicol amine D-(?)-threo-2-Amino-3-fluoro-1-[4-(methylsulfonyl)phenyl]-1-propanol (αR)-α-[(1S)-1-Amino-2-fluoroethyl]-4-(methylsulfonyl)benzenemethanol Benzenemethanol, α-[(1S)-1-amino-2-fluoroethyl]-4-(methylsulfonyl)-, (αR)- | Microbial metabolites |
| 256 | 148146-51-4 | Atorvastatin Epoxydione Impurity | 15-epi Carboprost Atorvastatin USP RC D Atorvastatin EP Imp D Atorvastatin Impurity 25 Atorvastatin Epoxydione Impurity Atorvastatin Calcium Hydrate impurity 25 3-(4-Fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyl-2-oxiranecarboxamide Atorvastatin Related Compound D (20 mg) (Epoxide impurity, or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2- carboxylic acid phenylamide) | Amines;Aromatics;Impurities;Pharmaceuticals;Atorvastatin calcium;Intermediates & Fine Chemi;Impurity reference substance;Intermediates & Fine Chemicals;Chemical impurity-atorvastatin;Reference substan |
| 257 | 36190-98-4 | Genistein 7,4'-di-O-β-D-glucopyranoside | Genistein 7 4'-di-O-β-D-glucopyranoside Genistein-4',7-O-diglucoside Genistein 7,4'-di-O-β-D-glucoside Genistein 7,4'-di-O-β-D-glucopyranoside Genistein 7,4'-di-O-beta-D-glucopyranoside 4H-1-Benzopyran-4-one, 7-(β-D-glucopyranosyloxy)-3-[4-(β-D-glucopyranosyloxy)phenyl]-5-hydroxy- | Reference substance;Analytical reagent standard |
| 258 | 6871-67-6 | Lotusine | Lotusine (-)-Lotusine D-(-)-Lotusine (1R)-1,2,3,4-Tetrahydro-6-hydroxy-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethylisoquinolinium | Standard;Reference substance;Standard substance, reference substance |
| 259 | 111755-37-4 | MICROCYSTIN RR | MCYST-RR Microcystin-RR MICROCYSTIN RR Cyanoginosin RR Microcystin RR from algae JIGDOBKZMULDHS-UUHBQKJESA-N MICROCYSTIN-RR, MICROCYSTIS AERUGINOSA microcystin-rr from microcystis*aerguinosa Cyclo[D-Ala-L-Arg-[(3S)-3-methyl-D-βAsp-]-L-Arg-[(2S,3S)-2-methyl-3-[(1E,3E,5S,6S)-3,5-dimethyl-6-methoxy-7-phenyl-1,3-heptadiene-1-yl]-βAla-]-D-γGlu-N-methyl-Dha-] | Biochemical Industry |
| 260 | 71991-88-3 | Petunidin 3-O-glucoside | Petunidin 3-O-glucoside | Reference substance |
| 261 | 14101-04-3 | FRANGULIN B | FRANGULIN B RAHMNOXANTHIN EMODIN-L-RHAMNOSIDE EMODIN-6-O-APIOSIDE EMODIN-6-(L)-O-APIOSIDE 3-(D-Apio-beta-D-furanosyloxy)-1,8-dihydroxy-6-methylanthraquinone 3-(D-apio-.betascsc.-furanosyloxy)-1,8-dihydroxy-6-methylanthraquinone 3-(D-Apio-β-D-furanosyloxy)-1,8-dihydroxy-6-methyl-9,10-anthracenedione | Plant extract;Standard substance;Other natural products;Anthraquinones, Hydroquinones and Quinones;Traditional Chinese medicine reference substance |
| 262 | 39025-24-6 | GUGGULSTERONE E | GS, TRANS GUGGULSTERONE GUGGULSTERONE E GUGGULESTERONE E TRANS-GUGGULSTERONE GUGGULSTERONE (E FORM) TRANS-4,17(20)-PREGNADIENE-3,16-DIONE 4,17(20)-(TRANS)-PREGNADIEN-3,16-DIONE | hormones;plant extracts |
| 263 | 117047-08-2 | Puerarin-4'-O-β-D-glucopyranoside | Puerarin Impurity 4 Puerarin4'-O-glucoside Puerarin-4′-O-β-D-glucopyranoside Puerarin-4'-O-β-D-glucopyranoside 4H-1-Benzopyran-4-one, 8-β-D-glucopyranosyl-3-[4-(β-D-glucopyranosyloxy)phenyl]-7-hydroxy- | Reference substance |
| 264 | 81360-22-7 | Peonidin-3-O-Sophoroside-5-O-β-D-glucoside | Peonidin-3-O-Sophoroside-5-O-β-D-glucoside Peonidin-3-O-Sophoroside- 5-O-β-D-glucoside | Reference substance |
| 265 | 35176-46-6 | 1,3-DIHYDROXY-5-NONADECYLBENZEN | 5-Nonadecylresorcinol 5-(n-nonadecyl)resorcinol 1,3-Benzenediol, 5-nonadecyl- 1,3-DIHYDROXY-5-NONADECYLBENZEN | Reference substance |
| 266 | 113-38-2 | 17-BETA-ESTRADIOL 3,17-DIPROPIONATE | Progynon-dp Ovocyclin-P Ovahormon depot ovocyclindipropionate Ovocyclin dipropionate 17-BETA-ESTRADIOL 3,17-DIPROPIONATE (17β)-estra-1,3,5(10)-triene-3,17-dioldipropionate 3,17BETA-DIHYDROXY-1,3,5(10)-ESTRATRIENE 3,17-DIPROPIONATE (17beta)-Estra-1,3,5(10)-triene-3,17-diol 3,17-dipropionate | APIs;Steroids;Raw drugs;Small molecule inhibitors;Drug impurities and intermediates |
| 267 | 127191-86-0 | 7-(2'-Deoxyadenosin-N6-yl)aristolactam I | A-Aai Aristolactam A 7-(deoxyadenosin-N(6)-yl)aristolactam I 7-(2'-Deoxyadenosin-N6-yl)aristolactam I Adenosine, 2'-deoxy-N-(5,6-dihydro-8-methoxy-5-oxobenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-7-yl)- | new product;Traditional Chinese medicine reference substance |
| 268 | 6988-81-4 | Petunidin-3-O-glucoside chloride | petunidin-3-O-glu PETUNIDIN 3-GLUCOSIDE PETUNIDIN3-O-GLUCOSIDE Petunidin-3-O-Glucoside Petunidin 3-monoglucoside Petunidin-3-glucoside chloride Petunidin-3-O-glucoside chloride Flavylium, 3-(beta-D-glucopyranosyloxy)-3',4',5,7-tetrahydroxy-5'-methoxy-, chloride (9ci) 1-Benzopyrylium, 5,7-dihydroxy-2-(3,4-dihydroxy-5-methoxyphenyl)-3-(beta-D-glucopyranosyloxy)-, chloride | Reference substance |
| 269 | 62512-19-0 | Fructo-oligosaccharide | Kestohexaose 1,1,1,1-Kestohexose 1,1,1,1-Kestohexaose Fructo-oligosaccharide Fructo-oligosaccharide GF5 Fructo-oligosaccharide DP6 α-D-Glucopyranoside, O-β-D-fructofuranosyl-(2→1)-O-β-D-fructofuranosyl-(2→1)-O-β-D-fructofuranosyl-(2→1)-O-β-D-fructofuranosyl-(2→1)-β-D-fructofuranosyl | Reference substance;Standard substance-reference substance;Standard substance, reference substance;Sugar chemical analysis standard substance |
| 270 | 112747-99-6 | 8-Hydroxypinoresinol diglucoside | 8-Hydroxypinoresinol diglucoside β-D-Glucopyranoside, [[(3R,3aS,6S,6aR)-tetrahydro-3a-hydroxy-1H,3H-furo[3,4-c]furan-3,6-diyl]bis(2-methoxy-4,1-phenylene)]bis | |
| 271 | 1333321-50-8 | Momordicoside X | Momordicoside X | Standard |
| 272 | 100986-86-5 | D-OFLOXACIN | DR 3354 DS-4632 Aids002308 D-OFLOXACIN 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (R)- [3R,(+)]-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3R)- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3R)- (9CI) | Aromatics;Heterocycl;Heterocycles;Chiral Reagents;Pharmaceuticals;Standard products;Impurity reference substance;Pharmaceutical raw materials;Intermediates & Fine Chemicals;Chiral ligand and chiral ca |
| 273 | 1092578-48-7 | (3S,4R)-Tofacitinib | (3S,4R)-Tofacitinib Tofacitinib Impurity FD+DX YYMGYZDHOQYMFO-DGCLKSJQSA-N Tofacitinib Impurity B(3S,4R) (3S,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile (3S,4R)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3S,4R)- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | pharmaceutical i;tofaitinib impurity;tofaitinib impurity 10;Reference substance-impurity reference substance;chemical reagents, fine chemicals, pharmaceutical intermediates, material intermediates |
| 274 | 1239233-87-4 | 2-[3-Carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid | Febuxostat-2 Febuxostat Impurity C (DA) Febuxostat Dicarboxylic Acid Impurity 2-(3-carboxy-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid 2-[3-Carboxy-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid 2-[3-Carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid 2-[3-carboxyl-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid Febuxostat Impurity 26 (2-(3-carboxy-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid) | ZY;Standard substance;Reference substance;Non-buxotan impurity;Impurity reference substance;Reference substance-impurity reference substance;Aromatics, Heterocycles, Impurities, Pharmaceuticals, Int;A |
| 275 | 161796-77-6 | (R)-Omeprazole Sodium Salt | (R)-Omeprazole sodium Omeprazole Impurity 24 R-Omeprazole Sodium Sal (R)-Omeprazole Sodium Salt OMeprazole R-IsoMer PotassiuM Salt 6-Methoxy-2-[(R)-[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]sulfinyl]- 6-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt | Inhibitors;Esomeprazole;Chiral Reagents;Pharmaceuticals;Esomeprazole sodium;Impurity reference substance;Intermediates & Fine Chemicals;Reference substance-impurity reference substance |
| 276 | 1632463-24-1 | 5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)ox | Rivaroxaban Pseudodimer Rivaroxaban impurity P3-I Rivaroxaban Open-Ring Dimer Rivaroxaban Impurity 94 (Rivaroxaban Dimer Impurity) 5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)ox 5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)amino)ethoxy)ethyl)thiophene-2-carboxamide 5-Chloro-N-[4-[(5S)-5-[[[(5-chloro-2-thienyl)carbonyl]amino]methyl]-2-oxo-3-oxazolidinyl]phenyl]-N-[2-[2-oxo-2-[[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]amino]ethoxy]ethyl]-2-Thiophenecarboxamide | Impurities;Rivaroxaban;053-Rivaroxaban;Impurity reference substance;Control substance-Impurity reference substance |
| 277 | 170571-01-4 | CELECOXIB CARBOXYLIC ACID | Celecoxib-8 Celecoxib Impurity N Carboxylic acid celecoxib CELECOXIB CARBOXYLIC ACID 4-[2-(4-sulfamoylphenyl)-5-(trifluoromethyl)pyrazol-3-yl]benzoic acid 4-(1-(4-sulfamoylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl) benzoic acid 4-[5-(4-Carboxyphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzene sulfon amide | Celecoxib;Heterocycles;Heterocyclic Compounds;Chemical raw materials;Metabolites & Impurities;Sulfur & Selenium Compounds;Impurity reference substance |
| 278 | 180587-75-1 | (R)-9-[2-(Diethylphosphonomethoxy)propyl] Adenine fumaric acid salt | Tenofovir diethyl ester Tenofovir alafenamide-25 Tenofovir Diethyl Ester (R)-Isomer (R)-9-[2-(DIETHYLPHOSPHONOMETHOXY)PROPYL] ADENINE 9-[(2R)-2-(diethoxyphosphorylmethoxy)propyl]purin-6-amine (R)-9-[2-(Diethylphosphonomethoxy)propyl] Adenine fumaric acid salt (R)-diethyl (1-(6-aMino-9H-purin-9-yl)propan-2-yloxy)Methylphosphonate [[(1R)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]phosphonic Acid Diethyl Ester P-[[(1R)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]phosphonic Acid Diethyl Ester | Nucleotides;Intermediates;Chiral Reagents;Control substance;Bases & Related Reagents;Impurity reference substance;Reference substance-impurity reference substance |
| 279 | 188649-48-1 | 3-((butyryloxy)methyl) 5-methyl 4-(2',3'-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate | Cleviprex Impurity D Cleviprex Impurity 6 Clevidipine Impurity D Dehydrogen clevidipine butyrate Clevidipine Butyrate iMpurity Ⅳ 3-((butyryloxy)methyl) 5-methyl 4-(2',3'-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate 3-((butyryloxy)Methyl) 5-Methyl 4-(2',3'-dichlorophenyl)-2,6-diMethylpyridine-3,5-dicarboxylate 4-(2,3-Dichlorophenyl)-2,6-dimethyl-3,5-pyridinedicarboxylic acid 3-methyl 5-[(1-oxobutoxy)methyl] ester | Green vidipine impurity;Clevidipine Butyrate impurity;Clovidipine butyrate impurity;Reference substance-impurity reference substance |
| 280 | 2088771-60-0 | ((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl) aspartic acid | Sitagliptin-14 Sitagliptin Impurity 21 Sitagliptin Impurity FP-A Sitagliptin FP Impurity A 2-(((R)-4-oxo-4-(3-(trifluoromethyl) Sitagliptin Fumarate Adduct(Sitagliptin Impurity FP-A) ((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl) aspartic acid L-Aspartic acid, N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]- | Peptides;Impurity reference substance;Reference substance-impurity reference substance |
| 281 | 477594-28-8 | N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide | Parecoxib Sodium-31 Parecoxib Impurity 46 Parecoxib Sodium Impurity 46 Parecoxib Sodium Impurity 42 N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide Propanamide, N-[[4-(3-methyl-5-phenyl-4-isoxazolyl)phenyl]sulfonyl]- | Impurity of parecoxib sodium;Impurity reference substance;Reference substance-Impurity reference substance |
| 282 | 60079-22-3 | ((S)-3-amino-3-carboxypropanoyl)-L-aspartic acid | Beta-Asp-Asp Nmda,ornithine Impurity Aspartic acid condensate Beta-Aspartyl-Aspartic Acid 2-[(3-aMino-3-carboxy-propanoyl)aMino]butane ((S)-3-amino-3-carboxypropanoyl)-L-aspartic acid ((R)-3-amino-3-carboxypropanoyl)-L-aspartic acid 2-[(3-Amino-3-Carboxypropanoylamino]Butanedioic Acid (S)-2-((S)-3-Amino-3-carboxypropanamido)succinic acid | Anti-infection;Standard substance;037-ornithine aspartate;Impurity reference substance;Reference substance-impurity reference substance |
| 283 | 847949-49-9 | O-Desmethyl Gefitinib | M523595 Gefitinib impurity H Gefitinib Impurity 13 O-Desmethyl Gefitinib Gefitinib O-Desmethyl Impurity O-DesmethylGefitinibmetabolite 4-[(3-Chloro-4-fluorophenyl)amino]-6-[3-(4-morpholinyl)propoxy]-7-quinazolinol 7-Quinazolinol, 4-[(3-chloro-4-fluorophenyl)aMino]-6-[3-(4-Morpholinyl)propoxy]- | Gefitinib;Pharmaceuticals;Gefitinib impurity;Metabolites & Impuri;Metabolites & Impurities;Impurity reference substance;Intermediates & Fine Chemicals;Various Metabolites and Impurities;Medical impuri |
| 284 | 85647-43-4 | ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | Vinpocetine-5 Vinpocetine Impurity E Vinpocetine Impurity 5 (3S,16R)-ethyl apovincaminate Vinpocetine trans-(3S,16R) Isomer ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]phthyridine-12-carboxylate ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (41S,13aR)-ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | impurity reference substance;Reference substance-impurity reference substance |
| 285 | 621-64-7 | N-Nitrosodipropylamine | NSC 133 Dipropylnitrosamine N-Nitrosodipropylamine Di-N-propylnitrosamine N-Nitroso-N-propylamine N-NITROSODI-N-PROPYLAMINE N,N-dipropylnitrous amide 2-Oxo-1,1-dipropylhydrazine N-Nitroso-N-di-n-propylaMine N-nitroso-n-propyl-1-propanamine | Agricultural and environmental standards |
| 286 | 74712-19-9 | Bromobutide | s47 s-4347 SUMIHERB BROMOBUTIDE Bromobutide Bromobutide solution 2-bromo-3,3-dimethyl-n-(1-methyl-1-phenylethyl)-butanamid 2-bromo-3,3-dimethyl-n-(1-methyl-1-phenylethyl)butanamide | Herbicide;Analytical standard |
| 287 | 88678-67-5 | Pyributicarb | tsh-888 henyl)ester PYRIBUTYCARB Pyributicarb PYRIBUTICARB O-3-tert-Butylphenyl (6-methoxy-2-pyridyl)(methyl)thiocarbamate n-(6-methoxy-2-pyridyl)-n-methyl-thiocarbamicacio-3-tert-butylphenyleste carbamothioicacid,(6-methoxy-2-pyridinyl)methyl-,o-(3-(1,1-dimethylethyl)p n-(6-methoxy-2-pyridyl)-n-methylthiocarbamic acid o-3-tert-butylphenyl ester | Herbicide;Analytical standard |
| 288 | 29091-05-2 | Dinitramine | cobexo cobeko ifluoro- 5-dinitro- Dinitramine dinitroamine n(1),n(1)-diethyl-2,6-dinitro-4-trifluoromethyl-m-phenylenediamine n(3),n(3)-diethyl-2,4-dinitro-6-(trifluoromethyl)-1,3-benzenediamine 1,3-benzenediamine,n(sup3),n(sup3)-diethyl-2,4-dinitro-6-(trifluoromethyl) | Herbicides;3-Diethylamino-2;Analytical standards;Organochlorine insecticides;3-Diethylamino-2,4-dinitro-6-trifluoromethylaniline |
| 289 | 85785-20-2 | Esprocarb | R 22957 Esprocarb ESPROCARB Esprocarb [iso] ESPROCARB STANDARD ESPROCARB SOLUTION esprocar (bsi, draft e-iso, draft f-iso) N-(1,2-Dimethylpropyl)-N-ethylthiocarbamic acid S-benzyl ester (1,2-Dimethylpropyl)ethylcarbamothioic acid S-(phenylmethyl) ester Carbamothioic acid, (1,2-dimethylpropyl)ethyl-, S-(phenylmethyl) ester N-(1,2-Dimethylpropyl)-N-ethylcarbamothioic acid S-(phenylmethyl) ester | Herbicides;Analytical standards |
| 290 | 60207-93-4 | ETACONAZOLE | sonax benit cga64251 ETACONAZOL ETACONAZOLE 4-triazole,1-((2-(2,4-dichlorophenyl)-4-ethyl-1,3-dioxolan-2-yl)methyl)-1h-2 1h-1,2,4-triazole,1-((2-(2,4-dichlorophenyl)-4-ethyl-1,3-dioxolan-2-yl)methyl) | Fungicides;Analytical standards |
| 291 | 115-93-5 | Cythioate | CL 26691 CYTHIOATE Cythioate PROBAN(R) CYFLEE(R) American cl-26691 American CL-26,691 American Cyanamid CL-26,691 O,O-DIMETHYL-O-P-SULFAMOYL-PHENYLPHOSPHOROTHIOATE | insecticides;Organochlorine insecticides |
| 292 | 34681-10-2 | Butocarboxim | DRAWIN BUTOCARBOXIM Butocarboxim 3-METHYLTHIOBUTANONE O-METHYLCARBAMOYLOXIME 2-Methylthio-O-(N-methylcarbamoyl)-butanonoxim-3 2-Butanone,3-(methylthio)-,O-(N-methylcarbamoyl)oxime 2-Butanone, 3-(methylthio)-, O-(N-methylcarbamoyl)oxime 2-Butanone, 3-(methylthio)-, O-[(methylamino)carbonyl]oxime (2E)-2-(([(Methylamino)carbonyl]oxy)imino)-3-(methylsulfanyl)butane | B;Carbamates;Pesticides;Alpha sort;Alpha sort;Insecticides;BI-BZPesticides;BI - BZPesticides;AcaricidesAlphabetic;Pesticides&Metabolites |
| 293 | 12674-11-2 | Aroclor 1016 | Aroclor 1016 polychlorinated biphenyl mixture polychlorinatedbiphenyl(aroclor1016) | A;Aroclors;Alphabetic;Environmental Standards;Volatiles/ Semivolatiles;AR to AZEnvironmental Standa;8000 Series Solidwaste Methods;MISA Group 27 - Polychlorinated BiphenylsMore...Close... |
| 294 | 12672-29-6 | Aroclor 1248 | Aroclor 1248 kanechlor400 [40cfr136(1986)]pcb-1248 aroclor1248referencestandardforclp polychlorinatedbiphenyl(aroclor1248) | ;2000/60/EC;AroclorsEPA;Method 8082EPA;Method 8082EPA;AroclorsMethod Specific;Environmental Standards;AroclorsMethod Specific;Environmental Standards;Aroclors, PCBs, and Dioxins |
| 295 | 11097-69-1 | Aroclor 1254 | Aroclor 1254 [40cfr136(1986)]pcb-1254 | A;O;Alphabetic;AroclorsEPA;CLP Standards;CLP Standards;Method 8082EPA;Method 8082EPA;Aroclors, PCBs, and Dioxins;Aroclors, PCBs, and Dioxins |
| 296 | 54240-36-7 | Mabuterol hydrochloride | D01589 Broncholin MabuterolHCl Broncholin (tn) Mabuterolhydrochloride Mabuterol hydrochloride dl-Mabuterol hydrochloride Mabuterol hydrochloride (jan) Mabuterol hydrochloride solution,100ppm Benzenemethanol, 4-amino-3-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)-, monohydrochloride (9CI) | API;Clenbuterol;Intermediates;Analytical standards;Forensic and veterinary standards |
| 297 | 35256-85-0 | Butam | Butam TEBUTAM s-15544 Butam(TM) 2,6-DICHLOROBENZAMIDE PESTANAL n-benzyl-n-isopropylpivalamide n-benzyl-n-isopropyltrimethylacetamide N-benzyl-N-isopropyl-2,2-dimethylpropionamide n-benzyl-2,2-dimethyl-n-isopropyl-propionamid N-benzyl-2,2-dimethyl-N-propan-2-ylpropanamide | Herbicide;Analytical standard |
| 298 | 4812-40-2 | Metronidazole-OH | MNZOH Metronidazole-OH METRONIDAZOLE-OH Hydroxymetronidazole Metronidazole-hydroxy 2-hydroxymethyl-5-nitro-imidazole-1-ethano 4-Hydroxy-2-methyl-5-nitro-1H-imidazole-1-ethanol 1-(2-HYDROXYETHYL)-2-HYDROXYMETHYL-5-NITROIMIDAZOLE 1-(2-Hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole, Hydroxymetronidazole, MNZOH Metronidazole-OH,1-(2-Hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole, Hydroxymetronidazole, MNZOH | Imidazole;Heterocycles;Pharmaceuticals;Analytical standards;Life science standards;Metabolites & Impurities;Intermediates & Fine Chemicals;Traditional Chinese medicine reference substance |
| 299 | 116355-83-0 | Fumonisin B1 | MACROFUSINE Fumonisin B1 Standard Solution Fumonisin B1 1,2,3-propanetricarboxylicacid,1,1'-(1-(12-amino-4,9,11-trihydroxy-2-methyltr 1,2,3-PROPANETRICARBOXYLIC ACID 1,1'-[1-(12-AMINO-4,9,11-TRIHYDROXY-2-METHYLTRIDECYL)-2-(1-METHYLPENTYL)-1,2-ETHANEDIYL] ESTER | Traditional Chinese medicine reference substance |
| 300 | 1217226-46-4 | Nitrofurantoin-13C3 | Nitrofurantoin-13C3 [13C3]-Nitrofurantoin 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione-13C3 | |
| 301 | 84496-56-0 | Clomeprop | my-15 Clomeprop CLOMEPROP chlormeprop Clomeprop [iso] clomeprop (bsi,iso) 2-(2,4-Dichloro-3-methylphenoxy)propionanilide (RS)-2-(2,4-DICHLORO-M-TOLYLOXY)PROPIONANILIDE N-Phenyl-2-(2,4-dichloro-3-methylphenoxy)propionamide Propanamide, 2-(2,4-dichloro-3-methylphenoxy)-N-phenyl- | Herbicide;Analytical standards;Organochlorine pesticides |
| 302 | 1173021-13-0 | Leucomalachite green-D6 | Leucomalachite green-D6 LEUCOMALACHITE GREEN D6 [2H6]-Leucomalachite Green LeucoMalachite green-D6 (LMG-D6) Leucomalachite Green-d6 (phenylmethylene-d6) 4-[deuterio-[4-(dimethylamino)phenyl]-(2,3,4,5,6-pentadeuteriophenyl)methyl]-N,N-dimethylaniline | Isotope markers;Malachite green and crystal violet |
| 303 | 18181-70-9 | IODOFENPHOS | C 9491 NSC 190998 JODFENPHOS IODOFENPHOS monocron9491 NUVANOL(R) N JODFENPHOS(R) O-2,5-DICHLORO-4-IODOPHENYL-O,O-DIMETHYLPHOSPHOROTHIOATE 3,4-dichloro-phenoo-esterwitho-methylmethylphosphoramidothioate | Alphabetic;Pesticides;Alpha sort;JPesticides;Alpha sort;Insecticides;Organophorous;Pesticides&Metabolites;H-MAnalytical Standards;H-MAnalytical Standards |
| 304 | 1015854-55-3 | Di-n-hexyl phthalate-d4 | Di-n-hexyl phthalate-d4 Di-n-hexyl phthalate-d4 DI-N-HEXYL PHTHALATE-3,4,5,6-D4 Dihexyl phthalate-3,4,5,6-d4 Solution, 100ppm 1,2-Benzene-3,4,5,6-d4-dicarboxylic acid, 1,2-dihexyl ester Di-n-hexyl Phthalate-3,4,5,6-d4 DISCONTINUED PLEASE SEE B185432 | |
| 305 | 1116-54-7 | Diethanolnitrosamine | Diethanolnitrosamine diethanolnitrosoamine N-Nitrosodiethanolamine 2,2'-nitrosiminodi-ethano di-(2-hydroxyethyl)-nitrosamine bis-2-hydroxy-ethyl-nitroso-amine bis(beta-hydroxyethyl)nitrosamine bis(beta-hydroxyaethyl)nitrosamin bis-(2-hydroxy-ethyl)-nitroso-amine | Amines;Nitric Oxide Reagents |
| 306 | 183193-59-1 | 2-NP-AMOZ | NPAMOZ 2-NP-AMOZ NP-AMOZ 2- 2-NP-AMOZ Solution, 100ppm 5-(4-MorpholinylMethyl)-3-[[(2-nitrophenyl)Methylene]aMino]- 5-(4-Morpholinylmethyl)-3-[[(2-nitrophenyl)methylene]amino]-2-oxazolidinone | Amines;Furans;Aromatics;Heterocycles;Analytical standards;Life science standards |
| 307 | 623145-57-3 | 2-NP-AHD | NP-AHD NP-AHD2- 2-NP-AHD 2-NP-AHD-13C,15N3 1-[[(2-Nitrophenyl)Methylene]aMino]- 1-(2-nitrobenzylidenamino)-2,4-imidazolidinedione 1-[[(2-Nitrophenyl)methylene]amino]-2,4-imidazolidinedione 2,4-Imidazolidinedione, 1-[[(2-nitrophenyl)methylene]amino]- 1-[(2-Nitrobenzylidene)-amino]- imidazolidin-2,4-dione-13C,15N3 | Furans;Aromatics;Heterocycles;Pharmaceuticals;Analytical standards;Intermediates & Fine Chemicals |
| 308 | 645-93-2 | Ammelide | Ammelide Cyanuramide MELANURIC ACID MELAMINE POWDER MELAMINE MONOMER 2,4,6-Triamino symtriazine MELAMINE FORMALDIHYDE RESIN METFORMIN HYDROCHLORIDE IMP D 2,4,6-TRIAMINO-1,3,5-TRIAZINE MONOMER 6-amino-1,3,5-triazine-2,4(1H,3H)-dione | Melamine |
| 309 | 1173097-59-0 | 2-NP-AMOZ-d5 | 2-NP-AMOZ-D5 2-NP-AMOZ-d5 D5-2-NP-AMOZ [2H5]-2-NP-AMOZ 5-(MORPHOLINOMETHYL)-3-(2-NITROBENZYLIDENAMINO)-2-OXAZOLIDINONE-D5 5-(4-Morpholinylmethyl)-3-[[(2-nitrophenyl)methylene]amino]-2-oxazolidinone-d5 4,4,5-Trideuterio-5-[dideuterio(morpholin-4-yl)methyl]-3-[(E)-(2-nitrophenyl)methylideneamino]-1,3-oxazolidin-2-one | Amines;Furans;Aromatics;Heterocycles;Isotope markers |
| 310 | 26116-56-3 | Erythromycylamine | Brn 4241492 Erythromycylamine 9-Epierythromycylamine Epierythromycyl-A-amine (9S)-9-Amino-9-deoxoerythromycin (9S)-9-amino-9-deoxyerythromycin 9-Amino-9-deoxo-erythromycin, stereoisomer Erythromycin, 9-amino-9-deoxo-, (9S)- (9ci) Erythromycin, 9-amino-9-deoxo-, stereoisomer | Pharmaceuticals;Microbial metabolites;Metabolites & Impurities;Various Metabolites and I;Pharmaceutical intermediates;Intermediates & Fine Chemicals;Various Metabolites and Impurities;Reference substa |
| 311 | 1089736-73-1 | Valsartan-d9 (Major) | Valsartan D9 [2H9]-Valsartan rac-Valsartan D9 Valsartan-d9 (Major) [2H9]-Valsartan (mixture) ACWBQPMHZXGDFX-KDDXQTGLSA-N VALSARTAN-D9 (D7-D9 MIXTURE) L-Valine, N-(1-oxopentyl-d9)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]- (2S)-3-methyl-2-[2,2,3,3,4,4,5,5,5-nonadeuteriopentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid | Reference substance;Impurity reference substance;Reference substance-impurity reference substance |
| 312 | 81148-15-4 | ALS 8123 | ALS 8123 Esmolol free acid reference substance 4-[2-Hydroxy-3-(isopropylamino)propoxy]benzenepropanoic acid 3-[4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl]propanoic acid 4-(2-Hydroxy-3-((1-Methylethyl )amino)Propoxy)benzenepropanoic Acid Benzenepropanoic acid,4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- | impurity reference substance;Reference substance-impurity reference substance |
| 313 | 1173021-85-6 | Tetramisole-d5 Hydrochloride | Citarin-d5 Concurat-d5 Anthelvet-d5 CuraMinth-d5 Tetramisole-d5 Hydrochloride DL-TetraMisole-d5 Hydrochloride 2,3,5,6-Tetrahydro-6-phenyl-iMidazo[2,1-b]thiazole-d5 Hydrochloride | Aromatics;Imidazole;Heterocycles;Pharmaceuticals;Isotope Labelled Compounds;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals |
| 314 | 1325559-20-3 | Closantel-13C6 | 13C6-Closantel Closantel-13C6 [13C6]-CLOSANTEL Closantel-(benzoyl ring-13C6) N-{5-Chloro-4-[(4-chlorophenyl)cyanomethyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide-13C6 | Imidazole;Isotope marker;Stable isotope labeled compounds |
| 315 | 1015856-60-6 | Flunixin-d3 | D3-Flunixin Flunixin-d3 FLUNIXIN-D3 Sch 14714-d3 NOOCSNJCXJYGPE-FIBGUPNXSA-N 2-(2-(Methyl-d3)-3-trifluoromethylanilino)nicotinic Acid 2-[2-METHYL-D3-3-(TRIFLUOROMETHYL)PHENYLAMINO]NICOTINIC ACID 2-[[2-(Methyl-d3)-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid 2-[2-(trideuteriomethyl)-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid | Aromatics;Inhibitors;Pharmaceuticals;Isotope markers;Aromatics Compounds;Isotope Labeled Compounds;Isotope Labelled Compounds;Intermediates & Fine Chemicals |
| 316 | 1173021-02-7 | (±)-Carazolol-d7 | Carazolol D7 (±)-Carazolol-d7 | isotope marker;Stable isotope labeled compounds |
| 317 | 3646-73-9 | α-D-Galactose | C00984 GALACTOSE α-D-Galactose Α-D-GALACTOSE alpha-D-Galactose α-D-galactopyranose | Carbohydrates & Derivatives, Pharmaceuticals, Intermediates & Fine Chemicals |
| 318 | 30684-07-2 | 1M-3PP HCl (Methyl-3-phenylpropylamine Hydrochloride) | Fluoxetine Impurity 3 Fluoxetine Impurity 2(EP-B) Fluoxetine EP Impurity B HCl N-methylbenzenepropanamine hydrochloride N-Methyl-3-phenylpropylammonium chloride 1M-3PP HCl (Methyl-3-phenylpropylamine Hydrochloride) N-Methyl-3-phenylpropan-1-aMine hydrochloride (RelCpd B) | impurity reference substance;Reference substance-impurity reference substance |
| 319 | 3953-65-9 | Demethyl Chlorpromazine Hydrochloride | SKF 4514A CHLORPROMAZINE EP IMPURITY D HCL 3-(2-chloro-10H-phenothiazin-10-yl)- DesMethylchlorproMazine Hydrochloride Demethyl Chlorpromazine Hydrochloride Mono-N-deMethylchlorproMazine Hydrochloride Mono-N-deMethylchloroproMazine Hydrochloride 2-Chloro-10-(3-MethylaMinopropyl)phenothiazine Hydrochloride 2-Chloro-N-Methyl-10H-phenothiazine-10-propanaMine Hydrochloride | Heterocycles;Pharmaceuticals;Metabolites & Impurities;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 320 | 1173021-09-4 | Clenproperol | Clenproperol D7-Clenproperol Clenproperol-d7 Clenproperol-d6 [2H7]-Clenproperol 1-(4-amino-3,5-dichlorophenyl)-2-(1,1,1,2,3,3,3-heptadeuteriopropan-2-ylamino)ethanol | Amines;Pharmac;Aromatics;Clenbuterol;Isotope markers;Intermediates & Fine Che;Isotope Labelled Compounds;Intermediates & Fine Chemicals;Stable isotope labeled compounds;Amines, Aromatics, Isotope Labe |
| 321 | 1353867-92-1 | Albendazole-D3 | Albendazole-D3 D3-Albendazole Albendazole-(methyl-d3) Albendazole-d3 (methoxy-d3) Methyl-d3 5-(propylthio)-2-benzimidazolecarbamate | Imidazole;Isotope marker;Stable isotope labeled compounds |
| 322 | 1868135-06-1 | Sofosbuvir D6 | PSI-7977-d6 Sofosbuvir D6 Sofosbuvir IMpurity Sofosbuvir Impurity S | Anti-infection;Impurity reference substance;Worderson Customized Catalog 1;Reference substance-impurity reference substance |
| 323 | 1435902-07-0 | Albendazole-2-aminosulfone-D3 hydrochloride | Albendazole-2-Aminosulfone-d3 HCl ALBENDAZOLE-2-AMINOSULFONE-D3 HCL Albendazole-2-aminosulfone-D3 hydrochloride Albendazole-2-aMinosulfone-D3 hydrochloride 2-Aminoalbendazole sulfone-d3 hydrochloride [2H3]-Albendazole-2-aminosulfone hydrochloride Albendazole-?2-?amino-?sulphone-?D3 Hydrochloride Albendazole-2-aminosulfone-(propyl-3,3,3-d3) hydrochloride 2-Amino-5-(propyl-3,3,3-d3)-sulfonylbenzimidazole hydrochloride | Imidazole;Isotope marker;Stable isotope labeled compounds |
| 324 | 1015855-83-0 | 3Ipronidazole-d | 3Ipronidazole-d Ipronidazole-d3 D3-Ipronidazole 3Ipronidazole-D [2H3]-Ipronidazole Ipronidazole-d3 (1-methyl-d3) 1-(Methyl-d3)-2-(1-Methylethyl)-5-nitro- 2-ISOPROPYL-1-METHYL-D3-5-NITRO-1H-IMIDAZOLE Ipronidazole-d3 DISCONTINUED PLEASE SEE I747002 1H-Imidazole, 1-(methyl-d3)-2-(1-methylethyl)-5-nitro- | Imidazole;Heterocycles;Pharmaceuticals;Isotope markers;Isotope Labelled Compounds;Intermediates & Fine Chemicals |
| 325 | 287476-11-3 | Melamine-15N3 | Melamine-15N3 [15N3]-Melamine Sudan Red 7B Solution, 100ppm 1,3,5-Triazine-2,4,6-triamine-[15N3] (Melamine-[15N3]) | Melamine;Nucleotides;Heterocycles;Bases & Related Reagents;Isotope Labelled Compounds;Heterocycles, Isotope Labelled Compounds, Nucleotides, Bases & Related Reagents |
| 326 | 1448345-60-5 | Albendazole sulfone-D3 | Albendazole sulfone-D3 Albendazole sulfone-(methyl-d3) Methyl-d3 [5-(propylsulfonyl)-1H-benzimidazol-2-yl]carbamate | Imidazole;Isotope marker;Stable isotope labeled compounds |
| 327 | 102120-87-6 | 1,1-BIS-(4-ISOBUTYLPHENYL)ETHANE | IBUPROFEN IMPURITY R IBuprofen Impurity 18 Ibuprofen EP Impurity R 1,1-Bis(p-isobutylphenyl)ethane 1,1-BIS-(4-ISOBUTYLPHENYL)ETHANE 1,1'-(Ethane-1,1-diyl)-4,4'-(2-meth 1,1-Bis(p-isobutylphenyl)ethane(Ibuprofen EP Impurity R) | impurity reference substance;Reference substance-impurity reference substance |
| 328 | 501665-88-9 | PD 224378 | PD 224378 Pregabalin conjugate PD0224378 Pregabalin Amide Lactose Adduct (4R)-1-(4-O-b-D-Galactopyranosyl-b-D-glucopyranosyl)-4-(2-methylpropyl)-2-pyrrolidinone (4R)-1-(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)-4-(2-methylpropyl)-2-pyrrolidinone 2-Pyrrolidinone, 1-(4-O-β-D-galactopyranosyl-β-D-glucopyranosyl)-4-(2-methylpropyl)-, (4R)- (4R)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-4-(2-methylpropyl)pyrrolidin-2-one (R)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-4-isobutylpyrrolidin-2-one | Chemical impurity-pregabalin;Standard/reference substance/chemical reagent/experiment;Neurochemicals, Pharmaceuticals, Intermediates & Fine Chemicals |
| 329 | 573691-09-5 | Aripiprazole N1-Oxide | Aripiprazole N1-Oxide Aripiprazole impurity F Aripiprazole Related CoMpound F USP Aripiprazole Related Compound F 7-[4-[4-(2,3-Dichlorophenyl)-1-oxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone 7-[4-[4-(2,3-Dichlorophenyl)-1-oxidopiperazin-1-yl]butoxy]-3,4-dihydroquinolein-2(1H)-one 4-(2,3-dichlorophenyl)-1-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl)piperazine 1-oxide Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide) | Aromatics;Neurochemicals;Pharmaceuticals;239-aripiprazole;Aripiprazole impurities;Metabolites & Impurities;Pharmaceutical raw materials;Impurity reference substance;Intermediates & Fine Chemicals |
| 330 | 693793-53-2 | Difluoro Atorvastatin Calcium Salt | Atorvastatin impurity C Atorvastatin EP IMpurity C Atorvastatin Related CoMpound C Atorvastatin Related Compound C Difluoro Atorvastatin SodiuM Salt Difluoro Atorvastatin Calcium Salt Difluoro Atorvastatin CalciuM Salt Difluoro iMpurity, or (3R,5R)-7-[3-(phenylcarbaMoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt Atorvastatin Related Compound C (20 mg) (Difluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)- 2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt) | Impurities;Standard substance;Impurity reference substance;Reference substance-impurity reference substance |
| 331 | 887196-29-4 | O-Methyl Atorvastatin Calcium Salt | Atorvastatin EP Imp G Atorvastatin EP IMpurity G Atorvastatin IMpurity-G(EP) O-Methyl Atorvastatin Calcium Salt Atorvastatin EP Impurity G Sodium Salt Calcium(3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxy-3-methoxyheptanoate (3R,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-5-hydroxy-3-methoxy-heptanoic acid Calcium salt (βR,δR)-2-(4-Fluorophenyl)-δ-hydroxy-β-Methoxy-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrole-1-heptanoic Acid CalciuM Salt | Pha;Impurities;Chiral Reagents;Pharmaceuticals;049-atorvastatin calcium;Impurity reference substance;Intermediates & Fine Chemicals;Chemical impurity-atorvastatin;Reference substance-impurity referenc |
| 332 | 612069-25-7 | 3'-Des(dimethylamino)-3'-keto Azithromycin | Azithromycin EP Impurity N Azithromycin Impurity N(BP) 3'-Des(diMethylaMino)-3'-keto AzithroMycin 3'-Des(dimethylamino)-3'-keto Azithromycin 3'-Des(dimethylamino)-3'-keto Azithromycin (Azithromycin EP Impurity N) (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[[4,6-dideoxy-β-D-erythro-hexopyranos-3-ulos-1-yl]oxy]-13-[(2,6-dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptaMe (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-11-[(2S,3S,6R)-3-hydroxy-6-methyl-4-oxooxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one | Im;Impurities;Chiral Reagents;Pharmaceuticals;096-azithromycin;Impurity reference substance;Intermediates & Fine Chemicals;Impurity-azithromycin standard;Azithromycin impurity advantage supply;Referen |
| 333 | 87475-54-5 | 5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester | Bendamustine USP RC I Bendamustine Impurity 11 Bendamustine USP RC I (base)) Bendamustine Related Impurity 11 Bendamustine related impurities 11 Bendamustine USP Related Compound I 5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester | 210-Bendamustine;Chemical raw materials;Bendamustine hydrochloride intermediate |
| 334 | 72570-70-8 | 4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic Acid | Bisoprolol Impurity 18 Bisoprolol Benzoic acid IMpurity Bisoprolol Carboxylic Acid IMpurity 4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic Acid 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzoic Acid 4-[2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzoic Acid-d7 4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic Acid (Bisoprolol Metabolite) | Aromatics;Pharmaceuticals;Chemical raw materials;Metabolites & Impurities;Impurity reference substance;Intermediates & Fine Chemicals |
| 335 | 105394-83-0 | Decarboxy Ciprofloxacin | Decarboxy Ciprofloxacin Ciprofloxacin EP IMpurity E Ciprofloxacin IMpurity E(EP) Ciprofloxacin Impurity 5(Ciprofloxacin EP Impurity E) 1-Cyclopropyl-6-fluoro-7-(1-piperazinyl)-4(1H)-quinolinone 1-Cyclopropyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one | Impurities;Heterocycles;Pharmaceuticals;Impurity World-Ciprofloxacin;Intermediates & Fine Chemicals |
| 336 | 254452-96-5 | (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium | 5-epi-NK-104 Pitavastatin Impurity M Pitavastatin Calcium 1(R,R) (3R,5R)-Pitavastatin Calcium Pitavastatin -3R,5R- Calcium salt (3R, 5R)-Pitavastatin CalciuM Salt (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium (3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid CalciuM Salt | 216-pitavastatin;Organic chemistry;Impurity reference substance;Aromatics, Chiral Reagents, Inhibit;Standard substance/reference substance/chemical reagent/experiment;Aromatics, Chiral Reagents, Inhib |
| 337 | 145576-25-6 | ACETYLSIMVASTATIN | ACETYLSIMVASTATIN SiMvastatin Acetate 4'-Acetyl Simvastatin SiMvastatin IMpurity-B Simvastatin EP Impurity B SiMvastatin IMpurity B (Acetyl SiMvastatin) Simvastatin Impurity 2(Simvastatin EP Impurity B) 2,2-DiMethylbutanoic Acid (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(Acetyloxy)tetrahydro -6-oxo-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-3,7-diMethyl-1-naphthalenyl Ester | Impurities;Chiral Reagents;Pharmaceuticals;168-simvastatin;Intermediates & Fine Chemicals |
| 338 | 1346604-18-9 | 4-Acetylamino-3-hydroxybenzoic Acid Ethyl Ester | OseltaMivir IMpurity D Oseltamivir EP Impurity D Oseltamivir Phosphate EP Impurity D Ethyl-4-acetamido-3-hydroxybenzoate Oseltamivir Phosphate impurity D (EP) 4-Acetylamino-3-hydroxybenzoic Acid Ethyl Ester Oseltamivir Impurity 4(Oseltamivir EP Impurity D) 5,5-diallyl-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione | impurity;oseltamivir;Impurity reference substance;impurity reference substance;reference substance-impurity reference substance |
| 339 | 748812-53-5 | 1-(Pentanoylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide | Irbesartan EP Impurity A Irbesartan impurity A (EP) N-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide 1-(Pentanoylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide 1-(pentanoylamino)-N-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]cyclopentane-1-carboxamide Irbesartan ImpurityI (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide) Irbesartan Related Compound A (25 mg) (1-pentanoylaminocyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide) IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE) | Reference substance;Pharmaceutical intermediate;Impurity reference substance;Reference substance-impurity reference substance |
| 340 | 774538-96-4 | cis-Montelukast | cis-Montelukast Montelukast EP IMpurity G Montelukast sodium impurity G Montelukast EP Impurity G (Cis-Montelukast) (R,Z)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropyl)acetic acid 1-[[[(1R)-1-[3-[(1Z)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-Methylethyl)phenyl]propyl]thio]Methyl]cyclopropaneacetic Acid | Aromatics;Impurities;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Impurity reference substance;Intermediates & Fine Chemicals;Reference substance-impurity reference substance |
| 341 | 25459-12-5 | 4-Nitro-5-desnitro Tinidazole | Tinidazole EP Impurity B Tinidazole impurity B CRS Tinidazole Related CoMpound B 4-Nitro-5-desnitro Tinidazole Tinidazole EP Impurity B (USP RC B) 1-(2-ethylsulfonylethyl)-2-methyl-4-nitroimidazole 1H-Imidazole, 1-[2-(ethylsulfonyl)ethyl]-2-methyl-4-nitro- TINIDAZOLE RELATED COMPOUND B (20 MG) (1-(2-ETHYL-SULFONYLETHYL)-2-METHYL-4-NITROIMIDAZOLE) | Pharmaceutical raw materials |
| 342 | 1309349-64-1 | 3'-6'-Dehydro Clindamycin 2-Phosphate | Clindamycin Impurity E Clindamycin EP Impurity J Dehydroclindamycin Phosphate Clindamycin Phosphate EP IMP J 3'-6'-Dehydro Clindamycin 2-Phosphate | Impurities;Standard substance;Impurity standard substance;Impurity reference substance;Reference substance-impurity reference substance;Standard substance/reference substance/chemical reagent/exp |
| 343 | 1373321-04-0 | D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1R)- | DLZ-F Dapagliflozin-1 1R-Dapagliflozin Dapagliflozin Impurity 77 Dapagliflozin alpha-Isomer Alpha-Isomer of Dapagliflozin Dapagliflozin Alpha isomer(Crude) D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1R)- | Dagliejing;Dagliejing impurity G;Impurity reference substance;Waterson Customized Catalog 2;Reference substance-impurity reference substance |
| 344 | 1191900-51-2 | Brexpiprazole sulfoxide impurity | DM-3411 Epipiprazole862 Brexpiprazole S-Oxide Brexpiprazole Sulfoxide Brexpiprazole sulfoxide (Crude) Brexpiprazole sulfoxide impurity 7-[4-[4-(1-oxo-1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one 2(1H)-Quinolinone, 7-[4-[4-(1-oxidobenzo[b]thien-4-yl)-1-piperazinyl]butoxy]- | 174-Ipiperazole;Impurity reference substance |
| 345 | 844694-84-4 | 1-Benzyl-4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl]piperidine | Donepezil-012 Donepezil Impurity Donepezil Deoxy Imp Donepezil Impurity I 1-Benzyl-4-[(5,6-dimethoxy-2,3-dihy 1-Benzyl-4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl]piperidine 1-benzyl-4-((5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl)piperidine Piperidine, 4-[(2,3-dihydro-5,6-dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)- | API impurities;Drug impurities |
| 346 | 1034439-57-0 | Deoxy Donepezil Hydrochloride | Donepezil Deoxy IMpurity Deoxy Donepezil Hydrochloride 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindane hydrochloride 4-[(2,3-Dihydro-5,6-diMethoxy-1H-inden-2-yl)Methyl]-1-benzylpiperidineHCl 1-benzyl-4-[(5,6-dimethoxy-2,3-dihydro-1H-inden-2-yl)methyl]piperidine,hydrochloride 4-[(2,3-Dihydro-5,6-dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine Hydrochloride | Aromatics;Impurities;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 347 | 106266-09-5 | Desfluoro Risperidone | Desfluoro Risperidone Risperidone impurity K Risperidone EP IMpurity K Risperidone EP Impurity K (Desfluoro Risperidone) Risperidone Impurity 11(Risperidone EP Impurity K) 3-[2-[4-(1,2-Benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one 3-[2-[4-(1,2-Benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-Methyl-4H-pyrido[1,2-a]pyriMidin-4-one 3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone) | Impurities;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 348 | 119018-30-3 | N-[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]c | GliMepiride urethane GliMepiride EP IMpurity C GliMepiride Related CoMpound C GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE) 2GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE) methyl N-[4-[2-[(4-ethyl-3-methyl-5-oxo-2H-pyrrole-1-carbonyl)amino]ethyl]phenyl]sulfonylcarbamate N-[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]c METHYL (4-(2-(((3-ETHYL-4-METHYL-2-OXO-2,5-DIHYDRO-1H-PYRROL-1-YL)CARBONYL)AMINO)ETHYL)PHENYL)SULFONYLCARBAMATE N-[[4-[2-[[(3-Ethyl-2,5-dihydro-4-Methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]aMino]ethyl]phenyl]sulfonyl]carbaMic Acid Methyl Ester | Pharmaceutical raw materials |
| 349 | 197010-20-1 | Hydroxy Donepezil (Mixture of Diastereomers) | Donepezil-011 Hydroxy Donepezi Donepezil Impurity M Hydroxy Donepezil (Mixture of DiastereoMers) Hydroxy Donepezil (Mixture of Diastereomers) 2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one 2-((1-Benzylpiperidin-4-yl)(hydroxy)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one 2,3-Dihydro-2-[hydroxy[1-(phenylMethyl)-4-piperidinyl]Methyl]-5,6-diMethoxy-1H-inden-1-one 1H-Inden-1-one, 2,3-dihydro-2 -[hydroxy[1-(phenylMethyl)-4- piperidinyl]Methyl]-5,6- diMethoxy- | Impurities;Impurities in bulk drugs;Aromatics, Heterocycles, Inhibitors, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 350 | 66147-29-3 | Methotrexate α-Methyl Ester | Methotrexate EP Impurity I Methotrexate α-Methyl Ester JYFDQHNTJJOKAS-AWEZNQCLSA-N Methotrexate Impurity 9(EP-I) Methotrexate α-Methyl Ester (Impurity I) (4S)-4-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid | 145-methotrexate;Impurity reference substance;Aromatics, Chiral Reagents, Heterocycles, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |
| 351 | 85440-79-5 | rac 1-Nitroso-2-methylindoline | Einecs 287-218-1 Indapamide EP Impurity A 1-Nitroso-2-methylindoline IndapaMide Related CoMpound D (1)-2-Methyl-1-nitrosoindoline rac 1-Nitroso-2-Methylindoline rac 1-Nitroso-2-methylindoline (±)-2-methyl-1-nitrosoindoline 2,3-Dihydro-2-methyl-1-nitroso-1H-indole | Amines;Aromatics;Pharmaceuticals;Indole Derivatives;Indapamide impurity;Intermediates & Fine Chemicals;Reference substance-impurity reference substance |
| 352 | 83881-09-8 | 21-Chloro-17α-[(2-furanylcarbonxyl)oxy]-9β,11β-oxido-16α-methylpregna-1,4-diene-3,20-dione Mometason | Mometasone EP Impurity D MoMetasone Furoate IMpurity D Mometasone Furoate EP Impurity D Mometasone Furoate Epoxy Impurity -oxido-16α-methylpregna-1,4-diene-3,20-dione Mometasone Furoate Impurity D 21-Chloro-17α-[(2-furanylcarbonxyl)oxy]-9β,11β-oxido-16α-Methylpregna-1,4-diene-3,20-dione 21-Chloro-17α-[(2-furanylcarbonxyl)oxy]-9β,11β-oxido-16α-methylpregna-1,4-diene-3,20-dione Mometason (4aS,4bS,5aS,6aS,7R,8R,9aS,9bS)-7-(2-chloroacetyl)-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl furan-2-carboxylate | Mometasone 178-furoate;Impurities of bulk drug;Mometasone furoate impurity;Impurity reference substance;Pharmaceuticals, Intermediates & Fine Chemicals, Steroids |
| 353 | 118267-18-8 | N-Demethyl Roxithromycin | RU 44981 N-DEMETHYLROXITHROMYCIN Roxithromycin Impurity F N-Demethyl Roxithromycin Roxithromycin Impurity R (E)-N-DeMethylroxithroMycin Roxithromycin Impurity 6(Roxithromycin EP Impurity F) (9E)-9-[O-[(2-Methoxyethoxy)Methyl]oxiMe]-N-deMethyl ErythroMycin | Inte;Chiral Reagents;Pharmaceuticals;Standard substance;Roxithromycin impurity;Metabolites & Impurities;Roxithromycin EP impurity;Impurity standard substance;Impurity reference substance;Intermediates |
| 354 | 101666-68-6 | N-Desmethyl Clarithromycin | N-Desmethyl Clarithromycin Clarithromycin EP Impurity D N-DeMethyl-6-O-MethylerythroMycin 3″-N-Demethyl-6-O-methylerythromycin A Clarithromycin Impurity 1(Clarithromycin EP Impurity D) Clarithromycin Impurity D (10 mg) (N-desmethyl clarithromycin) (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione | Chiral Reagents;Pharmaceuticals;Metabolites & Impurities;EP impurity of carat mold;Intermediates & Fine Chemicals;Various Metabolites and Impurities |
| 355 | 205826-86-4 | (R)-α-[(2,2-Dimethyl-1-oxopropyl)amino]-4-hydroxybenzeneacetic Acid | Amoxycillin EP Impurity H Amoxicillin trihydrate impurity H (2R)-2-[(2,2-Dimethylpropanoyl)amin (R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid (R)-α-[(2,2-Dimethyl-1-oxopropyl)amino]-4-hydroxybenzeneacetic Acid (2R)-2-[(2,2-dimethylpropanoyl)amino]-2-(4-hydroxyphenyl)acetic acid | Amoxicillin impurity;Pesticide raw materials;Impurity reference substance;Superior supply of amoxicillin;Chiral Reagents, Metabolites & Impurities;Reference substance-impurity reference substance;Chir |
| 356 | 177472-30-9 | Levofloxacin Ethyl Ester | Levofloxacin USP RC C Levofloxacin Impurity 10 Levofloxacin Ethyl Ester Levofloxacin Related CoMpound C Ethyl 8-Fluoro-3-Methyl-9-(4-Methyl-piperazin-1-yl)-6-oxo-2,3-dihydro- 6H-1-oxa-3a-aza-phenalene-5-carboxylate ethyl 9-fluoro-3-Methyl-10-(4-Methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate ethyl (S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate) | Impurity world-levofloxacin;Impurity reference substance;Reference substance-impurity reference substance |
| 357 | 911661-90-0 | Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED | Levothyroxine EP IMpurity F Levothyroxine Sodium Impurity L Thyroxine-4-hydroxy-3,5-diiodophenyl Ether Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED O-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-3,5-diiodo-L-tyrosine β-[4-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenoxy]-3,5-diiodophenyl]alanine (2S)-2-Amino-3-[4-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenoxy]-3,5-diiodophenyl]propanoic acid | Aromatics;Drug Analogues;Pharmaceuticals;Organic intermediates;Amino Acids & Derivatives;Impurity reference substance;Intermediates & Fine Chemicals |
| 358 | 1255507-88-0 | Carbendazim-d3 | CARBENDAZIM D3 D3-Carbendazim Carbendazim-d3 [2H3]-Carbendazim | Imidazole;Fungicides;Isotope markers;Stable isotope labeled compounds |
| 359 | 544-71-8 | trans,trans-9,11-Octadecadienoicacid | JBYXPOFIGCOSSB-XBLVEGMJSA-N Linoleicacid,c Linoleic Acid Conjugated (9E,11E)-Linoleic acid (9E,11E)-9,11-Octadecadienoic Acid 9 E),11(E)-Conjugated Linoleic Acid trans,trans-9,11-Octadecadienoicacid 9,11-Octadecadienoic acid, (9E,11E)- | Chemical reagents |
| 360 | 23470-00-0 | 2-Palmitoyl-rac-glycerol | 2-MONOPALMITIN 2-O-Palmitoylglycerol 2-O-Palmitoyl-L-glycerol 2-O-Hexadecanoylglycerol 2-Palmitoyl-rac-glycerol Palmitic acid 2-hydroxy-1-(hydroxymethyl)ethyl ester Hexadecanoic acid [2-hydroxy-1-(hydroxymethyl)ethyl] ester | Glycerols;Cannabinoid receptor;Fatty Acid Derivatives & Lipids |
| 361 | 13405-60-2 | β-Glucogalin | Aids085620 β-Glucogalin 1-Galloyl-glucose .beta.-D-Glucogallin 1-O-Galloyl-β-D-glucose .beta.-D-Glucose, 1-gallate .beta.-D-Glucopyranose, 1-(3,4,5-trihydroxybenzoate) 1-O-(3,4,5-Trihydroxybenzoyl)-beta-D-glucopyranoside, beta-D-Glucose gallate, beta-D-Glucogallin | Standard |
| 362 | 35380-71-3 | Estradiol hemihydrate | Estradiol (1250008) Estradiol hemihydrate Estradiol Hemihydrates EESTRADIOL HEMIHYDRATE beta-Estradiol semihydrate BETA-OESTRADIOL VETRANAL, 250 MG (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol,hydrate | API;API and intermediates;Pharmaceutical raw materials |
| 363 | 631-64-1 | Dibromoacetic Acid | DIBROMOACETIC ACID Dibromoacetic Acid | Chemical reagent |
| 364 | 16339-04-1 | ETHYLISOPROPYLNITROSAMINE | Azilsartan Impurity 100 ETHYLISOPROPYLNITROSAMINE N-NITROSOETHYLISOPROPYLAMINE Ethyl(nitroso)(isopropyl)amine N-Ethyl-N-nitroso-2-propanamine N-Ethyl-N-isopropylnitrous amide N-Nitrosoisopropylethyl Amine (Mixture of Isomers) | organic chemistry;Impurity reference substance |
| 365 | 3336-40-1 | Ioxynil-Methyl | IOXYNIL-METHYL Ioxynil-Methyl IOXYNIL-METHYL ETHER IOXYNIL-METHYL PESTANAL 3,5-diiodo-4-methoxybenzonitrile Benzonitrile,3,5-diiodo-4-methoxy- | Benzene;Herbicides |
| 366 | 1201920-88-8 | 5-Chloro-6-(2,3-dichlorophenoxy)-1,3-dihydro-2H-benzimidazol-2-one | Triclabendazole Impurity 1 Triclabendazole Impurity 8 Ketotriclabendazole Solution, 100ppm 5-Chloro-6-(2,3-dichlorophenoxy)-1,3-dihydro-2H-benzimidazol-2-one 5-Chloro-6-(2,3-dichlorophenoxy)-1,3-dihydro-2H-benziMidazol-2-one 2H-Benzimidazol-2-one, 5-chloro-6-(2,3-dichlorophenoxy)-1,3-dihydro- | Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 367 | 79921-43-0 | Sulfisozole sodium | Sulfisozole sodium sulfisozole sodium (4-aminophenyl)sulfonyl-(1,2-oxazol-3-yl)azanide | Analytical standard |
| 368 | 335104-84-2 | Tembotrione | BAY 747 Tembotrione Tembotrione Tembotrione [iso] TEMBOTRIONE(WXC06044) 2-{2-CHLORO-4-METHANESULFONYL-3-[(2,2,2-TRIFLUOROETHOXY)METHYL]BENZOYL}CYCLOHEXANE-1,3-DIONE 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione 2-[2-Chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl]-1,3-cyclohexanedione | Herbicides;Heterocyclic rings;Other raw materials;Chemical raw materials;Pesticide raw materials;Agricultural raw drugs-raw drugs |
| 369 | 16773-52-7 | 3-(2-Methyl-5-nitro-1H-imidazol-1-yl)-1,2-epoxypropane | Brn 0613771 Ornidazole Impurity Ⅳ 1-(2,3-EPOXYPROPYL)-2-METHYL-5-NITROIMIDAZOLE 1-(2,3-epoxypropyl)-2-methyl-5-nitro-imidazol 2-methyl-5-nitro-1-(oxiran-2-ylmethyl)imidazole Imidazole, 1-(2,3-epoxypropyl)-2-methyl-5-nitro- 1-(Oxiranylmethyl)-2-methyl-5-nitro-1H-imidazole 2-Methyl-5-nitro-1-(oxiran-2-ylmethyl)-1H-imidazole 3-(2-Methyl-5-nitro-1H-imidazol-1-yl)-1,2-epoxypropane | Impurity reference substance;Reference substance-Impurity reference substance |
| 370 | 1091621-62-3 | Loxoprofen Impurity 15 | Loxoprofen Related 4 Loxoprofen Impurity 15 Loxoprofen Impurity 50 Loxoprofen Impurity 43 Loxoprofen Degradation Impurity A Loxoprofen Related Compound 2 (Mixture of Diastereomers) 4-[(1-Hydroxy-2-oxocyclopentyl)methyl]-α-methylbenzeneacetic Acid Benzeneacetic acid, 4-[(1-hydroxy-2-oxocyclopentyl)methyl]-α-methyl- Loxoprofen Sodium Degradation Impurity A(Loxoprofen Related Compound 2) | Chemical drug impurities;Impurity reference substance;Reference substance-impurity reference substance |
| 371 | 1395056-41-3 | Moxifloxacin Impurity 29 | Moxifloxacin-24 2-Oxymoxifloxacin 5-oxydemoxifloxacin Moxifloxacin Impurity 51 Moxifloxacin Impurity 29 Azilsartan medoxomil impurity269 1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-((4aS,7aS)-2-oxooctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-1,4-dihydroquinoline-3-carboxylic acid 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-2-oxo-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo- 1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-((4aR,7aS)-5-oxooctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride | Moxifloxacin;Impurity world-moxifloxacin;Impurity reference substance;Reference substance-impurity reference substance |
| 372 | 496024-43-2 | Amlodipine Impurity 31 | Amlodipine Impurity 31 5-ethyl 7-methyl 6-(2-chlorophenyl)- 5-Ethyl 7-methyl 6-(2-chlorophenyl)-3,4,6,7-tetrahydro-8-methyl-2H-1,4-benzoxazine-5,7-dicarboxylate 5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate 5-Ethyl 7-Methyl 6-(2-Chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H-1,4-benzo[b][1,4]oxazine-5,7-dicarboxylate 2H-1,4-Benzoxazine-5,7-dicarboxylic acid, 6-(2-chlorophenyl)-3,4,6,7-tetrahydro-8-methyl-, 5-ethyl 7-methyl ester | Standard;Amlodipine;Impurity Reference;Impurity World-Amlodipine;Wardson Customized Catalog 1 |
| 373 | 67681-84-9 | 6-Chloro-1-Ethyl-4-Oxo-7-(Piperazin-1-yl)-1,4-Dihydroquinoline-3-Carboxylic acid | Norfloxacin Impurity 8 6-chloro-1-ethyl-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid 6-Chloro-1-Ethyl-4-Oxo-7-(Piperazin-1-yl)-1,4-Dihydroquinoline-3-Carboxylic acid 3-Quinolinecarboxylic acid, 6-chloro-1-ethyl-1,4-dihydro-4-oxo-7-(1-piperazinyl)- | Impurity world-ciprofloxacin;Impurity reference substance;Reference substance-impurity reference substance |
| 374 | 951661-85-1 | Tadalafil iMpurity A | TDF-DB-M1-JXA Tadalafil iMpurity A Taladafil impurity A Tadalafil Impurity 75 (1S,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide 1H-Pyrido[3,4-b]indole-3-carboxamide, 1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-N-methyl-, (1S,3R)- | Impurity reference substance |
| 375 | 105331-00-8 | 6-Amino-5-azacytidine | 6-AMino-5-azacytidine 6-Amino-5-azacytidine Azacitidine Impurity ABCDEFG 4,6-diamino-1-((2R,3R,4S,5R) 6-Amino-5-azacytidine formate salt 1,3,5-Triazin-2(1H)-one, 4,6-diamino-1-β-D-ribofuranosyl- 4,6-Diamino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one 4,6-Diamino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one 4,6-diamino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one | 114-azacitidine;Standard substance;Impurity reference substance |
| 376 | 2080-75-3 | 5-Methoxy-2-Benzimidazolinone | BUTTPARK 121 4-68 5-METHOXY-2-BENZIMIDAZOLINONE 5-Methoxy-2-Benzimidazolinone 5-Methoxy-benzimidazolin-2-on Esomeprazole Sodium Impurity 44 2-HYDROXY-5-METHOXYBENZIMIDAZOLE 5-Methoxy-1H-benzimidazole-2(3H)-one 1,3-dihydro-5-methoxy-2h-benzimidazole-2-one 2H-Benzimidazol-2-one,1,3-dihydro-5-methoxy-(9CI) 1,3-Dihydro-5-methoxy-2H-benzimidazole-2-one~2-Hydroxy-5-methoxybenzimidazole | Aromatics;Heterocycles;BENZIMIDAZOLE;Pharmaceutical;Pharmaceuticals;API intermediates;Aromatics Compounds;Impurity reference substance;Intermediates & Fine Chemicals;Reference substance-impurity refer |
| 377 | 96166-39-1 | 2-Pyrrolidinecarboxamide,1-(hydroxyacetyl)-,(S)-(9CI) | Vildagliptin Impurity 48 1-Glycoloyl-L-prolinamide 1-glycoloyl-L-proline amide Vildagliptin Impurity -01 VN-01 (S)-1-(Hydroxyacetyl)-2-pyrrolidinecarboxamide (S)-1-(2-hydroxyacetyl)pyrrolidine-2-carboxamide 2-Pyrrolidinecarboxamide,1-(hydroxyacetyl)-,(S)-(9CI) | PYRROLE |
| 378 | 2174001-92-2 | Venlafaxine-2 Venlafaxine Impurity B HCl Venlafaxine Impurity B Hydrochloride Venlafaxine Hydrochloride Impurity B as Hydrochloride Venlafaxine Hydrochloride EP Impurity B as Hydrochloride ethyl 3-(dimethylamino)-2-(4-methoxyphenyl)propanoate hydrochloride | Venlafaxine | |
| 379 | 17434-18-3 | Picropodophyllotoxin | Picropodophyllotoxin | Plant extract;Standard substance;Reference substance;Traditional Chinese medicine reference substance;Standard substance-traditional Chinese medicine standard substance |
| 380 | 1526916-57-3 | Darunavir | Darunavir Darunavir Carbamic Acid Methyl Ester methyl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido) [(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic Acid Methyl Ester Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, methyl ester | Impurity reference substance |
| 381 | 151282-23-4 | 8-氟莫西沙星盐酸盐 | Moxifloxacin-1 Moxifloxacin EP Imp.A HCl Moxifloxacin Impurity A HCl Moxifloxacin Related Compound A (HCl salt form) 1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo [3,4-b]pyridine-6(2H)-yl)-4-oxo-1,4-Dihydroquinoline-3- carboxylic acid hydrochloride 1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4 -oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride | moxifloxacin |
| 382 | 381725-50-4 | 1-Phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-2-one | Perampanel Impurity 4 Perampanel Intermediate 2 1-phenyl-5-pyridin-2-ylpyridin-2-one 1'-Phenyl-[2,3'-bipyridin]-6'(1'H)-one [2,3'-Bipyridin]-6'(1'H)-one, 1'-phenyl- 1-PHENYL-5-(PYRIDIN-2-YL)PYRIDIN-2(1H)-ONE 1-Phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-2-one | Intermediates;Pharmaceutical intermediates;Impurity reference substance |
| 383 | 1369773-39-6 | AHU-377 hemicalcium salt | (alphar AHU-377 hemicalcium salt AHU-377 (heMicalciuM salt) LCZ696(valsartan + sacubitril) impurity 1 Ethyl (αR,γS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-[1,1'-biphenyl]-4-pentanoate hemicalcium salt Calciumbis(4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl] amino} -4-oxobutanoate) | Raw d;lcz696;LCZ 696;Intermediates;Anti-hypertension;LCZ696 intermediate;Chemical raw materials;Pharmaceutical Intermediates;Pharmaceutical intermediates;Impurity reference substance |
| 384 | 161594-54-3 | rel-(4aR,7aR)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine | Moxifloxacin Impurity 41 Moxifloxacin Impurity 115 rel-(4aR,7aR)-6-Benzyloctahydro-1H-pyrrolo[3,4-b]pyridine Cis-6-Benzyloctahydro-1H-Pyrrolo[3,4-B]Pyridine(WX110999) Racemic-(4aR,7aR)-6-benzyloctahydro-1H-pyrrolo[3,4-b]pyridine (4aR,7aR)-6-benzyl-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridine 1H-Pyrrolo[3,4-b]pyridine, octahydro-6-(phenylmethyl)-, (4aR,7aR)-rel- | Impurity World-Moxifloxacin |
| 385 | 20429-79-2 | α-Sophorose monohydrate | SOPHOROSE α-Sophorose monohydrate α-Sophorose Monohydrate ALPHA-SOPHOROSE MONOHYDRATE ALPHA-D-SOPHOROSE MONOHYDRATE D-Glucopyranose, 2-o-beta-D-glucopyranosyl- 2-O-BETA-D-GLUCOPYRANOSYL-ALPHA-D-GLUCOSE MONOHYDRATE β-D-Glc-(1-2)-D-Glc, 2-O-β-D-Glucopyranosyl-D-glucopyranose β-D-Glc-(1-2)-D-Glc, 2-O-β-D-Glucopyranosyl-D-glucopyranose | Carbohydrates;Biochemical reagents;Standard for Chemical Analysis of Sugar |
| 386 | 14818-35-0 | 6-Cyclohexyl-4-methyl-2H-pyran-2-one | MCP 2,6-Dimethyl-4-nitrosophenol 2,6-DIMETHYL-4-NITROSOPHENOL 6-CYCLOHEXYL-4-METHYL-2-PYRONE 4-Methyl-6-cyclohexyl-2-pirone 6-CYCLOHEXYL-4-METHYL PYRAN-2-ONE Ciclopirox Related CoMpound B, USP 6-Cyclohexyl-4-Methyl-2H-pyran-2-one 6-Cyclohexyl-4-methyl-2H-pyran-2-one Ciclopirox Related Compound B (25 mg) (6-Cyclohexyl-4-methyl-2-pyrone) | Heterocycles;Intermediates;Organic chemical raw materials |
| 387 | 16156-50-6 | Hexyl methanesulfonate | n-HexylMesylate 1-Hexylmesylate Hexyl methanesulfonate Methanesulfonic Acid Hexyl Ester Hexyl methanesulfonate(Dabigatran Impurity) | Impurity reference substance |
| 388 | 878143-33-0 | Dalasetron Mesylate Hydrate | Dalasetron Mesylate Hydrate Dolasetron methanesulfonate Dolasetron Mesylate (125 mg) Dolasetron Mesylate (1224959) Dalasetron (Mesylate hydrate) rel-(6R,9aS)-Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl 1H-indole-3-carboxylate methanesulfonate hydrate | Inhibitors;Chemical reagents;Small molecule inhibitors;Pharmaceutical bulk drugs;Pharmaceutical raw materials;Small molecule inhibitors, natural products |
| 389 | 97468-37-6 | Cephapirin benzathine | Benzyl ceftime Cefapirin Benzathine Cephapirin benzathine CEPHAPIRIN BENZATHINE (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Other series;Raw materials;Chemical raw ma;Chemical reagents;Pharmaceutical bulk drugs;Pharmaceutical intermediates;Pharmaceutical raw materials;Pharmaceutical, pesticide and dye intermediates |
| 390 | 4228-66-4 | 3,4-dihydroxyphenylpyruvic acid | Levodopa Impurity 1 3,4-dihydroxyphenylpyruvic acid 3-(3,4-Dihydroxyphenyl)pyruvic acid Benzenepropanoic acid, 3,4-dihydroxy-α-oxo- Benzenepropanoic acid, 3,4-dihydroxy-alpha-oxo- | Chemical impurity-levodopa |
| 391 | 475271-62-6 | 4-O-Des(difluoromethyl) Roflumilast | Roflumilast-2 RofluMilast IMp.B RofluMilast related substance 4-O-Des(difluoroMethyl) RofluMilast 4-O-Des(difluoromethyl) Roflumilast Roflumilast Desdifluoromethyl Impurity N-(3,5-dichloropyridin-4-yl)-4-hydroxybenzaMide 3-(CyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-hydroxybenzaMide 3-(cyclopropylMethoxy)-N-(3,5-dichloropyridin-4-yl)-4-hydroxybenzaMide | Standard;Impurities;Roflumilast;Impurity reference substance;Reference substance-impurity reference substance;Stable isotope, fluorine chemistry, halogenated hydrocarbon Halogenated Hydrocarbons |
| 392 | 56970-78-6 | 3-Bromo-2-Methylpropionic Acid | Captopril impurity D 3-BROMOISOBUTYRIC ACID Captopril EP IMpurity D 3-broMo-2-Methylbutanoate Methyl-3-bromopropionicacid 3-BROMO-2-METHYLPROPIONIC ACID 3-Bromo-2-Methylpropionic Acid 2-METHYL-3-BROMOPROPIONIC ACID | Synthesis |
| 393 | 5817-26-5 | ethyl (2S)-pyrrolidine-2-carboxylate | Pro-oet PRO-OET Proline ethyl ester L-proline ethyl ester (-)-L-Proline ethyl ester (S)-Ethyl pyrrolidine-2-carboxylate ethyl (2S)-pyrrolidine-2-carboxylate | Impurity reference substance |
| 394 | 73200-73-4 | 3-phenylpyrazin-2-ol | 3-Phenylpyrazinol cefaclor iMpurity F Pyrazinol, 3-phenyl- 3-PHENYLPYRAZIN-2-OL 3-phenylpyrazin-2-ol Cefaclor Impurity F (EP) Ampicillin EP Impurity H (Cefaclor EP Impurity F) | Cefaclor impurity;Chemical impurity-ampicillin |
| 395 | 888327-36-4 | 2-Bromo-5-trifluoromethoxypyridine | 2-Bromo-5-(trifluoromethoxy) 2-Bromo-5-trifluoromethoxypyridine Pyridine,2-bromo-5-(trifluoromethoxy)- | |
| 396 | 90725-68-1 | Methyl 2-bromomethyl-5-nitrobenzoate | Lenalidomide Impurity 17 Methyl 2-bromomethyl-5-nitrobenzoate ethyl 2-(bromomethyl)-5-nitrobenzoate METHYL 2-BROMOMETHYL-5-NITRO-BENZOATE 2-Bromomethyl-5-nitro-benzoic acid methyl ester Benzoic acid, 2-(bromomethyl)-5-nitro-, methyl ester | Pharmaceutical intermediates;drug impurity reference substance |
| 397 | 112559-91-8 | HYDROXY ITRACONAZOLE | R 63373 HYDROXY ITRACONAZOLE Itraconazole 2-Hydroxy Metabolite Itraconazole metabolite Hydroxy Itraconazole Itraconazole Impurity 8(Hydroxy Itraconazole) 4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylMethyl)-1,3-dioxolan-4-yl]Methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-hydroxy-1-Methylpropyl)- 3H-1,2,4-Triazol-3-one, 4-4-4-4-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-ylmethoxyphenyl-1-piperazinylphenyl-2,4-dihydro-2-(2-hydroxy-1-methylpropyl)- 4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-hydroxy-1-methylpropyl)-3H-1,2,4-triazol-3-one | Isotoo;metabolites;Pharmaceuticals;Metabolites & Impurities;Isotooe labelled metabolites;Intermediates & Fine Chemicals;Isotopically Labeled Pharmaceutic;Various Metabolites and Impurities;Clinical te |
| 398 | 147657-22-5 | CALCIPOTRIOL MONOHYDRATE | CALCIPOTRIOL MONOHYDRATE Calcipotriol monohydrate CRS Calcipotriol (Calcipotriene) Monohydrate (5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1α,3β,24-triol (1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-5-cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol hydrate (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-Cyclohexanediol hydrate (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4S)-4-cyclopropyl-4-hydroxy-1-methyl-2-buten-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-Cyclohexanediol monohydrate | API;API intermediates;Other intermediates |
| 399 | 187227-45-8 | OSELTAMIVIR ACID | GS 4071 OSELTAMIVIR ACID Oseltamivir (acid) OSELTAMIVIR CARBOXYLATE Oseltamivir Impurity C (EP) Oseltamivir Carboxylic Acid HCl Oseltamivir Phosphate Impurity Ⅲ (3R,4R,5S)-4-acetamido-5-amino-3 (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid (3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexence-1-carboxylic Acid | Impurity reference substance |
| 400 | 6104-71-8 | N-Desmethyl Clozapine | NORCLOZAPINE Desmethylclozapine N-Desmethyl Clozapine 8-CHLORO-11-PIPERAZINYL-5H-DIBENZO[B,E][1,4]DIAZEPINE 8-CHLORO-11-(1-PIPERAZINYL)-5H-DIBENZO[B,E][1,4]DIAZEPINE 8-CHLORO-11-1[1-PIPERAZINYL)-5H-DIBENZO[B,E][1,4]DIAZEPINE CLOZAPINE, NORMETHYL(NORMETHYLCLOZAPINE, NOR-CLOZAPINE, DESMETHYLC 8-Chloro-11-piperazinyl-5H-dibenzo[b,e][1,4]diazepine, Norclozapine, Normethylclozapine | Chemical raw materials |
| 401 | 1084-65-7 | METICRANE | Arresten SD 17102 METICRANE SD-171-02 thiochroman-7-sulfonamide,6-methyl-,1,1-dioxide 1,1-diketo-6-methyl-3,4-dihydro-2H-thiochromene-7-sulfonamide 3,4-DIHYDRO-6-METHYL-2H-1-BENZOTHIOPYRAN-7-SULFONAMIDE-1,1-DIOXIDE 6-METHYL-1-THIA-1,2,3,4-TETRA-HYDRONAPHTHALENE-7-SULFONAMIDE 1,1-DIOXIDE | Small molecule inhibitor |
| 402 | 1092578-47-6 | (3S,4S)-Tofacitinib | SS-tofacitinib (3S,4S)-Tofacitinib Tofacitinib IMpurity A Tofacitinib Impurity C(3S,4S) Tofacitinib IMpurity C Citrate (3S,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3S,4S)- 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | Topatinib impurity;(3RS,4RS)-Topatinib;Impurity reference substance;Reference substance-impurity reference substance;Chemical reagents, fine chemicals, pharmaceutical intermediates, material interm |
| 403 | 1268836-55-0 | (R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile | Alogliptin-12 Alogliptin Impurity B Alogliptin Impurity 23 Alogliptin benzoate impurity B Alogliptin related compounds 44 Alogliptin Benzoate Dimer Impurity 6-Despiperidinyl-6-(alogliptin-Namino-yl) Alogliptin (R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile (R)-2-((6-(3-((3-(2-cyanobenzyl)-1-Methyl-2,6-dioxo-1,2,3,6-tetrahydropyriMidin-4-yl)aMino)piperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile | Alogliptin impurity;Chemical raw materials;Impurity reference substance |
| 404 | 134404-52-7 | Seocalcitol | Seocalcitol (1R,3S,5Z)-5-((2E)-((1R,3aS,7aR)-1-((1R,2E,4E)-6-Ethyl-6-hydroxy-1-methyl-2,4-octadienyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-1,3-cyclohexanediol (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4E)-6-Ethyl-6-hydroxy-1-methyl-2,4-octadien-1-yl]-octahydro-7α-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4E)-6-ethyl-6-hydroxy-1-methyl-2,4-octadien-1-yl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-, (1R,3S,5Z)- EB 1089,(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,2E,4E)-6-Ethyl-6-hydroxy-1-methyl-2,4-octadien-1-yl]-octahydro-7α-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol | API |
| 405 | 1445580-43-7 | (1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol | Ticagrelor-7 Ticagrelor 7-Hydroxy Ticagrelor Impurity I (UL136) Ticagrelor Related Compound 47 (1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol 3-((1R,2S,3S,4S)-2,3-Dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one | ticagrelor impurity;impurity reference substance;Reference substance-impurity reference substance |
| 406 | 148857-42-5 | (S)-2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione | Rivaroxaban Impurity 49 (S)-2-(3-chloro-2-hydroxypropyl)isoindoline-1,3-dione 2-[(2S)-3-Chloro-2-hydroxypropyl]-1H-isoindole-1,3(2H)-dione 1H-Isoindole-1,3(2H)-dione, 2-[(2S)-3-chloro-2-hydroxypropyl]- 1H-Isoindole-1,3(2H)-dione, 2-(3-chloro-2-hydroxypropyl)-, (S)- | Pharmaceutical intermediates;Impurity reference substance;Reference substance-Impurity reference substance |
| 407 | 1496551-72-4 | 1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | EOS-61178 Sofosbuvir Impurity 68 Sofosbuvir Chloro Dephosphate (2'R)-2'-Chloro-2'-deoxy-2'-methyl-uridine Uridine, 2'-chloro-2'-deoxy-2'-methyl-, (2'R)- sofosbuvir (2'R)-2'-Chloro-2'-deoxy-2'-methyl-uridine 1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione 1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione 1-[(2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione | Sofosbuvir impurity;Reference substance-impurity reference substance |
| 408 | 149709-44-4 | Sacubitrilat | LBQ657 LCZ696-4 Sacubitrilat LCZ-696 Impurity 1 Diacid of Sacubitril Sacubitril Impurity 7 Sacubitril Desethyl Impurity (2R,4S)-4-(3-carboxypropanoylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acid | Impurity reference substance |
| 409 | 1675248-19-7 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide | Tofacitinib-24 Tofacitinib Imp.Q Tofacitinib Impurity T Tofacitinib Impurity JJ Tofacitinib Related Compound 7 Tofacitinib Citrate Impurity 05 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide | Tofatinib impurity;impurity reference substance;Reference substance-impurity reference substance |
| 410 | 21343-40-8 | 25-Hydroxy Vitamin D2 | 25-hydroxyvitamind 25-hydroxycalciferol 25-HydroxyvitaMin D2 25-Hydroxy Vitamin D2 25-Hydroxyvitamin D2 solution 4-methylene-3-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexenyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-cyclohexanol | Nutrition research;reference substance |
| 411 | 41270-66-0 | 5-Chloro-2,3-diphenylpyrazine | Selexipag Impurity 31 5-Chloro-2,3-diphenylpyrazine 5-chloro-2,3-diphenylpyrazine 2-Chloro-5,6-diphenylpyrazine Pyrazine, 5-chloro-2,3-diphenyl- 5-Chloro-2,3-diphenylpyrazine fandachem chloro-2,3-diphenylpyrazine (Selexipag Intermediate) | Pyrrole;Pyrazine;Series 1;Organic intermediate;Celesipa intermediate;Selexipag intermediate;Selexipag intermediate;Pharmaceutical raw materials;Impurity reference substance;Synthetic material interme |
| 412 | 428854-24-4 | 2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidine-4,5,6-triamine | riociguat Intermediates Riociguat Triamino Impurity N-Desmethyl-N-desmethylcarbamoly Riociguat 2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimid... 2{1[(2fluorophenyl)Methyl]1Hpyrazolo[3,4 b]pyridin3yl}pyriMidine4,5,6triaMine 2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidine-4,5,6-triamine 2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine 4,5,6-Pyrimidinetriamine, 2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]- | Reference substance-impurity reference substance |
| 413 | 571188-82-4 | 1-Piperazinecarboxylic acid, 4-[6-[(6-bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-, 1,1-dimethylethyl ester | Palbociclib-016 Palbociclib Intermediate 4 tert-butyl 4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]p tert-butyl 4-{6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl}piperazine-1-carboxylat tert-butyl 4-(6-((6-broMo-8-cyclopentyl-5-Methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyriMidin-2-yl)aMino)pyridin-3-yl)piperazine-1-carboxylate 4-[6-(6-BROMO-8-CYCLOPENTYL-5-METHYL-7-OXO-7,8-DIHYDRO-PYRIDO[2,3-D]PYRIMIDIN-2-YLAMINO)-PYRIDIN-3-YL]-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER 4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester 1-Piperazinecarboxylic acid, 4-[6-[(6-broMo-8-cyclopentyl-7,8-dihydro-5-Methyl-7-oxopyrido[2,3-d]pyriMidin-2-yl)aMino]-3-pyridinyl]-, 1,1-diMethylethyl ester 1-Piperazinecarboxylic acid, 4-[6-[(6-bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-, 1,1-dimethylethyl ester 4- [6- (6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido [2,3-d] pyrimidin -2- ylamino) - pyridine 3-yl] - piperazine-1- carboxylic acid tert-butyl ester | ;PD 0332991;Anticancer;Palbociclib;Daily chemicals;Pabuclib intermediate;Pabosiclib intermediate;Pharmaceutical intermediates;Impurity reference substance;Reference substance-impurity reference substa |
| 414 | 627530-84-1 | BMS-564929 | 929 BMS-564 BMS564929 BMS 564929 BMS-564929 BMS 564929 2-chloro-4-((7R,7aS)-7-hydroxy-1,3-dioxotetrahydro-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl)-3-methylbenzonitrile 2-Chloro-3-methyl-4-[(7R,7aS)-tetrahydro-7-hydroxy-1,3-dioxo-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl]benzonitrile Benzonitrile, 2-chloro-3-methyl-4-[(7R,7aS)-tetrahydro-7-hydroxy-1,3-dioxo-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl]- | |
| 415 | 65445-14-9 | 1α-Hydroxy-5,6-trans-vitamin D3 | BRN 4715875 Alfacalcidol Impurity A Alfacalcidol EP impurity A 1α-Hydroxy-5,6-trans-vitamin D3 (1R,3S,5Z,7E)-9,10-Secocholesta-5,7,10-triene-1,3-diol (1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)hexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol (1R,3S,E)-5-((E)-2-((3aS,7aR)-7a-Methyl-1-((R)-6-Methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diol | Impurity reference substance;Worderson Customized Catalog 1;Reference substance-impurity reference substance |
| 416 | 84468-24-6 | 1-(5-ISOQUINOLINESULFONYL)PIPERAZINE, DIHYDROCHLORIDE | C-1 HA-100 1-(5-ISOQUINOLINESULFONYL)PIPERAZINE 1-(5-isoquinolinylsulfonyl)piperazine 1-(5-isoquinolinylsulfonyl)-piperazin 1-(5-ISOQUINOLINYLSULFONYL)PIPERAZINE 2HCL 1-(5-ISOQUINOLINYLSULFONYL)-PIPERAZINE HYDROCHLORIDE 1-(5-ISOQUINOLINESULFONYL)PIPERAZINE, DIHYDROCHLORIDE | Protein Kinase;Protein Kinase Inhibitors and Activators |
| 417 | 863329-62-8 | Benzamide, N-[1-(3,5-di-O-benzoyl-2-C-methyl-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]- | Sofosbuvir Impurity 12 sofosbuvir impurity Y008001-C Sofosbuvir Benzamido Impurity Benzamide, N-[1-(3,5-di-O-benzoyl-2-C-methyl-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]- BenzaMide, N-[1-(3,5-di-O-benzoyl-2-C-Methyl-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyriMidinyl]- (2R,3R,4S,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-hydroxy-4-methyltetrahydrofuran-3-yl benzoate | |
| 418 | 125316-60-1 | CD437 | CD437 ADAP-IMH ADAP-IME Adapalene IMpurity F O-DesMethyl Adapalene AHPN, 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid 6-(4-hydroxy-3-tricyclo(3.3.1.1(3,7))dec-1-ylphenyl)-2-naphthalenecarboxylic 2-naphthalenecarboxylicacid,6-(4-hydroxy-3-tricyclo(3.3.1.1(3,7))dec-1-ylphen | Aromatics;Pharmaceuticals;Impurity reference substance;Intermediates & Fine Chemicals |
| 419 | 705260-08-8 | Vorapaxar Sulfate | SCH530348 SCH-530348 Sch 530348 Vorapaxar Sulfate vorapaxar impurity A SCH 530348 (H2SO4 Salt) Vorapaxar Sulfate (SCH 530348) N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-Fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-Methyl-3-oxonaphtho[2,3-c]furan-6-yl]carbaMic Acid Ethyl Ester Sulfate | API;Aromatics;Heterocycles;Chiral Reagents;Pharmaceuticals;Intermediates & Fine Chemicals |
| 420 | 1337482-15-1 | isopropyl ((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl)oxy)(phenoxy)phosph | Ofosbuvi rimpurity Sofosbuvir IMpurity C Sofosbuvir impurity G sofosbuvir impurity Y008005-G Sofosbuvir IMpurity C 1337482-15-1 Sofosbuvir 5'-Desphosphate 3'-O-[(S)-Phosphate] isopropyl ((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl)oxy)(phenoxy)phosph isopropyl ((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl)oxy)(phenoxy)phosphoryl)-L-alanite isopropyl ((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl)oxy)(phenoxy)phosphoryl)-L-alaninate (2S)-Isopropyl 2-(((((2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl)oxy)(phenoxy)phosphoryl)amino)propanoate | |
| 421 | 5853-29-2 | Cephaeline hydrochloride | NSC 32944 Cephaeline DiHCl Cephaeline HCl salt cephaelin hydrochloride Cephaeline hydrochloride cephaeline hydrochloride Cephaeline dihydrochloride Cephaeline hydrochloride CRS (-)-CEPHAELINE DIHYDROCHLORIDE (1R)-1-[[(2S,3R,11bS)-3-Ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-2-yl]methyl]-1,2,3,4-tetrahydro-7-methoxy-6-isoquinolinol hydrochloride | Customizable;Reference substance;Analytical reagent standard;Impurity reference substance;Traditional Chinese medicine referen;Reference substance-traditional Chinese medicine reference substance |
| 422 | 110406-94-5 | Benzoic acid, 2-(hexahydro-1-Methyl-1H-azepin-4-yl)hydrazide | Azelastine EP Impurity B Methylazepan benzohydrazide Azelastine EP Impurity B DiHCl N'-(1-Methylazepan-4-yl)benzohydrazide N''-[(4RS)-1-Methylhexahydro-1H-azepin-4-yl]benzohydrazide 1-Benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane Benzoic acid, 2-(hexahydro-1-Methyl-1H-azepin-4-yl)hydrazide | Azelastine impurity |
| 423 | 123367-26-0 | (2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one | (E)-3-(dimethylamino) Nilotinib Impurity 16 (Imatinib EP Impurity A) Imatinib EP Impurity A (Nilotinib Impurity 16) (2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one (E)-3-(Dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one (2E)-3-(DiMethylaMino)-1-(pyridin-3-yl)prop-2-en-1-one (2E)-3-(DiMethylaMino)-1-(3-pyridyl)prop-2-en-1-one (IMpurity of Nilotinib) | Standard;Intermediate;Imatinib impurity;Impurity reference substance |
| 424 | 14215-97-5 | 1-O-Acetyl-2,3,5-Tri-O-Benzoyl-D-Ribofuranose | 1-O-Acetyl-2,3,5-tri-O-benzoylribose TRI-O-BENZOYL-1-O-ACETYL-D-RIBOFURANOSE 1-ACETYL-2,3,5-TRIBENZOYL-3-D-RIBOFURANOSIDE 1-O-Acetyl-2,3,5-tri-0-benzoyl-D-ribofuranose 1-O-Acetyl-2,3,5-Tri-O-Benzoyl-D-Ribofuranose 1-O-ACETYL-2,3,5-TRI-O-BENZOYL-D-RIBOFURANOSE 1-O-Acetyl-2,3,5-tri-O-benzoyl-α,β-D-ribofuranose 1-O-Acetyl-2,3,5-tri-O-benzoyl-alpha,beta-D-ribofuranose | Sugar;Inhibitors;Benchmark reagent;Carbohydrates & Derivatives |
| 425 | 201166-22-5 | 2,2-Dimethyl-4-isopropyl-1,3-benzodioxole | Propofol Impurity L Propofol EP Impurity L 2,2-Dimethyl-4-isopropyl-1,3-benzodioxole 4-ISOPROPYL-2,2-DIMETHYL-BENZO[1,3]DIOXOLE 2,2-dimethyl-4-propan-2-yl-1,3-benzodioxole 4-Isopropyl-2,2-dimethylbenzo[d][1,3]dioxole 2,2-Dimethyl-4-(1-methylethyl)-1,3-benzodioxole 2,2-Dimethyl-4-isopropyl-1,3-benzodioxole (Propofol Impurity L) | Impurity reference substance |
| 426 | 22246-17-9 | 7-Methoxy-3,4-dihydro-1H-quinolin-2-one | Brexpiprazol Brexpiprazole Impurity 69 7-Methoxy-3,4-dihydroquinolin-2(1H) 7-Methoxy-3,4-dihydro-1H-quinolin-2-one 7-Methoxy-3,4-dihydroquinolin-2(1H)-one 7-Methoxy-2,3-dihydro-2(1H) quinolinone 7-Methoxy-3,4-dihydro-2(1H)-quinolinone 3,4-dihydro-7-Methoxy-2(1H)-Quinolinone | Impurity reference substance;Phenanthroline quinoline isoquinoline |
| 427 | 348635-87-0 | Amisulbrom | Amisulbrom Amisulbrom 1 Amisulbrom Standard Amisulbrom solution 3-(3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide 3-[(3-Bromo-6-fluoro-2-methyl-1H-indol-1-yl)sulfonyl]-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide | Herbicides;Analytical standards;Medicine, pesticide intermediates;Agricultural and environmental standards |
| 428 | 59690-97-0 | 10-Bromo-5H-dibenzo[b,f]azepine-5-carboxamide | 10-bromocarbamazepine Carbamazepine EP Imp G Carbamazepine Impurity 7 Carbamazepine EP Impurity G 5-bromobenzo[b][1]benzazepine-11-carboxamide 10-BroMo-5H-Dibenz[B,F]Azepine-5-CarboxaMide 10-Bromo-5H-dibenzo[b,f]azepine-5-carboxamide 10-BroMo-5H-dibenzo[b,f]azepine-5-carboxaMide CARBAMAZEPINE EP IMPURITY G (10-BROMOCARBAMAZEPINE) Carbamazepine EP Impurity G (10-Bromocarbamazepine) | Reference substance-impurity reference substance |
| 429 | 326-58-9 | benzo-1,3-dioxol-5-ol acetate | 1,3-benzodioxol-5-yl acetate 1,3-Benzodioxol-5-ol acetate benzo-1,3-dioxol-5-ol acetate 1,3-Benzodioxol-5-ol,5-acetate 1,3-benzodioxol-5-yl ethanoate Benzo[d][1,3]dioxol-5-yl acetate acetic acid 1,3-benzodioxol-5-yl ester Acetic acid benzo[1,3]dioxol-5-yl ester | Paroxetine |
| 430 | 30165-97-0 | 3-Hydroxy-4-morpholino-1,2,5-thiazole | Timolol Maleate EP Impurity D 4-morpholino-1,2,5-thiadiazol-3-ol 3-Hydroxy-4-morpholino-1,2,5-thiazole 4-MORPHOLIN-4-YL-1,2,5-THIADIAZOL-3-OL Timolol EP Impurity D Timolol EP Impurity D 3-Hydroxy-4-(morpholin-4-yl)-1,2,5-thiadiazole | Heterocycles;Timolol impurity;Oxadiazoles & Thiadiazoles;Sulfur & Selenium Compounds;Oxadiazoles & Thiadiazoles;Impurity reference substance |
| 431 | 35175-14-5 | Ipronidazole-OH-D2 | IPZOH IPRONIDAZOLE-OH Ipronidazole-OH-D2 HYDROXY-IPRONIDAZOLE Ipronidazole-hydroxy α,α,1-TriMethyl-5-nitro- 2-(1-METHYL-5-NITRO-1H-IMIDAZOL-2-YL)-PROPAN-2-OL 2-(1-Methyl-5-nitro-1H-imidazol-2-yl)propan-2-ol, Hydroxy-ipronidazole, IPZOH | Imidazole;Heterocycles;Pharmaceuticals;Metabolites & Impurities;Analysis of standard products;Intermediates & Fine Chemicals |
| 432 | 1156068-41-5 | 1-Propanol, 3-(2-methoxy-5-nitrophenoxy)- | 1156068-41-5 3-(2-methoxy-5-nitrophenoxy)propan-1-ol 1-Propanol, 3-(2-methoxy-5-nitrophenoxy)- | Impurity reference substance |
| 433 | 35367-31-8 | Penfluoron | PH60-44 TH 6044 PENFLURON PENFLUORON Penfluoron Superdiflubenzuron 1-(2,6-Difluorobenzoyl)-3-(4-trifluoro-methylphenyl)urea N-(2,6-Difluorobenzoyl)-N'-(4-trifluoromethylphenyl)urea 2,6-Difluoro-N-[[[4-(trifluoromethyl)phenyl]amino]carbonyl]benzamide | Pesticides;Analytical standards;Organochlorine pesticides |
| 434 | 1691249-44-1 | (R)-Zanubrutinib | (R)-BGB-3111 (R)-Zanubrutinib Zanubrutinib Impurity 1 ((R)-Zanubrutinib) Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7R)- | |
| 435 | 1379005-34-1 | N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide | Agomelatine Impurity 20 Agomelatine Impurity 39 Agomelatine Diacetyl Impurity N-Acetyl-N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide N-Acetyl-N-[2-(7-methoxy-1-naphthalenyl)ethyl]acetamide Acetamide, N-acetyl-N-[2-(7-methoxy-1-naphthalenyl)ethyl]- | agomelatine |
| 436 | 54707-71-0 | Acetylclonidine | Acetylclonidine Clonidine IMpurity-B(BP) Clonidine Related CoMpound A Clonidine Impurity B(USP RCA) CLONIDINE RELATED COMPOUND A (25 MG) (ACET-YLCLONIDINE) 1-acetyl-2-(2,6-dichloro-anilino)-4,5-dihydro-1H-imidazole 1-Acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole Clonidine Related Compound A (25 mg) (1-acetyl-2-(2,6-dichlorophenylimino)imidazolidine) (acetylclonidine) | Pharmaceutical raw materials;Impurity reference substance |
| 437 | 77017-20-0 | (16α)-21-Acetyloxy-16,17-dihydroxy-pregna-1,4,9(11)-triene-3,20-dione | BNKY015-BD01 Budesonide Impurity 12 Pregna-1,4,9(11)-triene-16,17-diol-3,20-dione 21-acetate 16,17-Dihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate 21-(Acetyloxy)-16α,17-dihydroxypregna-1,4,9(11)-triene-3,20-dione 16alpha,17,21-trihydroxypregna-1,4,9(11)-triene-3,20-dione 21-acetate (16α)-21-Acetyloxy-16,17-dihydroxy-pregna-1,4,9(11)-triene-3,20-dione 16-alpha,17-alpha-dihydroxy-3,20-dioxopregna- 1,4,9(11)-trien-21-yl acetate | Steroids;Pharmaceuticals;Budesonide impurity;Impurity reference substance;Intermediates & Fine Chemicals |
| 438 | 709615-25-8 | (11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one | Aromatic A-ring Ulipristal Acetate (11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one (112)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one (11β)-17-(Acetyloxy)-11-[4-(diMethylaMino)phenyl]-3-hydroxy-19-norpregna-1,3,5(10)-trien-20-one (8S,9R,11S,13S,14S,17R)-17-Acetyl-11-(4-(dimethylamino)phenyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl Acetate | Reference substance-impurity reference substance;Pharmaceuticals, Intermediates & Fine Chemicals, Steroids |
| 439 | 152551-75-2 | 1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone | Terazosin EP IMP J Terazosin IMpurity J Terazosin Hydrochloride Dihydrate - Impurity J Terazosin Impurity 10(Terazosin EP Impurity J) 1-[4-(4-AMino-6,7-diMethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone 1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-2-hydroxypentan-1-one 1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone 1-Pentanone, 1-[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy- | Terazosin impurity;Aromatics, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 440 | 243145-00-8 | Vildagliptin Impurity 19 | Vogliptin impurity 19 Vildagliptin Impurity 19 1-Amino-3-nitroadamantane 3-Nitro-adamantan-1-ylamine (1r,3s,5R,7S)-3-nitroadamantan-1-amine Tricyclo[3.3.1.13,7]decan-1-amine, 3-nitro- | 110-vetagliptin;Impurity reference substance |
| 441 | 106447-44-3 | 7-AMINO-3-[(Z)-PROP-1-ENYL]-3-CEPHEM-4-CARBOXYLIC ACID | Cefprozil Related CoMpound D Cefprozil Monohydrate EP Impurity D 7-AMINO-3-[(Z)-PROP-1-ENYL]-3-CEPHEM-4-CARBOXYLIC ACID 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-Amino-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-AMino-8-oxo-3-(1Z)-1-propen-1-yl-5--thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Cefprozil Related Compound D (30 mg) ((6R,7R)-7-amino-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | Chemical impurity-cefprozil;Dominant supply of cefprozil;Impurities related to cefprozil;Aromatics, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Comp;Ar |
| 442 | 192118-08-4 | [2-[4-(Aminosulfonyl)phenyl]ethyl]carbamic Acid Ethyl Ester | Glipizide EP Impurity F Ethyl [2-(4-Sulphamoylphenyl)ethyl] ethyl (4-sulfamoylphenethyl)carbamate Glipizide Impurity 6(Glipizide EP Impurity F) ethyl N-[2-(4-sulfamoylphenyl)ethyl]carbamate [2-[4-(Aminosulfonyl)phenyl]ethyl]carbamic Acid Ethyl Ester [2-[4-(AMinosulfonyl)phenyl]ethyl]carbaMic Acid Ethyl Ester Carbamic acid, [2-[4-(aminosulfonyl)phenyl]ethyl]-, ethyl ester (9CI) | Amines;Impurities;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;Amines, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Se |
| 443 | 51742-84-8 | 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-methoxy- | Fludarabine Impurity 9-β-D-Arabinofuranosyl-2-methoxy-9H-purin-6-amine 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-methoxy- 1-(6-amino-2-methoxy-purin-9-yl)-β-D-1-deoxy-arabinofuranose | Impurity reference substance |
| 444 | 11100-14-4 | Arochlor 1232 | PCB-1268 AROCLOR 5460 AROCLOR 6040 AROCLOR 5442 AROCHLOR 1232 Arochlor 1232 Aroclor 1268 solution | A;Alphabetic;Separate Source Standards;Single Component Solutions;Aroclors, PCBs, and Dioxins;AroclorsEnvironmental Standards;AR to AZEnvironmental Standards |
| 445 | 37324-23-5 | Arochlor 1262 | AROCHLOR 1232 Arochlor 1262 AROCLOR(R) 1232 AROCLOR(R) 1248 polychlorinatedbiphenyl(aroclor1262) | A;Separat;Aroclors;Alphabetic;Single Compone;Volatiles/ Semivolatiles;Volatiles/ Semivolatiles;Separate Source Standards;Aroclors, PCBs, and Dioxins;Aroclors, PCBs, and Dioxins |
| 446 | 947249-30-1 | tert-butyl 2-((4R,6S)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl- 4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate | Atorvastatin calcium-27 tert-butyl 2-((4R,6S)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl- 4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate | Atorvastatin calcium;Impurity reference substance |
| 447 | 22601-59-8 | Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]- | Solu-tracin 50 Bacitracin A (Technical Grade) 1-[N-[[2-(1-Amino-2-methylbuyl)-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucine]bacitracin F Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]- N2-[N-[[2-(1-Amino-2-methylbutyl)-4,5-dihydrothiazol-4-yl]carbonyl]-L-Leu-D-Glu-L-Ile-]cyclo(L-Lys-D-Orn-L-Ile-D-Phe-L-His-D-Asp-L-Asn-) L-Asparagine, N-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-α-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-α-aspartyl-, (10→4)-lactam | |
| 448 | 474668-76-3 | (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid | Tadanafil Impurity V Tadalafil Impurity V Tadalafil Acid Impurity Tadala non intermediate I impurity A (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid (1R,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Hydrochloride (1R,3R)-1-(1,3-BENZODIOXOL-5-YL)-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLIC ACID HYDROCHLORIDE (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid hydrochloride (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carbox ylic acid hydrochlorid | Impurity reference substance |
| 449 | 60263-54-9 | [1,1'-bicyclohexyl]-1-carboxylic acid | Ai3-19842 Einecs 262-131-1 Dicyclomine Impurity A Dicycloverine EP Impurity A 1,1'-Bicyclohexane-1-carboxylic acid [1,1'-bicyclohexyl]-1-carboxylic acid 1-CYCLOHEXYLCYCLOHEXANE-1-CARBOXYLIC ACID | Reference substance-impurity reference substance |
| 450 | 333749-57-8 | α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol | Ranolazine Dimer Impurity Bis[(2-Methoxyphenoxy)methyl]-1,4-p α,α'-Bis[(2-Methoxyphenoxy)methyl]-1,4-piperazinediethanol α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol Α,Α'-BIS[(2-METHOXYPHENOXY)METHYL]-1,4-PIPERAZINEDIETHANOL α,α''-Bis[(2-Methoxyphenoxy)methyl]-1,4-piperazinediethano 1,4-Piperazinediethanol, α1,α4-bis[(2-methoxyphenoxy)methyl]- 3,3''-(Piperazine-1,4-diyl)bis(1-(2-methoxyphenoxy)propan-ol) | Impurity reference substance;Reference substance-impurity reference substance;Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 451 | 26973-80-8 | 7-Bromoacetylaminocephalosporanic Acid | 7-Bromoacetylaminocephalosporanic Acid 7-(a-Bromoacetamido)cephalosporanicacid 7-(2-BroMoacetaMido)cephalosporanic Acid 7-(ALPHA-BROMOACETAMIDO)CEPHALOSPORANIC ACID 7-(2-Bromoacetamido)cephalosporanic Acid(7-Bromoacetylaminocephalosporanic Acid) (6R,7R)-3-(acetyloxymethyl)-7-[(2-bromoacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 3[(Acetyloxy)methyl]-7-[(bromoacetyl)amino]-8-oxo-(6R-trans)-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylicacid (6R-trans)-3-[(Acetyloxy)Methyl]-7-[(broMoacetyl)aMino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid | Amines;Heterocycles;Pharmaceutic;Chiral Reagents;Pharmaceuticals;Standard substance;Impurity reference substance;Intermediates & Fine Chemicals;MTS & Sulfhydryl Active Reagents;Related impurities of c |
| 452 | 80629-35-2 | 1-[(2S)-3-Bromo-2-methyl-1-oxopropyl]-L-proline | captopril-ep-imp-B Captopril impurity B Captopril Impurity 2(Captopril EP Impurity B) 1-[(2S)-3-BroMo-2-Methyl-1-oxopropyl]-L-proline 1-[(2S)-3-Bromo-2-methyl-1-oxopropyl]-L-proline L-Proline, 1-(3-bromo-2-methyl-1-oxopropyl)-, (S)- 1-(3-bromo-2S-methylpropionyl)-pyrrolidine-2S-carboxylic acid (S)-1-((S)-3-bromo-2-methylpropanoyl)pyrrolidine-2-carboxylic acid (2S)-1-[(2S)-3-Bromo-2-methylpropanoyl]pyrrolidine-2-carboxylic acid | 245-captopril;Inhibitors, Intermediates, Pharmaceuticals, Intermediates & Fine Chemicals |
| 453 | 55699-12-2 | 4-tert-Butyl-2,6-dimethyl-3-hydroxyphenylacetic Acid | Oxymetazoline EP Impurity D [4-(1,1-Dimethylethyl)-3-hydroxy-2, Oxymetazoline hydrochloride EP impurity D 4-tert-Butyl-2,6-dimethyl-3-hydroxyphenylacetic Acid 4-tert-Butyl-2,6-diMethyl-3-hydroxyphenylacetic Acid 2-(4-tert-Butyl-3-hydroxy-2,6-dimethylphenyl)acetic acid Benzeneacetic acid, 4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethyl- | Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 454 | 73837-24-8 | 5,6-trans-Calcitriol | 1,25-Dihydrox 5,6-trans-Calcitriol Calcitriol Impurities A 5,6-trans-1a,25-Dihydroxyvitamin D3 (1α,3β,5E,7E)- 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol 5-{2-[1-(5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol (1R,3S,5E)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aS)-octahydro-1-[(1R)-5-hydroxy-1,5-diMethylhexyl]-7a-Methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol (1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diol | Interme;Impurities;Osteoporosis;Chiral Reagents;Pharmaceuticals;Reference substance;Chemical raw materials;Treatment of osteoporosis;Impurity reference substance;Intermediates & Fine Chemicals |
| 455 | 14599-46-3 | Trifluridine Related Compound A (5-Carboxy-2'-deoxyuridine) | 5-Carboxy-2'-dU Trifluridine Impurity A 5-carboxy-2'-deoxyuridine 5-Carboxy-2'-deoxyuridine Trifluridine Related CoMpound A Trifluridine USP Related Compound A Trifluridine Related Compound A (5-Carboxy-2'-deoxyuridine) TRIFLURIDINE RELATED COMPOUND A (20 MG) (5-CARBOXY-2'-DEOXYURIDINE) 1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinecarboxylic acid | Impurities;Modifiers nucleoside;Reference substance-impurity reference substance;Carbohydrates & Derivatives, Heterocycles, Nucleotides, Bases & Related Reagents |
| 456 | 1322626-65-2 | Cefazolin Amide | Cefazolin Amide Cefazolin Impurity 9 Cefazolin Impurity 54 Cefazolin Sodium EP Impurity K Cefazolin Impurity 10(Cefazolin EP Impurity K) 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxamide, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-, (7R)- | Cefazolin;Impurity reference substance;Reference substance-impurity reference substance |
| 457 | 70993-70-3 | Cefmetazole Lactone | Cefmetazole Lactone 2-((cyanomethyl)thio) Cefmetazole Impurity 3 Cefmetazole inner ester Cefmezole sodium decomposition Cefmetazole Related Compound inner ester (5aR-cis)-2-[(Cyanomethyl)thio]-N-(1,4,5a,6-tetrahydro-6-methoxy-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-acetamide | Standard;Cefmetazole Sodium Impurities |
| 458 | 92676-86-3 | Cefprozil (E)-Isomer | BMY-28167 E-Cefprozil Cefprozil (E)-Isomer Cefprozil (E)-IsoMer Cefprozil (E)-Isomer (50 mg) (6R,7R)-7α-[[(R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1E)-1-propenyl]-8-oxo-5-thia-1-azabicyclo[4.2.1]non-2-ene-2-carboxylic acid 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1E)-1-propen-1-yl-, (6R,7R)- | Impurities;Chemical impurity-cefprozil;Superior supply of cefprozil;Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 459 | 102772-66-7 | Ceftazidime t-Butyl Ester | Ceftazidime EP Imp E Ceftazidime t-Butyl Ester Ceftazidime Ep Impurity E CeftazidiMe t-Butyl Ester Ceftazidime Impurity D(EP) Ceftazidime tert-butyl ester (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(((1-(tert-butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 1-[[(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[[2-(1,1-diMethylethoxy)-1,1-diMethyl-2-oxoethoxy]iMino]acetyl]aMino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]Methyl]pyridiniuM Inner Salt | Impurities;Heterocycles;Intermediates;Chiral Reagen;Chiral Reagents;Pharmaceuticals;Ceftazidime impurity;Analytical chemistry;Intermediate raw materials;Sulfur & Selenium Compounds |
| 460 | 97148-38-4 | Ceftazidime EP Impurity B | Ceftazidime EP Impurity B E-Ceftazidime Ceftazidime Impurity B Ceftazidime EP Impurity B(E-Ceftazidime) Ceftazidime Impurity B (EP) (E-Ceftazidime) (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (6R,7R)-7-({(2E)-2-(2-Amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]ethanoyl}amino)-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Ceftazidime;Standard substance;Ceftazidime impurity;Impurity reference substance;Chemical drug impurity-ceftazidime;Standard substance/reference substance/chemical reagent/experiment |
| 461 | 79750-46-2 | Δ2-Cephalexin | Δ2-Cephalexin Cefalexin-EP-Imp-F Cephalexin IMpurity F Cefalexin EP Impurity F Cefalexin EP Impurity F Trifluoroacetate [6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0 (6R,7R)-7-[[(2R)-AMinophenylacetyl]aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic Acid (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid | Amines;Impurities;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Chemical impurity-cephalexin;Intermediates & Fine Chemicals;Impurities related to cephalexin |
| 462 | 21165-77-5 | N-[[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]carbamic Acid Methyl Ester | Einecs 244-254-2 Glyburide USP Related Compound B methyl N-[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonylcarbamate [4-[2-(2-Methoxy-5-chlorobenzoylamino)ethyl]phenylsulfonyl]carbamic acid methyl ester [[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]carbamic acid methyl ester N-[[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulfonyl]carbamic Acid Methyl Ester Carbamic acid, ((4-(2-((5-chloro-2-methoxybenzoyl)amino)ethyl)phenyl)sulfonyl)-, methyl ester Glyburide Related Compound B (25 mg) (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS) GLYBURIDE RELATED COMPOUND B (25 MG) (METHYL-[[4-[2-[(5-CHLORO-2-METHOXYBENZOYL)-AMINO]ETHYL]PHENYL]SULFONYL]CARBAMATE) (AS) | Impurity reference substance |
| 463 | 67987-08-0 | 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-[4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]phen | Haloperidol EP Impurity D Haloperidol Related CoMpound A 4,4′-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]butyrophenone 4,4-Bis[4-(P-Chlorophenyl)-4-Hydroxypiperidino]-Butyrophenone(WXC03520) 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-[4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]phen Haloperidol Related Compound A (10 mg) (4,4'-Bis[4-(p-chlorophenyl)-4-hydroxy-piperidino]-butyrophenone) HALOPERIDOL RELATED COMPOUND A (15 MG) (4,4'-BIS[(4-P-CHLOROPHENYL)-4-HYDROXY-PIPERIDINO]-BU-TYROPHENONE) 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-{4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]pphenyl}-1-butanon 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-[4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]phenyl]-1-butanone | Haloperidol impurity;Impurity reference substance;Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 464 | 1329745-98-3 | Citalopram Dimethylaminobutanone Dihydrochloride Salt | Citalopram EP Imp G Citalopram Impurity G Citalopram Impurity 24 EsCitalopram EP Impurity G CitalopraM DiMethylaMinobutanone Citalopram Impurity 9(Citalopram EP Impurity G) Citalopram Dimethylaminobutanone Dihydrochloride Salt Citalopram Dimethylaminobutanone Di-Oxalate (Citalopram Impurity G) 4-(DiMethylaMino)-1-[1-[3-(diMethylaMino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuranyl]-1-butanone | Amines;Aromatics;Impurities;Heterocycles;Neurochemicals;Pharmaceuticals;229-escitalopram;Escitalopram impurity (p);Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 465 | 10080-05-4 | 1-Cyclohexyl-3-(p-sulfamoylphenethyl)urea | Glipizide IMpurity H Glipizide EP Impurity H 4-[2-[(Cyclohexylcarbamoyl)amino]et 1-Cyclohexyl-3-(p-sulfamoylphenethyl)urea 1-Cyclohexyl-3-(p-sulfaMoylphenethyl)urea Glipizide Impurity 8(Glipizide EP Impurity H) 4-(2-(3-cyclohexylureido)ethyl)benzenesulfonamide 4-[2-[[(CyclohexylaMino)carbonyl]aMino]ethyl]benzenesulfonaMide Benzenesulfonamide, 4-[2-[[(cyclohexylamino)carbonyl]amino]ethyl]- | Amines;Impurities;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;Amines, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Se |
| 466 | 952722-64-4 | Cyclopropyl 3-Fluorobenzyl Ketone | Cyclopropyl 3-Fluorobenzyl Ketone 1-cyclopropyl-2-(3-fluorophenyl)ethanone 1-CYCLOPROPYL-2-(3-FLUOROPHENYL)ETHAN-1-ONE Ethanone, 1-cyclopropyl-2-(3-fluorophenyl)- | Impurity reference substance;Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals |
| 467 | 1794-55-4 | D 517 Hydrochloride (Verapamil Impurity) | Verapamil EP Impurity I Verapamil Impurity I HCl Verapamil EP Impurity I(HCl) D 517 Hydrochloride (Verapamil Impurity) 2-(3,4-dimethoxyphenyl)-2-[2-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]ethyl]-3-methylbutanenitrile,hydrochloride alpha-[2-[[2-(3,4-diMethoxyphenyl)-ethyl]MethylaMino]ethyl]-3,4-diMethoxy-alpha-(1-Methylethyl)-benzeneacetonitrile MonoHydrochloride Verapamil Related Compound B (50 mg) (alpha-[2-[[2-(3,4-dimethoxyphenyl)-ethyl]methylamino]ethyl]-3,4-dimethoxyalpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE) | Amines;Aromatics;Impurities;Pharmaceuticals;Verapamil impurity;Intermediates & Fine Chemicals |
| 468 | 502626-06-4 | N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel | Paclitaxel EP Impurity Q N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Paclitaxel EP Impurity Q N-debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxe Benzenepropanoic acid, α-hydroxy-β-[[(2E)-1-oxo-2-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)- | Standard;Impurity reference substance |
| 469 | 130996-24-6 | Dehydro Lacidipine | GR 51092 GR 51092X GR 510922qopenyl] Dehydro Lacidipine diethyl 4-[2-[(E)-3-tert-butoxy-3-oxo-prop-1-enyl]phenyl]-2,6-dim ethyl-pyridine-3,5-dicarboxylate (E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-prphenyl]-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Diethyl Ester (E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-propenyl]phenyl]-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester | Heterocyles;Pharmaceuticals;Metabolites & Impurities;Intermediates & Fine Chemicals;Heterocyles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 470 | 1346605-18-2 | rac Deoxy-O-desmethyl Venlafaxine | Venlafaxine Impurity 46 rac Deoxy-O-desmethyl Venlafaxine rac Deoxy-O-desMethyl Venlafaxine 4-[1-Cyclohexyl-2-(diMethylaMino)ethyl]phenol Phenol, 4-[1-cyclohexyl-2-(dimethylamino)ethyl]- Cyclohexyl-4-hydroxy-N,N-diMethylbenzeneethanaMine | Amines;Aromatics;Impurities;Pharmaceuticals;Intermediates & Fine Chemicals |
| 471 | 603-41-8 | p,p'-(2-pyridylmethylene)bisphenol | Desdiacetyl Bisacodyl Bisacodyl EP Impurity A Picosulfate EP Impurity B Bisacodyl Related CoMpound A dihydroxydiphenyl-pyridyl methane p,p'-(2-pyridylmethylene)bisphenol 4,4'-(pyridin-2-ylmethylene)diphenol | Aromatics;Heterocycles;Pharmaceuticals;Pharmaceutical raw materials;Impurity reference substance;Intermediates & Fine Chemicals;Organic chemical intermediates |
| 472 | 1797099-76-3 | N,N-Didesethylene Levofloxacin Hydrochloride | Levofloxacin Impurity 9 Levofloxacin Impurity 28 HCl Levofloxacin Hydrochloride Impurity 28 Levofloxacin Diamine Hydrochloride Salt N,N-Didesethylene Levofloxacin Hydrochloride N,N'-Desethylene-N-Desmethyl Levofloxacin Hydrochloride Hydrochloride (S)-10-((2-aminoethyl)amino)-9-fluoro-3- methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino [2,3,4-ij]quinoline-6-carboxylic acid | |
| 473 | 1346604-00-9 | O-Desisopropyl-O-methyl Bisoprolol Hemifumarate | Bisoprolol EP Imp Q Bisoprol EP Impurity Q Bisoprolol EP Impurity Q (2RS)-1-(Isopropylamino)-3-[4-(2-me O-Desisopropyl-O-methyl Bisoprolol Hemifumarate Bisoprolol Impurity 13(Bisoprolol EP Impurity Q) 2-Propanol, 1-[4-[(2-methoxyethoxy)methyl]phenoxy]-3-[(1-methylethyl)amino]- | Bisoprolol impurity;Chemical raw materials;Impurity reference substance |
| 474 | 107362-12-9 | 2-Desisopropyl-2-phenyl Repaglinide (Repaglinide Impurity) | Repaglinide Impurity 19 Repaglinide Related CoMpound C 2-Desisopropyl-2-phenyl Repaglinide 2-Desisopropyl-2-phenyl Repaglinide (Repaglinide IMpurity) 2-Desisopropyl-2-phenyl Repaglinide (Repaglinide Impurity) (S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]aMino]-2-oxoethyl] benzoic acid Repaglinide Related Compound C (25 mg) ((S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid) REPAGLINIDE RELATED COMPOUND C (25 MG) ((S)-2-ETHOXY-4-[2-[[2-PHENYL-1 -[2-(1 -PIPERIDINYL)PHE-NYL]ETHYL]AMINO]-2-OXOETHYL] BENZOIC ACID) | Aromatics;Impurities;Heterocycles;Pharmaceuticals;Endocrine and metabolism;Amino Acids & Derivatives;Impurity reference substance;Intermediates & Fine Chemicals |
| 475 | 334981-12-3 | N-Desmethyl Almotriptan | Almotriptan USP RC C N-Desmethyl Almotriptan N-DesMethyl AlMotriptan N-Desmethyl Almotriptan Malate AlMotriptan Related CoMpound C N-Methyl-5-[(1-pyrrolidinylsulfonyl)Methyl]-indole-3-ethanaMine N-Methyl-5-[(1-pyrrolidinylsulfonyl)methyl]-1H-indole-3-ethanamine 1-[[[3-[2-(MethylaMino)ethyl]-1H-indol-5-yl]Methyl]sulfonyl]-pyrrolidine Almotriptan Related Compound C (15 mg) (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine) | Neurochemicals;Pharmaceuticals;Metabolites & Impurities;Intermediates & Fine Chemicals;Metabolites & Impurities, Neurochemicals, Pharmaceuticals, Intermediates & Fine Chemicals |
| 476 | 1370190-94-5 | Posaconazole Impurity 40 | Desethylene Posaconazole Posaconazole Impurity 67 Posaconazole Impurity 40 Posaconazole Desethylene Impurity D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[[2-[[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]amino]ethyl]amino]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)- | impurity reference substance;Reference substance-impurity reference substance |
| 477 | 98626-59-6 | Ropivacaine-ET-S | Ropivacaine-ET-S Ropivacaine-007-S Ropivacaine Impurity 4 Ropivacaine EP Impurity D N-2-Desmethyl Ropivacaine D Ropivacaine Impurity D(EP) (2S)-N-(2,6-dimethylphenyl)-1-ethylpiperidine-2-carboxamide | Impurity reference substance;Reference substance-Impurity reference substance |
| 478 | 1346601-14-6 | rac N-Desmethyl-N-(4-methoxyphenethyl) Venlafaxine | Venlafaxine Impurity I Venlafaxine Impurity 25 Venlafaxine Impurity 18 Venlafaxine hydrochloride I rac N-DesMethyl-N-(4-Methoxyphenethyl) Venlafaxine rac N-Desmethyl-N-(4-methoxyphenethyl) Venlafaxine 1-(2-((4-methoxyphenethyl)(methyl)amino)-1-(4-methoxyphenyl)ethyl )cyclohexanol 1-[1-(4-Methoxyphenyl)-2-[N-Methyl-N-[(4-Methoxyphenyl)ethyl]aMino]ethyl]cyclohexanol Cyclohexanol, 1-[1-(4-methoxyphenyl)-2-[[2-(4-methoxyphenyl)ethyl]methylamino]ethyl]- | Amines;Aromatics;Impurities;Venlafaxine;Pharmaceuticals;Intermediates & Fine Chemicals |
| 479 | 18172-50-4 | N-Desmethylvinblastine | Vincristine EP-C N-Deformylvincristine N-Desmethylvinblastine Vinblastine Impurity C N-Deformylleurocristine Vincristine EP Impurity C 1-Demethyl-vincaleukoblastine Vincristine Impurity 3(Vincristine EP Impurity C) | Pharmaceuticals;Impurities of bulk drug;Metabolites & Impurities;Intermediates & Fine Chemicals;Various Metabolites and Impurities;Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chem; |
| 480 | 73899-76-0 | Diacetolol Hydrochloride | Einecs 277-629-4 Diacetolol Hydrochloride N-[3-Acetyl-4-[(2RS)-2-hydroxy-3-[( Acebutolol Impurity 2(Acebutolol EP Impurity B) Acebutolol Hydrochloride Impurity B Acebutolol Impurity 2 (+-) 3'-acetyl-4'-(2-hydroxy-3-isopropylaminopropoxy)acetanilide HCl N-[3-Acetyl-4-(2-hydroxy-3-isopropylamino-propoxy)-phenyl]-acetamide Hydrochloride (±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide monohydrochloride (1)-N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide monohydrochloride | Chemical raw materials |
| 481 | 141271-12-7 | 4-(2,5-Diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol) | Abacavir Abacavir USP RC B Abacavir USP Impurity B ( Abacavir USP Related Compound B) Abacavir Impurity 7( Abacavir USP Related Compound B) 4-(2,5-Diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol) 2-Cyclopentene-1-methanol, 4-[(2,5-diamino-6-chloro-4-pyrimidinyl)amino]-, (1S,4R)- | |
| 482 | 224-42-0 | Dibenz[a,j]acridine | Db(a,j)ac dibenzacridine Dibenz[a,j]acridine DIBENZ(A,J)ACRIDINE DIBENZO(A,J)ACRIDINE 1,2,7,8-DIBENZACRIDINE 3,4,5,6-dibenzacridine 3,4,6,7-dinaphthacridine 7-AZADIBENZ[A,J]ANTHRACENE | Aromatics;Heterocycles;Aromatics Compounds;Mutagenesis Research Chemicals |
| 483 | 158810-73-2 | 10-O-2,2-Dichloroethoxycarbonyl Docetaxe | 10- Dec Docetaxel Docetaxel Impurity 15 6-Dichloroethoxy-carbonyl docetaxel 10-O-2,2-Dichloroethoxycarbonyl Docetaxe | Plant extract;Impurity reference substance |
| 484 | 124379-29-9 | 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one | Sertraline Tetralone (S)-IsoMer (S)-4-(3,4-Dichlorophenyl)-1-tetralon 4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)-NAPHTHALENONE 4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE (4S)-(34Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one 4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)-NAPHTALENE-1-ONE 4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)-NAPHTHALENE-1-ONE (4S)-4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRONAPHTHALEN-1(2H)-ONE | Catalyst;Chiral Reagents;Sertraline impurities;Miscellaneous Reagents;Pharmaceutical intermediates |
| 485 | 795313-24-5 | 8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane Bromide | Aripiprazole Impurity 12 Aripiprazole Impurity 12 Bromide 8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane BroMide 8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium bromide 8-(2,3-Dichlorophenyl)-8-aza-5-azoniaspiro[4.5]decane Bromide | 239-aripiprazole;Impurity reference substance;Reference substance-impurity reference substance;Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 486 | 87864-08-2 | N-[2-(Diethylamino)ethyl]-2-hydroxyquinoline-4-carboxamide | Cinchocaine impurity Dibucaine Impurity C) Cinchocaine EP Impurity C Cinchocaine Hydrochloride Impurity C Cinchocaine Hydrochloride EP Impurity C CINCHOCAINE EP IMPURITY C (DIBUCAINE IMPURITY C) Cinchocaine EP Impurity C (Dibucaine Impurity C) N-(2-(diethylamino)ethyl)-2-hydroxyquinoline-4-carboxamide N-[2-(Diethylamino)ethyl]-2-hydroxyquinoline-4-carboxamide 4-Quinolinecarboxamide, N-[2-(diethylamino)ethyl]-1,2-dihydro-2-oxo- | Impurity World-Occaine |
| 487 | 943515-58-0 | 3,4-O-(Diethylmethylidene) Shikimic Acid Ethyl Ester | Oseltamivir Impurity 87 3,4-O-(Diethylmethylidene) Shikimic Acid Ethyl Ester 3,4-O-(DiethylMethylidene) ShikiMic Acid Ethyl Ester (3aR,7R,7aS)-ethyl 2,2-diethyl-7-hydroxy-3a,6,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-carboxylate 1,3-Benzodioxole-5-carboxylic acid, 2,2-diethyl-3a,6,7,7a-tetrahydro-7-hydroxy-, ethyl ester, (3aR,7R,7aS)- | Impurity reference substance;Chiral Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |
| 488 | 135270-13-2 | Efinaconazole Impurity 2;1-(((2R,3R)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole | 135270-13-2 Efinaconazole Impurity 2 Efinaconazole Epoxy Impurity Efinaconazole Related Impurity Efinaconazole Related Impurity 6 1-(((2R,3R)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole 1-[[(2R,3R)-2-(2,4-Difluorophenyl)-3-methyl-2-oxiranyl]methyl]-1H-1,2,4-triazole 1H-1,2,4-Triazole, 1-[[(2R,3R)-2-(2,4-difluorophenyl)-3-methyl-2-oxiranyl]methyl]- Efinaconazole Impurity 2 1-(((2R,3R)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole | Impurity reference substance |
| 489 | 357189-97-0 | Posaconazole Impurity 44 | Posaconazole Impurity 44 Posaconazole Impurity 89 Posaconazole Formamide Impurity (5R-cis)-4-[5-(2,4-Difluorophenyl)-5-[1,2,4]triazol-1-ylmethyltetrahydrofur an-3-ylmethyl]methoxy-formanilide N-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)formamide D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-(formylamino)phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)- | Impurity reference substance |
| 490 | 94305-25-6 | 3,4-Dihydro-4-phenyl-2H-benzo[h]chromene | Dapoxetine-007 Dapoxetine iMpurity Dapoxetine Impurity 7 Dapoxetine Impurity 2 Dapoxetine Impurity 13 (R)-Dapoxetine N-Oxide 3,4-Dihydro-4-phenyl-2H-benzo[h]chromene | Urogenital system;Impurity reference substance;Control substance-impurity reference substance;Analysis and detection of impurities in new drugs |
| 491 | 1150310-15-8 | (2E)-3-(3,4-Dihydroxy-5-nitrophenyl)-2-(piperidin-1-ylcarbonyl)acrylonitrile | Entacapone impurity H (2E)-3-(3,4-Dihydroxy-5-nitrophenyl Entacapone Impurity 24(Entacapone EP Impurity H) (2E)-3-(3,4-Dihydroxy-5-nitrophenyl)-2-(piperidin-1-ylcarbonyl)acrylonitrile (E)-3-(3,4-dihydroxy-5-nitrophenyl)-2-(piperidine-1-carbonyl)prop-2-enenitrile 1-Piperidinepropanenitrile, α-[(3,4-dihydroxy-5-nitrophenyl)methylene]-β-oxo-, (αE)- (alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile | Enhe Capone impurity |
| 492 | 94109-61-2 | 1-(3,5-Dihydroxyphenyl)-2-[(1,1-dimethylethyl)(phenylmethyl)amino]ethanone Hydrobromide | Terbutaline-013 Terbutaline Impurity D TerButaline Ep Impurity D Terbutaline Impurity D HBr Terbutaline Impurity 4(Terbutaline EP Impurity D) Ethanone, 1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)(phenylmethyl)amino]- 1-(3,5-Dihydroxyphenyl)-2-[(1,1-diMethylethyl)(phenylMethyl)aMino]ethanone HydrobroMide 1-(3,5-Dihydroxyphenyl)-2-[(1,1-dimethylethyl)(phenylmethyl)amino]ethanone Hydrobromide Terbutaline IMpurity D (2-[benzyl-(1,1-diMethylethyl) aMino]-1-(3,5-dihydroxyphenyl) ethanone) HBr | Impurity reference substance;Reference substance-impurity reference substance;Amines, Aromatics, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 493 | 38284-47-8 | (1S,2S,5S)-4-[2-[2-(6,6-Dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholine | Pinaverium Impurity Pinaverium Impurity 1 Pinaverium Bromide Impurity 9 4-{2-[2-(6,6-dimethyl-norpinan-2-yl)-ethoxy]-ethyl}-morpholine Morpholine, 4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]- (1S,2S,5S)-4-[2-[2-(6,6-Dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholine (1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine 4-(2-(2-(6,6-dimethylbicyclo[3.1.1] heptan-2-yl)ethoxy)ethyl)morpholine (PNB-II) | Impurity reference substance;Pharmaceuticals, Intermediates & Fine Chemicals |
| 494 | 334981-13-4 | Almotriptan Impurity 1 | Almotriptan Impurity 1 Almotriptan Impurity 3 2H-Indol-2-one, 3-[2-(dimethylamino)ethyl]-1,3-dihydro-5-[(1-pyrrolidinylsulfonyl)methyl]- 1-[[[3-[2-(Dimethylamino)ethyl]-2,3-dihydro-2-oxo-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine | Reference substance-impurity reference substance |
| 495 | 102193-41-9 | Dimethoxy Dienogest | Dimethoxy Dienogest DiMethoxy Dienogest Dienogest Dimethoxy Impurity Dienogest Impurity 8 (Dienogest EP Impurity E) [(17β)-17-Hydroxy-3,3-dimethoxyestra-5(10),9(11)-dien-17-yl]acetonitrile (17alpha)-17-Hydroxy-3,3-dimethoxy-19-norpregna-5(10),9(11)-diene-21-nitrile 2-[(8S,13S,14S,17R)-17-hydroxy-3,3-dimethoxy-13-methyl-1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile | Dinogestin impurity;Impurity reference substance;Pharmaceuticals, Intermediates & Fine Chemicals, Steroids |
| 496 | 1119449-38-5 | 4-(3',6'-Dimethyl-3'-heptyl)phenol Diethoxylate | 363-NP2EO 4-(3',6'-Dimethyl-3'-heptyl)phenol Diethoxylate 4-(3',6'-DiMethyl-3'-heptyl)phenol diethoxylate 4-(3,6-Dimethyl-3-heptyl)phenol diethoxylate solution 2-{2-[4-(3',6'-Dimethyl-3'-heptyl)phenoxy]ethoxy}ethanol 2-[2-[4-(1-Ethyl-1,4-diMethylpentyl)phenoxy]ethoxy]ethanol Ethanol, 2-[2-[4-(1-ethyl-1,4-dimethylpentyl)phenoxy]ethoxy]- | Aromatics;Miscellaneous Reagents;Aromatics, Miscellaneous Reagents |
| 497 | 1262333-25-4 | [N(Z)]-N-(3,5-Dimethyl-2(3H)-thiazolylidene)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1 | N-Methyl Meloxicam Meloxicam EP Impurity C Meloxicam Impurity C(EP) Meloxicam impurity C (Y0001037) Meloxicam Impurity 3(Meloxicam EP Impurity C) [N(Z)]-N-(3,5-Dimethyl-2(3H)-thiazolylidene)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1 [N(Z)]-N-(3,5-DiMethyl-2(3H)-thiazolylidene)-4-hydroxy-2-Methyl-2H-1,2-benzothiazine-3-carboxaMide 1,1-Dioxide 2H-1,2-Benzothiazine-3-carboxamide, N-(3,5-dimethyl-2(3H)-thiazolylidene)-4-hydroxy-2-methyl-, 1,1-dioxide, [N(Z)]- | Impurity reference substance;Reference substance-impurity reference substance;Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 498 | 95603-44-4 | 7,10-Di-O-trichloroethoxycarbonyl-10-deacetyl Baccatin III | 7,10-Troc-10-DAB CABAZITAXEL IMPURITY 34 (DITROC) 7,10-DiTroc-10-deacetylbaccatin III 7,10-Di-O-trichloroethoxycarbonyl-10-deacetyl Baccatin 7,10-Di-O-[(2,2,2-trichloroethoxy)carbonyl]baccatin III 7,10-Di-O-trichloroethoxycarbonyl-10-deacetyl Baccatin III 7,10-Di(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III 7,10-Bis(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III 7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III Carbonic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4a,8,13,13-tetraMethyl-5-oxo-7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete-4,6-diyl bis(2,2,2-trichloroethyl) Ester | Metabolites;Pharmaceuticals;Organic chemistry;Impurity reference substance;Intermediates & Fine Chemicals |
| 499 | 229614-05-5 | (1S,2S,3R,4R)-Methyl 3-((R)-1-acetaMido-2-ethylbutyl)-4-(tert-butoxycarbonylaMino)-2-hydroxycyclopentanecarboxylate | Peramivir impurities27 Peramivir impurities437 (S)-1-(2-nitrobenzyl)-5-oxopyrrolidine-2-carboxylic acid (1S,2S,3R,4R)-METHYL 3-((S)-1-ACETAMIDO-2-ETHYLBUTYL)-4-(TERT-BUTOXYCARBONYLAMINO)-2-HYDROXYCYCLOPENTANECARBOXYLATE (1S,2S,3R,4R)-Methyl 3-((R)-1-acetaMido-2-ethylbutyl)-4-(tert-butoxycarbonylaMino)-2-hydroxycyclopentanecarboxylate Methyl (1S,2S,3R,4R)-3-((R)-1-acetamido-2-ethylbutyl)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclopentane-1-carboxylate methyl (1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclopentane-1-carboxylate Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-, methyl ester, (1S,2S,3R,4R)- | 189-peramivir;Paramivir impurity;Impurity reference substance |
| 500 | 121577-35-3 | Moxifloxacin Impurity 40 | Moxifloxacin Impurity 72 Moxifloxacin Impurity 40 Moxifloxacin dimethylamine Moxifloxacin intermediate impurity 1 Moxifloxacin Intermediate Impurity 1 Control Ethyl (E)-3-(dimethylamino)-2-(2,4,5-trifluoro-3-methoxybenzoyl)acrylate Benzenepropanoic acid, α-[(dimethylamino)methylene]-2,4,5-trifluoro-3-methoxy-β-oxo-, ethyl ester | Impurity World-Moxifloxacin;Impurity reference substance |
| 501 | 1234858-94-6 | (1R,5S,6S)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Methyl Ester | BWNDCLRNSUNXGU-GRYCIOLGSA-N Methyl (1S,5R,6S)-5-(pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate (1R, 5S, 6R) 5 - (pentane-2-oxy) - 7-Oxabicyclo [4.1.0] hept-2-ene-3-carboxylic acid (1R,5S,6S)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Methyl Ester 7-Oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid, 5-(1-ethylpropoxy)-, methyl ester, (1R,5S,6R)-rel- | Impurity reference substance;Chiral Reagents, Miscellaneous Reagents |
| 502 | 31055-19-3 | 3-(Formylamino)-1H-pyrazole-4-carboxylic Acid Ethyl Ester | Allopurinol EP Imp E Allopurinol Related CoMpound E ethyl 5-forMaMido-1H-pyrazole-4-carboxylate ethyl 5-(forMylaMino)-1H-pyrazole-4-carboxylate 3-(Formylamino)-1H-pyrazole-4-carboxylic Acid Ethyl Ester Allopurinol EP Impurity E or Allopurinol USP Related Compound E Allopurinol Impurity 5(Allopurinol EP Impurity E)(Allopurinol USP Related Compound E ) Allopurinol Related Compound E (25 mg) (ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate) | Chemical raw materials;Impurity reference substance |
| 503 | 127955-44-6 | Erythromycin EP Impurity L | ERYTHROMYCIN IMPURITY L Erythromycin EP Impurity L Erythromycin, N-demethyl-N-formyl- Erythromycin Impurity 12(Erythromycin EP Impurity L) Erythromycin EP Impurity L (N-Formyl Erythromycin A) | Erythromycin impurity |
| 504 | 74050-97-8 | Haloperidol Decanoate | KD-136 R-13672 Halomonth Depot haloperidol Haloperidol Deconate Haloperidol Decanoate 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate Decanoic acid, 4-(4-chlorophenyl)-1-4-(4-fluorophenyl)-4-oxobutyl-4-piperidinyl ester Decanoic acid 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl ester | Organics;Aromatics;Heterocycles;Pharmaceuticals;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 505 | 1616967-26-0 | Formoterol EP Impurity E | Formoterol EP Impurity E Formoterol Fumarate EP Impurity E Formoterol Impurity E (Mixture of Diastereomers) Formoterol EP Impurity E (Mixture of Diastereomers) Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxy-3-methylphenyl)-1-methylethyl]amino]ethyl]phenyl]- | 190-formoterol;Impurity reference substance |
| 506 | 1391054-00-4 | Hydroxy Chlorodenafil | Hydroxy Chlorodenafil Chlorodenafil Impurity 1 Hydroxychlorodenafil (5-[5-(2-Chlor Hydroxychlorodenafil (5-[5-(2-Chloro-1-hydroxyethyl)-2-ethoxyphenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one) | Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals |
| 507 | 1071765-44-0 | 5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-isopropyl-1,3-oxazolidin-2-one (Bisoprolol Oxazolidinonebenzylalcohol) | Bisoprolol Impurity O Bisoprolol EP Impurity 21 Bisoprolol impurities1636 5-[[4-(Hydroxymethyl)phenoxy]methyl 5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-isopropyl-1,3-oxazolidin-2-one 5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone 2-Oxazolidinone, 5-[[4-(hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)- 5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-isopropyl-1,3-oxazolidin-2-one (Bisoprolol Oxazolidinonebenzylalcohol) | Bisoprolol impurity;Impurity reference substance |
| 508 | 1638785-23-5 | 1'-Hydroxy Bilastine | Bilastine Impurity 5 1'-Hydroxy Bilastine Bilastine Impurity 07 Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]-1-hydroxyethyl]-α,α-dimethyl- | Impurity reference substance-bilastine |
| 509 | 411221-53-9 | 3-Hydroxy Citalopram | Citalopram EP Imp B 3-Hydroxy CitalopraM 3-Hydroxy Citalopram CitalopraM EP IMpurity B Citalopram EP Impurity B (USP RC B) Citalopram Hydrochloride EP Impurity B Citalopram Impurity 4(Citalopram EP Impurity B) 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-3H-2-benzofuran-5-carbonitrile 1-[3-(DiMethylaMino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-3-hydroxy-5-isobenzofurancarbonitrile | Amines;Aromatics;Impurities;Heterocycles;Neurochemicals;Pharmaceuticals;229-Escitalopram;Chemical raw materials;Impurity reference substance;Intermediates & Fine Chemicals |
| 510 | 1346601-19-1 | 4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic Acid 2-Hydroxyethyl Ester | Bisoprolol Impurity 1 Bisoprolol Impurity 44 Bisoprolol Impurity 23 UPAZFOMIRKHLDX-UHFFFAOYSA-N Bisoprolol Hydroxyethyl Ester Impurity 4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic Acid 2-Hydroxyethyl Ester 2-Hydroxyethyl 4-[((2RS)-2-Hydroxy-3-(isopropylamino)propyl)oxy]benzoate | Impurity reference substance |
| 511 | 94749-02-7 | 4-Hydroxy-α1-[[[6-(2-phenylethoxy)hexyl]amino]methyl]-1,3-benzenedimethanol | Salmeterol EP Impurity B Salmeterol Xinafoate BP Impurity B 4-Hydroxy-α1-[[[6-(2-phenylethoxy)hexyl]aMino]Methyl]-1,3-benzenediMethanol 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(2-phenylethoxy)hexylamino]ethyl]phenol 4-Hydroxy-α1-[[[6-(2-phenylethoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 1-[4-Hydroxy-3-(hydroxymethyl)phenyl]-2-[[6-(2-phenylethoxy)hexyl]amino] ethano 4-Hydroxy-alpha1-[[[6-(2-phenylethoxy)hexyl]amino]methyl]-1,3-benzenedimethanol | Impurities in bulk drugs;Impurity reference substance;Salmeterol Impurity-Salmeterol Impurity;Amines, Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals |
| 512 | 1795133-96-8 | Formoterol EP Impurity D | Formoterol EP Impurity D Formoterol Fumarate EP Impurity D Formoterol EP Impurity D (Mixture of Diastereomers) N-(2-hydroxy-5-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)(methyl)amino)ethyl)phenyl)formamide N-[2-hydroxy-5-[1-hydroxy-2-[methyl[2-(4-methoxy phenyl)-1-methylethyl]amino]ethyl]phenyl]formamide Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]methylamino]ethyl]phenyl]- | 190-formoterol;Reference substance;Impurity reference substance;Reference substance-impurity reference substance |
| 513 | 770703-11-2 | Benzoic acid, 3-[[[(2S,4R)-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]- (9CI) | 3-[[[(2S,4R)-4-Hydroxy-2-pyrrolidinyl]carbonyl]amino]benzoic Acid Benzoic acid, 3-[[[(2S,4R)-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]- (9CI) | AMIDE;Impurity reference substance;Standard/reference/chemical reagent/experiment |
| 514 | 59865-16-6 | Iso Cyclosporin A | isocyclosporin A Isocyclosporin A Iso Cyclosporin A [2S-(2R*,3S*,4S*,6E)]-N-[3-Hydroxy-4-methyl-2-(methylamino)-1-oxo-6-octenyl]-L-alpha-aminobutyryl-N-me Cyclo[L-Abu-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-[(3R,4R)-3-hydroxy*-N-methyl-5-[(E)-1-propenyl]-L-Leu-]] (2S,3R,4R,6E)-3-Hydroxy-4-Methyl-2-(MethylaMino)-6-octenoyl-(2S)-2-aMinobutanoyl-N-Methylglycyl-N-Methyl-L-leucyl-L-valyl-N-Methyl-L-leucyl-L-alanyl-D-alanyl-N-Methyl-L-leucyl-N-Methyl-L-leucyl-N-Methyl-L-valine (111)-Lactone 30-ethyl-34-[(Z)-hex-4-en-2-yl]-4,7,10,12,15,19,25,28-octamethyl-33-me thylamino-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1-oxa- 4,7,10,13,16,19,22,25,28,31-decazacyclotetratriacontane-2,5,8,11,14,17 ,20,23,26,29,32-undecone L-Valine, N-(3-hydroxy-4-methyl-2-(methylamino)-1-oxo-6-octenyl)-L-(alpha-aminobutyryl)-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-, theta1-1actone, (2S-(2R*,3S*,4S*,6E))- | Peptides;Impurities;Pharmaceuticals;Microbial metabolites;Impurity reference substance;Intermediates & Fine Chemicals |
| 515 | 247078-58-6 | Isopropyl (1S)-(+)-10-Camphorsulfate | Isopropyl Camphor Sulfonate Isopropyl-D-Camphorsulfonate Isopropyl (1S)-(+)-10-Camphorsulfate Isopropyl (1S)-(+)-10-CaMphorsulfate isopropyl ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate (1S,4R)-7,7-Dimethyl-2-oxo-Bicyclo[2.2.1]heptane-1-methanesulfonic Acid 1-Methylethyl Ester Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, 1-methylethyl ester, (1S,4R)- | Metabolites & Impurities |
| 516 | 1803079-49-3 | Linagliptin N-Acetyl Impurity | Linagliptin F Linagliptin Impurity 34 Linagliptin N-Acetyl Impurity tert-butyl (R)-(1-(7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-6-oxo-6,7-dihydro-3H-purin-8-yl)piperidin-3-yl)carbamate N-[(3R)-1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]acetamide Acetamide, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]- (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide (Linagliptin Impurity) | 044-limagliptin;standard substance;Reference substance-impurity reference substance |
| 517 | 2132-70-9 | 4,4-Methoxychlor Olefin | METHOXYCHLOROLEFIN 4,4'-Methoxychlor-olen 4,4-Methoxychlor Olefin 4,4'-metoxychlor olefin P,P'-METHOXYCHLOR OLEFIN 4,4'-METHOXYCHLOR OLEFIN METHOXYCHLOR-P,P'' OLEFIN P,P'-METHOXYCHLOR-OLEFIN SOLUTION 4,4'-(2,2-Dichlorovinylidene)bisanisole 1,1-Dichloro-2,2-bis(p-methoxyphenyl)ethene 1,1'-(Dichloroethenylidene)bis(4-methoxybenzene) | Standard;Pesticides;Organochlorine insecticides |
| 518 | 889443-69-0 | S-(-)-[1-(3-Methoxyphenyl)ethyl]-N,N-diMethylaMine | Rivastigmine EP Imp F RivastigMine IMpurity F HCl (S)-1-(3-Methoxyphenyl)-N,N-dimethylethanamine (1S)-1-(3-methoxyphenyl)-N,N-dimethylethanamine S-(-)-[1-(3-Methoxyphenyl)ethyl]-N,N-diMethylaMine Rivastigmine Impurity 6(Rivastigmine EP Impurity F) (alphaS)-3-Methoxy-N,N,alpha-trimethylbenzenemethanamine (S)-1-(3-methoxyphenyl)-N,N-dimethylethan-1-amine (2R,3R)- 2,3-dihydroxysuccinate | Ribalatin |
| 519 | 24757-70-8 | Cladribine Related Compound A (2-methoxy-2'-deoxyadenosine) | Cladribine Impurity B Cladribine EP Impurity B Cladribine USP Related Compound A Cladribine Impurity 2(Cladribine EP Impurity B) 9-(2-Deoxy-beta-D-ribofuranosyl)-2-methoxyadenine Cladribine Related Compound A (2-methoxy-2'-deoxyadenosine) 2-Methoxy-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine (2R,3S,5R)-5-(6-amino-2-methoxypurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol CLADRIBINE RELATED COMPOUND A (20 MG) (2-METHOXY-2'-DEOXYADENOSINE) | Reference substance-impurity reference substance |
| 520 | 3697-24-3 | 5-Methyl Chrysene (1mg/mL In Dichloromethane) | NSC 407620 5-METHYLCHRYSENE 5-methyl-chrysen CHRYSENE,5-METHYL- | M;Aromatics;Alphabetic;META - METH;Pharmaceuticals;Intermediates & Fine Chemicals;Mutagenesis Research Chemicals |
| 521 | 61592-45-8 | Bentazon Methyl | Bentazon Methyl BENTAZON METHYL N-Methylbentazon n-methylbentazone BENTAZON METHYL ESTER STANDARD 1H-2,1,3-Benzothiadiazin-4(3H)-one, 1-methyl-3-(1-methylethyl)-, 2,2-dioxide | Herbicide;Organochlorine insecticides |
| 522 | 641571-16-6 | 3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine | 3-(5-methylimidazol-1-yl)-5-(trifluoromethyl)aniline 3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)aniline 3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine 3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)benzenaMine Benzenamine, 3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)- | Impurity reference substance;Amines, Aromatics, Intermediates, Miscellaneous Reagents |
| 523 | 107257-20-5 | rac-4'-Methyl Ketoprofen | Ketoprofen IMpurity D rac-4'-Methyl Ketoprofen rac-4'-Methyl Ketoprofen Ketoprofen Related CoMpound A (AS) 2-[3-(4-Methylbenzoyl)phenyl]propanoic acid α-Methyl-3-(4-Methylbenzoyl)benzeneacetic Acid Ketoprofen Impurity 4(Ketoprofen EP Impurity D) alpha-Methyl-3-(4-Methylbenzoyl) benzeneacetic acid KETOPROFEN RELATED COMPOUND A (25 MG) (AL-PHA-METHYL-3-(4-METHYLBENZOYL) BENZENEACETIC ACID) (AS) | Aromatics;Impurities;Pharmaceuticals;Ketoprofen impurity;Intermediates & Fine Chemicals |
| 524 | 1075240-33-3 | N-Methylol Minocycline (~) | Minocycline Impurity 1 Minocycline Impurity F Minocycline?EP Impurity F N-Methylol Minocycline (~) CGFUYTDDWXBMJM-LRSHKJBPSA-N Minocycline N-Hydroxymethyl Impurity Minocycline Impurity 6(N-Hydroxymethyl Minocycline) 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-N-(hydroxymethyl)-1,11-dioxo-, (4S,4aS,5aR,12aS)- | Impurity reference substance |
| 525 | 1346600-54-1 | N-Des(cyclohexylaminocarbonyl) Glipizide | Glipizide IMpurity B Glipizide EP Impurity D N-Des(cyclohexylaminocarbonyl) Glipizide N-Des(cyclohexylaMinocarbonyl) Glipizide Glipizide Impurity 4(Glipizide EP Impurity D) 6-methyl-N-(4-sulfamoylphenethyl)pyrazine-2-carboxamide 6-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide 2-Pyrazinecarboxamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-6-methyl- | Amines, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 526 | 229019-44-7 | Methylprednisolone EP Impurity E | -CarboxylicAcid Methylprednisolone EP IMP E Methylprednisolone EP Impurity E 6a-Methyl Prednisolone 17-Deshydroxy 17-Carboxylic Acid 6α-Methyl Prednisolone 17-Deshydroxy 17β-Carboxylic Acid Methylprednisolone Impurity 12(Methylprednisolone EP Impurity E) Androsta-1,4-diene-17-carboxylic acid, 11-hydroxy-6-methyl-3-oxo-, (6α,11β)- (9CI) | 156-Methylprednisolone |
| 527 | 1932110-67-2 | Norepinephrine EP Impurity D | O-Methyl Norepinephrine Norepinephrine EP Impurity D Noradrenaline EP Impurity D HCl Norepinephrine Tartrate Impurity D Noradrenaline (Norepinephrine) EP Impurity D (R)-4-(2-amino-1-methoxyethyl)benzene-1,2-diol 1,2-Benzenediol, 4-[(1R)-2-amino-1-methoxyethyl]- | impurity reference substance;Reference substance-impurity reference substance |
| 528 | 208042-42-6 | Nalfurafine N-Oxide | Nalfurafine N-Oxide 2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-oxidomorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (2E)- | Agonists, Chiral Reagents, Heterocycles, Neurochemicals, Pharmaceuticals, Intermediates & Fine Chemicals |
| 529 | 41198-42-9 | 3-(1-Naphthalenyloxy)propiophenone | Dapoxetine Impurity 44 Dapoxetine impurities399 3-(1-Naphthyloxy)propiophenone 3-(1-Naphthalenyloxy)propiophenone 3-(1-Naphthalenyloxy)-1-phenyl-1-propanone 3-(naphthalen-1-yloxy)-1-phenylpropan-1-one 1-Propanone, 3-(1-naphthalenyloxy)-1-phenyl- | Aromatics;Impurities;Dapoxetine;Pharmaceuticals;Impurity reference substance;Intermediates & Fine Chemicals |
| 530 | 55576-67-5 | Neodigoxin | Neodigoxin Digoxin EP Impurity G Neodigoxin DISCONTINUED Digoxin IMpurity G (Neodigoxin Digoxin EP Impurity G (Neodigoxin) DIGOXIN EP IMPURITY G (NEODIGOXIN) Digoxin Impurity 7(Digoxin EP Impurity G) | Digoxin impurity;Impurity reference substance |
| 531 | 1173021-20-9 | 4-tert-Octylphenol-3,5-d2 | NSC 7248-d2 NSC 5427-d2 4-tert-Octylphenol-3,5-d2 4-(1,1,3,3-TetraMethylbutyl)phenol-d2 4-(2,4,4-TriMethylpentan-2-yl)phenol-d2 4-(2,4,4-trimethylpentan-2-yl)phen-3,5-d2-ol | Aromatics;Pharmaceuticals;Isotope markers;Isotope Labelled Compounds;Intermediates & Fine Chemicals |
| 532 | 208720-71-2 | Oseltamivir Acid Methyl Ester Phosphate Salt | Oseltamivir Methyl Ester Oseltamivir EP Impurity E OseltaMivir Acid Methyl Ester Oseltamivir Phosphate impurity E (EP) Oseltamivir Acid Methyl Ester Phosphate Salt (3R,4R,5S)-methyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate (3R,4R,5S)-ethyl 4-acetamido-5-(allylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate Methyl (3R,4R,5S)-4-(AcetylaMino)-5-aMino-3-(1-ethylpropoxy)- 1-cyclohexene-1-carboxyate (3R,4R,5S)-4-(AcetylaMino)-5-aMino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid Methyl Ester | Amines;Standards;Impurities;Anti-virals;Oseltamivir;Pharmaceuticals;Impurity reference substance;Intermediates & Fine Chemicals |
| 533 | 1391052-00-8 | rac-3-Oxo Atorvastatin Sodium Salt | Atorvastatin EP Impurity O Atorvastatin Impurity 3-OXO Atorvastatin 3-Oxo Impurity rac-3-Oxo Atorvastatin Sodium Salt rac-3-Oxo Atorvastatin SodiuM Salt Atorvastatin rac-3-oxo sodiuM salt Atorvastatin 3-Oxo Acid Sodium Salt sodium 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxy-3-oxoheptanoate | Impurity reference substance;Aromatics, Chiral Reagents, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 534 | 1242137-18-3 | Oxo Enzalutamide | EZ-YHAPI Oxo Enzalutamide Enzalutamide Impurities5 Enzalutamide Impurities750 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-2,4-dioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-2,4-dioxo-1-imidazolidinyl]-2-fluoro-N-methyl- | Standard;Impurities;181-enzalutamide;Impurity reference substance;Reference substance-impurity reference substance |
| 535 | 6639-62-9 | 3-Oxo-1,2-benzoisothiazoline-2-acetic Acid Methyl Ester 1,1-Dioxide (Piroxicam Impurity D) | NSC 49216 Einecs 229-646-3 PiroxicaM IMpurity D Saccharin N-(2-Acetic Acid Methyl Ester) methyl 3-oxo1,2-benzisothiazole-2(3H)-acetate 1,1-dioxide 3-Oxo-1,2-benzoisothiazole-2(3H)acetic acid methyl ester,1-dioxide 2,3-DIHYDRO-3-OXO-1,2-BENZOISOTHIAZOLE-2-ACETIC ACID METHYL ESTER 1,1-DIOXIDE 3-Oxo-1,2-benzoisothiazoline-2-acetic Acid Methyl Ester 1,1-Dioxide(Piroxicam Impurity D) 3-Oxo-1,2-benzoisothiazoline-2-acetic Acid Methyl Ester 1,1-Dioxide (Piroxicam Impurity D) | Aromatics;Heterocycles;Pharmaceuticals;Sulfur & Selenium Compounds;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 536 | 357189-94-7 | Posaconazole Impurity 51 | Posaconazole Impurity 51 Posaconazole Impurity 107 Posaconazole 3-Oxo Impurity 3-Oxo-posaconazole (3-?oxo-?1-?piperazinyl) 4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]-1-[4-[1-[(2S,3S)-2-hydroxypentan-3-yl]-5-oxo-1,2,4-triazol-4-yl]phenyl]piperazin-2-one 4-(4-(((3R,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)-tetrahydrofuran-3-yl)methoxy)phenyl)-1-(4-(1-((2S,3S)-2-hydroxypentan-3-yl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)phenyl)piperazin-2-one 1-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-4-(4-(1-((2S,3S)-2-hydroxypentan-3-yl)-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)phenyl)piperazin-2-one | 107-posaconazole;Impurity reference substance |
| 537 | 221264-21-7 | 3-Oxo Ropinirole Hydrochloride | Ropinirole Related CoMpound B 3-Oxo Ropinirole Hydrochloride 3-Oxo Ropinirole Hydrochloride (USP RC B) 4-(2-(dipropylaMino)ethyl)indoline-2,3-dione hcl 3-Oxo Ropinirole HCl (Ropinirole Related CoMpound B) 4-[2-(Dipropylamino)ethyl]indoline-2,3-dione monohydrochloride 4-[2-(Dipropylamino)ethyl]-1H-indole-2,3-dione monohydrochloride Ropinirole Related Compound B (50 mg) (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride) | Amines;Impurities;Heterocycles;Pharmaceuticals;Intermediates & Fine Chemicals |
| 538 | 3158-56-3 | 5-pentadecylresorcinol | cardol Nsc 776 Adipostatin A Einecs 221-599-7 5-pentadecylresorcinol 5-N-PENTADECYLRESORCINOL Resorcinol, 5-pentadecyl 5-PENTADECYL-1,3-BENZENEDIOL) 1,3-Benzenediol, 5-pentadecyl- | Preparation-inhibitor |
| 539 | 73738-05-3 | PENTOBARBITAL-D5 | PENTOBARBITAL-D5 PHENOBARBITAL (D5) PHENOBARBITAL (ETHYL-D5) PENTOBARBITAL-D5 (ETHYL-D5) PHENOBARBITAL-D5 (ETHYL-D5) Phenobarbital-D5 (side chain) solution Phenobarbital-D5 (deuterium label on side chain) 5-(Ethyl-d5)-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione | Aromatics;Heterocycles;Pharmaceuticals;Isotope Labeled Compounds;Isotope Labelled Compounds;Intermediates & Fine Chemicals;Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 540 | 173094-60-5 | octakis(6-chloro-6-deoxy)-γ-cyclodextrin | Org199074-1 Sugammadex Impurity 28 6-Chloro-6-deoxy-gamma-cyclodextrin 6-Perdeoxy-6-perchloro-γ-cyclodextrin octakis(6-chloro-6-deoxy)-γ-cyclodextrin Octakis(6-deoxy-6-chloro)-gamma-cyclodextrin γ-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G,6H-octachloro-6A,6B,6C,6D,6E,6F,6G,6H-octadeoxy- | Sulgo Glucose Sodium;Sulgo Glucose Sodium Intermediate |
| 541 | 265120-58-9 | Ropivacaine-iPr-S | Ropivacaine-iPr-S Ropivacaine-008-S Ropivacaine Impurity 16 Ropivacaine EP Impurity E Ropivacaine Impurity E(EP) (S)-N-(2,6-dimethylphenyl)-1-isopropylpiperidine-2-carboxamide 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-(1-methylethyl)-, (2S)- | Impurity reference substance |
| 542 | 6625-20-3 | Sancycline Hydrochloride | Fda 0129 Bonomycin hydrochloride Sancycline Hydrochloride Sancycline hydrochloride Minocycline EP IMpurity B 6-DeMethyl-6-deoxytetracycline Hydrochloride 6-DeMethyl-6-deoxytetracycline hydrochloride, NSC 51812 2-Naphthacenecarboxamide, 4-dimethylamino-1,4,4A,5,5A,6,11,12A-octahydro-3,10,12,12A-tetrahydroxy-1,11-dioxo-, hydrochloride (4S,4aS,5aR,12aS)-4-(DiMethylaMino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1-11-dioxo-2-naphthacenecarboxaMide Hydrochloride 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4A,5,5A,6,11,12A-octahydro-3,10,12,12A-tetrahydroxy-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4A.alpha.,5A.alpha.,12A.alpha.)]- | Amines;Raw drugs;Pharmaceuticals;Medical raw materials;Microbial metabolites;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 543 | 845870-40-8 | Scopoline Methobromide | Scopoline Methobromide Tiotropium EP Impurity H Tiotropium Bromide BP Impurity H Scopoline Methobromide (Tiotropium Bromide Impurity H) (1s,3RS,4RS,5RS,7SR)-4-hydroxy-6,6-dimethyl-2-oxa-6azoniatricyclo[3.3.1.03,7]nonanebromide (1s,3RS,4RS,5RS,7SR)-4-hydroxy-6,6-dimethyl-2-oxa-6- azatricyclo[3.3.1.03,7]nonan-6-ium bromide | Impurity |
| 544 | 163706-51-2 | (2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol | Cangrelor Impurity 5 2-(3,3,3-trifluoropropylthio)adenosine Adenosine,2-[(3,3,3-trifluoropropyl)thio]- (2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol (2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H- purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol 2-(3,3,3-trifluoropropylthio)adenosine | |
| 545 | 13533-58-9 | Ethyl α-Thioglucopyranoside | Ethyl α-Thioglucopyranoside Ethyl a-Thioglucopyranoside Ethyl α-D-Thioglucopyranoside Ethyl 1-Thio-α-D-glucopyranoside | Carbohydrates & Derivatives;Sulfur & Selenium Compounds;Carbohydrates & Derivatives, Sulfur & Selenium Compounds |
| 546 | 1403383-55-0 | (S)-4-(4-((3-amino-2-hydroxypropyl)amino)phenyl)morpholin-3-one hydrochloride | (R)-4-[4-[(3-amino-2-hydroxypropyl)amino]phenyl]-3-morpholinone (S)-4-(4-((3-amino-2-hydroxypropyl)amino)phenyl)morpholin-3-one hydrochloride | Reference substance-impurity reference substance |
| 547 | 6482-26-4 | Dibromoacetic Acid Methyl Ester | Methyl 2,2-Dibromoacetate Dibromoacetic Acid Methyl Ester Methyl dibromoacetate solution 2,2-Dibromoacetic acid methyl ester Acetic acid, 2,2-dibromo-, methyl ester | M;BromoEPA;Halogenated;Method 552;Alpha Sort;MAlphabetic;META - METH;Chemical Class;BromoVolatiles/ Semivolatiles;500 Series Drinking Water Methods |
| 548 | 149709-59-1 | (R)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxy carbonyl)amino)-2-methylpent-2-enoate... | LCZ696 59-1 LCZ-696-003-R LCZ696(valsartan + sacubitril) impurity 24 (R)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate (R,E)-ETHYL 5-([1,1'-BIPHENYL]-4-YL)-4-((TERT-BUTOXYCARBONYL)AMINO)-2-METHYLPENT-2-ENOATE (R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate Ethyl 5-(4-[1,1'-biphenyl]yl)-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-methyl-2-pentenoate (R)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxy carbonyl)amino)-2-methylpent-2-enoate... (4R)-5-[1,1'-Biphenyl]-4-yl-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-methyl-2-pentenoic acid ethyl ester 2-Pentenoic acid, 5-[1,1'-biphenyl]-4-yl-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-methyl-, ethyl ester, (4R)- | LCZ696;Impurity reference substance |
| 549 | 100403-24-5 | Deoxyribonucleic acid from fish sperm | DEOXYRIBONUCLEIC ACID DNA, Fish Sperm, Na Salt Deoxyribonucleic acid from fish sperm deoxyribonucleic acid from herring sperm DNAHerringspermsonicatedmolecularbiologygrade DEOXYRIBONUCLEIC ACID DEGRADED FREEACID FROM HERRI | biochemical reagent |
| 550 | 117947-85-0 | 1-Ethyl-1-Methylpyrrolidinium Tetrafluoroborate | [EMPyrr]BF4 1-ETHYL-METHYLPYRROLIDINIUM TETRAFLUOROBORATE 1-Ethyl-1-Methylpyrrolidinium Tetrafluoroborate N-ethyl methyl pyrrolidine four fluorine boric acid salt | Electronic materials |
| 551 | 19932-84-4 | 6-Chlorobenzoxazolone | 6-CHLOROOXAZONE TIMTEC-BB SBB003865 6-Chlorobenzoxazolone 6-CHLOROBENZOXAZOLONE 6-Chloro-2-benzoxazolinone 6-CHLORO-2-BENZOXAZOLINONE 2-Benzoxazolinone, 6-chloro- 6-CHLOROBENZOXAZOL-2(3H)-ONE 6-CHLORO-1,3-BENZOXAZOL-2(3H)-ONE 6-chloro-3a,7a-dihydro-3H-1,3-benzoxazol-2-one | Intermediates in the synthesis of materials |
| 552 | 213-46-7 | Picene | Pycene Picene Picene (purity) 39453, Picene (purity) Dibenzo(a,i)phenanthrene Picene (purified by sublimation) | Alphabetic |
| 553 | 25713-24-0 | 4-(2-Iodoacetamido)-Tempo | spinlabel 4-(2-IODOACETAMIDO)-TEMPO 4-(2-Iodoacetamido)-Tempo N-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyl)iodoacetamide 4-((IODOACETYL)AMINO)-2,2,6,6-TETRAMETHYL-1-PIPERIDINYLOXY 4-(2-Iodoacetamido)-2,2,6,6-tetramethylpiperidine 1-Oxyl Free Radical | Spin Labels;ESR Spectrometry;Analytical Chemistry;Electronic materials |
| 554 | 36519-25-2 | Neosolaniol | Nsc 197212 NEOSOLANIOL Brn 3657281 Neosolaniol 8-HYDROXYDIACETOXYSCIRPENOL NEOSOLANIOL FROM FUSARIUM SPECIES Solaniol NSC 197212 Neosolaniol 4BETA,15-DIACETOXY-3ALPHA,8ALPHA-DIHYDROXY-12,13-EPOXYTRICHOTHEC-9-ENE 12,13-epoxy-4-beta,15-diacetoxy-3-alpha,8-alpha-dihydroxy-trichothec-9-en | Antibiotics;Chemical raw materials |
| 555 | 37793-53-6 | n10-(Trifluoroacetyl)Pteroic Acid | TRIFLUOROACETYLPTEROIC ACID N10-(TRIFLUOROACETYL)PTEROIC ACID n10-(Trifluoroacetyl)Pteroic Acid N(sup 10)-(trifluoroacetyl)pteroic acid 4-[(2-amino-4-oxo-1H-pteridin-6-yl)methyl-(2,2,2-trifluoroacetyl)amino]benzoic acid 4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl](trifluoroacetyl)amino]benzoic acid 4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl](2,2,2-trifluoroacetyl)amino]-Benzoic acid Benzoic acid,4-[[(2-aMino-3,4-dihydro-4-oxo-6-pteridinyl)Methyl](2,2,2-trifluoroacetyl)aMino]- | Heterocycl;Quinazolines;Building Blocks;Building Blocks;Medical raw materials;Heterocyclic Building Blocks;Conventional original drug series;Raw materials [for scientific research only];Reference s |
| 556 | 441796-13-0 | Macitentan impurity B | Macitentan impurity B Macitentan impurity D Macitentan Impurity 04 Macitentan N-Ethyl Analog Macitentan N-Despropyl-N-Ethyl Impurity 5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(ethylsulfamoyl)pyrimidin-4-amine Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-ethyl- | Chemical reagent |
| 557 | 441798-25-0 | Macitentan impurity A | Macitentan impurity A Macitentan impurity B Macitentan Impurity 03 Macitentan N-Despropyl-N-Methyl Impurity 5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(methylsulfamoyl)pyrimidin-4-amine Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-methyl- | Chemical reagent |
| 558 | 443922-06-3 | Benzaldehyde,4,4',4”-(1,3,5-triazine-2,4,6-triyl)tris- | TZ422 TRZ22 2,4,6-Tris(4-formylphenyl)-1,3,5-triazine 4,4',4“-(1,3,5-triazine-2,4,6-triyl)tribenzaldehyde Benzaldehyde,4,4',4”-(1,3,5-triazine-2,4,6-triyl)tris- | Synthetic material intermediates |
| 559 | 88337-96-6 | 15-Acetyl Deoxynivalenol | 15-ADON 15-ACDON 3-D3-ACDON 15-ACETYLVOMITOXIN 15-ACETYLDEOXYNIVALENOL 15-Acetyl Deoxynivalenol 3-ACETYL-D3-DEOXYNIVALENOL 15-O-ACETYL-4-DEOXYNIVALENOL 15-ACETOXY-3ALPHA,7ALPHA-DIHYDROXY-12,13-EPOXYTRICHOTHEC-9-EN-8-ONE | Inhibitor;Synthesis;Inhibitors;Pharmaceuticals;Intermediates & Fine Chemicals |
| 560 | 486459-98-7 | Sitagliptin Defuoro IMpurity 4 | SIG80-III Sitagliptin impurity R Sitagliptin EP Impurity 8 SITAGLIPTIN DEFUORO IMPURITY 4 Sitagliptin Defuoro IMpurity 4 (R)-Sitagliptin Defluoro Impurity 4 (R)-b-(Boc-amino)-2,5-difluorobenzenebutanoic acid (3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid (R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid | sitagliptin;impurity reference substance;Worderson Customized Catalog 1;reference substance-impurity reference substance |
| 561 | 654073-32-2 | 1-Azetidinesulfonamide | 102882 CPD1543-A9 1-Azetidinesulfonamide azetidine-1-sulfonaMide azetidine-1-sulphonamide 1-Azetidinesulfonamide(9CI) | Others;SULFONAMIDE |
| 562 | 1132709-15-9 | (1R,2R)-Bortezomib | (1R,2R)-Bortezomib (1R,2R)-BortezoMib (1R,2R)-Bortezomib Impurity N-(2-Pyrazinecarbonyl)-D-phenylalanine-L-leucine boronic anhydride ((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid [(1R)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid | 163-bortezomib;Impurity reference substance;Reference substance-impurity reference substance;Chiral Reagents, Boron Derivatives, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals |
| 563 | 118689-07-9 | 2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)-1,2-propanediol | Fluconazole-6 Fluconazole EP Impurity F Fluconazole Diol IMpurity Fluconazole impurity F (EP) 2-(2,4-difluorophenyl)-3-(1,2,4-triazol-1-yl)propane-1,2-diol 2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)-1,2-propanediol 2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol | Aromatics;Impurities;Heterocycles;Pharmaceuticals;Standard substance;Chemical impurities;Impurity reference substance;Intermediates & Fine Chemicals |
| 564 | 121659-86-7 | Methyl 4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinecarboxylate | Pitavastatin Impurity 66 Methyl 2-cyclopropyl-4-(4-fluorophenyl)-quinoline-3-carboxylate methyl 4-(4'-fluorophenyl)-2-cyclopropylquinoline-3-carboxylate Methyl 4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinecarboxylate METHYL 4-(4''-FLUOROPHENYL)-2-(CYCLOPROPYL)-3-QUINOLINECARBOXYLATE 2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinecarboxylic Acid Methyl Ester 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylic acid methyl ester 4-(4-Fluorophenyl)-2-cyclopropylquinoline-3-carboxylic acid methyl ester | Aromatics;Intermediat;Intermediates;Pharmaceuticals;Organic chemistry;Pharmaceutical intermediates;Impurity reference substance;Intermediates & Fine Chemicals;Pitavastatin Calcium Intermediates;Refere |
| 565 | 1371638-05-9 | 1,2-Bis[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethane | Quetiapine Impurity E Quetiapine Impurity 23 Quetiapine EP Impurity E Quetiapine EP Impurity E (base)) Quetiapine Impurity 6(Quetiapine EP Impurity E) 1,2-Bis[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethane 1,2-bis(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethane 1,2-bis(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethane tetrahydrochloride | Reference substance-impurity reference substance;Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 566 | 1403474-70-3 | ethyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)- [1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | Azilsartan-22 Azilsartan impurity V ethyl ester of azilsartan Ethyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate ethyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate ethyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)- [1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid ethyl ester 1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester | Heterocyclic;Impurity reference substance;Pharmaceutical raw materials;Azirsartan series (hypertension intermediate);Reference substance-impurity reference substance |
| 567 | 162204-30-0 | 5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine | Capecitabine iMpurity F Capecitabine 3-Methylbutyloxy Impurity 5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine 5'-Deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine Cytidine, 5'-deoxy-5-fluoro-N-[(3-Methylbutoxy)carbonyl]- 5'-Deoxy-5-fluoro-N4-(3-methyl-1-butyloxycarbonyl)cytidine 5'-Deoxy-5-fluoro-N4-(2-methyl-1-butuloxycarbonyl)cytidine [1-(5-Deoxy--D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-carbamic Acid 3-Methylbutyl Ester | Nucleotides;Intermediates;Pharmaceuticals;Bases & Related Reagents;Intermediates & Fine Chemicals;Reference substance-impurity reference substance |
| 568 | 22236-11-9 | 4'-(Difluoromethoxy)acetanilide | 4'-(Difluoromethoxy) Pantoprazole Impurity 26 4-DIFLUOROMETHOXY-ACETANILIDE 4'-(Difluoromethoxy)acetanilide N-(4-DIFLUOROMETHOXYPHENYL)ACETAMIDE N-[4-(Difluoromethoxy)phenyl]acetamide 4-Acetamido-alpha,alpha-difluoroanisole | Impurity reference substance |
| 569 | 721401-53-2 | (R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl) amino)propyl)thiophene-2-carboxamide | Rivaroxaban L Decarbonyl Rivaroxaban Rivaroxaban impurity P4D-P Rivaroxaban Descarbonyl Impurity (R)-5-Chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide (R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl) amino)propyl)thiophene-2-carboxamide 5-chloro-N-((2R)-2-hydroxy-3-{[4-(3-oxo-4-morpholinyl)-phenyl]amino}propyl)-2-thiophenecarboxamide 2-ThiophenecarboxaMide, 5-chloro-N-[(2R)-2-hydroxy-3-[[4-(3-oxo-4-Morpholinyl)phenyl]aMino]propyl]- | impurity reference substance;Reference substance-impurity reference substance |
| 570 | 7729-94-4 | Norlidocaine Hydrochloride (Monoethylglycinexylidide Hydrochloride) | Lidocaine-006-HCl Lidocaine EP Impurity D Lidocaine BP Impurity D Lidocaine Impurity D(EP) Nor Lidocaine Hydrochloride Lidocaine impure Hydrochloride Lidocaine Impurity 1(Lidocaine EP Impurity D) Norlidocaine Hydrochloride (Monoethylglycinexylidide Hydrochloride) | Lidocaine impurity;Impurity reference substance;Amines, Aromatics, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 571 | 910129-15-6 | 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | Capecitabine iMpurity E Capecitabine EP Impurity D Capecitabine 2-Methylbutyloxy Impurity Capecitabine Impurity 2(Capecitabine EP Impurity D) 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine 5'-Deoxy-5-fluoro-N4-[(2-methylbutoxy)carbonyl]-cytidine Cytidine, 5'-deoxy-5-fluoro-N-[(2-Methylbutoxy)carbonyl]- 2-Methylbutyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate | Nucleotides;Intermediates;Pharmaceuticals;Bases & Related Reagents;Intermediates & Fine Chemicals;Reference substance-impurity reference substance |
| 572 | 203395-82-8 | 2-Deschloro Aripiprazole | Aripiprazole Imp.D 2-DESCHLORO ARIPIPRAZOLE 2-Deschloro Aripiprazole Aripiprazole 2-Deschloro Imp Aripiprazole 2-Deschloro Impurity Aripiprazole EP Impurity D Hydrochloride 7-[4-[4-(3-chlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one 2(1H)-Quinolinone, 7-[4-[4-(3-chlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro- | 239-aripiprazole;Control substance;Chemical raw materials;Aripiprazole impurities;Impurity reference substance;Aromatics, Impurities, Neurochemicals, Pharmaceuticals, Intermediates & Fine Chemica;Arom |
| 573 | 1173-26-8 | 11Beta,21-Dihydroxy-4-Pregnene-3,20-Dione 21-Acetate | Nsc81764 CORTICOSTERONE 21-ACETATE 2-((8S,9S,10R,11S,13S,14S,17S) 21-Acetoxy-11β-hydroxypregn-4-ene-3,20-dione 11Beta,21-Dihydroxy-4-Pregnene-3,20-Dione 21-Acetate 20-dione,11-beta,21-dihydroxy-pregn-4-ene-21-acetate Pregn-4-ene-3,20-dione, 11.beta.,21-dihydroxy-, 21-acetate Pregn-4-ene-3,20-dione, 21-(acetyloxy)-11-hydroxy-, (11.beta.)- -11-Hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl) | Steroids;Biochemistry;Pharmaceuticals;Hydroxyketosteroids;Intermediates & Fine Chemicals |
| 574 | 462-20-4 | γ-Lipoic Acid | DHLA γ-Lipoic Acid Dihydrolipoic Acid DIHYDROLIPOIC ACID DL-6,8-THIOCTIC ACID, REDUCED DL-ALPHA-LIPOIC ACID, DIHYDRO- DL-ALPHA-LIPOIC ACID REDUCED FORM DL-6,8-THIOCTIC ACID REDUCED FORM DL-1,2-DITHIOLANE-3-PENTANOIC ACID REDUCED FORM | biochemical reagent |
| 575 | 17708-87-1 | (R,S)-NORCOTININE | (R,S)-NORCOTININE (R,S)-Norcotinine solution (5RS)-5-(Pyridin-3-yl)pyrrolidin-2-one ((RS)-Norcotinine) | Nicotine Derivatives;Metabolites & Impurities |
| 576 | 115540-28-8 | ((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimeth | Calcipotriol Impurity 17 Doxercalciferol Impurity 15 (((1R,3R,E)-5 - ((E)-2 - ((1R,3AS,7AR)-1 - ((2R,5R 1(S),3(R)-bis(tert-butyldimethylsiloxy)-9,10-secoergosta-5(E),7(E),10(19),22(E)-tetraene (1S,3R)-bis(tert-butyldimethylsilyloxy)-9,10-seco-ergosta-5(E),7(E),10(19),22(E)-tetraene Silane, [[(1β,3β,5E,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl- (9CI) ((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene) ((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diy... ((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimeth ((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane) | Wardson Custom Catalog 1 |
| 577 | 401564-34-9 | tert-Butyl (2S,4S)-4-hydroxy-2-(thiazolidine-3-car bonyl)pyrrolidine-1-carboxylate... | tert-butyl (2S,4S)-4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate (2S,4S)-tert-butyl 4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate tert-Butyl (2S,4S)-4-hydroxy-2-(thiazolidine-3-car bonyl)pyrrolidine-1-carboxylate... 1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- 4-Des((3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl)-4-hydroxy-N-(tert-butyl formate) Teneligliptin | Impurity reference substance |
| 578 | 340700-94-9 | (11bR)- 2,6-dimethyl-N,N-bis[(1R)-1- phenylethyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin- 4-amine | Reagent | |
| 579 | 5391-52-6 | 1-Acetylimidazolidinethione | Tizanidine USP RC C TIZANIDINE IMPURITY 4 1-Acetylimidazolidinethione 1-AcetyliMidazolidinethione 1-Acetyl-2-imidazolidinethione Tizanidine USP Related Compound C Ethanone, 1-(2-thioxo-1-imidazolidinyl)- TIZANIDINE RELATED COMPOUND C (50 MG) (1-ACETYLIMIDAZOLIDINE-2-THIONE) Tizanidine Related Compound C (1-acetylimidazolidine-2-thione) (1667938) | Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 580 | 163269-30-5 | Bethoxazin | bethoxazin Bethoxazin Bethoxazin [iso] Bethoxazin(Bethoguard) 3-benzo[b]thien-2-yl-5,6-dihydro-1,4,2-oxathiazine 4-oxide 1,4,2-Oxathiazine, 3-benzobthien-2-yl-5,6-dihydro-, 4-oxide | Medicine, pesticide intermediates |
| 581 | 2161380-87-4 | 5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine | Avatrombopag Impurity 7 Avatrombopag Impurity 12 2-Thiazolamine, 5-bromo-4-(4-chloro-2-thienyl)- 5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine 5-Bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine (Avatrombopag Impurity) 5-chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide | Intermediate;Standard substance;Impurity reference substance |
| 582 | 712-09-4 | 5-Methoxytryptophol | 5-METHOXYTRYPTOPHOL 5-Methoxytryptophol 5-METHOXYINDOLE-3-ETHANOL 5-methoxy-indole-3-ethano 5-methoxy-1h-indole-3-ethano 5-methoxy-1h-indole-3-ethanol 5-METHOXY-3-(2-HYDROXYETHYL)INDOLE 2-(5-Methoxy-1H-indole-3-yl)ethanol 2-(5-METHOXY-1H-INDOL-3-YL)-1-ETHANOL | Indoles and derivatives |
| 583 | 39642-60-9 | N,N'-Bis(3-pyridyl)urea | DI(3-PYRIDYL)UREA N,N'-Di(3-pyridyl)urea 1,3-Bis(3-pyridyl)urea N,N'-Bis(3-pyridyl)urea N,N'-Bis(3-pyridyl)urea N,N'-di-3-pyridinylurea N,N'-DIPYRIDIN-3-YLUREA N,Na€-Bis(3-pyridyl)urea 1,3-Bis(3-pyridinyl)urea | Heterocycles;Impurity reference substance |
| 584 | 1581-13-1 | 2-AMINO-2'-FLUOROBENZOPHENONE | Pitavastatin Impurity 83 2-AMINO-2'-FLUOROBENZOPHENONE 2-[(2-fluorophenyl)carbonyl]aniline (2-Aminophenyl)(2-fluorophenyl)methanone (2-azanylphenyl)-(2-fluorophenyl)methanone Methanone, (2-aMinophenyl)(2-fluorophenyl)- | Impurity reference substance |
| 585 | 1988-11-0 | 2,6-dipropan-2-ylcyclohexa-2,5-diene-1,4-dione | Propofol EP Impurity J Propofol IMpurity J (EP) 2,6-diisopropylbenzoquinone 2,6-Diisopropyl-p-benzoquinone 2,6-Diisopropyl-1,4-benzoquinone 2,6-DIISOPROPYL-[1,4]BENZOQUINONE 2,6-Diisopropylcyclohexa-2,5-diene-1,4-dione 2,6-dipropan-2-ylcyclohexa-2,5-diene-1,4-dione 2,6-Bis(1-Methylethyl)-2,5-cyclohexadiene-1,4-dione Propofol Related Compound B (25 mg) (2,6-diisopropylbenzoquinone) | Impurities;Benzene rings;Pharmaceuticals;Propofol impurities;Intermediates & Fine Chemicals |
| 586 | 249289-10-9 | N-(1,1-Bis(hydroxymethyl)-3-(4-octylphenyl)propyl)acetamide-d4 | Fingolimod Impurity 26 Fingolimod EP Impurity I Fingolimod Impurity 26 (Fingolimod EP Impurity I) N-(1,1-Bis(hydroxymethyl)-3-(4-octylphenyl)propyl)acetamide Acetamide, N-[1,1-bis(hydroxymethyl)-3-(4-octylphenyl)propyl]- N-(1,1-Bis(hydroxymethyl)-3-(4-octylphenyl)propyl)acetamide-d4 N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)a... N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide Fingo A-2 N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide | Intermediate;Fengolimod intermediate;Impurity reference substance |
| 587 | 120570-05-0 | (S)-quinuclidin-3-amine | (3S)-Aminoquinuclidine (S)-quinuclidin-3-amine (S)-quinuclidin-3-aMine (3S)-quinuclidin-3-amine Palonosetron Impurity 34 (S)-1-Aza-bicyclo[2.2.2]oct-3-ylamine (3S)-1-azabicyclo[2.2.2]octan-3-amine 1-Azabicyclo[2.2.2]octan-3-amine, (S)- 1-Azabicyclo[2.2.2]octan-3-amine, (3S)- | Spot |
| 588 | 415973-05-6 | Rivastigmine impurity D | SDZ 212712 Rivastigmine EP Imp D Rivastigmine impurity D R-Isomer Of Rivastigmine RivastigMine Tartrate R-IsoMer (R)-Rivastigmine (Rivastigmine EP Impurity D) [3-[(1R)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate (S)-1-(3-((ethyl(Methyl)carbaMoyl)oxy)phenyl)-N,N-diMethylethanaMine (S)-1-(3-((ethyl(methyl)carbamoyl)oxy)phenyl)-N,N-dimethylethanamine N-Ethyl-N-methylcarbamic acid 3-[(1R)-1-(dimethylamino)ethyl]phenyl ester | Impurity reference substance |
| 589 | 1034305-23-1 | Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]- | Ipragliflozin-003 Ipragliflozin Impurity A Ipragliflozin impurity A (C7) Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]- Methyl 1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-α-D-glucopyranoside Methyl 1-C-[3-(1-benzothien-2-ylmethyl)-4-fluorophenyl]-alpha-glucopyranoside Methyl 1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-alpha-D-glucopyranoside (2S,3R,4S,5S,6R)-2-(3-(benzo[b]thiophen-2-ylMethyl)-4-fluorophenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol | Iglifloin intermediate;reference substance-impurity reference substance |
| 590 | 61337-88-0 | 1-(3-Cyano-2-pyridyl)-4-methyl-2-phenylpiperazine | Mirtazapine Impurity 8 Mirtazapine Cyano Impurity Mirtazapine Carbonitrile IMpurity 1-(3-Cyanopyridyl-2)-2-Phenyl-4-Methylpyperazine 1-(3-Cyano-2-pyridyl)-4-methyl-2-phenylpiperazine 1-(3-Cyano-2-pyridyl)-4-Methyl-2-phenylpiperazine 2-(4-Methyl-2-phenylpiperazin-1-yl)-3-cyanopyridine 3-cyano-2-(4-methyl-2-phenyl-1-piperazynyl)pyridine 2-(4-Methyl-2-phenylpiperazin-1-yl)pyridine-3-carbonitrile | Impurities;Heterocycles;Pharmaceuticals;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 591 | 7440-03-1 | NIOBIUM | NIOBIUM COLUMBIUM Niobium powder COLUMBIAN METAL NIOBIUM PLASMA EMISSION STANDARD NIOBIUM, PLASMA STANDARD SOLUTION NIOBIUM PLASMA EMISSION SPECTROSCOPY STANDARD | Biochemical Reagents-Medium Class |
| 592 | 1912-30-7 | Ethanesulfonic acid ethyl ester | Brn 1748749 Ees [sulfonate] Diethyl sulfonate Ethyl ethanesulfonate Ethyl ester ethanesulfonic acid Ethanesulfonic acid ethyl ester | Impurity reference substance |
| 593 | 64436-13-1 | ARSENOBETAINE | ARSENOBETAINE ARSENOBETAINE STANDARD Arsenobetaine solution Arsenobetaine in water Arsenobetaine Standard solution (Carboxylatomethyl)trimethylarsonium Arsonium, (carboxymethyl)trimethyl-, inner salt (carboxymethyl)trimethylarsoniumhydroxideinnersalt arsonium,(carboxymethyl)trimethyl-,hydroxide,innersalt | Analytical standard |
| 594 | 75-34-3 | 1,1-Dichloroethane | 1,1-Dichloraethan clorurodietilidene 1,1-Dichloroethane Chlorure D'ethylidene 1,1-Dichloroethane solution chlorured'ethylidene(french) [srp]alphaalphadichloroethane | Organic chemical raw materials |
| 595 | 31737-09-4 | 6-Chloro-1-methyluracil | Urapidil Impurity 19 6-Chloro-1-methyluracil Trelagliptin Impurity 35 6-chloro-1-methylpyrimidine-2,4-dione 6-Chloro-1-methylpyrimidine-2,4(1H,3H)-dione 2,4(1H,3H)-Pyrimidinedione, 6-chloro-1-methyl- | Impurity control |
| 596 | 1520-96-3 | Perylene-d12 | 48081 Perylene-d12 Perylene, perdeutero- perylene-d12 solution | Chemical reagents |
| 597 | 11018-89-6 | Ouabain octahydrate | OUABAIN 8H20 STROPHANTHIN G OUABAIN HYDRATE Ouabain octahydrate (-)-OUABAIN OCTAHYDRATE STROPHANTHIN G, OCTAHYDRATE Ouabain octahydrate,1β,3β,5β,11α,14,19-Hexahydroxycard-20(22)-enolide 3-(6-deoxy-α-L-mannopyranoside), Acocantherine, G-Strophanthin | Cell Biology;Bioactive small molecules |
| 598 | 34302-69-7 | 2,9-DIMETHYL-1,10-PHENANTHROLINE HEMIHYDRATE | Neocuproine NEOCUPROINE HYDRATE NEOCUPROINE 0.5-WATER NEOCUPROINE HEMIHYDRATE 2,9-DIMETHYL-1,10-PHENANTHROLINE HYDRATE 2,9-DIMETHYL-1,10-PHENANTHROLINE 0.5-WATER 2,9-DIMETHYL-O-PHENANTHROLINE, HEMIHYDRATE 2,9-DIMETHYL-1,10-PHENANTHROLINE HEMIHYDRATE NEOCUPROINE HEMIHYDRATE, FOR THE DETER-M INATION OF CU | Intermediates in the synthesis of materials |
| 599 | 1012341-54-6 | (2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid | LCZ704 LCZ 696 Impurity F LCZ-696 Impurity 18 Sacubitril Impurity F (2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid (2S,4R)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid (αS,γR)-γ-[[(1,1-Dimethylethoxy)carbonyl]amino]-α-methyl-[1,1-biphenyl]-4-pentanoic Acid | Impurity control;Chemical engineering |
| 600 | 2371-42-8 | 2-METHYLISOBORNEOL | 2-METHYLISOBORNEOL 2-Methylisoborneol solution (R)-(+)-EXO-2-METHYLISOBORNEOL exo-1,2,7,7-Tetramethylbicyclo[2.2.1]heptan-2-ol (1R-EXO)-1,2,7,7-TETRAMETHYLBICYCLO(2.2.1)HEPTAN-2-OL | Chemical reagents |
| 601 | 13286-32-3 | Kitazine solution | 13286-32-3 Isoprobenphos Kitazine solution DIETHYL-S-BENZYLTHIOPHOSPHATE Phosphorothioic acid O,O-diethyl S-benzyl Thiophosphoric acid O,O-diethyl S-benzyl ester Phosphorothioic acid, O,O-diethyl S-(phenylmethyl) ester | Analytical standards;analytical reagents-standards;pesticide residues, veterinary drugs and fertilizers |
| 602 | Ammonia as N IC standard | NH3-N Ammonia as N IC standard AMMonia as N IC standard | Agricultural and environmental standards;Inorganic single element standard solution | |
| 603 | 174794-02-6 | Olanzapine N-Oxide | OLANZAPINE N-OXIDE Olanzapine N-Oxide Olanzapine EP IMpurity D Olanzapine Related CoMpound C Olanzapine Related Impurity D Olanzapine N-oxide (Olanzapine IMpurity D) 1-methyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazine 1-oxide 2-Methyl-4-(4-Methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide Olanzapine Related Compound C (2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide) Olanzapine Related Compound C (5 mg) (2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide) | Heterocycles;057-olanzapine;Pharmaceuticals;Metabolites & Impurities;Sulfur & Selenium Compounds;Impurity reference substance;Intermediates & Fine Chemica;Intermediates & Fine Chemicals;Various Metabo |
| 604 | 2131-18-2 | Pentadecylbenzene | Pentadecylbenzene PHENYLPENTADECANE PENTADECYLBENZENE pentadecyl-benzen N-PENTADECYLBENZENE benzene,pentadecyl- 1-PHENYLPENTADECANE 1-phenyl-pentadecan pentadecane,1-phenyl- Pentadecane, 1-phenyl- | Aromatic hydrocarbons;organic intermediates |
| 605 | 59461-30-2 | Hydroxocobalamin monohydrochloride | Einecs 261-772-4 Vitamin B12a monohydrochloride hydroxocobalamin monohydrochloride Hydroxocobalamin monohydrochloride Cobinamide hydroxide dihydrogen phosphate (ester), inner salt 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole monohydrochloride Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3-ester with (5,6-dimethyl-1-.alpha.-D-ribofuranosyl-1H-benzimidazole-.kappa.N3), monohydrochloride | |
| 606 | 104632-27-1 | Dexpramipexole dihydrochloride | Kns 760704 KNS 760704 Snd 919cl2x SND 919CL2X Pramipexole R-Isomer PraMipexole IMpurity D Pramipexole Impurity 16 Dexpramipexole dihydrochloride (R)-PRAMIPEXOLE DIHYDROCHLORIDE DexpraMipexole (dihydrochloride) 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, dihydrochloride, (R)- | Nervous system;Impurity standard;Pramipexole impurity |
| 607 | 570407-42-0 | 4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine | Avatrombopag Impurity 13 Avatrombopag Impurity 47 2-Thiazolamine, 4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)- 4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine 5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine4-(4-chlorothiophen-2-yl)- | Intermediate;Chemical reagents;Conventional products;Impurity reference substance |
| 608 | 22518-27-0 | 4-(4-Chlorophenyl)pyrrolidin-2-one | Baclofen EP Impurity A Baclofen Related CoMpound A 4-(4-Chlorophenyl)-2-pyrrodinone 4-(4-Chlorophenyl)pyrrolidin-2-one 4-(4-Chlorophenyl)-2-pyrrolidinone 4-(4-chlorophenyl)pyrrolidin-2-one (4RS)-4-(4-Chlorophenyl)pyrrolidin-2-one | Reference substance-impurity reference substance |
| 609 | 51765-51-6 | N-(2-Phenoxyphenyl)methanesulfonamide | Einecs 257-399-1 2-PHENOXYMETHANESULFOANILIDE 2-Phenoxymethanesulfonailide 2-PHENOXYMETHANESULFONANILIDE (2-PHENOXY)METHYLSULFONYLANILINE N-(2-Phenoxyphenyl)methanesulfonamide N-(2-phenoxyphenyl)methanesulphonamide | Pharmaceutical, pesticide and dye intermediates |
| 610 | 1379324-09-0 | 4,6-Dichloro-N-methyl-2-pyridinecarboxamide | Regorafenib Impurity 18 Sorafenib Impurity HC121-201808 4,6-dichloro-N-methylpicolinamide 4,6-Dichloro-N-methyl-2-pyridinecarboxamide | Hybrization;Impurity reference substance;Products-pharmaceutical products;Reference substance-impurity reference substance |
| 611 | 87375-91-5 | Dehydronitrosonisoldipine | Nisoldipine USP RC E Nisoldipine Impurity 3 Nisoldipine Impurity D Dehydronitrosonisoldipine Nisoldipine Impurity 3 (Dehydronitrosonisoldipine) 3-isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate 3,5-Pyridinedicarboxylic acid, 2,6-dimethyl-4-(2-nitrosophenyl)-, 3-methyl 5-(2-methylpropyl) ester | Reference substance-impurity reference substance |
| 612 | 52807-12-2 | 4'-hydroxy Flurbiprofen (FPH) | FPH 4'-hydroxyflurbiprofen Flurbiprofen 4-Hydroxy 4'-hydroxy Flurbiprofen Flurbiprofen EP Impurity G 4'-hydroxy Flurbiprofen (FPH) 2-(4'-Hydroxy-2-fluoro-4-biphenylyl)propionic Acid 2-(2-fluoro-4'-hydroxy-[1,1'-biphenyl]-4-yl)propanoic acid 2-Fluoro-4'-hydroxy-α-Methyl-[1,1'-biphenyl]-4-acetic Acid [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-4'-hydroxy-α-methyl- (1,1'-Biphenyl)-4-acetic acid, 2-fluoro-4'-hydroxy-alpha-methyl- | Aromatics;Pharmaceuticals;Standard substance;Metabolites & Impurities;Impurity reference substance;Intermediates & Fine Chemicals |
| 613 | 19741-14-1 | 4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzoic acid | DAMPA Nsc 131463 Deoxyaminopteroic acid N-10-Methyl-4-deoxy-4-aminopteroate 2,4-Diamino-N(10)-methylpteroic acid p-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic acid 4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoic acid 4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzoic acid 4-[N-(2,4-DIAMINO-6-PTERIDINYLMETHYL)-N-METHYLAMINO] BENZOIC ACID 4-[N-[(2,4-DiaMinopyriMido[4,5-b]pyrazin-6-yl)Methyl]-N- MethylaMino]benzoic Acid | API;Nucleot;Compounds;Nucleotides;Heterocycles;Drug Analogues;Pharmaceuticals;145-methotrexate;Bases & Related Reagents;Impurity reference substance |
| 614 | 1314324-00-9 | (1R,2S)-2-(4-Fluorophenyl)cyclopropanamine Hydrochloride | 1),(1R,2S)- Ticagrelor Impurity 61 Ticagrelor Related Compound 63 HCl CyclopropanaMine, 2-(4-fluorophenyl)-(hydrochloride)(1 (1R,2S)-2-(4-Fluorophenyl)cyclopropanamineHydrochloride (1R,2S)-2-(4-Fluorophenyl)cyclopropanamine Hydrochloride (1R,2S)-2-(4-fluorophenyl)cyclopropan-1-amine hydrochloride 2-(((3aR,4S,6R,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | impurity reference substance;Reference substance-impurity reference substance |
| 615 | 67381-50-4 | 4-Carboxy-α-methylbenzeneacetic Acid | Ibuprofen Impurity 52 Ibuprofen EP Impurity 52 Ibuprofen Related Compound 2 2-p-carboxyphenylpropionic acid 4-(1-Carboxy-ethyl)-benzoic acid DL-2-(4-Carboxyphenyl)propionic Acid 4-Carboxy-α-Methylbenzeneacetic Acid 4-Carboxy-α-methylbenzeneacetic Acid Ibuprofen Related Compound (4-(1-Carboxy-ethyl)-Benzoic Acid) | Aromatics;Impurities;Pharmaceuticals;Impurity reference substance;Intermediates & Fine Chemicals |
| 616 | 36039-36-8 | 2-(4-Isobutylphenyl)propan-1-ol | Ibuprofen-11 IBUPROFEN IMP P Ibuprofen Alcohol IBUPROFEN IMPURITY P Ibuprofen Impurity P(EP) 2-(4-Isobutylphenyl)propan-1-ol (2RS)-2-(4-ISOBUTYLPHENYL)PROPAN-1-OL (2RS)-2-[4-(2-METHYLPROPYL)PHENYL]PROPAN-1-OL 2-(4-Isobutylphenyl)propanol(Ibuprofen EP Impurity P) | Organic block;Pharmaceutical raw materials;Impurity reference substance;Reference substance-impurity reference substance |
| 617 | 1657014-33-9 | 2-(4-Butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid | Febuxostat-9 FeBuxostat Impurity 23 Febuxostat impurities 11 Febuxostat n-Butoxy Acid (K) 2-(4-Butoxy-3-cyanophenyl)-4-methyl-5-thiazolecarboxylic acid 2-(4-Butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid 5-Thiazolecarboxylic acid, 2-(4-butoxy-3-cyanophenyl)-4-methyl- | Standard substance;Non-buxotan impurity;Pharmaceutical impurity;Impurity reference substance;Reference substance-impurity reference substance |
| 618 | 86604-80-0 | 4-Methoxy-2,3,5-trimethylpyride-N-oxide | Omeprazole Impurity 4 Omeprazole Related Compound 6 Esomeprazole Sodium Impurity 37 4-METHOXY-2,3,5-COLLIDINE N-OXIDE 4-Methoxy-2,3,5-trimethylpyride-N-oxide 2,3,5-Trimethyl-4-methoxypyridine N-oxide Pyridine, 4-methoxy-2,3,5-trimethyl-, 1-oxide 4-methoxy-2,3,5-trimethyl-1-oxidopyridin-1-ium | Organic reagents;API intermediates;Pharmaceutical intermediates;Synthetic material intermediates;Reference substance-impurity reference substance |
| 619 | 145546-80-1 | (2E)-Dehydrodonepezil | Donepezil-013-E (2E)-Dehydrodonepezil Donepezil EP Impurity F Donepezil related coMpound A Donepezil Related Compound A(USP) (2E)-Dehydrodonepezil (Donepezil Impurity) 2-[(E)-(1-BENZYL-4-PIPERIDINYL)METHYLIDENE]-5,6-DIMETHOXY-1-INDANONE 2-[(1-benzylpiperidin-4-yl)methylidene]-5,6-dimethoxy-3H-inden-1-one Donepezil Related Compound A (25 mg) ((E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one) | Impurities;Chemical Impurities-Donepezil |
| 620 | 358730-89-9 | Di-n-pentyl Phthalate-3456-d4 | Amyl Phthalate-d4 DI-N-PENTYL PHTHALATE-D4 [2H4]-di-n-Pentyl Phthalate Di-n-pentyl Phthalate-3456-d4 Di-pentyl Phthalate-3,4,5,6-D4 DI-N-PENTYL PHTHALATE-3,4,5,6-D4 Phthalic acid, bis-n-pentyl ester D4 | |
| 621 | 38090-53-8 | TACA | TACA Afatinib Impurity 71 Afatinib impurity 42 Trans-4-aminocrotonicacid TRANS-4-AMINOCROTONIC ACID (E)-4-aminobut-2-enoic acid (E)-4-AMINO-2-BUTENOIC ACID 2-Butenoic acid, 4-amino-, (2E)- trans-4-Aminocrotonic acid, TACA (6r-trans)-7-amino-8-oxo-3-[(1h-1,2,3-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | GABA/Glycine receptor;Impurity reference substance;Reference substance-impurity reference substance |
| 622 | 1038924-70-7 | (3R,5S)-5-([1,1'-Biphenyl]-4-ylmethyl)-3-methylpyrrolidin-2-one | LCZ696-7 (3R,5S)- Sacubitril Impurity 37 Cyclic impurity of Sacubitril valsartan + sacubitril impurity LCZ696(valsartan + sacubitril) impurity 7 (3R,5S)-5-biphenyl-4-ylMethyl-3-Methylpyrrolidin-2-one (3R,5S)-5-([1,1'-Biphenyl]-4-ylmethyl)-3-methylpyrrolidin-2-one 2-Pyrrolidinone, 5-([1,1'-biphenyl]-4-ylMethyl)-3-Methyl-, (3R,5S)- | Impurities;LCZ696 impurities;Impurity reference substance;Reference substance-impurity reference substance |
| 623 | 1357289-37-2 | Dolutegravir Impurity 16 | Dolutegravir 4-Epimer Dolutegravir Impurity 43 Dolutegravir Impurity 16 | Walderson Spot Catalog 2;Impurity reference substance;Reference substance-impurity reference substance |
| 624 | 1076199-40-0 | Quetiapine N-Oxide | Quetiapine N-Oxide Quetiapine Impurity H Quetiapine EP Impurity H Quetiapine EP Impurity H (Quetiapine-N-Oxide) Quetiapine Impurity 1(Quetiapine EP Impurity H) 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol N-Oxide Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-oxido-1-piperazinyl)ethoxy]- 2-[2-(4-benzo[b][1,4]benzothiazepin-6-yl-1-oxidopiperazin-1-ium-1-yl)ethoxy]ethanol | Heterocycles;Pharmaceuticals;Heterocyclic Compounds;Metabolites & Impurities;Sulfur & Selenium Compounds;Impurity reference substance |
| 625 | 1346606-28-7 | 3-Oxo Rosuvastatin SodiuM Salt | Rosuvastatin 3-O impurity Rosuvastatin Impurity 4 Rosuvastatin 3-oxo impurity 3-Oxo Rosuvastatin SodiuM Salt Rosuvastatin 3-Oxo Sodium Salt -7-[4-(4-Fluorophenyl)-6-(1-Methylethyl)-2-[Methyl(Methylsulfonyl)aMino]-5-pyriMidinyl]-5-hydroxy-3-oxo- (E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-hydroxy-3-oxohept-6-enoate sodium 7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-3-oxo-6-heptenoic acid sodium salt | Heterocycles;Rosuvastatin;Intermediates;Pharmaceuticals;Sulfur & Selenium Compounds;Impurity reference substance;Intermediates & Fine Chemicals;Reference substance-impurity reference substance |
| 626 | 1443421-68-8 | 9-((1R,4S)-4-(tert-Butoxymethyl)cyclopent-2-en-1-yl)-N6-cyclopropyl-9H-purine-2,6-diamine | Abacavir EP Imp F Abacavir impurity 3 Abacavir Impurity F Abacavir t-Butyl Ether (Abacavir EP Impurity F) Abacavir Impurity 6(Abacavir EP Impurity F) 9-((1R,4S)-4-(tert-Butoxymethyl)cyclopent-2-en-1-yl)-N6-cyclopropyl-9H-purine-2,6-diamine 6-N-cyclopropyl-9-[(1R,4S)-4-[(2-methylpropan-2-yl)oxymethyl]cyclopent-2-en-1-yl]purine-2,6-diamine 9H-Purine-2,6-diamine, N6-cyclopropyl-9-[(1R,4S)-4-[(1,1-dimethylethoxy)methyl]-2-cyclopenten-1-yl]- 6-(Cyclopropylamino)-9-[(1R,4S)-4-[[(1,1-dimethylethyl)oxy]methyl]cyclopent-2-enyl]-9H-purine-2-amine | |
| 627 | 646051-52-7 | Bis(4-fluorobenzyl)amine hydrochloride | Pimavanserin-001-HCl Pimovanserin Impurity1 Pimavanserin Impurity 1 Bis(4-fluorobenzyl)aMine Pimavanserin Impurity 15 HCl Bis(4-?uorobenzyl)amine hydrochloride Bis(4-fluorobenzyl)amine hydrochloride Bis(4-fluorobenzyl)aMine hydrochloride | Impurity reference substance |
| 628 | 2490599-18-1 | GMB-475 | GMB-475 (2S,4R)-1-((S)-3,3-Dimethyl-2-(2-(2-(4-(6-((4-(trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)phenoxy)ethoxy)acetamido)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide | Standard |
| 629 | 142449-93-2 | Myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside | Myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside Myricetin 3-O-beta-D-xylopyranosyl(1-2)-beta-D-glucopyranoside 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-[(2-O-β-D-xylopyranosyl-β-D-glucopyranosyl)oxy]- | Analytical reagent standard;standard material,plant extracts;Traditional Chinese medicine reference substance |
| 630 | 2401-64-1 | (4,6-Dichloro-[1,3,5]triazin-2-yl)-dimethyl-amine | SALOR-INT L118281-1EA 2,4-dichloro-6-dimethylamino-s-triazin 2-(N,N-DIETHYLAMINO)-4,6-DICHLOROTRIAZINE 2,4-DICHLORO-6-(DIMETHYLAMINO)-S-TRIAZINE 5-triazin-2-amine,4,6-dichloro-n,n-dimethyl-3 2,4-Dichloro-6-(dimethylamino)-1,3,5-triazine 4,6-Dichloro-N,N-dimethyl-1,3,5-triazin-2-amine (4,6-Dichloro-[1,3,5]triazin-2-yl)-dimethyl-amine | Impurity reference substance |
| 631 | 170569-87-6 | Desmethyl Celecoxib | PTPBS CAY10452 CAY10454 Celecoxib-004 Desmethyl Celecoxib Celecoxib Impurity 3 COX-2 INHIBITOR, PTPBS 4-[5-PHENYL-3-(TRIFLUOROMETHYL)PYRAZOL-1-YL]BENZENESULFONAMIDE 1-HEXADECANOYL-2-(P-NITROPHENOXYSUCCINOYL)-SN-GLYCERYL-3-PHOSPHORYLCHOLINE | Celecoxib;Impurity reference substance;Reference substance-impurity reference substance |
| 632 | 581772-29-4 | Atorvastatin acetonide | Atorvastatin 3 Atorvastatin Acetonide Atorvastatin acetonide Atorvastatin calcium-13 Atorvastatin Impurity 30 Atorvastatin Acetonide Acid 2-((4R,6R)-6-(2-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)et 2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid (4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-diMethyl-1,3-dioxane-4-acetic Acid | Intermediates;Chiral Reagents;Pharmaceuticals;Atorvastatin calcium;Intermediates & Fine Chemicals |
| 633 | 254452-92-1 | (3S,5S)-Pitavastatin calcium | monocalcium mono Pitavastatin calcium 2 (3S,5S)-Pitavastatin Calcium (3S,5S)-Pitavastatin calcium (3S,5S)-Pitavastatin CalciuM Salt Pitavastatin (3S,5S)-Isomer Calcium Pitavastatin 3S, 5S-Isomer Calcium Salt (3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid CalciuM Salt (3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt | 216-pitavastatin;Standard substance;Impurity reference substance;Reference substance-impurity reference substance;Aromatics, Chiral Reagents, Inhibitors, Pharmaceutic;Aromatics, Chiral Reagents, Inhib |
| 634 | 1191921-01-3 | Oseltamivir-acetate | Oseltamivir-acetate Oseltamivir Impurity455 Oseltamivir Impurity456 (3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate | Oseltamivir;100-Oseltamivir |
| 635 | 1350352-70-3 | Febuxostat impurity 7 | Febuxostat-17 Febuxostat impurity 7 Febuxostat Impurity M Febuxostat Impurity 7 Febuxostat Impurity 7 (F) 3-Descyano-3-((hydroxyimino)methyl) Febuxostat 2-(3-((Hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylicacid (Z)-2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid 2-[3-((HYDROXYIMINO)METHYL)-4-(2-METHYLPROPOXY)PHENYL]-4-METHYLTHIAZOLE-5-CARBOXYLIC ACID 2-[3-[(E)-hydroxyiminomethyl]-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid | Hybrid;Non-buxotan impurity;Impurity reference substance;Reference substance-impurity reference substance |
| 636 | 254452-88-5 | (3S,5R)-Pitavastatin calcium | Pitavastatin calcium 3 (3S,5R)-Pitavastatin calcium (3S,5R)-Pitavastatin CalciuM (3S, 5R)-Pitavastatin Calcium Salt Pitavastatin 3S,5R-IsoMer CalciuM Salt monocalcium mono((3S,5R,E)-7-(2-cyclopropyl- (3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid CalciuM Salt (3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt | 216-pitavastatin;Standard substance;Impurity reference substance;Reference substance-impurity reference substance;Aromatics, Chiral Reagents, Inhibitors, Pharmaceuticals, Inter;Aromatics, Chiral Reage |
| 637 | 1640971-51-2 | Tofacitinib metabolite-1 | Tofatinib impurity Tofatinib Impurity 32 Tofacitinib Impurity 77 Tofacitinib metabolite-1 Azilsartan medoxomil impurity322 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-6-oxo-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)- 3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | toafatinib |
| 638 | 1995065-79-6 | ROCK2-IN-2 | ROCK2-IN-2 1H-Indazol-5-amine, N-[5-[3-(2-oxazolyl)phenyl]-1,3,4-thiadiazol-2-yl]- | Reference substance |
| 639 | 1249080-59-8 | Isopropyl 2-(2-oxopyrrolidin-1-yl)acetate | Captopril Impurity 21 Piracetam Impurity 18 Piracetam Isopropyl Ester isopropyl 2-(2-oxopyrrolidin-1-yl)acetate Isopropyl 2-(2-oxopyrrolidin-1-yl)acetate 1-Pyrrolidineacetic acid, 2-oxo-, 1-methylethyl ester | Piracetam |
| 640 | 1333472-28-8 | 1-(4-Bromo-3,5-dimethoxyphenyl)ethan-1-one | 1-(4-bromo-3,5-dimethoxyphenyl)ethanone 1-(4-Bromo-3,5-dimethoxyphenyl)ethan-1-one 1-(4-bromo-3,5-dimethoxyphenyl)ethan-1-one Ethanone, 1-(4-bromo-3,5-dimethoxyphenyl)- | Terbutaline |
| 641 | 97963-75-2 | N-(4-(Difluoromethoxy)-2-nitrophenyl)acetamide | antoprazole Impurity 9 Pantoprazole Impurity 9 Pantoprazole Impurity 22 Pantoprazole Sodium Impurity U 2-nitro-4-difluoromethoxyphenylacetamide N-[4-(difluoromethoxy)-2-nitrophenyl]acetamide N-(4-(Difluoromethoxy)-2-nitrophenyl)acetamide Acetamide, N-[4-(difluoromethoxy)-2-nitrophenyl]- | Impurity reference substance |
| 642 | 727375-13-5 | 2-(Hydroxymethyl)-3,5-dimethylpyridin-4-ol | Esomeprazole Impurity 7 Esomeprazole Impurity 114 2-(Hydroxymethyl)-3,5-dimethylpyridin-4-ol 2-(hydroxymethyl)-3,5-dimethylpyridin-4-ol 2-Pyridinemethanol, 4-hydroxy-3,5-dimethyl- 2-Pyridinemethanol, 4-hydroxy-3,5-dimethyl- (9CI) | ALCOHOL;Impurity reference substance |
| 643 | 56161-71-8 | N-Methyl-3-phenyl-3-(2-(trifluoromethyl)phenoxy)propan-1-amine | Fluoxetine Impurity FXT-L N-Methyl-3-phenyl-3-(2-(trifluoromethyl)phenoxy)propan-1-amine Fluoxetine Impurity 29,methyl({3-phenyl-3-[2-(trifluoromethyl)phenoxy]propyl})amine | Impurity reference substance |
| 644 | 295357-66-3 | 2-(4-Amino-1-oxoisoindolin-2-yl)pentanedioic acid | Lenalidomide Impurity 3 Lenalidomide Impurity DA 2-(4-Amino-1-oxoisoindolin-2-yl)pentanedioic acid 2-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)glutaric acid 2-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)pentanedioic acid | Hybrization;197-lenalidomide;Standard substance;Impurity reference substance;Drug impurity reference substance;Reference substance-impurity reference substance |
| 645 | 1447715-45-8 | N-(2-Hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl)-N-isopropylformamide | Bisoprolol Impurity 3 BISOPROLOL IMPURITY 10 Bisoprolol Impurity 10 Bisoprolol Impurity 24 N-(2-Hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl)-N-isopropylformamide N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide Formamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)- | Bisoprolol impurity;impurity reference substance;Zhishang chemical intermediate;reference substance-impurity reference substance |
| 646 | 22568-64-5 | N-(3-Acetyl-4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide | rac Diacetolol Acebutolol EP IMpurity B Acebutolol Impurity B HCl Acebutolol Impurity 2 Monomer DL-3'-Acetyl-4'-[2-hydroxy-3-(isopropylaMino)propoxy]acetanilide 1-(4-AcetaMido-2-acetylphenoxy)-2-hydroxy-3-isopropylaMinopropane N-(3-Acetyl-4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide (±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide N-{3-Acetyl-4-{(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy}phenyl}acetamide | Amines;Aromatics;Pharmaceuticals;Metabolites & Impurities;Intermediates & Fine Chemicals |
| 647 | 1012864-23-1 | 2-(Diethylamino)-N-(2,5-dimethylphenyl)acetamide hydrochloride | Lidocaine-014-HCl USP Lidocaine impurity J Lidocaine Impurity J(EP) Lidocaine EP Impurity J HCl 2-(DiethylaMino)-N-(2,5-diMethylphenyl)acetaMide Hydrochloride 2-(Diethylamino)-N-(2,5-dimethylphenyl)acetamide hydrochloride | Lidocaine impurity;Impurity reference substance;Reference substance-impurity reference substance;Amines, Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals |
| 648 | 158778-58-6 | Demethyl Irbesartan | DeMethyl Irbesartan Demethyl Irbesartan Irbesartan Impurity-II Irbesartan Impurity (Demethyl Irbesartan) Irbesartan Impurity 8 (Demethyl Irbesartan) 3-((2'-(1H-Tetrazol-5-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-2-Propyl-1,3-Diazaspiro[4.4]Non-1-En-4-One 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- 3-((2-(1H-Tetrazol-5-Yl)-[1,1-Biphenyl]-4-Yl)Methyl)-2-Propyl-1,3-Diazaspiro[4.4]Non-1-En-4-One(WXC02339) | Reference substance-impurity reference substance;Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 649 | 138113-07-2 | 2-(7-methoxynaphthalen-1-yl)acetamide | Agomelatine-9 AgoMelatine IMp.VIII AgoMelatine IMpurity H (7-Methoxy-1-naphthyl)acetamide 7-Methoxy-1-naphthaleneacetamide 2-(7-Methoxynaphthalen-1-yl)acetamide 2-(7-methoxynaphthalen-1-yl)acetamide (7-Methoxy-[1]naphthyl)-acetic acid aMide | Agomelatine;Impurity reference substance |
| 650 | 2304444-49-1 | 2,2'-[[12,13-Bis(2-ethylhexyl)-12,13-dihydro-3,9-diundecylbisthieno[2'',3'':4',5']thieno[2',3':4,5]pyrrolo[3,2-e:2',3'-g][2,1,3]benzothiadiazole-2,10-diyl]bis[methylidyne(5,6-difluoro-3-oxo-1H-indene-2,1(3H)-diylidene)]]bis[propanedinitrile] | Y6 PM378 N5101 Y6-EH-4F Y6(BTPTT-4F) Y6 (Y6-EH-4F) | s;OTFT/OLED;OPV materials;Chemical reagents;organic chemistry;thiophene derivatives;organic optoelectronics;synthetic intermediates;optoelectronic materials;OPV materials and intermediates-OPV materia |
| 651 | 35891-87-3 | 2-(Isopropylamino)-2',6'-acetoxylidide Hydrochloride | Lidocaine-010-HCl Lidocaine EP Impurity G Lidocaine BP Impurity G Lidocaine EP Impurity G Hydrochloride N-isopropyl-glycine-(2,6-dimethyl-anilide) 2-(Isopropylamino)-2',6'-acetoxylidide Hydrochloride 2-(IsopropylaMino)-2',6'-acetoxylidide Hydrochloride | Impurity reference substance;Amines, Aromatics, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals;Amines, Aromatics, Isotope Labelled Compounds, Pharmaceuticals, Intermediat |
| 652 | 857170-72-0 | 2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide hydrochloride | Lidocaine-008-HCl Lidocaine BP Impurity F Lidocaine EP Impurity F Lidocaine Impurity F(EP) Lidocaine EP Impurity F HCl Lidocaine Impurity 6(Lidocaine EP Impurity F) 2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide hydrochloride 2-(DiethylaMino)-N-(2,3-diMethylphenyl)acetaMide Hydrochloride | Drug impurities;Lidocaine impurity;Impurity reference substance;Amines, Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals |
| 653 | 6163-63-9 | Phosphine oxide, tris (2-methylphenyl)- | Palbociclib-003 Eletriptan Impurity 14 Palbociclib Impurity 70 tri-o-tolylphosphine oxide Phosphine oxide, tris (2-methylphenyl)- LAURETH-4Phosphine oxide, tris (2-methylphenyl)- | Impurity control;Chemical raw materials |
| 654 | 217636-48-1 | FENOFIBRATE RELATED COMPOUND C (25 MG) (1-METHYLETHYL 2-[[2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOYL]OXY]-2-METHYLPROPANOATE) | Fenofibrate EP IMpurity G Fenofibrate impurity G (EP) Fenofibrate Impurity 7(Fenofibrate EP Impurity G) Fenofibric Acid 1,1-DiMethyl-2-(1-Methylethoxy)-2-oxoethyl Ester propan-2-yl 2-[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy-2-methylpropanoate 1-isopropoxy-2-methyl-1-oxopropan-2-yl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate 2-[4-(4-Chlorobenzoyl)phenoxy]-2-Methylpropanoic Acid 1,1-DiMethyl-2-(1-Methylethoxy)-2-oxoethyl Ester FENOFIBRATE RELATED COMPOUND C (25 MG) (1-METHYLETHYL 2-[[2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOYL]OXY]-2-METHYLPROPANOATE) | Aromatics;Impurities;Impedances;Pharmaceuticals;241-fenofibrate;Impurities controls;Intermediates & Fine Chemicals |
| 655 | 75965-74-1 | 42468 2-NITRO-7-METHOXYNAPHTHO[2 1-B]FU | r7000 1-b)furan,7-methoxy-2-nitro-naphtho( 7-methoxy-2-nitronaphtho(2,1-b)furan 7-METHOXY-2-NITRONAPHTHOL[2,1-B]FURAN NAPHTHO(1,2-B)FURAN,7-METHOXY-2-NITRO 42468 2-NITRO-7-METHOXYNAPHTHO[2 1-B]FU 42468, 2-Nitro-7-methoxynaphtho[2,1-b]fu ran (purity) | N;Nitro-PAH;Alphabetic;Environmental CRM;NA - NIApplication CRMs |
| 656 | 60415-61-4 | 2-PENTYL BUTYRATE | sec-Amyl butyrate 2-PENTYL BUTYRATE 1-Methylbutyl butyrate 1-methylbutyl butanoate Butanoic acid, 2-pentyl ester Butyric acid, sec-pentyl ester butanoicacid,1-methylbutylester | O-P;Alphabetical Listings;Flavors and Fragrances |
| 657 | 11068-95-4 | 78909 ZIRCALOY-4 (TRACE ELEMENT IMPURIT | Zircaloy (C, N, O) Zirconium tin alloy 42853, Zircaloy (C, N, O) 52999, Zircaloy (C, N, O) Zircaloy-4 (trace element impurities) 78909 ZIRCALOY-4 (TRACE ELEMENT IMPURIT 78909, Zircaloy-4 (trace element impurities) | |
| 658 | 11141-16-5 | AROCHLOR 1232 | AROCHLOR 1232 [40cfr136(1986)]pcb-1232 polychlorinatedbiphenyl(aroclor1232) | ;A;800;Alphabetic;8000 Series Solidwaste Methods;Method 8082international Standards;Method 8082International Standards;Single Component SolutionsMore...Close...;Single Component SolutionsMore.. |
| 659 | 21236-54-4 | W 36017 | W 36017 Lidocaine-017 Lidocaine EP Impurity Lidocaine Impurity 19 Monomer Acetamide, 2-(dimethylamino)-N-(2,6-dimethylphenyl)- | Control-impurity control |
| 660 | 12791-76-3 | 53968 ZNAL4 (TRACE ELEMENTS) | Aluminum zinc alloy 23412, ZnAl4 (trace elements) 70339, ZnAl4 (trace elements) 53968 ZNAL4 (TRACE ELEMENTS) 71601, ZnAl4 (trace elements) 78066, ZnAl4 (trace elements) | |
| 661 | 119302-22-6 | Androstane-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl) | Rocuronium Bromide Impurity 31 Rocuronium Bromide Impurity 28 Rocuronium Bromide Impurity 45 Rocuronium bromide Impurity 54 Androstane-3,17-diol,2-(4-morpholinyl)-16-(1-pyrrolidinyl) (2β,3α,5α,16β,17β)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)-3,17-bis(acetyloxyoxy)androstane Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, 3,17-diacetate, (2β,3α,5α,16β,17β)- | Impurity control substance;Control substance-impurity control substance |
| 662 | 24407-49-6 | 94987 10-AZABENZO[A]PYRENE (PURITY) | Anthra[2,1,9-def]quinoline 94987 10-AZABENZO[A]PYRENE (PURITY) | A;Alphabetic;AR to AZ |
| 663 | 10221-08-6 | NSC525120 | NSC525120 2-chloro-1,4-bis(chloromethyl)benzene Benzene, 2-chloro-1,4-bis(chloromethyl)- | 095-plesafur |
| 664 | 135729-55-4 | RS 42358-197 | RS 42358-197 Palonosetron Impurity 1 HCl Palonosetron-3-ene Hydrochloride Palonosetron USP Related Compound E Palonosetron Hydrochloride Impurity 1 2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-5,6-dihydro-4~{H}-benzo[de]isoquinolin-1-one (S)-2-(quinuclidin-3-yl)-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride 2-[(3S)-1-Azabicyclo[2.2.2]oct-3-yl] 2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride | Impurity control |
| 665 | 33978-72-2 | YS-035 HCL | YS-035 YS-035 HCL Dobutamine hydrochloride impurity 6 YS-035 HYDROCHLORIDE VERAPAMIL DERIVATIV E N,N-bis(3,4-dimethoxyphenethyl)-N-methylamine n-(-2-[3,4-dimethoxyphenyl]ethyl)-3,4-dimethoxy-n-methylbenzeneethanamine Benzeneethanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-3,4-dimethoxy-N-methyl- | |
| 666 | 87500-74-1 | OPEN RING AZTREONAM (25 MG) | SQ 26992 Open Ring AztreonaM AztreonaM IMpurity A Open Ring Aztreonam (15 mg) OPEN RING AZTREONAM (25 MG) Open Ring Aztreonam (10 mg) Aztreonam USP Related Compound A (Open-ring Aztreonam) (2S,3S)-2-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)butanoic Acid | Aztreonam;Impurity control substance;Chemical impurity-aztreonam;Control substance-impurity control substance;Standard substance/reference substance/chemical reagent/experiment |
| 667 | 671225-26-6 | PREDNICARBATE RELATED COMPOUND A (20 MG) (1,2-DIHYDROPREDNICARBATE) | 1,2-Dihydro Prednicarbate Prednicarbate EP Impuirty F Prednicarbate EP Impurity F 1,2-Dihydroprednicarbate (IMpurity F) Cortisol 17-(Ethyl Carbonate) 21-Propionate PREDNICARBATE RELATED COMPOUND A (20 MG) (1,2-DIHYDROPREDNICARBATE) (11β)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)pregn-4-ene-3,20-dione Pregn-4-ene-3,20-dione, 17-[(ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)-, (11β)- (9CI) | Steroids;Pharmaceuticals;Impurity controls;Mediates & Fine Chemicals;Controls-impurity controls;Intermediates & Fine Chemicals |
| 668 | 98296-48-1 | GANODERIC ACID C2(SH) | GANODERIC ACID C2(SH) (3beta,15alpha)-3,7,15-Trihydroxy-11,23-dioxo-lanost-8-en-26-oic acid Lanost-8-en-26-oic acid, 3,7,15-trihydroxy-11,23-dioxo-, (3β,15α)- (9CI) | Control;Plant extract;Standard-control;Control, standard;Standard, control |
| 669 | 10429-07-9 | Androstan-17-one,3-[[(4-methylphenyl)sulfonyl]oxy]-,(3,5)- | Rocuronium Impurity 15 (3S,5S,8R,9S,10S,13S,14S)- Rocuronium bromide Impurity 1 3β-Tosyloxy-5α-androstan-17-one 3β-(4-methylphenylsulfonyloxy)-5α-androstan-17-one Androstan-17-one,3-[[(4-methylphenyl)sulfonyl]oxy]-,(3,5)- (5S,10S)-10,13-dimethyl-17-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl 4-methylbenzenesulfonate ((3S,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl 4-methylbenzenesulfonate | Control-impurity control |
| 670 | 69304-48-9 | BRN 0758154 | BRN 0758154 Brivudine Impurity H Uridine, 2'-deoxy-5-[(1E)-2-iodoethenyl]- | Impurity control |
| 671 | 5393-61-3 | NSC4751 | NSC4751 Edaravone Impurity 20 Edaravone impurity DO 5-Methyl-2-phenyl-2H-pyrazole-3,4-diol 5-methyl-2-phenyl-2h-pyrazol-3, 4-diol 4-hydroxy-5-methyl-2-phenyl-1,2-dihydro-pyrazol-3-one 4-hydroxy-5-methyl-2-phenyl-2,4-dihydro-3h-pyrazol-3-one 3H-Pyrazol-3-one, 2,4-dihydro-4-hydroxy-5-methyl-2-phenyl- | Standard;Impurity control;Control-impurity control |
| 672 | 2786-19-8 | MECOPROP METHYL ESTER | Mecoprop-methyl Mecoprop-methyl [iso] MECOPROP METHYL ESTER MECOPROP-METHYL ESTER PESTANAL 250 MG Methyl 2-((4-chloro-o-tolyl)oxy)propionate Propionic acid, 2-((4-chloro-o-tolyl)oxy)-, methyl ester 2-(4-CHLORO-2-METHYLPHENOXY)-PROPANOIC ACID METHYL ESTER | M;MA-MDEPA;Herbicides;Alpha sort;Alpha sort;MA - MDEPA;H-MAlphabetic;Method 8150/8151;Methods 8150/8151;Pesticides&Metabolites |
| 673 | 91147-46-5 | 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine | UK 14819 Brimonidine EP Imp H Brimonidine Impurity 5 Brimonidine Impurity H Brimonidine Impurity 12 Brimonidine EP Impurity H Brimonidine Impurity 8 (Brimonidine EP Impurity H) 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine | Impurity control |
| 674 | 41411-66-9 | 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]- | 6-Epidoxycycline HCl DOXYCYCLINE 6-EPIMER HCL 6-Epidoxycycline hydrochl 6-epidoxycline hydrochloride 6-epidoxycyline hydrochloride 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, 4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)- | Tetracyclines |
| 675 | 132172-14-6 | L 683519 | L 683519 Tacrolimus 13 DMT Demethyltacrolimus 13-Desmethyl FK 506 Desmethyl Tacrolimus Tacrolimus Impurity 14 16,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,15,19-trihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14-methoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,... | Impurity;Impurity control;Tacrolimus impurity |
| 676 | 78756-33-9 | Ro 15-3505 | Ro 15-3505 Ro-15-1310 FluMazenil IMpurity F Flumazenil Impurity A Flumazenil EP Impurity F Ethyl 8-chloro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]b enzodiazepine-3-carboxylate 8-Chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester 4H-IMidazo[1,5-a][1,4] benzodiazepine-3-carboxylic acid, 8-chloro-5,6-dihydro-5- Methyl-6-oxo-, ethyl ester | Control-impurity control |
| 677 | 11068-69-2 | 28846, NIMONIC 75 FOR CREEP TESTING | Nimonic 75 for creep testing 28846, NIMONIC 75 FOR CREEP TESTING | |
| 678 | 70172-96-2 | NIMODIPINE RELATED COMPOUND B (50 MG) (BIS(2-METHOXYETHYL) 2,6-DIMETHYL-4-(3-NITROPHE-NYL)-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE) (AS) | Nimodipine Impurity 3 Nimodipine impurity B Cilnidipine Compound 5 Nimodipine EP Impurity C (RS)-Di-2-methoxyethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(2-methoxyethyl) ester Nimodipine Related Compound B (50 mg) (bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) NIMODIPINE RELATED COMPOUND B (50 MG) (BIS(2-METHOXYETHYL) 2,6-DIMETHYL-4-(3-NITROPHE-NYL)-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE) (AS) | Impurity control;Nimodipine impurity |
| 679 | 99906-66-8 | 80211 TI6 AL4 V ALLOY (O) | Ti 6Al 4V alloy (O) 80211 TI6 AL4 V ALLOY (O) 52670, Ti6 Al4 V alloy (O) | |
| 680 | 58073-59-9 | (endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide | Sch-1178 Ipratropium Impurity B Ipratropium EP Impurity B IpratropiuM BroMide Related CoMpound B (endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide (3-endo,8-anti)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-Azoniabicyclo[3.2.1]octane Bromide (1R,3r,5S,8s)-3-[[(2RS)-3-Hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide Ipratropium Bromide Related Compound B (10 mg) ((1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide) | Control-impurity control |
| 681 | 78756-03-3 | Ro 14-7437 | Ro 14-7437 Flumazenil EP Impurity E Flumazenil impurity E (EP) Flumazenil Related Compound C (USP) ethyl 5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate 5,6-Dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester 4H-IMidazo[1,5-a][1,4] benzodiazepine-3-carboxylic acid, 5,6-dihydro-5-Methyl-6 -oxo-, ethyl ester | Control-impurity control |
| 682 | 537-29-1 | HYOSCYAMINE RELATED COMPOUND A (10 MG) (NORHYOSCYAMINE SULFATE) | NorhyoscyaMine Sulfate Hyoscyamine EP Impurity E HyoscyaMine Related CoMpound A Noratropine hydrochloride solution Tropic acid, 3alpha-nortropanyl ester HYOSCYAMINE RELATED COMPOUND A (10 MG) (NORHYOSCYAMINE SULFATE) Hyoscyamine EP Impurity E (Hyoscyamine USP Related Compound A, Norhyoscyamine) | Watson custom catalog 2 |
| 683 | 180683-37-8 | INDINAVIR (100 MG)F0D3080.971MG/MG(AI) | Indinavir CRS Indinavir (100 mg) Indinavir (1339178) Indinavir monohydrate Indinavir for system suitability CRS Indinavir System Suitability (100 mg) Indinavir System Suitability (1339189) | |
| 684 | 28197-66-2 | N-[3-acetyl-4-(oxiranylmethoxy)phenyl]butyramide | Acebutolol EP IMP A Acebutolol EP IMpurity A Acebutolol IMpurity A (EP) 3Acetyl-4(2,3-epoxypropoxy)-butyranilide N-[3-acetyl-4-(oxiranylmethoxy)phenyl]butyramide N-[3-Acetyl-4-(oxiranylmethoxy)phenyl]-butanamid N-[3-Acetyl-4-(oxiranylmethoxy)phenyl]-butanamide N-[3-acetyl-4-(oxiran-2-ylmethoxy)phenyl]butanamide N-(3-acetyl-4-(oxiran-2-ylMethoxy)phenyl)butyraMide | Amines;Aromatics;Heterocyces;Heterocycles;Pharmaceuticals;Chemical raw materials;Mediates & Fine Chemicals;Intermediates & Fine Chemicals |
| 685 | 5786-78-7 | disodium dihydrogen N,N'-1,2-cyclohexanediylbis[N-(carboxylatemethyl)glycinate] | 1,2-Diaminocyclohexanetetraacetic acid disodium salt solution Glycine, N,N-1,2-cyclohexanediylbisN-(carboxymethyl)-, disodium salt Dinatriumdihydrogen-N,N'-1,2-cyclohexandiylbis[N-(carboxylatmethyl)glycinat] disodium dihydrogen N,N'-1,2-cyclohexanediylbis[N-(carboxylatemethyl)glycinate] disodium2-[carboxymethyl-[2-[carboxymethyl-(2-oxido-2-oxoethyl)amino]cyclohexyl]amino]acetate | |
| 686 | 404958-08-3 | TERT-BUTYL (R)-6-CHLORO-5-HYDROXY-3-OXOHEXANOATE | Rosuvastatin Impurity 112 tert-Butyl 6-Chloro-(R)-hydroxy-3-oxohexanoate (R)-tert-butyl 6-chloro-5-hydroxy-3-oxohexanoate TERT-BUTYL (R)-6-CHLORO-5-HYDROXY-3-OXOHEXANOATE Hexanoic acid, 6-chloro-5-hydroxy-3-oxo-, 1,1-dimethylethyl ester, (5R)- | Impurity control |
| 687 | 37209-23-7 | WARFARIN RELATED COMPOUND A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) | Alice's ketone Warfarin EP IMpurity-A Warfarin Related CoMpound A 3-(2-Hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one 3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one (5RS)-3-(2-Hydroxyphenyl)-5-phenylcyclohex-2-enone WARFARIN RELATED COMPOUND A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) Warfarin Related Compound A (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one) (1719102) | Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 688 | 65621-78-5 | cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole | Asenapine Impurity 5 (Cis-Asenapine) | |
| 689 | 6091-13-0 | physostigmine hydrobromide | physostigmine hydrobromide | |
| 690 | 1132709-16-0 | Boronic acid, B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]- | (1S,2R)-BortezoMib Bortezomib (1R,2R)Isomer (1S,2R)-Bortezomib Impurity Bortezomib Impurity (1S,2R - Isomer) N-(2-Pyrazinecarbonyl)-D-phenylalanine-D-leucine boronic anhydride (S)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butylboronic acid Boronic acid, B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]- | 163-bortezomib;Impurity controls;Radial Reagents, Boron Derivatives, Inhibitors, Pharmaceuticals, mediates & Fine Chemicals;Chiral Reagents, Boron Derivatives, Inhibitors, Pharmaceuticals, Intermediat |
| 691 | 77532-85-5 | Trelagliptin IMpurity | (S)-Trelagliptin 3-Fluoro Trelagliptin Trelagliptin IMpurity 6-Fluoro Trelagliptin trelagliptin iMpurities Trelagliptin Impurity 5 N-Desmethyl Trelagliptin Trelagliptin Succinate Impurity | Impurity control;Impurities, control;Control-impurity control;Endocrine and metabolic systems |
| 692 | 193265-47-3 | 4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoic Acid | Pemetrexed Impurity 59 PeMetrexed acid oxo iMpurity Pemetrexed acid oxo impurities 4-(2-(2-amino-4,6-dioxo-4,5,6,7- 4-(2-{2-amino-4,6-dioxo-3H,4H,5H,6H,7H-pyrrolo[2,3- d]pyrimidin-5-yl}ethyl)benzoic acid 4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoic Acid 4-[2-(2-amino-4,6-dioxo-4,5,6,7-tetrahydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)-ethyl]-benzoic acid Benzoic acid, 4-[2-(2-amino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]- | Aromatics, Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 693 | 120533-30-4 | δ-2-CefodiziMe (2 :1 Mixture) | δ-2-Cefodizime Δ-2-CEFODIZIME (Δ3)-CEFODIZIME Cefodizime impurity 10 d3- Cefodizime impurity Cefodizime double bond displacement impurity (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((5-(carboxymethyl)-4-methylthiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid | Controls-impurity controls;Chiral Reagents, Heterocycles, Pharmaceuticals, Metabolites & Impurities, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 694 | 105356-90-9 | [4-(4-AMino-7-hydroxy-6-Methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)Methanone | Terazosin EP IMP H Terazosin Impurity H Terazosin EP Impurity H Terazosin Impurity 8(Terazosin EP Impurity H) 4-amino-6-methoxy-2-[4-(oxolane-2-carbonyl)piperazin-1-yl]-1H-quinazolin-7-one [4-(4-AMino-7-hydroxy-6-Methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)Methanone Methanone, [4-(4-amino-7-hydroxy-6-methoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)- 1-(4-Amino-7-hydroxy-6-methoxyquinazolin-2-yl)-4-(((2RS)-tetrahydrofuran-2-yl)carbonyl)piperazine | Terazosin Impurities;Aromatics, heterotypes, manipulations, Pharmaceuticals, mediates & Fine Chemicals;Aromatics, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 695 | 461432-24-6 | (3R,4R,5R,6S)-2-(acetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | EOS-61485 Dapagliflozin-2 Dapagliflozin Impurity 149 Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucopyranoside D-Glucopyranoside, Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]- (3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol (3R,4R,5R,6S)-2-(acetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | Pharmaceutical raw material;Reference substance-impurity reference substance |
| 696 | 1442400-68-1 | O-Desethyl Azilsartan | Azilsartan-11 O-Desethyl Azilsartan Azilsartan Impurity 11 Azilsartan O-Desethyl Imp Azilsartan O-Desethyl Impurity 2-Oxo-3-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylicacid 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | Impurity control;Azilsartan impurity (K);Control-impurity control;Azilsartan Ester impurity;Aromatics, heterotypes, Metabolites & impedances, Pharmaceuticals, Intermediates & Fine Chemicals;Aromatics, |
| 697 | 22432-95-7 | α-Decitabine | α-Decitabine alpha-Decitabine Decitabine Impurity 38 Decitabine alpha-Isomer Decitabine Alpha Isomer Impurity Decitabine Impurity 4(Alpha-Isomer) 1-(2-Deoxy-a-D-ribofuranosyl)-5-azacytosine 4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one 1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-α-D-erythro-pentofuranosyl)- | Aromatic;Impurities;Impurity controls;Heterocycles, Pharmaceuticals, mediates & Fine Chemicals;Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 698 | 31349-38-9 | DesMethyl BendaMustine Hydrochloride | BendamustineImpurity5-d8HCl Bendamustine Desmethyl Impurity Bendamustine N-Desmethyl Impurity DesMethyl BendaMustine Hydrochloride Bendamustine Impurity 5 HCl (BendamustineDesmethyl Impurity HCl) | Amines, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 699 | 204254-92-2 | (3R,4R,5R)-3-(1-Ethylpropoxy)-4-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester | Oseltamivir Impurity 86 XZBIOECQKNRLEH-MGPQQGTHSA-N (1S,5R,6S)-ethyl 5-(sec-butoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate (3R,4R,5R)-ethyl 4-hydroxy-5-((methylsulfonyl)oxy)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate ethyl (3R,4R,5R)-3-(1-ethyl-propoxy)-4-hydroxy-5-methanesulfonyloxycyclohex-1-ene-1-carboxylate (3R,4R,5R)-3-(1-Ethylpropoxy)-4-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester 1-Cyclohexene-1-carboxylic acid, 3-(1-ethylpropoxy)-4-hydroxy-5-[(methylsulfonyl)oxy]-, ethyl ester, (3R,4R,5R)- | Oseltamivir;Impurity controls;Pharmaceuticals, intermediate & Fine Chemicals, Sulfur & Selenium Compounds;Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 700 | 949141-22-4 | (E)-Olopatadine Hydrochloride | Olopatadine Impurity 36 HVRLZEKDTUEKQH-JUIXXEQESA-N (E)-Olopatadine Hydrochloride trans-olopatadine hydrochloride (E )-11-[ 3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride (E)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid hydrochloride | 148-olopatadine;Controls-impurity controls;Amines, heterotypes, impacts, Pharmaceuticals, mediates & Fine Chemicals;Amines, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 701 | 122483-73-2 | 3-Acetyl RocuroniuM BroMide | Rocuronium impurity B Rocuronium EP Impurity B 3-Acetyl RocuroniuM BroMide Rocuronium bromide EP impurity B Rocuronium Bromide Impurity 2(EP Impurity B) RocuroniuM BroMide EP IMpurity B (IMpurity 15) 1-[3α,17β-diacetoxy-2β-(morpholin-4-yl)-5α-androstan-16β-yl]-1-(prop-2-enyl)pyrrolidinium 1-[3α,17β-diacetoxy-2β-(morpholin-4-yl)-5α-androstan-16β-yl]-1-(prop-2-enyl)pyrrolidinium Bromide | Controls;Impurity controls;Impurity standards;Rocuronium Impurities;Controls-impurity controls;Heterocyces, imports, Pharmaceuticals, mediates & Fine Chemicals, Steroids;Heterocycles, Impurities, Phar |
| 702 | 404874-93-7 | 3-[5-(1,5-Dioxo-5-(p-fluophenylpentyl]-4R-phenyl-2-oxazolidinone | Ezetimibe Impurity Enantiomer Ezetimibe Impurity 8 Enantiomer 3-[5-(1,5-Dioxo-5-(p-fluophenylpentyl]-4R-phenyl-2-oxazolidinone 3 [ 5(1,5-DIOXO-5 -(P-FLUOPHENYLPENTYL ] - 4R-PHENYL-2-OXAZOLIDINONE (R)-1-(4-fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione 1,5-Pentanedione, 1-(4-fluorophenyl)-5-[(4R)-2-oxo-4-phenyl-3-oxazolidinyl]- | Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals |
| 703 | 138564-61-1 | 1-[[2-[(2-AMinophenyl)aMino]-5-Methyl-3-thienyl]carbonyl]-4-Methyl-piperazine | Olanzapine EP Impurity L Olanzapine open ring impurity Olanzapine Ring-opening IMpurity Olanzapine Aminomethanone Impurity 1-[[2-[(2-AMinophenyl)aMino]-5-Methyl-3-thienyl]carbonyl]-4-Methyl-piperazine Methanone, [2-[(2-aminophenyl)amino]-5-methyl-3-thienyl](4-methyl-1-piperazinyl)- | Impurity world-Olanzapine;Amines, Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |
| 704 | 1190105-67-9 | 1,2-Dehydro-3-oxo RocuroniuM BroMide | Rocuronium impurity H Rocuronium EP Impurity H 1-((5S,8R,9S,10S,13S,14S,16S,17R) 1,2-Dehydro-3-oxo RocuroniuM BroMide Rocuronium Bromide EP Impurity H Bromide RocuroniuM BroMide IMpurity 21 (EP iMpurity H) 1-((5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2-morpholino-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-16-yl)-1-allylpyrrolidin-1-ium | Impurity controls;Impurity standards;Rocuronium Impurities;Controls-impurity controls;Heteroses, aberrations, Pharmaceuticals, mediates & Fine Chemicals, Steroids;Heterocycles, Impurities, Pharmaceuti |
| 705 | 947723-87-7 | (αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide | Cefuroxime axetil impurity E Cefuroxime Axetil EP Impurity E Cefuroxime Axetil Impurity E (EP) E-isomers (Cefuroxime Axetil Impurity) Cefuroxime Sodium EP Impurity H(Cefuroxime Axetil EP Impurity E) Cefuroxime Impurity 8(Cefuroxime Sodium EP Impurity H)(Cefuroxime Axetil EP Impurity E) (αZ)-α-(MethoxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-2-furanacetaMide (Z)-N-((5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(furan-3-yl)-2-(methoxyimino)acetamide | Impurities;Impurity controls;Chiral Reagents, he;169-Cefuroxime Axetil;Controls-impurity controls;Cefuroxime Axetil impurities;Cefuroxime sodium impurities;Chemical impurities-cefuroxime sodium;Chiral |
| 706 | 4380-55-6 | Deltacortinene Acetate (Predisolone Acetate IMpurity) | Deltacortinene Acetate Prednisolone Impurity 14 Prednisolone Acetate EP Impurity E DELTACORTINENE ACETATE (PREDISOLONE ACETATE IMPURITY) Deltacortinene Acetate (Predisolone Acetate IMpurity) Pregna-1,4,9(11)-triene-17a,21-diol-3,20-dione 21-acetate pregna-1,4,9(11)-triene-17α,21-diol-3,20-dione 21-acetate 2-((8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate | Impurity control;Steroid hormone raw material Intermediates;Pharmaceuticals, mediates & Fine Chemicals, Steroids;Pharmaceuticals, Intermediates & Fine Chemicals, Steroids |
| 707 | 178949-04-7 | Cefdinir IMpurity 3 (Cefdinir Decarboxy Open Ring Lactone (Mixture of A and B)) | Cefdinir Decarboxy Open Ring Lactone Impurity Cefdinir Impurity 6 (Mixture of Diastereomers) Cefdinir IMpurity 3 (Cefdinir Decarboxy Open Ring Lactone (Mixture of A and B)) (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyimino-N-[(5-methyl-7-oxo-1,2,4,5-tetrahydrofuro[3,4-d][1,3]thiazin-2-yl)methyl]acetamide (Z)-2-(2-AMINOTHIAZOL-4-YL)-2-(HYDROXYIMINO)-N-{[(2RS,5RS)-5-METHYL-7-OXO-2,4,5,7-TETRAHYDRO-1H-FURO[3,4-D][1,3]THIAZIN-2-YL]METHYL}ACETAMIDE (Z)-2-(2-AMinothiazol-4-yl)-2-(hydroxyiMino)-N-{[(2RS,5RS)-5-Methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]Methyl}acetaMide Discontinued | Cefdinir;Chemical impurities-cefdinir;Chiral Reagents, Impurity, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds;Chiral Reagents, importance, Pharmaceuticals, intermediate |
| 708 | 871838-58-3 | (rac,syn)-4-Deschloro-sertraline | Sertraline iMpurity D Sertraline Impurity 30 (rac,syn)-4-Deschloro-sertraline Sertraline Hydrochloride Impurity 4 (1S,4S)-4-(3-chlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine 1-Naphthalenamine, 4-(3-chlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1S,4S)- | Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, Inhibitors |
| 709 | 117620-84-5 | (3S)-10-Fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid | Levofloacin Impurity J Levofloxacin Impurity 2 Levofloxacin Impurity J (S)-10-fluoro-3-methyl-7-oxo (S)-10-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (3S)-10-Fluoro-2,3-dihydro-3-Methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Levofloxacin (3S)-10-Fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid | Impurity controls;Controls-impurity controls;Impurity world-levofloxacin;Chiral Reagents, Inhibitors, Pharmaceuticals, mediates & Fine Chemicals;Chiral Reagents, Inhibitors, Pharmaceuticals, Intermedi |
| 710 | 98293-81-3 | Milrinone IMpurity 3 | Milrinone IMpurity 3 Milrinone ImpuritiesC 5-cyano-6-oxo-3-pyridin-4-yl-1H-pyridine-2-carboxylic acid 5-Cyano-1,6-dihydro-6-oxo-[3,4'-bipyridine]-2-carboxylic Acid 5-cyano-6-oxo-1,6-dihydro-[3,4'-bipyridine]-2-carboxylic acid [3,4'-Bipyridine]-2-carboxylic acid, 5-cyano-1,6-dihydro-6-oxo- | Controls-impurity controls;Aromatics, heterocyces, miscellular Reagents;Aromatics, Heterocycles, Miscellaneous Reagents |
| 711 | 1346600-38-1 | rac Dehydro-O-desMethyl Venlafaxine | Venlafaxine Impurity 6 Desvenlafaxine Impurity 3 Desvenlafaxine Anhydro Impurity Desmethylvenlafaxine Impurity B rac Dehydro-O-desMethyl Venlafaxine Venlafaxine Anhydro O-Desmethyl Impurity Venlafaxine O-Desmethyl Anhydro Impurity 2-Cyclohexenyl-2-(4-hydroxyphenyl)-N,N -dimethylethanamine | Chemical raw materials;Amines, atomatics, Chemicals, Pharmaceuticals, mediates & Fine Chemicals;Amines, Aromatics, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 712 | 190595-66-5 | EzetiMibe IMpurity 1 | Ezetimibe-6 EzetiMibe IMpurity 1 (3'S,3R,4S)-Desfluoro EzetiMibe (3R,4S)-1-(4-fluorophenyl)-3-((S) Ezetimibe Desfluorobenzene Analog EzetiMibe IMpurity 1 ((3'S,3R,4S)-Desfluoro EzetiMibe) (3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-phenylpropyl)-4-(4-hydroxyphenyl)azetidin-2-one | Impurity controls;Pharmaceutical impurities;Controls-impurity controls;Aromatics, heterotypes, effects, Inhibitors, Pharmaceuticals, mediates & Fine Chemicals;Aromatics, Heterocycles, Impuities, Inhib |
| 713 | 1393911-57-3 | D-Valganciclovir Hydrochloride | Ganciclovir Impurity 11 Ganciclovir EP Impurity 6 Valganciclovir Impurity 4 Ganciclovir D-Valinate HCl D-Valganciclovir Hydrochloride Valganciclovir HCl D-Valine Analog D-Valganciclovir HCl (Mixture of Diastereomers) | Impurity control |
| 714 | 142885-92-5 | 5-Methoxy-2-[[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]thio]-1H-benziMidazole N-Oxide | Ufiprazole Impurity 1 Omeprazole Impurity 26 Esomeprazole impurity E1 Omeprazole Sulfide N-Oxide 5-Methoxy-2-[[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]thio]-1H-benziMidazole N-Oxide 4-Methoxy-2-(((6-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine1-oxide 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl-1-oxide)methyl]sulfanyl]-1H-benzimidazole 4-methoxy-2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)thio)methyl)-3,5-dimethylpyridine 1-oxide | Impurity controls;Controls-impurity controls;Metabolisms & impedances, Pharmaceuticals, mediates & Fine Chemicals;Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 715 | 103816-16-6 | 11-Desethyl Irinotecan | Irinotecan Impurity A 7-Desethyl Irinotecan Irinotecan Impurity 11 11-Desethyl Irinotecan (S)-4-ethyl-4-hydroxy-3 Irinotecan EP Impurity A Irinotecan Hydrochloride impurity A 10-[4-(1-Piperidino)-1-piperidinocarbonyloxy]camptothecin | Impurity controls;Irinotecan Impurities;Controls-impurity controls;Aromatics, heterotypes, impedances, Inhibitors, Pharmaceuticals, mediates & Fine Chemicals;Aromatics, Heterocycles, Impurities, Inhib |
| 716 | 94749-11-8 | 4-Hydroxy-α1-[[[6-(3-phenylpropoxy)hexyl]aMino]Methyl]-1,3-benzenediMethanol | Salmeterol EP Impurity C Salmeterol Xinafoate BP Impurity C 4-Hydroxy-α1-[[[6-(3-phenylpropoxy)hexyl]aMino]Methyl]-1,3-benzenediMethanol 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl]phenol 1,3-Benzenedimethanol, 4-hydroxy-α1-[[[6-(3-phenylpropoxy)hexyl]amino]methyl]- 1-[4-Hydroxy-3-(hydroxymethyl)phenyl]-2-[[6-(3-phenylpropoxy)hexyl]amino] ethanol | Impurity controls;Drug Substance impurities;Salmeterol impurities-salmeterol impurities;Amines, atomics, Pharmaceuticals, mediates & Fine Chemicals;Amines, Aromatics, Pharmaceuticals, Intermediates & |
| 717 | 148516-54-5 | DesMethyl AMisulpride | PLC AMI4002 DesMethyl AMisulpride Amisulpride EP Impurity B 4-Amino-N-[[(2RS)-1-ethyl-pyrrolidi 4-amino-N-((1-ethylpyrrolidin-2-yl)methyl)-5-(ethylsulfonyl)-2-hydroxybenzamide 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-hydroxybenzamide Benzamide, 4-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-hydroxy- 4-Amino-N-[[(2RS)-1-ethylpyrrolidin- 2-yl]methyl]-5-(ethylsulphonyl)-2-hydroxybenzamide 4-Amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethylsulfonyl)-2-hydroxybenzamide HBr | 226-amisulpride;Impurity comparators;Amisulpride impurity;Chemical raw materials;Pharmaceutical raw materials;Comparators-impurity comparators;Aromatics, Drug Analogues, heterotypes, Pharmaceuti;Aroma |
| 718 | 1373038-59-5 | BenzenesulfonaMide, 3-[4-[4-(aMinosulfonyl)phenyl]-5-Methyl-3-isoxazolyl]- | Parecoxib-007 Parecoxib Impurity 34 Parecoxib SodiuM iMpurity PR-12-E 3,3'-(5-methylisoxazole-3,4-diyl)dibenzenesulfonamide 3-[5-Methyl-4-(4-sulfamoylphenyl)-1,2-oxazol-3-yl]benzenesulfonamide 3-[4-[4-(Aminosulfonyl)phenyl]-5-methyl-3-isoxazolyl]benzenesulfonamide BenzenesulfonaMide, 3-[4-[4-(aMinosulfonyl)phenyl]-5-Methyl-3-isoxazolyl]- | Standard;Impurity control;Parecoxib impurity;073-parecoxib sodium;Control-impurity control;Parecoxib sodium impurity;Impurity-parecoxib sodium |
| 719 | 56796-66-8 | 4-Benzyl Albuterol | 4-Benzyl Albuterol O-BENZYL SALBUTAMOL(OBS) Salbutamol Sulfate BP Impurity I 4-((BENZYLOXY)-ALPHA-(TERT-BUTYLAMINO)METHYL)-M-XYLENE-ALPHA 1-(4-Benzyloxy-3-hydroxymethyl-phenyl)-2-(tert-butylamino)ethanol 4-(benzyloxy)-alpha-[[tert-butylamino]methyl]-m-xylene-alpha,alpha'-diol a1-[[(1,1-Dimethylethyl)amino]methyl]-4-(phenylmethoxy)-1,3-benzenedimethanol Salbutamol [-Alpha[ (Tert-Butylamino) Methyl)-4-Benzyloxy Sulphate 1,3-Benzene Dimethanol] | Salbutamol;125-salbutamol;Pharmaceuticals;Impurity control;Salbutamol EP impurity;Mediates & Fine Chemicals;Chemical impurity-salbutamol;Intermediates & Fine Chemicals |
| 720 | 947502-66-1 | 5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-7a-hydroxy-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one | Prasugrel impurity F Prasugrel EP Impurity F Desacetyl hydroxyprasugrel DESACETYL HYDROXYPRASUGREL Prasugrel Hydroxy Thiolactone 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-7a-hydroxy-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-one 5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-7a-hydroxy-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one 5-(2-CYCLOPROPYL-1-(2-FLUOROPHENYL)-2-OXOETHYL)-5,6,7,7A-TETRAHYDRO-7A-HYDROXYTHIENO[3,2-C]PYRIDIN-2(4H)-ONE | Prasugrel;Impurity control;Control-impurity control |
| 721 | 869791-42-4 | PeMetrexed EP IMpurity A | PeMetrexed IMpurity N-Methyl Pemetrexed PeMetrexed EP IMpurity A JKULRGFPYBAJTE-AWEZNQCLSA-N Pemetrexed disodium EP impurity A (sodium (S)-2-(4-(2-(2-amino-1-methyl Pemetrexed Impurity 2(Pemetrexed EP Impurity A) | Control;121-pemetrexed;Impurity control;Control-impurity control;Chemical impurity-pemetrexed |
| 722 | 1039307-95-3 | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid | 1039307-95-3 (2R,4S)-4-AMINO-5-(BIPHENYL-4-YL)-2-METHYL PENTANOIC ACID [1,1'-Biphenyl]-4-pentanoic acid, γ-amino-α-methyl-, (αR,γS)- (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid | |
| 723 | 866157-50-8 | Ozagrel methylester | Ozagrel methylester Methyl 3-(4-(1H-imidazol-1-yl)phenyl)acrylate methyl 3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate (E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate 3-[4-(1H-Imidazol-1-yl)phenyl]-2-propenoic acid methyl ester Methyl (2E)-3-[4-(1H-iMidazol-1-ylMethyl)phenyl]prop-2-enoate -Propenoicacid, 3-[4-(1H-iMidazol-1-yl)phenyl]-, Methyl ester Ozagrel methyl ester 3-[4-(1H-Imidazol-1-yl)phenyl]-2-propenoic acid methyl ester | Medical;Raw material;Ozagrel Intermediate;Chemical raw material;Cardio-cerebrovascular;Pharmaceutical raw material;Impurity reference substance;Reference substance-impurity reference substance |
| 724 | 92878-95-0 | 2-(3-CHLOROPROPOXY)-1-METHOXY-4-NITROBENZENE | 1-(2-methoxy-5-nitrophenoxy)-3-chloropropane 2-(3-CHLOROPROPOXY)-1-METHOXY-4-NITROBENZENE Benzene, 2-(3-chloropropoxy)-1-methoxy-4-nitro- | Product;Bosutinib;Impurity control |
| 725 | 149949-01-9 | 6(S)-Hydroperoxy Simvastatin | Simvastatin Impurity 11 6(S)-Hydroperoxy Simvastatin 6(S)-Hydroperoxy SiMvastatin 2,2-DiMethylbutanoic Acid (1S,6S,7R,8S,8aR)-1,2,6,7,8,8a-Hexahydro-6-hydroperoxy-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester Butanoic acid, 2,2-dimethyl-, (1S,6S,7R,8S,8aR)-1,2,6,7,8,8a-hexahydro-6-hydroperoxy-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester | Impurities;Inhibitors;Heterocycles;Chiral Reagents;Pharmaceuticals;Impurity controls;Cervical Reagents;Intermediates & Fine Chemicals;Chiral Reagents, Heterocycles, Impurities, Inhibitors, Pharmaceuti |
| 726 | 108928-81-0 | Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) | SalMeterol Related CoMpound B Salmeterol Xinafoate BP Impurity E 4-Hydroxy-α1-[[[6-(1-Methyl-3-phenylpropoxy)hexyl]aMino]Methyl]-1,3-benzenediMethanol (4-{1-Hydroxy-2- [6-(4-phenylbutan-2-yloxy)hexylaMino]ethyl}-2- (hydroxyMethyl)phenol) 4-Hydroxy-alpha1-[[[6-(1-methyl-3-phenylpropoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 4-Hydroxy-α1-[[[6-(1-Methyl-3-phenylpropoxy)hexyl]aMino]Methyl]-1,3-benzenediMethanol (SalMeterol IMpurity) Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) | Impurities;Salmeterol Impurities-salmeterol Impurities;Amines, Aromatics, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals |
| 727 | 127254-10-8 | 7-[(4S)-4-Amino-6-azaspiro[2.4]heptan-6-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid | Sitafloxacin SitafloxacinisomerⅢ(RRS) sitafloxacin isomer III(RRS) Sitafloxacin Isomer Impurity 7 7-((R)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4 7-[(4S)-4-Amino-6-azaspiro[2.4]heptan-6-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid 7-[(7R)-7-amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluoro-cyclopropyl]-1,4-dihydro-4-oxo-Quinolin-3-carboxylic acid 3-Quinolinecarboxylic acid, 7-[(7R)-7-aMino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo- | Impurities;Impurity control;242-sitafloxacin;Control-impurity control |
| 728 | 36159-03-2 | Donepezil Impurity | Donepezil-024 Donepezil Impurity Donepezil Impurity 22 (Z)-5,5',6,6'-tetramethoxy-2,3-dihydro-[1,2'-biindenylidene]-1'(3'H)-one 2-(2,3-Dihydro-5,6-dimethoxy-1H-inden-1-ylidene)-2,3-dihydro-5,6-dimethoxy-1H-inden-1-one 1H-Inden-1-one, 2-(2,3-dihydro-5,6-dimethoxy-1H-inden-1-ylidene)-2,3-dihydro-5,6-dimethoxy- | Drug impurity |
| 729 | 1824506-44-6 | 1-(5,6-dihydronaphthalen-1-yl)ethan-1-amine hydrochloride | Cinacalcet-3 Cinacalcet Impurity 62 5,6-Dihydro-α-methyl-1-naphthalenemethanamine 1-Naphthalenemethanamine, 5,6-dihydro-α-methyl- 1-(5,6-dihydronaphthalen-1-yl)ethan-1-amine hydrochloride (R)-N-(1-(phthalen-1-yl)ethyl)-3-(m-tolyl)propan-1-amine hydrochloride | Standard;067-cinacalcet;Impurity control |
| 730 | 178677-39-9 | (E)-N-(2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethyl)acetamide | Agomelatine-4 Agomelatine Impurity 23 Agomelatine Impurity 42 (E)-N-(2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethyl)acetamide (E)-1-[2-(acetylamino)ethylidene]-7-methoxy-1,2,3,4tetrahydronaphthalene Acetamide, N-[2-(3,4-dihydro-7-methoxy-1(2H)-naphthalenylidene)ethyl]-, € Acetamide, N-[2-(3,4-dihydro-7-methoxy-1(2H)-naphthalenylidene)ethyl]-, (E)- (9CI) | Impurity control |
| 731 | 1353428-89-3 | 2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine | 1-Naphthaleneethanamine, 3,4-dihydro-7-methoxy- 2-(7-METHOXY-3,4-DIHYDRONAPHTHALEN-1-YL)ETHANAMINE 2-(7-Methoxy-3,4-dihydronaphthalen-1-yl)ethanamine 2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine | Impurity control |
| 732 | 2041584-99-8 | 1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | 2,4(1H,3H)-Pyrimidinedione, 1-[(2R)-2-deoxy-2-fluoro-2-methyl-α-D-erythro-pentofuranosyl]- 1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | Control-impurity control |
| 733 | 156453-50-8 | Dapoxetine Impurity 13 | Dapoxetine Impurity09 Dapoxetine Impurity 13 Dapoxetine impurities393 (S)-3-(naphthalen-1-yloxy)-1-phenylpropan-1-ol Benzenemethanol, α-[2-(1-naphthalenyloxy)ethyl]-, (S)- (9CI) | 113-dapoxetine;Impurity control |
| 734 | 468104-18-9 | (E)-2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethan-1-amine | 2-(7-Methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethan-1-amine Ethanamine, 2-(3,4-dihydro-7-methoxy-1(2H)-naphthalenylidene)- (E)-2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethan-1-amine | Impurity control |
| 735 | 2037385-84-3 | N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide | Nintedanib-007-HCl Nintedanib Impurity 31 N-methyl-N-(4-nitrophenyl) N-methyl-N-(4-nitrophenyl)-2 N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide H... N-METHYL-N-(4-NITROPHENYL)-2-(PIPERAZIN-1-YL)ACETAMIDE H... N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide Hydrochloride | Hybridization;Impurity control |
| 736 | 928325-68-2 | 1-(2-chloro-5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | Vonoprazan-020 2-Chloro Vonoprazan 1-(2-chloro-5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine | Hybridization;084-vonoprazan |
| 737 | 1971858-36-2 | 1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one | Flibaserin-010 Flibanserin Impurity 9 1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piper... 1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one 1,3-Dihydro-1-(1-methylethenyl)-3-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-2H-benzimidazol-2-one | Impurity control |
| 738 | 1987887-92-2 | (Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate | Nintedanib-011 Intedanib Impurity D Nintedanib Impurity q Nintedanib Impurity 34 (Z)-METHYL 3-(((4-(METHYLAMINO)PHENYL)AMINO)(PHENYL)METH... (Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)meth... (Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-(methylamino)phenyl]amino]phenylmethylene]-2-oxo-, methyl ester, (3Z)- | Hybridization;050-nintegrob;Impurity reference substance |
| 739 | 1823404-28-9 | 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine | Palbociclib-001 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine 2-Pyrimidinamine, 5-bromo-4-chloro-N-cyclopentyl- | Hybridization;Impurity control |
| 740 | 1403389-05-8 | Indacaterol Impurity 7 | indacaterol743 Indacaterol Impurity Indacaterol Impurity 7 Indacaterol Intermediate impurity 1 8-Hydroxy-3,4-dihydroquinolin-2-oxo-indacaterol 2(1H)-Quinolinone, 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-3,4-dihydro-8-hydroxy- (R)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1- hydroxyethyl)-8-hydroxy-3,4-dihydroquinolin-2(1H)-one hydrogenchloride | 111-indacaterol;Control-impurities control;Indacaterol maleate impurity |
| 741 | 170570-09-9 | Celecoxib Impurity | Celecoxib-14 Celecoxib-003 Celecoxib Impurity Celecoxib 2,4-Dimethyl 4-(5-(2,4-dimethylphenyl) 4-[5-(2,4-Dimethyl-phenyl)-3-trifluoromethyl-pyrazol-1-yl]-benzenesulfonamide 4-(5-(2,4-dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | Drug impurity;Impurity control substance;Control substance-impurity control substance |
| 742 | 773895-24-2 | Indacaterol Impurity 22 | indacaterol735 Indacaterol Impurity 22 Indacaterol isomer Impurity 8-(benzyloxy)-5-(1-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-2-hydroxyethyl)quinolin-2(1H)-one | 111-indacaterol;Impurity control |
| 743 | 780736-98-3 | Bupivacaine Impurity | Ropivacaine-002 Bupivacaine Impurity Ropivacaine Impurity 9 2-Piperidinecarboxamide, N-(3,5-dimethylphenyl)- | Impurity control |
| 744 | 1883672-48-7 | tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | Palbociclib-008-HCl Pabociclib Impurity B Hydrochloride tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | Impurity control |
| 745 | 51299-16-2 | 1,2-bis(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethane | Flibaserin-008 Flibanserin Impurity 7 1,2-bis(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethane Piperazine, 1,1'-(1,2-ethanediyl)bis[4-[3-(trifluoromethyl)phenyl]- 1,?1'-?(1,?2-?Ethanediyl)?bis[4-?[3-?(trifluoromethyl)?phenyl]?-piperazine | Impurity control |
| 746 | 1204222-85-4 | BMS-639432 | BMS-639432 Dapagliflozin-5 Dapagliflozin Impurity N Dapagliflozin Hydroxy Impurity Dapagliflozin Impurity 24 (Mixture of Diastereomers) D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)hydroxymethyl]phenyl]-, (1S)- (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(hydroxy)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | Control;Impurity control;Chemical impurity;Control-impurity control;Chemical impurity-dapagliflozin |
| 747 | 52144-90-8 | Terbutaline Impurity | Terbutaline-005 Terbutaline Impurity Terbutaline Impurity 9 Terbutaline sulfate Impurity J Ethanone, 1-[3,5-bis(phenylmethoxy)phenyl]-2-[(1,1-dimethylethyl)amino]- | Control-impurity control |
| 748 | 83508-83-2 | methyl (41S,12R,13aR)-13a-ethyl-12-
hydroxy-2,3,41,5,6,12,13,13aoctahydro-
1H-indolo[3,2,1-
de]pyrido[3,2,1-ij][1,5]naphthyridine-
12-carboxylate | Vinpocetine-11 Vinpocetine Impurity K Vinpocetine Impurity 11 (41S,12R,13aR)-methyl 13a-ethyl Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3α,14α)- (9CI) methyl (41S,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]phthyridine-12-carboxylate (41S,12R,13aR)-methyl 13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate methyl (41S,12R,13aR)-13a-ethyl-12- hydroxy-2,3,41,5,6,12,13,13aoctahydro- 1H-indolo[3,2,1- de]pyrido[3,2,1-ij][1,5]naphthyridine- 12-carboxylate | 064-vinpocetine;Impurity control;Control-impurity control |
| 749 | 251327-00-1 | methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate | tube1184 Peramivir Impurity 41 Peramivir impurities 41 methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate | Peramivir impurity |
| 750 | 1388858-78-3 | 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea | Pimavanserin-005 Pimovanserin Impurity6 Pimavanserin Impurity 6 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea | Impurity control |
| 751 | 220182-11-6 | 1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one | Atosiban impurity 14 1,4,7,10-tetrazabicyclo[8.2.2]tetradecan-11-one 1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one 2,2'-(7-((2R,3S)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4-diyl)diacetic acid | 117-cyanobutol;Control-impurities control |
| 752 | 352637-51-5 | PDXA-226 | PDXA-226 Ropivacaine-004 Ropivacaine Impurity 11 N-(2,4-dimethylphenyl)picolinamide 2-Pyridinecarboxamide, N-(2,4-dimethylphenyl)- | Impurity control |
| 753 | 802918-35-0 | (R)-N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine | (R)-1-(phthalen-1-yl)-N-(3-(trifluoromethyl)benzyl)ethan-1-aminehydrochloride (R)-1-(naphthalen-1-yl)-N-(3-(trifluoromethyl)benzyl)ethan-1-aminehydrochloride (R)-N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine 1-(7,8-Dihydro-napthalen-1-yl)-ethyl]- [3-(3-trifluoromethyl-phenyl)]-amine hydrochloride (αR)-7,8-Dihydro-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine (E)-N-(1-(5,6-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide hydrochloride | 067-cinacalcet;Impurity control;Cinacalcet impurity |
| 754 | 944263-08-5 | Demiditraz racemate | Demiditraz-004 Demiditraz racemate Demiditraz Impurity 1 Demiditraz Impurity 5 Dexmedetomidine Hydrochloride ImpurityA 1H-Imidazole, 2-[1-(2,3-dimethylphenyl)ethyl]- | Standard;Drug impurity;Impurity control;Watson spot catalog 2;Control-impurity control |
| 755 | 19943-27-2 | cis-cyclo(Pro-Pro) | cis-cyclo(Pro-Pro) Vildagliptin Impurity 41 | |
| 756 | 1945965-95-6 | Ropivacaine-cycle | Ropivacaine-009-S Ropivacaine-cycle Ropivacaine Impurity 18 Ropivacaine EP Impurity F Ropivacaine Impurity F(EP) (8aS)-2-(2,6-dimethylphenyl)hexahydro-3,3-dimethyl-imidazo[1,5-a]pyridin-1(5H)-one Imidazo[1,5-a]pyridin-1(5H)-one, 2-(2,6-dimethylphenyl)hexahydro-3,3-dimethyl-, (8aS)- | Control-impurity control |
| 757 | 98626-60-9 | Ropivacaine-ET-R | Ropivacaine-ET-R Ropivacaine-007-R Ropivacaine Impurity 14 (2R)-N-(2,6-dimethylphenyl)-1-ethylpiperidine-2-carboxamide 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-ethyl-, (2R)- | Amino acid;Impurity control |
| 758 | 1033803-59-6 | 2-(3-(methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol | Duloxetine-6 Duloxetine EP Imp E Duloxetine IMpurity E Duloxetine hydrochloride impurity E 2-(3-(methylamino)-1-(thiophen-2-yl) Duloxetine Impurity 5(Duloxetine EP Impurity E) 2-(3-(methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol | 072-Duloxetine;Impurity control;Duloxetine impurity;Control-impurity control |
| 759 | 84951-65-5 | N-(2,6-dimethylphenyl)nicotinamide | Ropivacaine-011 Ropivacaine Impurity 20 N-(2,6-dimethylphenyl)nicotinamide 3-Pyridinecarboxamide, N-(2,6-dimethylphenyl)- | Impurity control |
| 760 | 175888-75-2 | Ropivacaine-iPr | Ropivacaine-iPr Ropivacaine-008 Ropivacaine Impurity 17 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-(1-methylethyl)- | Impurity control |
| 761 | 1144516-14-2 | Neratinib Impurity 6 | Neratinib Impurity 11 Neratinib Impurity 6 Neratinib Impurity OACQ Ethanediamide, N1-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]- | Impurity control |
| 762 | 473465-11-1 | ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate | Parecoxib Sodium-24 Parecoxib Impurity 69 Parecoxib Impurity 42 Parecoxib Sodium Impurity 27 ethyl 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonate N-ethyl-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide | Impurity control;Parecoxib sodium impurity |
| 763 | 1714147-47-3 | (3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid | Rosuvastatin calcium-1 Rosuvastatin Related Compound A Rosuvastatin Impurity 9(Rosuvastatin EP Impurity A) (3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid Calcium(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate (3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt Calcium bis[ (3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy -N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin -5-yl)-3,5-dihydroxyhept-6-enoate] | Impurity control;Control-impurity control;Rosuvastatin calcium impurity |
| 764 | 849831-77-2 | 4R,5S)-2,4-diphenyl-4,5-dihydrooxazole-5-carboxylic acid | 4R,5S)-2,4-diphenyl-4,5-dihydrooxazole-5-carboxylic acid | |
| 765 | 181696-12-8 | 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide | Parecoxib Sodium-10 Parecoxib Impurity 11 Parecoxib Sodium Impurity 11 4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide Benzenesulfonamide, 4-(5-methyl-4-phenyl-3-isoxazolyl)- | Impurity control;Control-impurity control;Parecoxib sodium impurity |
| 766 | 1050482-18-2 | Ropivacaine-iPr-R | roivacaine Ropivacaine-008-R Ropivacaine-iPr-R Ropivacaine Impurity 5 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-(1-methylethyl)-, (2R)- | Impurity control |
| 767 | 2125995-27-7 | Bupivacaine Impurity | Bupivacaine Impurity Bupivacaine Impurity 6 Bupivacaine-001-SR-HCl Bupivacaine Impurity 12 HCl | Impurity control |
| 768 | 2059954-32-2 | Brexpiprazole Impurity | Brexpiprazole-002 Brexpiprazole Impurity Epipiprazole Impurity 8 7-(4-Chlorobutoxy)-1-(4-chlorobutyl)quinolin-2-one 2(1H)-Quinolinone, 7-(4-chlorobutoxy)-1-(4-chlorobutyl)- | Impurity control |
| 769 | 852804-30-9 | Bupivacaine Impurity | Bupivacaine-002 Bupivacaine Impurity Bupivacaine Impurity 8 Bupivacaine Impurity 14 Bupivacaine Impurity 8 ABCDEFGHJKL | Impurity control |
| 770 | 59413-21-7 | (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid | Vinpocetine-17 Vinpocetine Impurity X sodium (41S,12S,13aS)-13a Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, monosodium salt, (3α,14β,16α) (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]phthyridine-12-carboxylic acid (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid sodium (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12, 13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxylate | Vinpocetine impurity 16;Control-impurity control |
| 771 | 1204612-29-2 | 1204612-29-2 | 1204612-29-2 (R)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine hydrochloride | 060-ivabradine;Impurity control |
| 772 | 60548-08-5 | Terazosin Impurity | Terazosin Impurity Terazosin-004-2HCl Terazosin Impurity6 Doxazosin EP Impurity G HCl 2-(1-Piperazinyl)-4-amino-6,7-dimethoxyquinazoline-2HCl N-Des((tetrahydrofuran-2-yl)methanone)) Terazosin Dihydrochloride 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine Dihydrochloride 4-Quinazolinamine, 6,7-dimethoxy-2-(1-piperazinyl)-, dihydrochloride | Control-impurity control |
| 773 | 1384080-33-4 | (S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine | Duloxetine-20 Duloxetine Impurity47 3-Thiophenepropanamine, N,N-dimethyl-γ-(1-naphthalenyloxy)-, (γS) (S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine | Impurity control;Duloxetine impurity;Control-impurity control |
| 774 | 1384080-56-1 | (S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol | Duloxetine-19 Duloxetine Impurity48 (S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol (1S)-3-(dimethylamino)-1-(thiophen-3-yl)propan-1-ol 3-Thiophenemethanol, α-[2-(dimethylamino)ethyl]-, (αS) | Standard;Impurity control;Duloxetine impurity;Control-impurity control |
| 775 | 878757-08-5 | (R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine | Duloxetine-10 Duloxetine Impurity56 Duloxetine Impurity 14 2-Thiophenepropanamine, N,N-dimethyl-γ-(1-naphthalenyloxy)-, (γR)- (R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine | Standard;Impurity control;Duloxetine impurity;Control-impurity control |
| 776 | 36585-31-6 | BDJS-SH 2 | BDJS-SH 2 Ropivacaine-019-RS Ropivacaine Impurity 36 | Impurity control |
| 777 | 944267-48-5 | Demiditraz IMpurity | Demiditraz-001 Demiditraz IMpurity Demiditraz Impurity 2 (1-Benzyl-1H-imidazol-2-yl)(2,3-dimethylphenyl)methanone Methanone, (2,3-dimethylphenyl)[1-(phenylmethyl)-1H-imidazol-2-yl]- | Drug impurity;Impurity control substance;Control substance-impurity control substance |
| 778 | 36588-45-1 | BDJS-SH 1 | BDJS-SH 1 Ropivacaine-019-RR Ropivacaine Impurity 33 | Impurity control |
| 779 | 36588-46-2 | BDJS-SH 4 | BDJS-SH 4 Ropivacaine-019-SR Ropivacaine-019-6R12S Ropivacaine Impurity 35 | Impurity control |
| 780 | 944268-65-9 | Demiditraz IMpurity | Demiditraz-003 Demiditraz IMpurity Demiditraz Impurity 4 1-Benzyl-2-[1-(2,3-dimethylphenyl)vinyl]-1H-imidazole 1H-Imidazole, 2-[1-(2,3-dimethylphenyl)ethenyl]-1-(phenylmethyl)- | Drug impurity;Impurity control substance;Control substance-impurity control substance |
| 781 | 75202-36-7 | Timolol EP Impurity G | Timolol EP Impurity G Timolol Maleate EP Impurity G 3-Hydroxy-4-morpholino-1,2,5-thiadi 4-morpholin-4-yl-1-oxo-1,2,5-thiadiazol-3-one 4-morpholino-1,2,5-thiadiazol-3(2H)-one 1-oxide 4-(4-Morpholinyl)-1,2,5-thiadiazol-3(2H)-one 1-Oxide 1,2,5-Thiadiazol-3(2H)-one, 4-(4-morpholinyl)-, 1-oxide | Timolol impurity;Impurity control;Control-impurity control |
| 782 | 1902954-03-3 | Posaconazole Impurity 48 | Posaconazole Impurity 48 Posaconazole 1-Oxido Impurity posaconazole N-Oxide impurity 3 4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl) 4-(4-(((3R,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-1-(4-(1-((2S,3S)-2-hydroxypentan-3-yl)-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)phenyl)piperazine 1-oxide D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-4-oxido-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)- | Control-impurity control |
| 783 | 944268-66-0 | Demiditraz IMpurity | Demiditraz-002 Demiditraz IMpurity Demiditraz Impurity 3 Metformin Impurity 18 1-(1-Benzyl-1H-imidazol-2-yl)-1-(2,3-dimethylphenyl)ethanol 1H-Imidazole-2-methanol, α-(2,3-dimethylphenyl)-α-methyl-1-(phenylmethyl)- | Drug impurity;Impurity control substance;Control substance-impurity control substance |
| 784 | 117976-92-8 | 2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine | Rabeprazole Impurity 46 2-chloromexypropoxy)-3-methylpyridine 2-CHLOROMETHYL-4-(3-HYPROPOXY)-3-METHYLPYRIDINE 2-chloromethyl-4-(3-hydroxypropoxy)-3-methylpyridine 3-((2-(Chloromethyl)-3-methylpyridin-4-yl)oxy)propan-1-ol | Compound product;Impurity control |
| 785 | 1447693-83-5 | Aprepitant Impurity 15 | SSS-Morpholine Argatroban Morpholine Aprepitant Impurity 15 Fosaprepitant Impurity 11 HCl Aprepitant Impurity SM3FDY1-11 Aprepitant Impurity SM3FDY1-1 HCl Forzapitan Impurity 11 Hydrochloride | Control-impurity control |
| 786 | 1262243-12-8 | Fosfomycin Trometamol EP Impurity D | Fosfomycin EP Impurity D RDPFAWYPVPIZPV-UHFFFAOYSA-N Trometamoyloxy Fosfomycin-dimer Fosfomycin Trometamol Impurity 4 Fosfomycin Trometamol EP Impurity D Fosfomycin?dimer?tromethamine?adduct?(Imp?D) Fosfomycin Trometamol Impurity 4(Fosfomycin Trometamol EP Impurity D) Phosphonic acid, P-[2-[2-amino-3-hydroxy-2-(hydroxymethyl)propoxy]-1-hydroxypropyl]-, mono(2-hydroxy-1-methyl-2-phosphonoethyl) ester | Impurity control;Control-impurity control;Fosfomycin EP impurity D |
| 787 | 532414-36-1 | Formoterol Fumarate Dihydrate EP Impurity I | anti-rac-Formoterol Arformoterol Impurity 22 Formoterol Fumarate Dihydrate EP Impurity I N-(2-hydroxy-5-((R)-1-hydroxy-2-(((S)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide rel-N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide | 190-Formoterol |
| 788 | 1795135-61-3 | Formoterol EP Impurity C | Formoterol EP Impurity C Formoterol Related Compound C N-Deformyl-N-acetyl Formoterol DISCONTINUED, offer D229065 N-(2-hydroxy-5-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)acetamide Acetamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]- | Control;190-Formoterol;Impurity control |
| 789 | 39672-75-8 | Desonide 9, 11-Epoxide | Epoxydesonide Desonide Impurity 2 Desonide 9, 11-Epoxide Desonide Epoxy Impurity 9-Desfluoro-9(11)-epoxy Triamcinolone Acetonide 9,11β-Epoxy-16α,17,21-trihydroxy-9β-pregna-1,4-diene-3,20-dione, 16,17-acetonide Pregna-1,4-diene-3,20-dione, 9,11-epoxy-21-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (9β,11β,16α)- | |
| 790 | 172673-23-3 | Aprepitant Impurity 12 | Aprepitant Impurity 12 5-([(2R,3S)-2-((R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy)-3-(4-fluoro phenyl)-4-oxido-morpholino]methyl)-1H-1,2,4-triazol-3(2H)-one (2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-((5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)morpholine 4-oxide 3H-1,2,4-Triazol-3-one, 5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-oxido-4-morpholinyl]methyl]-1,2-dihydro-, [2R-[2α(R*),3α]]- (9CI) | |
| 791 | 66170-32-9 | Tramadol Impurity 1 | Tramadol imp B Tramadol Impurity 1 Tramadol Impurity B Tramadol EP Impurity B HCl Dehydroxytramadol Hydrochloride Tramadol Hydrochloride Impurity B as Hydrochloride [2-(3-Methoxyphenyl)cyclohex-1-enyl]-N,N-dimethylmethanamine Hydrochloride | |
| 792 | 74378-10-2 | Nifendipine Impurity G | Nifedipine-6 Nifedipine Impurity G Nifendipine Impurity G Nifendipine Impurity 7 2,6-Dimethyl-3,5-dicarboxy-4-(2-nitrophenyl)-1,4-dihydropyridine 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)- | Nifedipine |
| 793 | 950781-89-2 | imp.E | imp.E Varenicline impurity E Depyrazine 7-Nitro-8-aminophenyl N-Trifluoroacetyl Varenicline 3-(trifluoroacetyl)-8-nitro-2,3,4,5-tetrahydro-1H-1,5-methano-3-benzazepin-7-amine Ethanone, 1-(7-amino-1,2,4,5-tetrahydro-8-nitro-1,5-methano-3H-3-benzazepin-3-yl)-2,2,2-trifluoro- | Control-impurity control |
| 794 | 1815608-51-5 | Vortioxetine impurity S | Vortioxetine impurity S Vortioxetine Impurity 12 HCl 1-(4-((2,4-dimethylphenyl)thio)phenyl)piperazine Piperazine, 1-[4-[(2,4-dimethylphenyl)thio]phenyl]- 1-{4-[(2,4-Dimethylphenyl)sulfanyl]phenyl}piperazine 1-(4-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride | Impurity control;179-Vortioxetine |
| 795 | 1253056-01-7 | Sitagliptin Impurity 10 | Sitagliptin-8 Sitagliptin Impurity 10 Sitagliptin phosphate impurity 6 Sitagliptin Hydroxy Amide Impurity 1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluo 1-Butanone, 1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)- 3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | Impurity control;Sitagliptin EP impurity;Control-impurity control |
| 796 | 183613-77-6 | Ramosetron Impurity 13 | Ramosetron Impurity 13 | Impurity control |
| 797 | 1370190-85-4 | Posaconazole Impurity 35 | Posaconazole Impurity 35 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl) (R)-1-((2-(2,4-difluorophenyl)-4-methylenetetrahydrofuran-2-yl) methyl)-1H-1,2,4-triazole | Posaconazole;Control-impurity control |
| 798 | 53055-15-5 | Nifedipine Impurity F | Nifedipine Impurity F Nitrendipine Impurity 12 Azilsartan medoxomil impurity304 3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(2-... 3-ethyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine- 3,5-dicarboxylate 3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, ethyl methyl ester 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3-ethyl 5-methyl ester | Nifedipine;Control-impurity control |
| 799 | 786625-22-7 | Lercanidipine Impurity 6 | Lercandipine Impurity II Lercanidipine Impurity 6 Lercanidipine Ethyl Ester 5-Ethyl-demethyl Lercanidipine 1-[(3,3-Diphenylpropyl)(methyl)amino]-2-methylpropan-2-yla ethyl (4RS)-2,6-dimethyl-4-(3- nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-[2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-ethyl ester | 247-lercanidipine;Control-impurities control |
| 800 | 154361-55-4 | Iopromide EP Impurity D | Iopromide EP Impurity D Iopromide Impurity 4 (Iopromide EP Impurity D) Iopromide EP Impurity D (Mixture of Diastereomers) 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[[3-[[3-[[(2,3-dihydroxypropyl)methylamino]carbonyl]-2,4,6-triiodo-5-[(methoxyacetyl)amino]benzoyl]amino]-2-hydroxypropyl](methoxyacetyl)amino]-2,4,6-triiodo-N-methyl- (9CI) N-(2,3-Dihydroxypropyl)-N''-[3-[[3-[(2,3-dihydroxypropyl)carbamoyl]-5-[(2,3-dihydroxypropyl)methylcarbamoyl]-2,4,6-triiodophenyl](methoxyacetyl)amino]-2-hydroxypropyl]-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methylbenzene-1,3-dicarboxamide | Iopromide impurity |
| 801 | 1246929-02-1 | Eltrombopag Impurity 1 | ltrombopag Impurity 5 Eltrombopag Impurity 1 ELTROMBOPAG AMIDE IMPURITY DFBZGRQMLLZKDA-SLMZUGIISA-N (Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxamide (Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H- pyrazol-4-ylidene)hydrazineyl)-2'-hydroxy-[1,1'-biphenyl]-3- carboxamide [1,1'-Biphenyl]-3-carboxamide, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy- | Eltropaolamine;Impurity control substance;Control substance-impurity control substance |
| 802 | 132810-87-8 | Blonanserin Impurity 10 | BlonserinImpurity9 Blonanserin Impurity 10 4-(4-chlorophenyl)-2-(4-ethylpiperazin-1-yl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine N1-ethyl-N1-(4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2-yl)ethane-1,2-diamine | Control;248-bunanserin |
| 803 | 185613-71-2 | Betamethasone EP Impurity H | Betamethasone EP Impurity H 9-Desfluoro-14-fluoro Betamethasone 9-Desfluoro-14-fluoro Betamethasone DISCONTINUED | Betamethasone EP impurity;Control-impurities control |
| 804 | 99807-54-2 | Loxoprofen Impurity 18 | Loxoprofen Impurity 18 methyl 2-(4-(bromomethyl)phenyl)propanoate 4-(Bromomethyl)-α-methyl-benzeneacetic Acid Methyl Ester Benzeneacetic acid, 4-(bromomethyl)-α-methyl-, methyl ester | Control-impurity control |
| 805 | 2001051-99-4 | Isavuconazole Impurity 2 | Isavuconazole Impurity 2 1H-1,2,4-Triazole-1-butanenitrile, β-(2,5-difluorophenyl)-β-hydroxy-α-methyl-, (αS,βS)- | Isaconazole impurity;Control-impurity control |
| 806 | 142713-08-4 | Lidocaine EP Impurity F | Lidocaine-008 Lidocaine EP Impurity F 2-(diethylamino)-N-(2,3-dimethylphenyl)acetamide Acetamide, 2-(diethylamino)-N-(2,3-dimethylphenyl)- | Impurity;Drug impurity;Impurity control |
| 807 | 2072867-07-1 | Sitagliptin Impurity 14 | Sitagliptin Impurity 14 Sitagliptin Impurity 18 HCl (R)-3-amino-N-((R)-4-oxo-4-(3-(trifluoromethyl) 3-Amino-4-(2,4,5-trifluorophenyl)butanyl Sitagliptin (R)-3-amino-N-((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)-4-(2,4,5-trifluorophenyl)butanamide Benzenebutanamide, β-amino-N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-2,4,5-trifluoro-, (βR)- | Control-impurity control |
| 808 | 1496712-39-0 | Saxagliptin Impurity 15 | Saxagliptin Impurity 15 Saxagliptin Amide Impurity Saxagliptin Impurity 15 HCl Saxagliptin Impurity 19(BMS-554083) (1S,3S,5S)-2-((S)-2-amino-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide 2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- | Impurity control |
| 809 | 63235-39-2 | Procaterol Impurity 4 | Procaterol Impurity 4 8-hydroxy-5-(2-(isopropylamino)butanoyl)quinolin-2(1H)-one 2(1H)-Quinolinone, 8-hydroxy-5-[2-[(1-methylethyl)amino]-1-oxobutyl]- | Impurity control |
| 810 | 903563-43-9 | N-(5-Formyl-2-hydroxyphenyl)formamide | Formoterol Impurity 9 Formoterol Impurity 38 N-(5-Formyl-2-hydroxyphenyl)formamide (R)-N-(2-hydroxy-5-(2-((1-(4-methoxyphenyl)propan-2-yl)amino)vinyl)phenyl)formamide | 190-Formoterol |
| 811 | 1176988-44-5 | Isavuconazole Impurity 24 | Isavuconazole Impurity 24 | Isaconazole impurity |
| 812 | 1092578-43-2 | Tofacitinib impurity T | Tofacitinib-22 Tofacitinib impurity T Azilsartan medoxomil impurity335 2-cyano-N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)acetamide Acetamide, 2-cyano-N-methyl-N-[(3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-piperidinyl]- | Impurity control;Tofacitinib impurity |
| 813 | 1902957-95-2 | Posaconazole Impurity 50 | Posaconazole Impurity 50 Posaconazole Impurity YH3 Posaconazole Impurities16 posaconazoleN-Oxide impurity Posaconazole Dioxido Impurity posaconazole N-Oxide impurity 1 1-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-4-(4-(1-((2S,3R)-2-hydroxypentan-3-yl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)phenyl)piperazine 1,4-dioxide D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1,4-dioxido-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)- | Posaconazole;Impurity control;107-posaconazole;Control-impurity control |
| 814 | 142274-07-5 | Oxiracetam Impurity I | Oxiracetam Impurity I 1H-Pyrrole-1-acetic acid, 2,5-dihydro-4-methoxy-2-oxo- | |
| 815 | 114709-68-1 | Nifedipine Impurity J | Nifedipine Monoamide Nifedipine Impurity J Nifedipine EP Impurity E Nifedipine Amide Impurity XWBOVLISSVULHY-UHFFFAOYSA-N methyl 5-carbamoyl-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3-carboxylate 3-Pyridinecarboxylic acid, 5-(aminocarbonyl)-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl ester 5-(Aminocarbonyl)-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3-pyridinecarboxylic Acid Methyl Ester, Nifedipine Impurity 1 | Control-impurity control |
| 816 | 1429636-72-5 | Doxofylline Impurity 6 | Doxofylline Impurity 9 Doxofylline Impurity 6 Doxofylline Impurity 12 Theophylline impurities822 Doxofylline 2,2-Dimethoxyethyl 7-(2,2-dimethoxyethyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione 7-(2,2-dimethoxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione 1H-Purine-2,6-dione, 7-(2,2-dimethoxyethyl)-3,7-dihydro-1,3-dimethyl- | Doxofylline;Impurity control substance;Control substance-impurity control substance |
| 817 | 526204-10-4 | Ciprofloxacin Impurity D HCl | Ciprofloxacin EP Imp D Ciprofloxacin Impurity 24 Ciprofloxacin Impurity D HCl Ciprofloxacin EP Impurity D HCl Ciprofloxacin impurity D hydrochloride | |
| 818 | 357189-96-9 | Posaconazole Impurity 42 | Posaconazole Impurity 42 Posaconazole Desethylene Monoformyl Impurity N-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl) D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[[2-[[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]amino]ethyl]formylamino]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)- | Control-impurity control |
| 819 | 1042398-26-4 | Posaconazole Impurity 25 | Posaconazole Impurity 25 Posaconazole Impurity 131 4-(2,4-difluorophenyl)pent-4-enoic acid ((3S,5R)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydrofuran-3-yl) methyl isobutyrate (3S,5R)-5-(2,4-Difluorophenyl)-5-(iodomethyl)tetrahydro-3- furanyl]methyl 2-methylpropionate Propanoic acid, 2-methyl-, [(3S,5R)-5-(2,4-difluorophenyl)tetrahydro-5-(iodomethyl)-3-furanyl]methyl ester ((3S,5R)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydrofuran-3-yl) methyl isobutyrate with ((3S,5S)-5-(2,4-difluorophenyl)-5-(iodomethyl)tetrahydrofuran-3-yl) methyl isobutyrate | Posaconazole;107-posaconazole;Control-impurity control |
| 820 | 1005410-32-1 | Methylnaltrexone Bromide Impurity 4 | MethylltrexoneQuinoneImpurity Methylnaltrexone Bromide Impurity 4 | |
| 821 | 909279-46-5 | Levothyroxine Impurity 16 | Levothyroxine Impurity 3 Levothyroxine Impurity 4 Levothyroxine Impurity 16 Levothyroxine Impurity 10 Monochlorotriiodothyronine Levothyroxine?Monochloro Impurity 3-Chloro-3',5,5'-triiodo-L-thyronine 3-CHLORO-3',5,5'-TRIIODO-L-THYRONINE (2S)-2-amino-3-[3-chloro-4-(4-hydroxy-3,5-diiodophenoxy)-5-iodophenyl]propanoic acid | Impurity control |
| 822 | 1379292-16-6 | Cefradine impurity 5 | Cefradine impurity 5 Cefradine Impurity 3 Cefradine Impurity 3 HCl 1-Cyclohexene-1-acetic acid, α-amino-α-methyl-, methyl ester Cefradine Impurity 3 (2-Amino-2-Cyclohex-1-enyl-Propionic Acid Methyl Ester) Hydrochloride | Control-impurity control |
| 823 | 1947364-12-6 | Cefamandole Impurity A | Cefamandole Impurity A Cefamandole EP Impurity A Cefamandole EP Impurity C (Na) Cefamandole EP Impurity A(Triethylamine Salt) Cefamandole Impurity 1(Cefamandole EP Impurity A) 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-methyl-8-oxo-, (6R,7R)- | Control-impurity control |
| 824 | 185613-69-8 | Betamethasone EP Impurity I | Betamethasone EP Impurity I 9-Desfluoro-8-fluoro Betamethasone 9-Desfluoro-8-fluoro Betamethasone DISCONTINUED Pregna-1,4-diene-3,20-dione, 8-fluoro-11,17,21-trihydroxy-16-methyl-, (8α,9β,11β,16β)- (9CI) (8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | Betamethasone EP impurity |
| 825 | 189264-04-8 | Argatroban Impurity 6 | (2R,4S)-Argatroban Argatroban Impurity 6 Argatroban-2R,4S-Isomer Argatroban (L,2R,4S)-Isomer (2R, 4S)-1-(2S)- Argatroban Argatroban Impurity 6 ( (Mixture of Diastereomers) Argatroban (L,2R,4S)-Isomer (Mixture of Diastereomers) (2R,4S)-4-methyl-1-(((3-methyl-1,2,3,4-tetrahydroquinolin-8-yl) sulfonyl)-L-arginyl)piperidine-2-carboxylic acid 2-Piperidinecarboxylic acid, 1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-, (2R,4S)- | 065-Argatroban;Impurity control |
| 826 | 934540-48-4 | Aprepitant Impurity 22 | Aprepitant Impurity 22 (6R)-6-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3,6-dihydro-2H-1,4-oxazine | Control-impurity control |
| 827 | 1206456-44-1 | Olopatadine Isopropyl ester Hydrochloride | Olopatadine Impurity 7 Olopatadine Isopropyl Este Olopatadine Isopropyl ester Olopatadine (E)-Isopropyl ester Olopatadine Isopropyl ester Hydrochloride (Z)-Isopropyl 2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)Acetate Dibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, 1-methylethyl ester, (11Z)- | 148-olopatadine;Control-impurities control |
| 828 | 116384-54-4 | Adefovir Dipivoxil Impurity E | Adefovir Impurity 32 Adefovir Dipivoxil Impurity E Adefovir Dipivoxyl Impurity E Adefovir Dipivoxil Impurity 16 Adefovir Dipivoxil Impurity 33 ethyl hydrogen ((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphonate Phosphonic acid, P-[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-, monoethyl ester | |
| 829 | 869113-45-1 | Umeclidinium Impurity 3 | Umeclidinium Impurity 3 UmeclidiniumBromideImpurity4Bromide 1-(2-(benzoyloxy)ethyl)-4-(hydroxydiphenylmethyl)quinuclidin-1-ium bromide | |
| 830 | 1821520-42-6 | Trelagliptin Impurity 20 | Trelagliptin Impurity 20 Trelagliptin Impurity 20 HCl Acetamide, N-[(3R)-1-[3-[(2-cyano-5-fluorophenyl)methyl]-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]-3-piperidinyl]- | Control-impurity control |
| 831 | 809285-09-4 | Tamoxifen EP Impurity H | Tamoxifen EP Impurity H CAAILVUTOAUEHL-UHFFFAOYSA-N Tamoxifen citrate impurity H | Impurity control |
| 832 | 42459-30-3 | Lidocaine EP Impurity G | Lidocaine-010 Lidocaine EP Impurity G Lidocaine Impurity G(EP) N-(2,6-dimethylphenyl)-2-(isopropylamino)acetamide N-(2,6-dimethylphenyl)-2-(propan-2-ylamino)acetamide N-(2,6-dimethylphenyl)-2-((1-methylethyl)amino)acetamide, Acetamide, N-(2,6-dimethylphenyl)-2-[(1-methylethyl)amino]- | Impurities;Lidocaine impurities |
| 833 | 1276666-19-3 | Suvorexant Impurity 2 | MK-4305Impurity2 Suvorexant Impurity A Suvorexant Impurity 2 (R)-(4-(5-chlorobenzo[d]oxazol-2-yl)-5-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone Methanone, [(5R)-4-(5-chloro-2-benzoxazolyl)hexahydro-5-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]- | Impurity control |
| 834 | 1346599-85-6 | Esomeprazole Impurity 3 | JNKX-Omeprazole-001 someprazole Impurity 20 Esomeprazole Impurity 3 Esomeprazole Impurity 20 N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole DISCONTINUED. Please see M262313 Mixture of N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole and N'-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole 1H-Benzimidazole, 5-methoxy-1-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- 6-Methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole 5-METHOXY-1-((4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHYL)-2-(((4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZO[D]IMIDAZOLE | Control-impurity control |
| 835 | 1809224-82-5 | Dexamethasone EP Impurity K | Dexamethasone EP Impurity K Pregna-1,4,7,9(11)-tetraene-3,20-dione, 17,21-dihydroxy-16-methyl-, (16α)- (10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-12,14,15,16-tetrahydro-6H-cyclopenta[a]phenanthren-3-one | Dexamethasone impurity |
| 836 | 1147937-31-2 | Pramipexole Dimer Impurity (Mixture of Diastereomers) | N6-Propyl pramipexole (S)-Propyl Pramipexole Pramipexole Dimer Impurity (Mixture of Diastereomers) 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6,N6-dipropyl-, (6S)- | Control-impurity control |
| 837 | 330157-04-5 | Betamethasone EP Impurity F | Betamethasone EP Impurity F 9-Desfluoro-11-deshydroxy-11,12-dehydro Betamethasone 17,21-Dihydroxy-16β-methylpregna-1,4,11-triene-3,20-dione Pregna-1,4,11-triene-3,20-dione, 17,21-dihydroxy-16-methyl-, (16β)- (9CI) | Betamethasone EP impurity |
| 838 | 94975-84-5 | Argatroban Impurity 13 | Argatroban Impurity 13 3-methylquinoline-5-sulfonyl chloride 5-Quinolinesulfonyl chloride, 3-methyl- | Impurity control |
| 839 | 31785-64-5 | Lidocaine EP Impurity | Lidocaine-017-HCl Lidocaine Impurity 19 Lidocaine EP Impurity | Control-impurity control |
| 840 | 1333998-27-8 | Aprepitant Impurity 17 | Aprepitant Impurity 17 Aprepitant Impurity 8 HCl Fosaprepitant Impurity 9 HCl Aprepitant Impurity SM3FDY3-2 Aprepitant Impurity SM3FDY3-2 HCl Fosaprepitant Morpholine Hydrochloride Aprepitant M2 Metabolite (1S, 2S, 3S)-Isomer (2S,3S)-2-((1S)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluoro phenyl)morpholine | Control-impurity control |
| 841 | 1026461-20-0 | Indacaterol Impurity 12 | indacaterol742 Indacaterol Impurity 12 5-((1R)-2-((5-ethyl-2,3-dihydro-1H-inden-2-yl)amino)-1- hydroxyethyl)-8-hydroxyquinolin-2(1H)-one fumarate | 111-indacaterol;Indacaterol maleate impurity |
| 842 | 47493-14-1 | Hydroxychloroquine Impurity 7 | YEVQTWFAUWKTAU-UHFFFAOYSA-N Hydroxychloroquine Impurity 7 Hydroxychloroquine Impurity H Hydroxychloroquine Sulfate Impurity 14 2-((4-((7-chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethyl acetate 1-acetoxy-2-{[4-(7-chloro-quinolin-4-ylamino)-pentyl]-ethyl-amino}-ethane Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-, 1-acetate | Control-impurity control |
| 843 | 172822-01-4 | Fosaprepitant Impurity 1 | Fosaprepitant Impurity 1 Fosaprepitant Dimeglumine (1R,2S,3S) isomer (3-(((2S,3S)-2-((R)-1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic Acid Phosphonic acid, [3-[[(2S,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]- (9CI) | Control-impurity control |
| 844 | 1418224-75-5 | Cefathiamidine Impurity 4 | Cefathiamidine Impurity 4 Des-(E)-N,N'-diisopropylcarbamimidothioic acid 2-bromo desacetate hydroxy Cefathiamidine 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(2-bromoacetyl)amino]-3-(hydroxymethyl)-8-oxo-, (6R,7R)- | Impurity control |
| 845 | 84499-64-9 | Valaciclovir EP Impurity H | Valaciclovir Impurity H Valacyclovir Impurity 22 Valacyclovir EP Impurity H Valaciclovir EP Impurity H Valacyclovir Impurity H (EP) Valaciclovir EP Impurity H HCl 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-aminopropanoate L-Alanine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester | Chemical raw materials |
| 846 | 158636-97-6 | Timolol EP Impurity H | Timolol EP Impurity H Timolol EP Impurity H HCl 1-(2-(tert-Butylamino)-2-hydroxyethyl)-4-morpholino-1H-imidazol-5(2H)-one 2-[3-(tert-butylamino)-2-hydroxypropyl]-4-morpholin-4-yl-1,2,5-thiadiazol-3-one 1,2,5-Thiadiazol-3(2H)-one, 2-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl]-4-(4-morpholinyl)- | Timolol impurity;Impurity control |
| 847 | 1244022-55-6 | Tenofovir Impurity W | Tenofovir Impurity W Tenofovir impurity 89 ((hydroxy((((R)-1-(6-((hydroxymethyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl) phosphoryl)oxy)methyl isopropyl carbonate 2,4,7-Trioxa-5-phosphanonanoic acid, 5-hydroxy-9-[6-[(hydroxymethyl)amino]-9H-purin-9-yl]-8-methyl-, 1-methylethyl ester, 5-oxide, (8R)- | Impurity control |
| 848 | 1902954-05-5 | Posaconazole Impurity 49 | Posaconazole Impurity 49 Posaconazole Impurities17 Posaconazole Impurity YH1 Posaconazole 4-Oxido Impurity posaconazole N-Oxide impurity 2 1-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)- 1-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-4-(4-(1-((2S,3S)-2-hydroxypentan-3-yl)-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)phenyl)piperazine 1-oxide D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-oxido-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)- | Posaconazole;Impurity control;107-posaconazole;Control-impurity control |
| 849 | 74936-71-3 | Nifedipine Impurity H | Nifedipine Impurity H Azilsartan medoxomil impurity303 5-(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydrop 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3-methyl ester 1,?4-?Dihydro-?2,?6-?dimethyl-?4-?(2-?nitrophenyl)?-?3,?5-?pyridinedicarboxylic Acid 3-?Methyl Ester | Nifedipine |
| 850 | 105279-16-1 | Azelastine EP Impurity E | Azelastine EP Impurity E (Z)-3-(4-Chlorobenzylidene)isobenzo Azelastine EP Impurity E (Z-Isomer) Azelastine Hydrochloride Impurity E as Z-Isomer Azelastine Hydrochloride EP Impurity E as Z-Isomer 1(3H)-Isobenzofuranone, 3-[(4-chlorophenyl)methylene]-, (3Z)- | Azelastine impurity |
| 851 | 70336-49-1 | Lidocaine Impurity | Lidocaine-018 Lidocaine Impurity Lidocaine Impurity 2 Lidocaine Impurity 20 1,4-bis(2,6-dimethylphenyl)piperazine-2,5-dione 2,5-Piperazinedione, 1,4-bis(2,6-dimethylphenyl)- | Drug impurity |
| 852 | 959392-22-4 | (S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride | Duloxetine-7 Duloxetine impurity F Duloxetine EP Impurity F HCl (3S)-N-Methyl-γ-(1-naphthalenyloxy)-3-thiophenepropanamine 3-Thiophenepropanamine, N-methyl-γ-(1-naphthalenyloxy)-, (γS) (S)-(+)-N-methyl-3-(1-naphthalenyloxy)-3-(3-thienyl)propanamine (S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride | Standard;Impurity control;Duloxetine impurity;Control-impurity control |
| 853 | 740777-60-0 | Mivacurium Chloride Impurity 3 | Mivacurium Chloride Impurity 3 | Control-impurity control |
| 854 | 1872435-00-1 | Leuprorelin EP Impurity F | Leuprolide EP Impurity F Leuprorelin EP Impurity F D-His2, D-Ser4 Leuprolide [2-D-Histidine,4-D-serine]leuprorelin Leuprolide (Leuprorelin) EP Impurity F L-Prolinamide, 5-oxo-L-prolyl-D-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl- (S)-N-Ethyl-1-(((S)-5-oxopyrrolidine-2-carbonyl)-D-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl)pyrrolidine-2-carboxamide | Control-impurity control |
| 855 | 154361-54-3 | Iopromide EP Impurity F | iopromide impurity42 Iopromide Impurity 13 Iopromide EP Impurity F Iopromide Impurity 6 (Iopromide EP Impurity F) Iopromide EP Impurity F (Mixture of Diastereomers) N′-(2,3-dihydroxypropyl)-N-[[2-(hydroxymethyl)- 2-methyl-1,3-dioxolan-4-yl]methyl]-2,4,6-triiodo- 5-[(methoxyacetyl)amino]-N-methylbenzene-1,3- dicarboxamide 1,3-Benzenedicarboxamide, N3-(2,3-dihydroxypropyl)-N1-[[2-(hydroxymethyl)-2-methyl-1,3-dioxolan-4-yl]methyl]-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl- | 184-iopromide;Iopromide impurity |
| 856 | 89878-72-8 | Ibuprofen Impurity 59 | Ibuprofen Impurity 59 2-(1-chloroethyl)-2-(4-isobutylphenyl)-5,5-dimethyl-1,3-dioxane 1,3-Dioxane, 2-(1-chloroethyl)-5,5-dimethyl-2-[4-(2-methylpropyl)phenyl]- | |
| 857 | 1422063-97-5 | Esomeprazole Impurity 23 | Esomeprazole Impurity 23 2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazol-5-ol 1H-Benzimidazole, 2-[[[3,5-dimethyl-4-(methylsulfonyl)-2-pyridinyl]methyl]thio]-6-methoxy- | Esomeprazole;Impurity control;Control-impurity control |
| 858 | 710307-89-4 | Edaravone Impurity 10 | Edaravone Impurity 10 Edaravone impurity PBH 3-oxo-N'-phenylbutanehydrazide 3-Oxo-butyric acid N'-phenyl-hydrazide Butanoic acid, 3-oxo-, 2-phenylhydrazide | Standard;Impurity control;Control-impurity control |
| 859 | 188659-43-0 | Argatroban Impurity 7 | Argatroban-2 Agatroban Impurity 1 Argatroban Impurity E Argatroban Impurity 7 Argatroban Impurity 1 (Mixture of Diastereomers) Argatroban Impurity B (Mixture of Diastereomers) (2R,4R)-1-((2S)-5-amino-2-((3-methyl-1,2,3,4-tetrahydroquinoline)-8-sulfomido)pentanoyl)-4-methylpiperidine-2-carboxylic acid (2R,4R)-4-methyl-1-[(2S)-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sμlfonamido) -5-ureidopentanoyl]piperidine-2-carboxylic acid | Impurity control |
| 860 | 1984788-96-6 | 2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one | Entecavir EP Impurity Entecavir USP Impurity A 2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one 6H-Purin-6-one, 2-amino-9-[(3aS,4S,6S,6aR)-hexahydro-3a,6-dihydroxy-1H-cyclopenta[c]furan-4-yl]-1,9-dihydro- | Standard;Entecavir impurity |
| 861 | 1346918-32-8 | Tirofiban Impurity 3 | Tirofiban Impurity 3 Tirofiban Impurity 47 D-Tyrosine, N-(butylsulfonyl)- Tirofiban hydrochloride monohydrate Impurity 5 (R)-2-(butylsulfonamido)-3-(4-hydroxyphenyl)propanoic acid (S)-2-(methylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid hydrochloride | Tirofiban;Impurity control substance;Control substance-impurity control substance |
| 862 | 1229428-91-4 | Posaconazole Impurity 20 | PosacozoleImpurity23 Posacozole Impurity 20 Posaconazole Impurity 20 posaconazole impurity-91-4 Posaconazole Impurity(R,S,S,R) D-erythro-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2R)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)- | Posaconazole;Drug impurity;Impurity control substance;Control substance-impurity control substance |
| 863 | 501093-49-8 | Parecoxib Sodium Impurity H | Parecoxib Impurity 7 Parecoxib Sodium Impurity H Parecoxib Sodium Impurity 83 Benzenesulfonamide, N-hydroxy-4-(5-methyl-3-phenyl-4-isoxazolyl)- N-hydroxy-4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide | Impurity control article;Control article-impurity control article |
| 864 | 2028267-73-2 | N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide | Tofacitinib-23 Tofacitinib N-Oxide Tofacitib related impurities 8 N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide 1-Piperidinepropanenitrile, 4-methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R) 3,3'-((3R,3'R,4R,4'R)-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis (methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxo propanenitrile) | Tofacitinib;076 tofacitinib;Impurity control;Tofacitinib impurity |
| 865 | 1448355-87-0 | 4-(4-chlorophenyl)-5-methyl-3-phenylisoxazole | Parecoxib Sodium-29 Parecoxib Impurity 49 Parecoxib Sodium Impurity 82 4-(4-chlorophenyl)-5-methyl-3-phenylisoxazole | Impurity control;Parecoxib sodium impurity |
| 866 | 295357-72-1 | Lenalidomide Impurity 12 | Lenalidomide Impurity 47 Lenalidomide Impurity 12 2-(4-nitro-1-oxoisoindolin-2-yl)glutaric acid | Drug impurity control |
| 867 | 2094559-58-5 | Brexpiprazole Impurity 2 | Brexpiprazole-imJ Epipiprazole Impurity 15 Brexpiprazole Impurity 2 7-[4-[4-(Benzothiophen-4-yl)piperazin-1-yl]butoxy]-1-[4-[(2-oxo-1H-quinolin-7-yl)oxy]butyl]quinolin-2-one 2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-1-[4-[(1,2-dihydro-2-oxo-7-quinolinyl)oxy]butyl]- | Impurity control;Elipizole impurity |
| 868 | 2116542-19-7 | 7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) | Brexpiprazole Dimer Epipiprazole Impurity 9 Brexpiprazole Butoxydimer Impurity Brexpiprazole Piprazine Butoxydimer Impurity 7,7'-[(1,4-Butanediyl)bis(oxy)]bis-2(1H)-quinolinone 7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) 2(1H)-Quinolinone, 7,7'-[(1,4-butanediyl)bis(oxy)]bis- 7,7'-[(1,4-BUTANEDIYL)BIS(OXY)]BIS-2(1H)QUINOLINONE (DIMER IMPURITY) | Impurity control article;Control article-impurity control article |
| 869 | 1829588-57-9 | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- | Sildenafil-003 SildefilImpurity13 Sildenafil Impurity U 5-(5-chloro-2-ethoxyphenyl)-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one 5-(5-chloro-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- | Impurity control |
| 870 | 2138169-93-2 | Brexpiprazole Impurity | Brexpiprazole Impurity Epipiprazole Impurity 33 Brexpiprazole Impurity 33 2,7-Bis[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-quinoline 2,7-bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinoline 2,7-bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinoline dihydrochloride | 174-eplipizole |
| 871 | 2143944-64-1 | 8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride | Brexpiprazole-imO Brexpiprazole Impurity 32 Brexpiprazole Impurity 25 Brexpiprazole Impurity BPCL Brexpiprazole Impurity 32 Chloride 8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium bromide 8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride 8-?Benzo[b]?thien-?4-?yl-5,?8-?diazaspiro[4.5]?decan-?5-?ium Hydroxide | 174-epizole;Impurity control |
| 872 | 10184-69-7 | Prednisone impurity D (EP) | Deltacortinene Prednisone impurity D Prednisone EP Impurity D Prednisone impurity D (EP) | |
| 873 | 1500558-49-5 | Gabapentin EP Impurity G | Gabapentin impurity G Gabapentin EP Impurity G Gabapentin impurity G (EP) Gabapentin Impurity 6(Gabapentin EP Impurity G) | Control substance;Analytical reagent-chemical analysis;Control substance-impurity control substance |
| 874 | 1879903-65-7 | (R)-5-chloro-N-(4-(3-oxomorpholino)phenyl)-N- ((2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide | Rivaroxaban-18 Rivaroxaban Impurity 92 Rivaroxaban Impurity 126 Rivaroxaban Impurities26 Rivaroxaban Impurities353 (R)-5-chloro-N-(4-(3-oxomorpholino)phenyl)-N- ((2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide 2-Thiophenecarboxamide, 5-chloro-N-[4-(3-oxo-4-morpholinyl)phenyl]-N-[[(5R)-2-oxo-5-oxazolidinyl]methyl]- | Impurity control;Rivaroxaban impurity;Control-impurity control |
| 875 | 19666-03-6 | 2-butyrylbenzoic acid | n-Butylphthalide-003 2-butyrylbenzoic acid 2-Butanoylbenzoic acid Butyphthalide impurity5 Butylphthalide Impurity 37 3-Butylphthalide Impurity 3 3-Butylphthalide Impurity 2i | Drug impurity;Impurity control |
| 876 | 54088-21-0 | 3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)-rel- | 3-Piperidinemethanol, 4-(4-fluorophenyl)-1-methyl-, (3R,4R)-rel- ((3RS,4RS)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol hydrochloride | 106-Paroxetine |
| 877 | 111943-62-5 | 3-pentylisobenzofuran-1(3H)-one | n-Butylphthalide-005 Butyphthalide impurity2 3-Butylphthalide Impurity D 3-Butylphthalide Impurity 6 3-pentyl-3H-2-benzofuran-1-one 3-pentylbenzo[c]furan-1(3H)-one 3-pentylisobenzofuran-1(3H)-one 3-Pentyl-2-benzofuran-1(3H)-one | Impurity control |
| 878 | 80047-38-7 | 2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid | Milrinone Impurities3 5-Decyano 5-Carboxymilrinone 6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carboxylic acid 2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid [3,4'-Bipyridine]-5-carboxylic acid, 1,6-dihydro-2-methyl-6-oxo- | Control-impurity control |
| 879 | 95716-69-1 | (1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-
((trimethylsilyl)oxy)hept-3-en-2-yl)-7a-
methyloctahydro-4H-inden-4-one | Paricalcitol-10 Paricalcitol Impurity 11 Paricalcitol Intermediate CD (1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyl-octahydroinden-4-one (1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((trimethylsilyl)oxy)hept-3-en-2-yl)-7a- methyloctahydro-4H-inden-4-one | |
| 880 | 1884139-61-0 | (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy-
5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-
inden-4-ylidene)ethylidene)cyclohexane-1,3-diol | Paricalcitol-12 (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy- 5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H- inden-4-ylidene)ethylidene)cyclohexane-1,3-dio (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy- 5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H- inden-4-ylidene)ethylidene)cyclohexane-1,3-diol | |
| 881 | 2036283-13-1 | 2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid | Mirabelon-6 Mirabegron Impurities2 Azilsartan medoxomil impurity293 2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid 4-Thiazoleacetic acid, 2-[[2-(2-amino-4-thiazolyl)acetyl]amino]- N-(4-(2-amino-2-oxoethyl)thiazol-2-yl)-2-(2-aminothiazol-4-yl) acetamide | Impurity control |
| 882 | 857538-11-5 | 2-hexanoylbenzoic acid | n-Butylphthalide-004 2-hexanoylbenzoic acid Butyphthalide impurity6 2-(1-Oxohexyl)benzoic acid 3-Butylphthalide Impurity 4 3-Butylphthalide Impurity 2j Benzoic acid, 2-(1-oxohexyl)- | Impurity control |
| 883 | 142838-82-2 | Blonanserin N-Oxide | BlonserinImpurity12 Blonanserin N-Oxide Cycloocta[b]pyridine, 2-(4-ethyl-4-oxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- | Control substance;Impurity control substance;Control substance-impurity control substance |
| 884 | 1796545-19-1 | Tenofovir impurity E | Tenofovir ethyl Ethyl Tenofovir Tenofovir impurity E Tenofovir alafenamide-26 EthylTenofovirAmmoniumSalt RKTDGEHXFPNCDC-MRVPVSSYSA-N ethyl hydrogen ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, monoethyl ester | Impurity control;Control-impurity control;Tenofovir alafenamine impurity;Chemical impurity-tenofovir dipivoxil |
| 885 | 56796-19-1 | Cefmetazole impurity | Cefmetazole impurity Cefmetazole impurity L Cefmetazole sodium Impurity 18 Benzhydryl (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[2-[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, diphenylmethyl ester, (6R,7S)- | Impurities |
| 886 | 17475-41-1 | 3-ethylisobenzofuran-1(3H)-one | n-Butylphthalide-008 Butyphthalide impurity8 Butylphthalide Impurity 8 Butylphthalide Impurity 30 3-Butylphthalide Impurity B 3-Butylphthalide Impurity 7 3-ethylisobenzofuran-1(3H)-one 1(3H)-Isobenzofuranone, 3-ethyl- | Impurity control |
| 887 | 138998-47-7 | Levofloxacin Impurity 18 | Levofloxacin Impurity 18 Levofloxacin acylate impurities Levofloxacin acylate impurities826 3-dimethylamino-2 - (2,3,4, 5-tetrafluorbenzoyl) -ethyl acrylate ethyl (Z)-3-(dimethylamino)-2-(2,3,4,5-tetrafluorobenzoyl)acrylate α-[(Dimethylamino)methylene]-2,3,4,5-tetrafluoro-β-oxo-benzenepropanoic Acid Ethyl Ester Benzenepropanoic acid, α-[(dimethylamino)methylene]-2,3,4,5-tetrafluoro-β-oxo-, ethyl ester Levofloxacin α-[(Dimethylamino)methylene]-2,3,4,5-tetrafluoro-β-oxo-benzenepropanoic Acid Ethyl Ester | Impurity world-levofloxacin |
| 888 | 1346600-77-8 | Venlafaxine Impurity 5 | Venlafaxine Impurity 5 Venlafaxine Impurity 23 ethyl 3-(dimethylamino)-2-(4-hydroxyphenyl)propanoate | |
| 889 | 1251905-45-9 | Solifenacin Related Compound 13 | Solifenacin Related Compound 13 Solifenacin Methyl Ester Impurity (S)-methyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate Methyl (1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate methyl (S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, methyl ester, (1S)- | 215-solifenacin |
| 890 | 503834-41-1 | Paroxetine EP Impurity H HCl | Paroxetine EP Impurity H HCl Paroxetine hydrochloride EP impurity H Paroxetine Hydrochloride Anhydrous EP Impurity H | Paroxetine impurity |
| 891 | 327623-34-7 | Fosaprepitant Impurity 6 | 2S3S-S Fosaprepitant Fosaprepitant Impurity 6 (S)-4-benzyl-2-((S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)morpholin-3-one 3-Morpholinone, 2-[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(phenylmethyl)-, (2S)- | Control-impurity control |
| 892 | 1951467-29-0 | Canagliflozin Impurity 18 | Cagliflozin 18 Canagliflozin-3 Canagliflozin Impurity 18 Canagliflozin Impurity 38 Cagliflozin Impurity 18 (Mixture of Diastereomers) Canagliflozin Impurity 18 (Mixture of Diastereomers) D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]hydroxymethyl]-4-methylphenyl]-, (1S)- (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)(hydroxy)methyl)-4-methylphenyl)-6-(hydroxymethyl) tetrahydro-2H-pyran-3,4,5-triol | Control-impurity control |
| 893 | 161760-09-4 | Tenofovir Impurity 38 | Tenofovir Impurity 38 Tenofovir Impurity 112 ((Tosyloxy)methyl)phosphonic Acid tosyloxymethylphosphonicacidmonoethylester TOSYLOXYMETHYLPHOSPHONIC ACID MONOETHYL ESTER Phosphonic acid, P-[[[(4-methylphenyl)sulfonyl]oxy]methyl]- | Control-impurity control |
| 894 | 2116542-21-1 | Brexpiprazole Impurity | Brexpiprazole-imK Brexpiprazole Impurity Epipiprazole Impurity 31 Brexpiprazole Impurity 31 O-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole 7-[4-[7-[4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy]quinolin-2-yl]oxybutoxy]-1H-quinolin-2-one 2(1H)-Quinolinone, 7-[4-[[7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-2-quinolinyl]oxy]butoxy]- | Impurity control |
| 895 | 86347-62-8 | 4-(1-(2,3-dimethylphenyl)propyl)-1H-imidazole | Dexmedetomidine-011 Medetomidine Impurity 25 4-(1-(2,3-dimethylphenyl)propyl)-1H-imidazole | Impurity control |
| 896 | 873310-33-9 | Atomoxetine EP Impurity A | Atomoxetine EP Impurity A Atomoxetine EP Impurity A HCl Atomoxetine hydrochloride impurity A Atomoxetine hydrochloride impurities Atomoxetine Hydrochloride EP Impurity A Atomoxetine Impurity 1(Atomoxetine EP Impurity A) N-methyl-3-phenoxy-3-phenyl-propylamine hydrochloride N-methyl-3-phenoxy-3-phenylpropan-1-amine hydrochloride | 238-atomoxetine;Impurity control;Atomoxetine impurity |
| 897 | 2101651-50-5 | 1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide | Riociguat-23 1-(3-fluorobenzyl)-1H-pyrazolo 1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide 1-[(3-Fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide 1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(3-fluorophenyl)methyl]- 1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride | Standard;Liosiq impurity;Reference substance-impurity reference substance |
| 898 | 184972-09-6 | Exemestane impurity B -F | Exemestane impurity B Exemestane impurity B -F Exemestane EP Impurity B Androsta-1,4-diene-3,17-dione, 6-(hydroxymethyl)- Exemestane Related Compound B (6-hydroxymethylandrostra-1,4-diene-3,17-dione) (1269072) | Control-impurity control |
| 899 | 105685-06-1 | 1-(1-BENZOTHIOPHEN-7-YL)PIPERAZINE | Brexpiprazole Impurity 78 Piperazine, 1-benzo[b]thien-7-yl- 1-(1-BENZOTHIOPHEN-7-YL)PIPERAZINE 1-Benzo[b]thiophen-7-yl-piperazine | Impurity control |
| 900 | 812664-93-0 | Pantoprazole Impurity 1 | Pantoprazole-14 Pantoprazole Impurity 1 Pantoprazole Impurity I Pantoprazole Impurity 17 1H-Benzimidazole, 2-[[chloro(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-6-(difluoromethoxy)- 2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5-(difluoromethoxy)-1H-benzo[d]imidazole 2-[[Chloro(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-6-(difluoromethoxy)-1H-benzimidazole Sodium Salt | Control-impurity control |
| 901 | 177472-29-6 | Levofloxacin Impurity 22 | Levofloxacin Impurity 22 3-Quinolinecarboxylic acid, 6,8-difluoro-1,4-dihydro-1-[(1S)-2-hydroxy-1-methylethyl]-7-(4-methyl-1-piperazinyl)-4-oxo-, ethyl ester | Impurity world-levofloxacin |
| 902 | 122497-20-5 | Famciclovir Impurity 12 | Famciclovir Impurity 12 2-[2-(2-Amino-9H-purin-9-yl)ethyl]-propanedioic Acid 1 | Control-impurity control |
| 903 | 691863-84-0 | 3-pentylisoindolin-1-one | n-Butylphthalide-012 Butyphthalide impurity12 3-pentylisoindolin-1-one Butylphthalide Impurity 12 3-Butylphthalide Impurity 12 1H-Isoindol-1-one, 2,3-dihydro-3-pentyl- | Impurity control |
| 904 | 61658-90-0 | ethylidene phthalide | n-Butylphthalide-009 ethylidene phthalide 3-Ethylidenephthalide Butyphthalide impurity9 Butylphthalide Impurity 9 3-Butylphthalide Impurity 9 3-ethylideneisobenzofuran-1(3H)-one | Impurity control |
| 905 | 1818286-63-3 | pre-doxercalciferol | pre-doxercalciferol Cabergoline Impurity 1 Doxercalciferol Impurity 1 4-Methyl trans-Doxercalciferol | |
| 906 | 132015-95-3 | (24R)-paricalcitol | Paricalcitol-9 (24R)-paricalcitol (1R,3R,24R,7E,22E)-19-nor-9,10-secoergosta-5,7,22-trien-1,3,25-triol (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R,E)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4R)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3R)- | |
| 907 | 216161-87-4 | 3α-paricalcitol | 3α-paricalcitol Paricalcitol Impurity 23 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3S)- | |
| 908 | 861996-34-1 | 2β-trans-eldecalcitol | 2β-trans-eldecalcito 2β-trans-eldecalcitol Eldecalcitol Impurity 1 | Control-impurity control |
| 909 | 1818268-45-9 | (5-(4-fluorophenyl)thiophen-2-yl)(5-iodo-2-methylphenyl)methanol | Canagliflozin Impurity 80 (5-(4-fluorophenyl)thiophen-2-yl)(5-iodo-2-methylphenyl)methanol 2-Thiophenemethanol, 5-(4-fluorophenyl)-α-(5-iodo-2-methylphenyl)- | |
| 910 | 1169770-52-8 | 2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5-
dimethylpyrimidine-4,5,6-triamine | Riociguat-18 2-(1-(2-fluorobenzyl)-1H-pyrazolo 2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-N5,N5- dimethylpyrimidine-4,5,6-triamine | Standard |
| 911 | 625115-53-9 | ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate | Riociguat Im Riociguat-16 ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)- ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate | Standard |
| 912 | 14570-43-5 | 2-propyl-1H-indene-1,3(2H)-dione | n-Butylphthalide-017 Butyphthalide impurity17 Butylphthalide Impurity 17 3-Butylphthalide Impurity 16 2-propyl-1H-indene-1,3(2H)-dione 1H-Indene-1,3(2H)-dione, 2-propyl- | Impurity control |
| 913 | 2169996-11-4 | (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido [3,4-b]indole-3-carboxylate methyl | TDF-M2-2JA Tadalafil-009-RR Tadalafil-009-1R,3R Tadalafil Impurity 24 methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido [3,4-b]indole-3-carboxylate methyl 1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-2-[2-(dimethylamino)acetyl]-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)- | Impurity control |
| 914 | 2044709-72-8 | Afatinib Impurity 21 | Afatinib Impurity 21 (S)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine (S)-N4-(3,4-Difluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine 4,6-Quinazolinediamine, N4-(3,4-difluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]- | Control-impurity control |
| 915 | 1378831-29-8 | Sugammadex | Sugammadex Sugammadex Impurity 90 Sugammadex Sodium Impurity 2 3-(3-Mercaptopropanoylthio)propionic Acid 3-((3-Mercaptopropanoyl)thio)propanoic acid Propanoic acid, 3-[(3-mercapto-1-oxopropyl)thio]- 3-(3-Mercaptopropanoylthio)propionic Acid DISCONTINUED, UNSTABLE | Control-impurity control |
| 916 | 1598416-08-0 | (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate | Tadalafil-007-RR Tadalafil-007-1R3R Tadalafil Impurity 22 (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl) -2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2,2-dichloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate 1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-2-(2,2-dichloroacetyl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)- | Impurity control |
| 917 | 63785-59-1 | Diquafosol Impurity 2 | Diquafosol Impurity 2 Diquafosol ImpurityU2P3 Diquafosol Impurity UP3U Diquafosol Impurity 5(UP3U) Diquafosol Sodium Impurity F Uridine 5'-(tetrahydrogen triphosphate), P''→5'-ester with uridine | Standard substance;Impurity control substance;Control substance-impurity control substance |
| 918 | 870695-39-9 | (S)-ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate | Oxiracetam Impurity 23 Oxiracetam impurities1710 Ethyl (S)-2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate (S)-ethyl 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetate (S)-4-hydroxy-2-oxo-1-pyrrolidinacetic acid ethyl ester 1-Pyrrolidineacetic acid, 4-hydroxy-2-oxo-, ethyl ester, (4S)- | Control-impurity control |
| 919 | 1384752-15-1 | (E)-1-(3-chloroallyl)-2-methyl-5-nitro-1H-imidazole | Ornidazole Impurity Ⅶ Ornidazole 3-?Chloro-?2-?propen-?1-?yl 2-Methyl-5-nitroimidazole(Ornidazole Impurity B) (E)-1-(3-chloroallyl)-2-methyl-5-nitro-1H-imidazole 1H-Imidazole, 1-(3-chloro-2-propen-1-yl)-2-methyl-5-nitro- | Impurity control |
| 920 | 142885-95-8 | 2-acetyloxymethyl-3,5-dimethyl-4-nitropyridine | Omeprazole Impurity 56 Esomeprazole Impurity 62 2-acetyloxymethyl-3,5-dimethyl-4-nitropyridine (3,5-dimethyl-4-nitropyridin-2-yl)methyl acetate | |
| 921 | 1393717-46-8 | N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide | m-Ranolazine Meta-Ranolazine Ranolazine Impurity 11 Ranolazine Impurity H Meta Ranolazine Impurity N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(4-methoxyphenoxy)propyl)piperazin-1-yl)acetamide N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(3-methoxyphenoxy)propyl)piperazin-1-yl)acetamide | Impurity control |
| 922 | 1393717-45-7 | N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-1-piperazineacetamide | Para-Ranolazine P-Ranolazine Impurity Ranolazine Impurity I N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-1-piperazineacetamide 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]- | Impurity control |
| 923 | 1314799-74-0 | Valsartan Impurity 10 | Valsartan Impurity 10 Valsartan Decarboxylic Acid N-(2-Methylpropyl)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]pentanamide | Control-impurity control |
| 924 | 66801-40-9 | Olopatadine Impurity 1 | Olopatadine Impurity 1 11-oxo-6,11-dihydrodibenzo[b,e]oxepine-2-carboxylic acid Dibenz[b,e]oxepin-2-carboxylic acid, 6,11-dihydro-11-oxo- | Olopatadine impurity |
| 925 | 166734-80-1 | (R)-Ornidazole | (R)-Ornidazole Ornidazole Impurity 8 1H-Imidazole-1-ethanol, α-(chloromethyl)-2-methyl-5-nitro-, (αR)- | Control-impurity control |
| 926 | 1361569-10-9 | 6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dihydro-8H-purin-8-one | Riociguat-13 Riociguat Impurity I 6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)- 7,9-dihydro-8H-purin-8-one | Standard |
| 927 | 254912-65-7 | KetoconazoleN-Oxide | KetoconazoleN-Oxide Ketoconazole N-Oxide (and enantiomer) Ethanone, 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-oxido-1-piperazinyl]-, rel- | Standard;Impurity control |
| 928 | 2122800-38-6 | Trans-5-(Benzyloxyamino)piperidine-2-carboxylic acid,sodium salt | Avibactam Impurity 36 Trans-5-(Benzyloxyamino)piperidine-2-carboxylic acid,sodium salt | Control-impurity control |
| 929 | 1189547-11-2 | Valsartan Impurity 12 | Valsartan Impurity 12 Methyl pentanoyl-L-valinate (S)-methyl 3-methyl-2-pentanamidobutanoate | Control-impurity control |
| 930 | 1894176-44-3 | rac-Valsartan EP Impurity B | rac-Valsartan EP Impurity B Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl ester | Control-impurity control |
| 931 | 156033-07-7 | Milrinone Impurity 15 | Milinone Impurity B Milrinone Impurities4 Milrinone Impurity 15 [3,4'-Bipyridine]-5-carbonitrile, 1,6-dihydro-2-methyl-6-oxo-, 1'-oxide | Impurity control |
| 932 | 1361569-23-4 | 6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-
7,9-dimethyl-7,9-dihydro-8H-purin-8-one | Riociguat-12 Guanylate cyclase-IN-1 6-amino-2-(1-(2-fluorobenzyl) 6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)- 7,9-dimethyl-7,9-dihydro-8H-purin-8-one 8H-Purin-8-one, 6-amino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-7,9-dihydro-7,9-dimethyl- | Standard;Impurity control |
| 933 | 1255909-25-1 | 1-(3,4-Dimethoxyphenyl)-2-(methylsulfonyl)ethan-1-amine | Apremilast Impurity 36 1-(3,4-dimethoxyphenyl)-2-(methylsulfonyl)ethanamine 1-(3,4-Dimethoxyphenyl)-2-(methylsulfonyl)ethan-1-amine Benzenemethanamine, 3,4-dimethoxy-α-[(methylsulfonyl)methyl]- | Control-impurity control |
| 934 | 915280-81-8 | Celecoxib Impurity | Celebrex O Celecoxib-21 Celecoxib-008 Celecoxib Impurity Celecoxib impurity O Celecoxib Hydraziney 4-(2-(2,2,2-trifluoroacetyl) 4-(2-(2,2,2-trifluoroacetyl)hydrazinyl)benzenesulfonamide Acetic acid, 2,2,2-trifluoro-, 2-[4-(aminosulfonyl)phenyl]hydrazide | Celecoxib;Impurity control;Control-impurity control |
| 935 | 28240-16-6 | Cefathiamidine Impurity 6 | Cefathiamidine Impurity 6 | Impurity control |
| 936 | 1361570-27-5 | methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(ethyl)carbamate | Riociguat-26 Riociguat Impurity 25 trimethyl (2-(1-(2-fluorobenzyl) methyl (4,6-diamino-2-(1-(2-fluorobenzyl) methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(ethyl)carbamate Carbamic acid, N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-ethyl-, methyl ester | Standard substance;Control substance-impurity control substance |
| 937 | 1029684-20-5 | Nebivolol Impurity 3 | Nebivolol Impurity 3 Nebivolol Impurity 27 (S)-(benzylamino)((R)-6-fluorochroman-2-yl)methanol (R)-2-(Benzylamino)-1-((R)-6-fluorochroman-2-yl)ethan-1-ol 2H-1-Benzopyran-2-methanol, 6-fluoro-3,4-dihydro-α-[[(phenylmethyl)amino]methyl]-, (αR,2R)- | |
| 938 | 1882095-50-2 | Ticagrelor impurity | TICAGRELOR-007 Ticagrelor impurity 2,2'-(((3aR,3a'R,4S,4'S,6R,6aS,6'R,6a'S)-6,6'-((5-nitro-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))diethanol | Control-impurity control |
| 939 | 16130-28-2 | Sodium cromoglicate impurity | Cromolyn Impurity 1 Sodium cromoglicate-001 Cromolyn Sodium Impurity 4 Sodium cromoglicate impurity Sodium cromoglicate Impurity A Ethanone, 1-[2-hydroxy-6-(2-oxiranylmethoxy)phenyl]- 5,5'-((2-(3-((2-carboxy-4-oxo-4H-chromen-5-yl)oxy)-2-hydroxypropoxy)propane-1,3-diyl)bis(oxy))bis(4-oxo-4H-chromene-2-carboxylic acid) | Impurity control |
| 940 | 1371615-56-3 | Atorvastatin Impurity F | Atorvastatin Impurity F sodium (3R,5R)-7-((3R,5R)-7- Atorvastatin Sodium Impurity F Atorvastatin EP Impurity F (Na) Atorvastatin Impurity F(Sodium salt) Atorvastatin Impurity F Sodium Salt (Amide Impurity) Atorvastatin EP Impurity F (Amide Impurity) Sodium Salt Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide Sodium Salt | Impurity control |
| 941 | 2093243-16-2 | (Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate | Nintedanib-013-Z Nidanibu Impurity 8 Nintedanib impurities11 (Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate | 050-nintegrob;Chemical reagent;Control substance;Impurity control substance;Control substance-impurity control substance |
| 942 | 1207726-28-0 | Ampicillin | Ampicillin Ampicillin Impurity E(EP) Ampicillinyl-D-phenylglycine (R)-2-((2S,5R,6R)-6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxamido)-2-phenylaceticacid (2R)-2-[[(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carbonyl]amino]-2-phenylacetic acid Benzeneacetic acid, α-[[[(2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]amino]-, (αR)- | Chemical raw materials;Ampicillin superior supply;Impurity reference substance;Chemical impurity-Ampicillin;Ampicillin related impurities;Reference substance-impurity reference substance |
| 943 | 2230270-05-8 | ethyl 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-
carboxylate | Febuxostat-44 ethyl 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5- carboxylate ethyl 2-(3-formyl-4-isopropoxyphenyl)-4-methylthiazole-5- carboxylate | 061-febuxostat;Medical impurity;Impurity reference substance |
| 944 | 117811-11-7 | 8-CHLORO-6-11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO(5,6) | 8-CHLORO-6-11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO(5,6) 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-5-one | 234 desloratadine |
| 945 | 1572439-66-7 | methyl 7-bromo-4-hydroxyisoquinoline-3-carboxylate | Roxadustat Impurity 11 methyl 7-bromo-4-hydroxyisoquinoline-3-carboxylate 3-Isoquinolinecarboxylic acid, 7-bromo-4-hydroxy-, methyl ester | Impurity control |
| 946 | 191977-79-4 | 3,3'-(ethane-1,2-diyl)bis(1-(2-chloroethyl)-1H-benzo[d]imidazol-2(3H)-one) | Flibaserin-007 Flibanserin Impurity 6 3,3'-(ethane-1,2-diyl)bis(1-(2-chloroethyl)-1H-benzo[d]imid... 3,3'-(ethane-1,2-diyl)bis(1-(2-chloroethyl)-1H-benzo[d]imidazol-2(3H)-one) 2H-Benzimidazol-2-one, 1,1'-(1,2-ethanediyl)bis[3-(2-chloroethyl)-1,3-dihydro- | Impurity control |
| 947 | 1226543-90-3 | Terbutaline Impurity | Terbutaline-011 Terbutaline Impurity Terbutaline Impurity 22 Ethanone, 1-[3,5-bis(phenylmethoxy)phenyl]-2-hydroxy- 2,2'-(tert-butylazanediyl)bis(1-(3,5-bis(benzyloxy)phenyl)ethanol) hydrochloride | 105 terbutaline;Impurity control |
| 948 | 2242008-36-0 | Dapoxetine impurity | Dapoxetine-003 Dapoxetine impurity Dapoxetine Impurity 15 3-(4-(3-hydroxy-3-phenylpropoxy)naphthalen-1-yl)-1-phenylpropan-1-one 1-Propanone, 3-[4-(3-hydroxy-3-phenylpropoxy)-1-naphthalenyl]-1-phenyl- | Impurity control |
| 949 | 2242008-38-2 | Dapoxetine impurity | Dapoxetine-002-HCl Dapoxetine impurity Dapoxetine Impurity 6 HCL Dapoxetine Impurity 2 hydrochloride 3-(4-(3-(dimethylamino)-3-phenylpropoxy)naphthalen-1-yl)-1-phenylpropan-1-one hydrochloride | Impurity control |
| 950 | 380905-48-6 | Butylphthalide impurity | dl-PHPB Butyphthalide n-Butylphthalide-025 Butylphthalide impurity Butyphthalide impurity 22 Butylphthalide Impurity 26 3-Butylphthalide Impurity 23 Potassium-Hydroxypentyl Benzoate Benzoic acid, 2-(1-hydroxypentyl)- | Impurity control |
| 951 | 126113-24-4 | Dapoxetine impurity | Dapoxetine-005 Dapoxetine impurity Dapoxetine Impurity 74 3-(4-hydroxynaphthalen-1-yl)-1-phenylpropan-1-one 1-Propanone, 3-(4-hydroxy-1-naphthalenyl)-1-phenyl- | Impurity control |
| 952 | 2087874-92-6 | Trelagliptin Impurity 5 | DBAP Trelagliptin-12 Trelagliptin Impurity 5 Troxagliptin impurities5 Troxagliptin impurities146 (R)-4-((1-(3-(2-cyano-5-fluorobenzyl) 4-[[(3R)-1-[3-[(2-cyano-5-fluorophenyl)methyl]-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]-3-piperidinyl]amino]-4-oxo-butanoic acid Butanoic acid, 4-[[(3R)-1-[3-[(2-cyano-5-fluorophenyl)methyl]-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]-3-piperidinyl]amino]-4-oxo- | Troptin;Standard;Impurity control;Troptin impurity;Control-impurity control |
| 953 | 1467015-10-6 | Sunitinib Impurity 1 | Sunitinib Impurity 1 Sunitinib Impurity 40 (Z)-N-Ethyl-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide 1H-Pyrrole-3-carboxamide, N-ethyl-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl- 5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid ethylamide (Z)-N-Ethyl-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]- 2,4-dimethyl-1H-pyrrole-3-carboxamide | Control-impurity control |
| 954 | 1080689-87-7 | Esomeprazole Impurity 25 | Omeprazole Impurity 48 Esomeprazole Impurity 25 Esomeprazole Impurity 72 1H-Benzimidazole-2-sulfinic acid, 6-methoxy- 6-Methoxy-1H-benzo[d]imidazole-2-sulfinic acid 2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-6-methoxy-1H-benzo[d]imidazole | Esomeprazole;Impurity control |
| 955 | 358675-51-1 | someprazole Impurity 19 | someprazole Impurity 19 Esomeprazole Impurity 33 Esomeprazole Impurity 77 Esomeprazole Impurity 121 1H-Benzimidazol-6-ol, 2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]- (S)-2-(((4-Methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazol-6-ol | Control-impurity control |
| 956 | 133330-72-0 | Loratadine Impurity 17 | Loratadine Impurity 17 8-chloro-6,11-dihydro-5H-benzo[5,6] cyclohepta[1,2-b]pyridin-11-ol 8-Chloro-5,6-dihydro-11H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridin-11-ol | Control-impurity control |
| 957 | 2089061-92-5 | methyl 3-[[4-chloro-2-(phenylamino)phenyl]methylamino]-3-oxopropanoate. | Clobazam EP Impurity F methyl 3-[[4-chloro-2-(phenylamino)phenyl]methylamino]-3-oxopropanoate. | Impurity control |
| 958 | 1374010-02-2 | lidocaine impurity | Lidocaine-021 lidocaine impurity Lidocaine Impurity 22 2,2',2''-Nitrilotris[N-(2,6-dimethylphenyl)]-acetamide Acetamide, 2,2',2''-nitrilotris[N-(2,6-dimethylphenyl)- | Control-impurity control |
| 959 | 50882-18-3 | Loxoprofen | Loxoprofen Loxolophen sodium impurity Cyclopentanecarboxylic acid, 1-methyl-2-oxo- 1-(4-(1-carboxylatoethyl)benzyl)-2-oxocyclopentanecarboxylate Sodium | Impurity control |
| 960 | 1354055-68-7 | Rupatadine EP impurity A | Rupatadine EP impurity A Rupatadine Fumarate Impurity A Rupatadine Impurity 6(Rupatadine EP Impurity A) 3-carboxy-2-(3-((4-(8-chloro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(6H)-ylidene)piperidin-1-yl)methyl)-5-methylpyridin-1-ium-1-yl)propanoate -carboxy-3-(3-((4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)methyl)-5-methylpyridin-1-ium-1-yl)propanoate 3-carboxy-2-(3-((4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl)methyl)-5-methylpyridin-1-ium-1-yl)propanoate | Impurity control;Control-impurity control;Impurity control-rupatadine |
| 961 | 1786518-57-7 | Ropivacaine impurity | Ropivacaine-016-R Ropivacaine impurity Ropivacaine Impurity 29 (R)-methyl 1-picolinoylpiperidine-2-carboxylate 2-Piperidinecarboxylic acid, 1-(2-pyridinylcarbonyl)-, methyl ester, (2R)- | Hybridization;Impurity control |
| 962 | 1346238-15-0 | ethyl 2-(3-carbamoyl-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate | Febuxostat-52 Febuxostat Impurity 104 Febuxostat Impurity 106 ethyl 2-(3-carbamoyl-4-isobutoxyphenyl)-4-methylthiazole-5- carboxylate 5-Thiazolecarboxylic acid, 2-[3-(aminocarbonyl)-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester | Impurity control |
| 963 | 1166386-02-2 | 2-(((3,4-dimethoxypyridin-2-yl)methyl)thio)-1H-benzo[d]
imidazol-5-ol | Pantoprazole-18 Pantoprazole Impurity 59 2-(((3,4-dimethoxypyridin-2-yl)methyl)thio)-1H-benzo[d] imidazol-5-ol | |
| 964 | 1632287-34-3 | Dapagliflozin mono acetyl impurity | Dapagliflozin Mono acetyl Dapagliflozin Impurity 72 Dapagliflozin Methyl Acetate Dapagliflozin mono acetyl impurity D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 6-acetate, (1S)- [(2R,3S,4R,5R,6S)-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-3,4,5-trihydroxyoxan-2-yl]methyl acetate | Impurity control;Dapagliflozin impurity A |
| 965 | 2169998-23-4 | (2-Chloro-5-((3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4-ethoxyphenyl)methanone | Dapagliflozin-3 Dapagliflozin keto Dapagliflozin Impurity M Dapagliflozin Keto Impurity Methanone, (2-chloro-5-β-D-glucopyranosylphenyl)(4-ethoxyphenyl)- (2-Chloro-5-((3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4-ethoxyphenyl)methanone (2-chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6- (hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4- ethoxyphenyl)methanone | Control;Dapagliflozin;Impurity control;Chemical impurity;Control-impurity control;Dapagliflozin impurity B |
| 966 | 950781-87-0 | Varenicline Impurity 5 | Varenicline Impurity 5 Varenicline Impurity 20 8-nitro-2,3,4,5-tetrahydro-1H-1,5-methano-3-benzazepin-7-amine 1,5-Methano-1H-3-benzazepin-7-amine, 2,3,4,5-tetrahydro-8-nitro- (1S,5R)-8-nitro-2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepin-7-amine | Organic intermediates |
| 967 | 2180-94-1 | Ropivacaine-ET | Ropivacaine-ET Ropivacaine-007 Ropivacaine Impurity 15 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-ethyl- 1-ethyl-piperidine-2-carboxylic acid-(2,6-dimethyl-anilide) | Impurity control |
| 968 | 1175018-79-7 | Rasagiline Impurity 4 | Rasagiline Impurity 4 (R,E)-N-(3-chloroallyl)-2,3-dihydro-1H-inden-1-amine (R)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-1-one hydrochloride 1H-Inden-1-amine, N-[(2E)-3-chloro-2-propen-1-yl]-2,3-dihydro-, (1R)- | Standard;Impurity control;Control-impurity control |
| 969 | 1175018-74-2 | Rasagiline Impurity 3 | Rasagiline Impurity 7 Rasagiline Impurity 3 Rasagiline Impurity 15 (R,Z)-N-(3-chloroallyl)-2,3-dihydro-1H-inden-1-amine 1H-Inden-1-amine, N-[(2Z)-3-chloro-2-propen-1-yl]-2,3-dihydro-, (1R)- | Standard;Impurity control;Control-impurity control |
| 970 | 93848-82-9 | Amlodipine Impurity 29 | Amlodipine Impurity 29 | Control-impurity control |
| 971 | 1312077-04-5 | Rasagiline Impurity 5 Mesylate | Rasagiline Impurity 5 Mesylate (R)-N-allyl-2,3-dihydro-1H-inden-1-amine 3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-1-one methanesulfonate | Impurity control |
| 972 | 1449223-88-4 | Hydroxychloroquine Sulfate EP Impurity A | Hydroxychloroquine EP Impurity ABCDEFG Hydroxychloroquine Sulfate EP Impurity A Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethyloxidoamino]- 4-((7-chloroquinolin-4-yl)amino)-N-ethyl-N-(2-hydroxyethyl)pentan-1-amine oxide 4-[(7-Chloroquinolin-4-yl)amino]-N-ethyl-N-(hydroxyethyl)pentan-1-amineN-oxide (Mixture of diastereoisomers) | Chemical reagent;Standard substance;Impurity reference substance;Reference substance-impurity reference substance |
| 973 | 1621516-91-3 | Amlodipine Impurity 32 | Amlodipine Impurity 32 2H-1,4-Benzoxazine-5-carboxylic acid, 6-(2-chlorophenyl)-3,4,6,7-tetrahydro-8-methyl-, ethyl ester | |
| 974 | 1424944-35-3 | Rivaroxaban Impurity 93 | Rivaroxaban 30 Rivaroxaban Impurity 93 Rivaroxaban Impurity RC50 2-{2-Oxo-3-[4-(3-oxo-morpholin-4-yl)-phenyl]-oxazolidin-5-ylmethyl}-isoindole-1,3-dione 1H-Isoindole-1,3(2H)-dione, 2-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]- | Impurity controls;Rivaroxaban impurities;Watson custom catalog 1 |
| 975 | 1644286-36-1 | Pemetrexed Impurity 19 | Deoxo Pemetrexed Pemetrexed Impurity 19 Pemetrexed Hydroxy lactam Pemetrexed Alpha-hydroxy lactum L-Glutamic acid, N-[4-[2-(2-amino-4,5,6,7-tetrahydro-5-hydroxy-4,6-dioxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]- | Control-impurity control |
| 976 | 123663-50-3 | Iguratimod | Iguratimod Iguratimod Impurity 27 Methanesulfonamide, N-[3-(formylmethylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]- | Control-impurity control |
| 977 | 464175-13-1 | tirofiban | tirofiban Tirofiban Impurity 55 HCl Piperidine, 4-(4-chlorobutyl)- 4-(4-chlorobutyl)piperidine hydrochloride | 143-tirofiban |
| 978 | 887479-63-2 | Etoricoxib Impurity 38 | Etoricoxib Impurity 38 Etoricoxib Impurity Z10 Ethanone, 2-[4-(methylthio)phenyl]-1-(4-morpholinyl)- | Impurity control |
| 979 | 1700655-67-9 | Brexpiprazole Impurity 49 | Epipiprazole Impurity 49 Brexpiprazole Impurity 49 Brexpiprazole Acid impurity 4-Piperazin-1-yl-benzo[b]thiophene-2-carboxylic acid Benzo[b]thiophene-2-carboxylic acid, 4-(1-piperazinyl)- | Impurity control;Elipizole impurity |
| 980 | 444728-15-8 | Clopidogrel | Clopidogrel Clopidogrel EP Impurity E(R) Clopidogrel EP Impurity F (R-Isomer) Clopidogrel EP Impurity E (R-Isomer) Clopidogrel Impurity 38(Clopidogrel EP Impurity E R-Isomer) (R)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide | Control-impurity control |
| 981 | 201610-16-4 | 1,4,8,11- tetra(trifluoroacetyl)-1,4,8,11-tetraazacyclotetradecane | Plerixafor-22 Plerixafor Impurity O 1,4,8,11- tetra(trifluoroacetyl)-1,4,8,11-tetraazacyclotetradecane 1,4,8,11-Tetraazacyclotetradecane, 1,4,8,11-tetrakis(trifluoroacetyl)- (9CI) 1,1'',1'''',1''''''-(1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis(2,2,2-trifluoroethan-1-one) | |
| 982 | 128495-30-7 | 1-tosyl-1,4,8,11-tetraazacyclotetradecane trihydrochloride | Plerixafor-7 Plerixafor Impurity 8 Trihydrochloride 1-tosyl-1,4,8,11-tetraazacyclotetradecane trihydrochloride | |
| 983 | 88543-33-3 | Idebenone Impurity 5 | Idebenone Impurity 5 Idebenone Impurity 17 Idebenone Impurity HMD-2 2,5-Cyclohexadiene-1,4-dione, 2-hydroxy-6-(10-hydroxydecyl)-3-methoxy-5-methyl- | Control-impurity control |
| 984 | 1242175-36-5 | Aprepitant | Aprepitant Fosaprepitant Impurity 29 (2R,3R)-2-((S)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine Morpholine, 2-[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-, (2R,3R)- | Control-impurity control |
| 985 | 1459754-40-5 | Empagliflozin Impurity 35 | Empagliflozin Impurity 35 Empagliflozin Impurity 109 Empagliflozin Impurity 142 Empagliflozin Impurity 102 (2-Chloro-5-iodophenyl)(4-hydroxyphenyl)methanone Methanone, (2-chloro-5-iodophenyl)(4-hydroxyphenyl)- | Control-impurity control |
| 986 | 141745-36-0 | Irbesartan | Irbesartan Irbesartan Impurity 29 Irbesartan Dimethyl Impurity -biphenyl]-4-yl]methyl]-4,5-dihydroimidazol-5-one 2-Butyl-4,4-dimethyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4,5-dihydroimidazol-5-one | Control-impurity control |
| 987 | 1187966-91-1 | Pitavastatin Dihydrobenzophenanthridine | Pitavastatin Impurity 1 VZEBMUGCZPAAOY-KKKMTZTLSA-N Pitavastatin Impurity 1 Calcium Salt Pitavastatin Dihydrobenzophenanthridine Pitavastatin Dihybenzophenanthridine IMP Pitavastatin Dihydrobenzophenanthridine Impurity (3R,5S)-5-(6-cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid Benzo[k]phenanthridine-8-pentanoic acid, 6-cyclopropyl-10-fluoro-7,8-dihydro-β,δ-dihydroxy-, (βR,δS)- | 216-pitavastatin |
| 988 | 1817657-89-8 | BDJS-SH 3 | BDJS-SH BDJS-SH 3 Ropivacaine-019-SS Ropivacaine Impurity 34 | Impurity control |
| 989 | 18668-29-6 | Vecuronium Bromide EP Impurity F | Vecuronium EP Impurity F Vecuronium Bromide EP Impurity F 2beta-(Piperidin-1-yl)-17-oxo-5alph 2β-(Piperidin-1-yl)-17-oxo-5α-androstan-3α-yl Acetate Vecuronium Bromide Impurity 6(Vecuronium Bromide EP Impurity F) 5α-Androstan-17-one, 3α-hydroxy-2β-piperidino-, acetate (ester) (8CI) | Control-impurity control |
| 990 | 2216755-75-6 | Palonosetron Impurity 9 | Palonosetron Impurity 9 Palonosetron Impurity 17 Palonosetron Impurity ZZ2 (R,R)-Palonosetron intermediate 1 1-Naphthalenecarboxamide, N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-1,2,3,4-tetrahydro-, (1R)-rel- | Impurity control |
| 991 | 2216753-67-0 | Palonosetron Impurity 11 | Palonosetron Impurity 11 Palonosetron Impurity 16 Palonosetron Impurity ZZ4 (S,R)-Palonosetron intermediate 1 | Impurity control;Control-impurity control |
| 992 | 854898-50-3 | (3R,5S)-5-((S)-8-fluoro-4-isopropyl-2-(N-methylmethyl sulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5- dihydroxypentanoate calcium(II) | Rosuvastatin calcium-12 Rosuvastatin Calcium Impurity 2 Rosuvastatin Calcium (S,S,R)-Diastereomer calcium (3R,5S)-5-((S)-8-fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5-dihydroxypentanoate (3R,5S)-5-((S)-8-fluoro-4-isopropyl-2-(N-methylmethyl sulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5- dihydroxypentanoate calcium(II) | Rosuvastatin calcium;068-rosuvastatin calcium |
| 993 | 1480319-53-6 | Fudosteine Impurity 2 | Fudosteine Impurity 2 Fudosteine Impurity D Fudosteine Sulfone HCl Fudosteine Impurities1415 Fudosteine Sulfone Impurity ((3-hydroxypropyl)sulfonyl)-D-alanine L-Alanine, 3-[(3-hydroxypropyl)sulfonyl]- (R)-2-amino-3-((3-hydroxypropyl)sulfonyl)propanoic acid | Standard;Impurity control |
| 994 | 150513-24-9 | Formoterol Impurity 13 | Formoterol Impurity 13 Formoterol EP Impurity A Formoterol Impurity 1(Mixture of Diastereomers) Formoterol Impurity A (Mixture of Diastereomers) Formoterol EP Impurity A (Mixture of Diastereomers) 2-amino-4-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenol Benzenemethanol, 3-amino-4-hydroxy-α-[[[2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]- | 190-Formoterol;Impurity control |
| 995 | 2061958-41-4 | Edaravone Impurity 12 | Edaravone Impurity 12 Butanoic acid, 3-(2-phenylhydrazinylidene)-, ethyl ester, (3E)- | Control-impurity control |
| 996 | 1333995-14-4 | Aprepitant Impurity 19 | 2R3S-S Aprepitant Aprepitant Impurity 19 Aprepitant intermediate 3 Aprepitant Impurity 5 HCl Aprepitant Impurity 2 HCl Aprepitant Impurity SM3FDY1-2(HCl) | Control-impurity control |
| 997 | 2173049-85-7 | 1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl) benzyl)-1,4,8,11-tetraazacyclotetradecane dodecahydrochloride | Plerixafor-2 Plerixafor Impurity 2 DodecaHCl 1,8-bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl) benzyl)-1,4,8,11-tetraazacyclotetradecane dodecahydrochloride | Proxamod |
| 998 | 158808-75-4 | Tirofiban Impurity 19 | Tirofiban Impurity 63 Tirofiban Impurity 19 Tirofiban Impurity 19 DiHCl (S)-2-amino-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid (S)-2-amino-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid dihydrochloride | 143-tirofiban;Tirofiban impurities;Pharmaceutical raw materials |
| 999 | 118709-62-9 | Trimetazidine Impurity 16 | Trimetazidine Impurity 16 4-(2,3,4-Trimethoxyphenyl)but-3-en-2-one 3-Buten-2-one, 4-(2,3,4-trimethoxyphenyl)-, (E)- (9CI) | Control-impurity control |
| 1000 | 2250244-28-9 | Tirofiban hydrochloride monohydrate Impurity 7 | Tirofiban hydrochloride monohydrate Impurity 7 (S)-2-amino-3-(4-((butylsulfonyl)oxy)phenyl)propanoic acid | Tirofiban impurity |